{"meta":{"query_hash":"2f253091c182","filters":{"venue":"Current Medical Research and Opinion"},"cohort_total":286,"direct_labels_cover":0,"predictions_cover":286,"exported":286,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2f253091c182","api":"https://metacan.xera.ac/api/v1/cohort?venue=Current+Medical+Research+and+Opinion"},"results":[{"id":"W1765682497","doi":"10.1185/03007995.2015.1096242","title":"Adherence to non-vitamin-K-antagonist oral anticoagulant medications based on the Pharmacy Quality Alliance measure","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Medicine; Dabigatran; Rivaroxaban; Medicare Part D; Vitamin K antagonist; Internal medicine; Warfarin; Pharmacy; Medical prescription; Emergency medicine; Atrial fibrillation; Pharmacology; Family medicine; Prescription drug","score_opus":0.532264327907032,"score_gpt":0.5641930501442994,"score_spread":0.03192872223726739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1765682497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786512,0.00041084565,0.0016159065,0.00048301398,0.000016304364,0.0004956163,0.010709145,0.000058490277,0.0075595053],"genre_scores_gemma":[0.99303716,0.00014692842,0.0014009749,0.00008274771,0.000023414259,0.00029713803,0.004484471,0.0000044555404,0.00052259624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578923,0.001112809,0.0009612401,0.0003663848,0.0015518535,0.00021843197],"domain_scores_gemma":[0.9814511,0.0017359874,0.013337349,0.00060737616,0.0017680485,0.0011000768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004033686,0.00024061304,0.00039100266,0.0027160288,0.00038867886,0.00081674935,0.0006896181,0.00035190044,0.002918653],"category_scores_gemma":[0.010219438,0.00015608591,0.00084580743,0.0031502903,0.0003082405,0.0006732207,0.001064094,0.0006440378,0.0003860934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054518358,0.000081992606,0.99535286,0.00002907762,0.00011840029,0.0000075619632,0.00004750027,0.00016614901,0.000031565352,0.000072189,0.00071663375,0.0033215496],"study_design_scores_gemma":[0.000016129141,0.00010609528,0.9986731,0.000013856322,0.00002571777,0.000042313983,0.000042142383,0.0005612705,0.000052563166,0.000049026363,0.00041396762,0.000003909455],"about_ca_topic_score_codex":0.0064389077,"about_ca_topic_score_gemma":0.005715267,"teacher_disagreement_score":0.0064389077,"about_ca_system_score_codex":0.00074207387,"about_ca_system_score_gemma":0.0009118323,"threshold_uncertainty_score":0.021332443},"labels":[],"label_agreement":null},{"id":"W1829652422","doi":"10.1185/03007995.2015.1113400","title":"Efficacy and safety of diclofenac sodium 2% topical solution for osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled, 4 week study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Lethbridge; Pfizer","keywords":"Medicine; WOMAC; Osteoarthritis; Diclofenac; Diclofenac Sodium; Randomized controlled trial; Adverse effect; Discontinuation; Anesthesia; Knee pain; Physical therapy; Surgery; Internal medicine; Pharmacology","score_opus":0.12606139898720242,"score_gpt":0.4079615168479793,"score_spread":0.2819001178607769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1829652422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984486,0.003040805,0.00110901,0.000275703,0.00043991974,0.008762096,0.0006780253,0.00013179745,0.0010767647],"genre_scores_gemma":[0.9760283,0.0032682468,0.003211636,0.0009358684,0.0008645444,0.010852398,0.0009064565,0.00004355778,0.0038890478],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983708,0.000715865,0.00016768488,0.00034392122,0.00020494497,0.0001967177],"domain_scores_gemma":[0.9981976,0.00047765017,0.00047321722,0.00018453362,0.00022672428,0.0004402662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033443086,0.0019583185,0.0051723686,0.00090653385,0.0007767732,0.0010972568,0.0014946337,0.0025260085,0.006720468],"category_scores_gemma":[0.0022709537,0.0015179579,0.0020829092,0.0007208102,0.0019178431,0.0015505967,0.0005077106,0.002390075,0.0013738784],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9400483,0.03847579,0.0005046721,0.0007248378,0.00041623358,0.000037477,0.00007339571,0.00017161027,0.008510066,0.00004927179,0.00034554646,0.010642922],"study_design_scores_gemma":[0.7762088,0.22088711,0.0013332726,0.000023602377,0.00023064791,0.00002329552,0.000015619631,0.00018155578,0.0006974834,0.00003641693,0.00034703195,0.000015158771],"about_ca_topic_score_codex":0.0006689076,"about_ca_topic_score_gemma":0.0012468267,"teacher_disagreement_score":0.006720468,"about_ca_system_score_codex":0.00078575313,"about_ca_system_score_gemma":0.0020060933,"threshold_uncertainty_score":0.022482157},"labels":[],"label_agreement":null},{"id":"W1834765452","doi":"10.1185/03007990903044374","title":"Projected economic impact of clinical findings of generic entry of topiramate on G4 European countries","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Topiramate; Medicine; Demography; Cohort; Pharmacoepidemiology; Pediatrics; Medical prescription; Epilepsy; Psychiatry; Internal medicine","score_opus":0.32516430329213475,"score_gpt":0.5214437338699924,"score_spread":0.19627943057785768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1834765452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792148,0.0028010083,0.0016606032,0.0014037895,0.000033775104,0.00006610014,0.008005535,0.000043838772,0.00677052],"genre_scores_gemma":[0.99489814,0.0006901592,0.0006652453,0.00017408626,0.000016071728,0.000023418215,0.0031118714,0.0000043987175,0.00041656912],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986266,0.00067033386,0.00009928755,0.00011617326,0.0002060962,0.00028154487],"domain_scores_gemma":[0.9955937,0.0015321834,0.0014887198,0.0001006922,0.0008309401,0.00045367074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002295543,0.0004606384,0.00028643568,0.00065801106,0.00019115006,0.0014459037,0.0004493604,0.000632371,0.0023024487],"category_scores_gemma":[0.010497712,0.00016263557,0.0011800184,0.0009992531,0.0003257857,0.0006064594,0.0006568459,0.00042296082,0.00022931992],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027367033,0.00016643788,0.83863217,0.00027044097,0.00094372476,0.0013772103,0.000080862934,0.109459855,0.0006216302,0.0035976497,0.004275088,0.03783818],"study_design_scores_gemma":[0.00026391292,0.00077392015,0.9227606,0.00021001839,0.00078201597,0.0013525884,0.00048072843,0.0654472,0.0012551192,0.001228233,0.0053960932,0.00004961738],"about_ca_topic_score_codex":0.067145824,"about_ca_topic_score_gemma":0.03173764,"teacher_disagreement_score":0.067145824,"about_ca_system_score_codex":0.0031521283,"about_ca_system_score_gemma":0.0017438775,"threshold_uncertainty_score":0.13351},"labels":[],"label_agreement":null},{"id":"W1957215797","doi":"10.1185/03007995.2015.1077213","title":"Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Warfarin; Medicare Part D; Logistic regression; Internal medicine; Pharmacy; Atrial fibrillation; Medical prescription; Pharmacology; Family medicine","score_opus":0.6288805707270797,"score_gpt":0.599130403391937,"score_spread":0.029750167335142685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1957215797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232186,0.0029821005,0.009292055,0.0028373618,0.00014669834,0.0019644406,0.029787246,0.0003863446,0.029385174],"genre_scores_gemma":[0.98109895,0.00054443534,0.006458659,0.00037620406,0.000107437394,0.0011292221,0.009278604,0.000019539586,0.0009868699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98926055,0.0032719665,0.0025392645,0.000666411,0.0038432283,0.00041860386],"domain_scores_gemma":[0.95329833,0.004822799,0.032411415,0.0013857693,0.005249732,0.0028320262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008567617,0.00035857558,0.00076487486,0.004318545,0.0007034085,0.0011657142,0.0011429116,0.00064952305,0.0029408517],"category_scores_gemma":[0.019197341,0.00021171046,0.0016090814,0.004738307,0.0005106124,0.0011354191,0.0020881034,0.0011708612,0.00058631675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014452155,0.00017437566,0.9856559,0.00011587775,0.00036140348,0.000015251895,0.00009710355,0.00036188893,0.000058041434,0.00024042874,0.002883988,0.009891196],"study_design_scores_gemma":[0.00005392245,0.00029394493,0.9952062,0.000048835813,0.00006242188,0.00010355613,0.000083049694,0.0010165579,0.00010324294,0.00021978225,0.0027953184,0.000013133794],"about_ca_topic_score_codex":0.005084285,"about_ca_topic_score_gemma":0.0058996063,"teacher_disagreement_score":0.008567617,"about_ca_system_score_codex":0.0013065434,"about_ca_system_score_gemma":0.0015887878,"threshold_uncertainty_score":0.045310438},"labels":[],"label_agreement":null},{"id":"W1963836481","doi":"10.1185/030079904x15200","title":"Effects of a fast disintegrating/ rapid release oral formulation of sumatriptan on functional ability in patients with migraine","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"GlaxoSmithKline","keywords":"Sumatriptan; Medicine; Migraine; Placebo; Anesthesia; Dosing; Clinical trial; Acute migraine; Randomized controlled trial; Pharmacology; Internal medicine; Agonist","score_opus":0.052612889352196275,"score_gpt":0.38290973408426765,"score_spread":0.3302968447320714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963836481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715555,0.0021017536,0.00005883632,0.00009756991,0.000022174596,0.00007333277,0.00005473828,0.000007577501,0.00042841598],"genre_scores_gemma":[0.9984654,0.00085678906,0.00020333404,0.00012473747,0.000041039504,0.00006750543,0.00008163003,0.0000015600929,0.00015794887],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999739,0.00011306776,0.00003406722,0.000034426048,0.000038852,0.000040605642],"domain_scores_gemma":[0.9994282,0.00022270084,0.00015932205,0.000027076883,0.00003342544,0.00012926877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068194116,0.0003183748,0.0010174952,0.00017975237,0.00019490678,0.00026138886,0.000156042,0.00040595594,0.0014834689],"category_scores_gemma":[0.0014179312,0.00013904521,0.0005929936,0.00016467714,0.00027141665,0.00024560915,0.00016646631,0.0006877653,0.00019851554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4653339,0.022203308,0.061346825,0.0023345451,0.0025937436,0.0010287816,0.0007451805,0.0010380337,0.091208026,0.00016567172,0.0013896417,0.3506123],"study_design_scores_gemma":[0.07061173,0.65530145,0.26170823,0.00009710741,0.001292964,0.0009534783,0.00022260098,0.0007497152,0.0067571094,0.000105908184,0.0021612255,0.000038469283],"about_ca_topic_score_codex":0.0003170998,"about_ca_topic_score_gemma":0.00057103153,"teacher_disagreement_score":0.0014834689,"about_ca_system_score_codex":0.0001913678,"about_ca_system_score_gemma":0.00024732033,"threshold_uncertainty_score":0.0049626827},"labels":[],"label_agreement":null},{"id":"W1966702474","doi":"10.1185/03007995.2011.601733","title":"Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Tolerability; Methylphenidate; Medicine; Extended release; Rating scale; Pediatrics; Attention deficit hyperactivity disorder; Quality of life (healthcare); Adverse effect; Psychiatry; Anesthesia; Internal medicine; Pharmacology; Psychology","score_opus":0.06560861397264747,"score_gpt":0.4133331308105273,"score_spread":0.34772451683787986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966702474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944216,0.00022769364,0.000023443361,0.000017122487,0.000009352815,0.00012970611,0.000057064728,0.000004238145,0.0000891004],"genre_scores_gemma":[0.9985973,0.00035603956,0.00025528416,0.00006845125,0.00003747651,0.00029548968,0.00025755863,0.0000027672488,0.00012965828],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991648,0.00037417273,0.00009251043,0.00014195807,0.00011247288,0.00011403681],"domain_scores_gemma":[0.9984503,0.00038735126,0.00043665065,0.00013042017,0.000115770556,0.00047942885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001353055,0.0006196774,0.0015665307,0.00028745967,0.00050285744,0.0004704135,0.0004859026,0.0007501827,0.0011673722],"category_scores_gemma":[0.0020219763,0.0003158332,0.0012351854,0.0003219831,0.0005244039,0.0005711159,0.0003535623,0.0013940923,0.00019774742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5945652,0.193975,0.11039282,0.000783097,0.0019028188,0.00038299224,0.0010626104,0.0005003,0.00965555,0.0000351438,0.00045713573,0.0862873],"study_design_scores_gemma":[0.06940438,0.5930908,0.33366448,0.000053511158,0.0009386483,0.00022410753,0.00031049777,0.0004552897,0.0012958795,0.000032698772,0.00048969616,0.000040126277],"about_ca_topic_score_codex":0.0022016126,"about_ca_topic_score_gemma":0.0030092616,"teacher_disagreement_score":0.0022016126,"about_ca_system_score_codex":0.0005127601,"about_ca_system_score_gemma":0.00081010826,"threshold_uncertainty_score":0.0071557164},"labels":[],"label_agreement":null},{"id":"W1966827685","doi":"10.1185/03007995.2015.1040750","title":"Pregabalin for chronic pain: does one medication fit all?","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University Health Centre","funders":"","keywords":"Pregabalin; Medicine; Discontinuation; Fibromyalgia; Chronic pain; Medical prescription; Adverse effect; Analgesic; Gabapentin; Quality of life (healthcare); Physical therapy; Anesthesia; Internal medicine; Alternative medicine; Pharmacology; Nursing","score_opus":0.26721175846243683,"score_gpt":0.49362193061705956,"score_spread":0.22641017215462272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966827685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15119135,0.57977444,0.0014287756,0.25269538,0.0022842428,0.00014117197,0.00054391386,0.00006850892,0.01187215],"genre_scores_gemma":[0.6427612,0.2776244,0.0029432727,0.06734403,0.00496728,0.00010018079,0.00044681883,0.000029902398,0.0037829655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998909,0.00033423392,0.00013187257,0.000099400146,0.00043262282,0.00009294884],"domain_scores_gemma":[0.9955373,0.001885006,0.0013875052,0.00010877383,0.0006831715,0.00039827407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00215253,0.000259223,0.0010988023,0.00047866555,0.0007243286,0.0014500853,0.00060628395,0.0015170346,0.0047065],"category_scores_gemma":[0.008410233,0.0001527676,0.000521263,0.0010918119,0.0010630449,0.0021158394,0.00045861944,0.0015764551,0.0007722934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009619832,0.00035573903,0.25475276,0.004757689,0.00034446776,0.0013818969,0.0010113786,0.00016913119,0.0012857605,0.0013487402,0.036703613,0.6969269],"study_design_scores_gemma":[0.00051914854,0.0039863116,0.71833456,0.028843775,0.0015339857,0.014645167,0.012025577,0.0015395137,0.0010565484,0.010345584,0.2069935,0.00017643752],"about_ca_topic_score_codex":0.013222604,"about_ca_topic_score_gemma":0.040498424,"teacher_disagreement_score":0.013222604,"about_ca_system_score_codex":0.0013241085,"about_ca_system_score_gemma":0.0034608783,"threshold_uncertainty_score":0.02629131},"labels":[],"label_agreement":null},{"id":"W1970144467","doi":"10.1185/03007995.2012.762903","title":"The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Université de Montréal; University of Alberta; Université Laval; University of British Columbia; McGill University","funders":"Mylan; Valeant Pharmaceuticals International","keywords":"Tolerability; Medicine; Quetiapine; Discontinuation; Clinical Global Impression; Somnolence; Olanzapine; Adverse effect; Internal medicine; Quetiapine Fumarate; Anticholinergic; Antipsychotic; Clinical endpoint; Extrapyramidal symptoms; Atypical antipsychotic; Schizophrenia (object-oriented programming); Clinical trial; Psychiatry; Placebo","score_opus":0.045520969794869644,"score_gpt":0.41287104708607153,"score_spread":0.3673500772912019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970144467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758387,0.0019241687,0.000035148365,0.000053718486,0.000015049229,0.00002460547,0.000077754004,0.0000073119895,0.0002783631],"genre_scores_gemma":[0.9991079,0.00049190206,0.000085484455,0.00006472033,0.00002828905,0.00001356591,0.00011455973,0.0000011153326,0.00009235936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99937785,0.00025601077,0.00007725347,0.000092015274,0.00013738482,0.000059491176],"domain_scores_gemma":[0.99855894,0.00054893346,0.0005102175,0.00007036198,0.00007722793,0.00023432398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013269704,0.00034756793,0.00091558887,0.0002150511,0.00020336045,0.00043259727,0.0002569937,0.00054824376,0.0011279694],"category_scores_gemma":[0.003098312,0.00011393037,0.0007001398,0.00020482538,0.00023802985,0.00046685696,0.00016777652,0.00063360564,0.00014379703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36313528,0.013491489,0.20263368,0.0013698945,0.00403751,0.00040212765,0.0004205395,0.001853971,0.015660312,0.00007414476,0.00094790873,0.39597318],"study_design_scores_gemma":[0.031455472,0.19045618,0.7685118,0.00016877076,0.0024175455,0.0008853714,0.00023143388,0.002422623,0.0022429375,0.00015239301,0.0009781232,0.00007734614],"about_ca_topic_score_codex":0.0007977194,"about_ca_topic_score_gemma":0.0018163103,"teacher_disagreement_score":0.0013269704,"about_ca_system_score_codex":0.000410504,"about_ca_system_score_gemma":0.00025356896,"threshold_uncertainty_score":0.0070177317},"labels":[],"label_agreement":null},{"id":"W1971313899","doi":"10.1185/03007995.2010.522157","title":"Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Duloxetine; Medicine; Discontinuation; Adverse effect; Duloxetine Hydrochloride; Major depressive disorder; Fibromyalgia; Internal medicine; Psychiatry; Mood","score_opus":0.43976163016046,"score_gpt":0.570965811539683,"score_spread":0.13120418137922296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971313899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98027384,0.0134836305,0.00094617635,0.0005964706,0.00011997559,0.00067515945,0.00082146336,0.000080687416,0.0030026857],"genre_scores_gemma":[0.99485445,0.0017166694,0.00063357357,0.0006808444,0.00023987549,0.0005402369,0.00083136704,0.000010629868,0.0004922747],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996207,0.002180363,0.0005047317,0.00032309128,0.00057773734,0.00020702743],"domain_scores_gemma":[0.9880321,0.0037176034,0.0055391598,0.00072589266,0.0010022478,0.0009829586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062822383,0.00026907993,0.0015408803,0.00031679097,0.00056249753,0.0010059519,0.00043518023,0.00081476563,0.0018537015],"category_scores_gemma":[0.012753459,0.00018800938,0.0009910681,0.00046024143,0.00039893616,0.0006492,0.00040613825,0.00086783385,0.00044531497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24769408,0.004307471,0.2239831,0.0029950792,0.005587013,0.0007312899,0.00078623206,0.0010673663,0.012058611,0.000252391,0.0042934436,0.49624395],"study_design_scores_gemma":[0.06423028,0.17446755,0.71885717,0.0010908935,0.0046303147,0.003589113,0.00036753475,0.00415918,0.007790869,0.00055650057,0.02014021,0.000120371886],"about_ca_topic_score_codex":0.00036921407,"about_ca_topic_score_gemma":0.00113126,"teacher_disagreement_score":0.0062822383,"about_ca_system_score_codex":0.00083242526,"about_ca_system_score_gemma":0.00070506585,"threshold_uncertainty_score":0.033224046},"labels":[],"label_agreement":null},{"id":"W1971336557","doi":"10.1185/03007990802133914","title":"Clinical efficacy and time to symptom resolution of 5-day telithromycin versus 10-day amoxicillin–clavulanate in the treatment of acute bacterial sinusitis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Telithromycin; Tolerability; Amoxicillin; Regimen; Population; Internal medicine; Adverse effect; Sinusitis; Clinical endpoint; Surgery; Anesthesia; Randomized controlled trial; Antibiotics; Clarithromycin; Helicobacter pylori","score_opus":0.1528621227140363,"score_gpt":0.46754983840954767,"score_spread":0.31468771569551135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971336557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998497,0.0009709875,0.00007959792,0.000052201143,0.000029893488,0.00009860888,0.000032132724,0.0000067506444,0.00023287858],"genre_scores_gemma":[0.9988444,0.00035999788,0.00024608418,0.000086244065,0.00005745017,0.00013529939,0.00008287116,0.0000020903503,0.00018557241],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99862146,0.0008930458,0.0001282869,0.00012174954,0.00013921323,0.00009625635],"domain_scores_gemma":[0.9979075,0.00094113377,0.0005575145,0.00010058087,0.00008459587,0.00040859333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020401778,0.0004221194,0.0010962193,0.00018216363,0.00018689604,0.000445509,0.0005308912,0.00085428054,0.0018742908],"category_scores_gemma":[0.003138593,0.00025981484,0.0007504316,0.00015929952,0.0006200558,0.00050830696,0.00022117584,0.0011327174,0.0002339292],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.865975,0.01970965,0.008736611,0.0007438048,0.0011661698,0.00006899684,0.0001584368,0.00096421107,0.01693089,0.000066699315,0.00026830935,0.08521119],"study_design_scores_gemma":[0.21025509,0.71755403,0.06484778,0.0000720523,0.00080764707,0.0001877849,0.000087591325,0.0016957042,0.0036851487,0.00006073937,0.00070692424,0.000039477338],"about_ca_topic_score_codex":0.0003400077,"about_ca_topic_score_gemma":0.0008038231,"teacher_disagreement_score":0.0020401778,"about_ca_system_score_codex":0.00039733143,"about_ca_system_score_gemma":0.0005352586,"threshold_uncertainty_score":0.010789633},"labels":[],"label_agreement":null},{"id":"W1971352874","doi":"10.1185/030079903125002450","title":"Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors","year":2003,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Cholinesterase; Rivastigmine; Disease; Donepezil; Alzheimer's disease; Pharmacology; Intensive care medicine; Internal medicine; Dementia","score_opus":0.29772167137064165,"score_gpt":0.5340669825974191,"score_spread":0.2363453112267775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971352874","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08131345,0.13755195,0.04632755,0.61585176,0.0079276115,0.0016464738,0.00023339584,0.0010906642,0.10805719],"genre_scores_gemma":[0.5272296,0.11693455,0.09957757,0.21045487,0.00971247,0.0016463529,0.00068904075,0.00022058598,0.033535033],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976707,0.0009956795,0.00021526247,0.00019985186,0.0006713906,0.00024712278],"domain_scores_gemma":[0.99734616,0.0008379778,0.00036551364,0.00011870553,0.0006609596,0.00067070767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005405375,0.00059765024,0.0007110457,0.00082431675,0.0010968142,0.0018530461,0.0011581574,0.0027084295,0.004692732],"category_scores_gemma":[0.0067242985,0.00017279797,0.0007360711,0.0004319143,0.0007057489,0.0023639784,0.0018512259,0.004268415,0.0015181625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002540954,0.001223944,0.0034221977,0.0013875328,0.00010873243,0.0012883476,0.0017301886,0.00050023926,0.003384651,0.009509437,0.11433739,0.8628532],"study_design_scores_gemma":[0.0009062034,0.0026258652,0.02054622,0.0055790027,0.0004398656,0.004795025,0.0047247903,0.0026630252,0.0042622956,0.046256594,0.90707034,0.00013078836],"about_ca_topic_score_codex":0.0011078333,"about_ca_topic_score_gemma":0.0033908242,"teacher_disagreement_score":0.005405375,"about_ca_system_score_codex":0.0014371208,"about_ca_system_score_gemma":0.0029556719,"threshold_uncertainty_score":0.028586745},"labels":[],"label_agreement":null},{"id":"W1972258960","doi":"10.1185/03007995.2011.585396","title":"Impact of weight gain on outcomes in type 2 diabetes","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"U.S. National Library of Medicine; Novo Nordisk","keywords":"Medicine; Weight gain; Type 2 diabetes; Weight loss; Internal medicine; Metformin; Glycemic; Type 2 Diabetes Mellitus; Insulin; Insulin resistance; Diabetes mellitus; Endocrinology; Overweight; Liraglutide; Obesity; Body weight","score_opus":0.20904395534938966,"score_gpt":0.49920741509718247,"score_spread":0.2901634597477928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972258960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35490197,0.59634984,0.0005250303,0.010332521,0.0023816358,0.00019792122,0.013444121,0.00006719586,0.021799788],"genre_scores_gemma":[0.8696102,0.11996966,0.0005238638,0.0017533358,0.0014488761,0.00017192567,0.0055129686,0.000023766923,0.000985339],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99735767,0.0010765505,0.00045578688,0.00023420663,0.00064620905,0.0002295766],"domain_scores_gemma":[0.9889837,0.0053275493,0.0035098123,0.00028689846,0.000936662,0.00095548044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003925081,0.0005090631,0.0013670967,0.0018890676,0.0004057022,0.0016537391,0.0006187255,0.00087930827,0.0051331837],"category_scores_gemma":[0.017000834,0.00016479904,0.0037098585,0.0039512934,0.00030824138,0.00098592,0.0010697198,0.001981896,0.00040923632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065675587,0.0005261227,0.77474594,0.012407606,0.015319223,0.00060947303,0.00019616618,0.0006809455,0.00012351274,0.0007002783,0.008579978,0.17954321],"study_design_scores_gemma":[0.0005434508,0.0010667985,0.974208,0.0046440833,0.009007518,0.00076930004,0.00031494154,0.0005112674,0.000079852885,0.0017758198,0.0070289914,0.000050034414],"about_ca_topic_score_codex":0.0044127796,"about_ca_topic_score_gemma":0.003551512,"teacher_disagreement_score":0.0051331837,"about_ca_system_score_codex":0.00075942517,"about_ca_system_score_gemma":0.00103972,"threshold_uncertainty_score":0.020758092},"labels":[],"label_agreement":null},{"id":"W1972386063","doi":"10.1185/03007995.2015.1020365","title":"Effects of desvenlafaxine on blood pressure in patients treated for major depressive disorder: a pooled analysis","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Major depressive disorder; Pooled analysis; Blood pressure; Internal medicine; Psychiatry; Meta-analysis; Mood","score_opus":0.044244870102146276,"score_gpt":0.39600229107197615,"score_spread":0.35175742096982987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972386063","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24102336,0.73982716,0.0049013454,0.00048103483,0.0009832197,0.0014295581,0.009755348,0.00021121987,0.0013878109],"genre_scores_gemma":[0.9165313,0.071103744,0.003732243,0.00069860235,0.00048476542,0.0015695881,0.0052179457,0.000050253864,0.0006115574],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9827299,0.009248925,0.0043813135,0.001872362,0.0014905458,0.0002769809],"domain_scores_gemma":[0.98500687,0.007598951,0.0041855536,0.0012647983,0.0016461082,0.0002977934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01800157,0.0020021715,0.011155948,0.0031764973,0.0002674522,0.0019912214,0.0009615046,0.0014288764,0.0016426689],"category_scores_gemma":[0.02477827,0.0011259093,0.026309416,0.0030363293,0.0003730797,0.00092477666,0.001253464,0.00088435056,0.0002127222],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026600376,0.00005331172,0.012086646,0.019127753,0.93056524,0.000060673145,0.000048531478,0.0003816514,0.00056953373,0.00004085108,0.00048561598,0.009979832],"study_design_scores_gemma":[0.013382314,0.0023288631,0.054249167,0.001845042,0.92506105,0.00013740647,0.00007664629,0.0006100734,0.00041424402,0.00016161698,0.0016780427,0.000055688295],"about_ca_topic_score_codex":0.0024658884,"about_ca_topic_score_gemma":0.0048386753,"teacher_disagreement_score":0.01800157,"about_ca_system_score_codex":0.0008617021,"about_ca_system_score_gemma":0.00086374197,"threshold_uncertainty_score":0.095202565},"labels":[],"label_agreement":null},{"id":"W1973651333","doi":"10.1185/03007995.2010.547575","title":"Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Infliximab; Adverse effect; Crohn's disease; Internal medicine; Clinical trial; Randomized controlled trial; Disease; Inflammatory bowel disease; Physical therapy; Pediatrics","score_opus":0.07697412502220531,"score_gpt":0.3890091897877285,"score_spread":0.31203506476552323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973651333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953949,0.0028979795,0.00016469185,0.00009275462,0.000014253876,0.00024452928,0.0005339427,0.000019904284,0.00063698116],"genre_scores_gemma":[0.9969522,0.0010760379,0.0004869444,0.000081181504,0.00005560586,0.00034033397,0.00076756976,0.0000062444474,0.00023384856],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998314,0.0009150534,0.00014801178,0.00014123908,0.0003625295,0.00011918605],"domain_scores_gemma":[0.99612325,0.0011433809,0.0017582952,0.0002667422,0.0002187901,0.000489623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032404156,0.00041893206,0.0012668528,0.00024022818,0.00019140575,0.00050165027,0.0004763324,0.00067871064,0.0020407012],"category_scores_gemma":[0.0040456327,0.00023548715,0.0010081341,0.00031966742,0.00070133276,0.0007028891,0.0005351347,0.0008523631,0.00030644986],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79613715,0.0049264645,0.07695819,0.0015135548,0.0013368889,0.00025634308,0.00041531405,0.0008233623,0.008332582,0.00019249298,0.0013619129,0.10774585],"study_design_scores_gemma":[0.23925963,0.44644365,0.29996663,0.0005334755,0.0016491922,0.0012961272,0.0002737396,0.0011858923,0.0034119969,0.00016133394,0.0057633463,0.000055042372],"about_ca_topic_score_codex":0.00038333453,"about_ca_topic_score_gemma":0.0008989958,"teacher_disagreement_score":0.0032404156,"about_ca_system_score_codex":0.000553656,"about_ca_system_score_gemma":0.00082669867,"threshold_uncertainty_score":0.01713717},"labels":[],"label_agreement":null},{"id":"W1973734746","doi":"10.1185/030079906x132415","title":"Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; PharmIdeas (Canada)","funders":"","keywords":"Medicine; Internal medicine; Meta-analysis; Adverse effect; Rating scale; Confidence interval; Depression (economics); Hamd; Randomized controlled trial; Clinical trial; Psychiatry; Psychology","score_opus":0.36154163991176796,"score_gpt":0.5620345049789328,"score_spread":0.20049286506716485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973734746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018757937,0.97764254,0.0013197958,0.00020462355,0.00025751133,0.0006643062,0.0007560703,0.000058009296,0.00033911748],"genre_scores_gemma":[0.5157747,0.47083429,0.0050968085,0.0013204617,0.0006375387,0.0035415522,0.0020009142,0.00010582756,0.0006878579],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9672116,0.018308906,0.008840506,0.0025712426,0.0025891091,0.0004786398],"domain_scores_gemma":[0.94585323,0.04060459,0.009178581,0.0017564901,0.0020989622,0.00050822814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039577477,0.0036729036,0.023564948,0.0062932465,0.00064743374,0.004053256,0.0023683256,0.0025239296,0.0023459764],"category_scores_gemma":[0.07157912,0.0021130745,0.061383728,0.005645253,0.0010775729,0.0020606194,0.0018054036,0.0024175006,0.00026757183],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058644577,0.00002795369,0.0036537915,0.049882405,0.9345371,0.000050972965,0.000044741366,0.00041084268,0.00010517567,0.000046393445,0.00021275388,0.0051632626],"study_design_scores_gemma":[0.0021993204,0.00036829134,0.0033918673,0.0042625703,0.9887994,0.000065779896,0.00002838439,0.0001864691,0.000098463424,0.00015358905,0.00042919663,0.000016622265],"about_ca_topic_score_codex":0.0033601534,"about_ca_topic_score_gemma":0.005705823,"teacher_disagreement_score":0.039577477,"about_ca_system_score_codex":0.0023160262,"about_ca_system_score_gemma":0.0015712619,"threshold_uncertainty_score":0.20930815},"labels":[],"label_agreement":null},{"id":"W1974990443","doi":"10.1185/03007995.2014.918028","title":"Assessment of treatment-seeking behavior and healthcare utilization in an international cohort of subjects with overactive bladder","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Allergan","keywords":"Medicine; Overactive bladder; Demographics; Urinary incontinence; Cohort; Health care; Urge incontinence; Internal medicine; Physical therapy; Urinary system; Demography; Urology; Alternative medicine","score_opus":0.16312350381320675,"score_gpt":0.5201605181990953,"score_spread":0.35703701438588853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974990443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994276,0.00006910971,0.000027778755,0.000016250884,0.0000025318895,0.000007669832,0.00028035353,0.0000012240407,0.00016755912],"genre_scores_gemma":[0.99924445,0.00007319236,0.00007017379,0.00002503128,0.0000074297154,0.000013087347,0.00045901016,9.4746576e-7,0.000106873646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966824,0.0001081597,0.00004225307,0.00006661283,0.00006027536,0.000054358472],"domain_scores_gemma":[0.9990031,0.000104614955,0.00058682926,0.00005551366,0.000088667344,0.00016113889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070007605,0.00029160627,0.00029499986,0.0008551776,0.00051925116,0.0006422211,0.0002821793,0.0004076382,0.0013768361],"category_scores_gemma":[0.0014208725,0.0002636236,0.00043043087,0.0010259012,0.00022735442,0.0004314787,0.0004737062,0.00044585633,0.00032349906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014423005,0.000014149706,0.999603,0.0000027769258,0.000011496412,0.000008770139,0.000033654927,0.000005840384,0.000049012757,0.0000012306222,0.00001566766,0.00024013528],"study_design_scores_gemma":[0.000001489356,0.000044738244,0.9996749,0.0000022246727,0.0000059673694,0.00006522911,0.00011942697,0.000031946067,0.0000130897515,0.0000015936987,0.00003851337,9.772039e-7],"about_ca_topic_score_codex":0.007751762,"about_ca_topic_score_gemma":0.008315775,"teacher_disagreement_score":0.007751762,"about_ca_system_score_codex":0.00017704739,"about_ca_system_score_gemma":0.0002388091,"threshold_uncertainty_score":0.015413284},"labels":[],"label_agreement":null},{"id":"W1977273306","doi":"10.1185/03007995.2014.915803","title":"Use of prescription opioids with abuse-deterrent technology to address opioid abuse","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Oxycodone; Medicine; Oxymorphone; Opioid; Medical prescription; Opioid abuse; Chronic pain; Pharmacy; Substance abuse; Psychiatry; Internal medicine; Pharmacology; Family medicine","score_opus":0.08425675245155942,"score_gpt":0.41271037658871584,"score_spread":0.3284536241371564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977273306","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158454,0.0044170707,0.0005462099,0.00041506827,0.000022125323,0.00013997137,0.00041143168,0.000013126533,0.0024505884],"genre_scores_gemma":[0.9950063,0.002485462,0.0012253658,0.00033843712,0.00005082149,0.00004778428,0.0003756414,0.000002324607,0.00046776354],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987925,0.00027500745,0.0001944609,0.00014747432,0.00045935728,0.00013115788],"domain_scores_gemma":[0.99469924,0.00087514106,0.0036878071,0.0001372229,0.00036859102,0.00023207736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010594255,0.00016967475,0.00020780561,0.00046377073,0.0003115768,0.000448178,0.00035267492,0.00030726637,0.0016770317],"category_scores_gemma":[0.0051034484,0.00010809419,0.0003702062,0.0006008888,0.00021289749,0.00038683298,0.00042501302,0.00045239777,0.00013927877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026855327,0.0004086623,0.9227719,0.0003054668,0.00015590414,0.00040515195,0.00021876245,0.0002454359,0.0024474906,0.00017257492,0.00045308142,0.072147004],"study_design_scores_gemma":[0.000048082904,0.0011961457,0.9886601,0.0002087143,0.00010394727,0.002800423,0.00023664617,0.0006599227,0.0016083531,0.00004160776,0.0044256593,0.000010282745],"about_ca_topic_score_codex":0.0021730196,"about_ca_topic_score_gemma":0.004492614,"teacher_disagreement_score":0.0021730196,"about_ca_system_score_codex":0.0005699413,"about_ca_system_score_gemma":0.00096922787,"threshold_uncertainty_score":0.0056102276},"labels":[],"label_agreement":null},{"id":"W1977694976","doi":"10.1185/03007995.2013.836078","title":"Health-related quality of life and disease symptoms in postmenopausal women with HR<sup>+</sup>, HER2<sup>−</sup>advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"European Society for Medical Oncology; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Discontinuation; Internal medicine; Breast cancer; Quality of life (healthcare); Placebo; Confidence interval; Aromatase inhibitor; Hazard ratio; Oncology; Cancer; Aromatase","score_opus":0.04616009174512354,"score_gpt":0.38911583257544025,"score_spread":0.3429557408303167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977694976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851054,0.0010997481,0.00003431313,0.00004448035,0.000007386786,0.000023677872,0.00011514681,0.0000021955025,0.00016250962],"genre_scores_gemma":[0.9994394,0.0001894258,0.000065688124,0.000039244635,0.000010268014,0.000039779065,0.000092118506,6.3406617e-7,0.00012331792],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966466,0.00018372621,0.000029466417,0.000041600026,0.000047961363,0.000032722965],"domain_scores_gemma":[0.99966097,0.00010921658,0.0001288154,0.000016760585,0.000017972532,0.00006627208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010764331,0.00024441123,0.0007726225,0.00014729421,0.00009731119,0.0002577495,0.00014342333,0.00028668757,0.0012369821],"category_scores_gemma":[0.0012048928,0.00013506706,0.0006675762,0.0001698554,0.00016007196,0.00021954859,0.00018380192,0.00032877945,0.00010357295],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.438114,0.0067248167,0.38200483,0.0013283208,0.0068477965,0.0002010866,0.00050169753,0.0025745074,0.021530174,0.00009069104,0.00092027243,0.13916184],"study_design_scores_gemma":[0.015127766,0.072042525,0.9060471,0.00004990175,0.0017660471,0.00026619152,0.00013734432,0.0017486793,0.0018397352,0.00012640619,0.00082591764,0.000022298871],"about_ca_topic_score_codex":0.0003577447,"about_ca_topic_score_gemma":0.0007219961,"teacher_disagreement_score":0.0012369821,"about_ca_system_score_codex":0.00023164533,"about_ca_system_score_gemma":0.00017396397,"threshold_uncertainty_score":0.00569278},"labels":[],"label_agreement":null},{"id":"W1979282053","doi":"10.1185/030079906x115568","title":"Cost-effectiveness of alternative treatments for women with osteoporosis in Canada","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University; St. Joseph's Hospital; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Raloxifene; Osteoporosis; Selective estrogen receptor modulator; Cost effectiveness; Quality-adjusted life year; Etidronic acid; Internal medicine; Breast cancer; Tamoxifen; Risk analysis (engineering); Cancer","score_opus":0.11618627537555021,"score_gpt":0.4527852894941774,"score_spread":0.3365990141186272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979282053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85211486,0.042072445,0.0044260747,0.017043494,0.00027392776,0.0018954464,0.022268683,0.00014310399,0.059761994],"genre_scores_gemma":[0.986273,0.0068342895,0.0024401352,0.00038926426,0.000022785896,0.00016319676,0.0018244856,0.000011271814,0.0020415592],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977932,0.0006678049,0.000105347346,0.00011439949,0.0009502743,0.00036894815],"domain_scores_gemma":[0.998007,0.00069804024,0.00022898479,0.000035862893,0.0007213525,0.00030880107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016492609,0.00052279606,0.00062019,0.001717593,0.0010840013,0.0015775589,0.0012226874,0.0008208972,0.0055761803],"category_scores_gemma":[0.007980207,0.00034384223,0.0017646513,0.0025329972,0.0006546186,0.00045976698,0.0007821326,0.00083336054,0.00012145848],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01058474,0.0011910375,0.15965301,0.0053532524,0.003664158,0.0014284034,0.0006754907,0.40232438,0.0012663524,0.027918253,0.031341694,0.35459927],"study_design_scores_gemma":[0.0060723824,0.0024189344,0.3225344,0.0037475694,0.004244528,0.001578185,0.002413793,0.5801887,0.0014938801,0.019605307,0.05532889,0.00037335444],"about_ca_topic_score_codex":0.966861,"about_ca_topic_score_gemma":0.9720486,"teacher_disagreement_score":0.0861759,"about_ca_system_score_codex":0.0861759,"about_ca_system_score_gemma":0.08123409,"threshold_uncertainty_score":0.62525284},"labels":[],"label_agreement":null},{"id":"W1979643646","doi":"10.1185/030079906x148364","title":"Ezetimibe/simvastatin single tablet versus rosuvastatin in patients with hypercholesterolemia","year":2006,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"American Heart Association","keywords":"Rosuvastatin; Ezetimibe; Medicine; Simvastatin; Statin; Atorvastatin; Combination therapy; Pharmacology; Ldl cholesterol; Fixed-dose combination; Cholesterol; Internal medicine; Urology","score_opus":0.07781500923638612,"score_gpt":0.3735728337994214,"score_spread":0.2957578245630353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979643646","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011447763,0.010351932,0.00021853138,0.9409484,0.028755073,0.00006674989,0.00016067152,0.000061029234,0.007989865],"genre_scores_gemma":[0.09002094,0.012474312,0.0015483759,0.77084744,0.110515825,0.00021111559,0.0001340964,0.00004210028,0.014205744],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989604,0.00050983106,0.00015539896,0.000100388235,0.00018686471,0.00008712304],"domain_scores_gemma":[0.99791616,0.0014326497,0.00014367989,0.000032075157,0.0002508253,0.00022461056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017048588,0.00050436193,0.0014513887,0.00040259995,0.0010015544,0.0011347737,0.00077198184,0.012389384,0.002934999],"category_scores_gemma":[0.00996237,0.0002485932,0.0007012686,0.00054458145,0.00052627036,0.0010060688,0.00022325346,0.0074766553,0.0020351638],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031142882,0.00046664852,0.0050356244,0.00057637255,0.0001416491,0.018277114,0.00027131048,0.00021022349,0.0011320063,0.0017742404,0.88867927,0.080321215],"study_design_scores_gemma":[0.006585048,0.0038883756,0.027249662,0.0016818653,0.00064801594,0.038554627,0.0009546279,0.004056594,0.0018514347,0.01492932,0.8994809,0.00011952569],"about_ca_topic_score_codex":0.0016973134,"about_ca_topic_score_gemma":0.0043072337,"teacher_disagreement_score":0.012389384,"about_ca_system_score_codex":0.0020026164,"about_ca_system_score_gemma":0.00088917254,"threshold_uncertainty_score":0.014530063},"labels":[],"label_agreement":null},{"id":"W1981379267","doi":"10.1185/03007995.2010.541433","title":"Tolerability of solifenacin and oxybutynin immediate release in older (&gt;65 years) and younger (≤65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; University of Alberta; University of Calgary; University of Toronto; Dalhousie University; McGill University Health Centre; University of British Columbia Hospital","funders":"","keywords":"Medicine; Overactive bladder; Solifenacin; Oxybutynin; Tolerability; Tolterodine; Urology; Randomized controlled trial; Double blind; Internal medicine; Adverse effect; Placebo","score_opus":0.04259257354233033,"score_gpt":0.38527969621131486,"score_spread":0.34268712266898455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981379267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954627,0.0028703765,0.00008147214,0.00006367509,0.000025274034,0.00047692217,0.0006163206,0.000008003263,0.00039526416],"genre_scores_gemma":[0.99698955,0.0011616863,0.0002390595,0.00014998717,0.00004937023,0.00017931164,0.0009508786,0.0000033101803,0.00027689818],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9988174,0.00037735718,0.000110134046,0.00018625248,0.0003141855,0.00019466669],"domain_scores_gemma":[0.99724543,0.00049519236,0.0008422976,0.00014439266,0.0004719509,0.0008008167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024204496,0.00093056116,0.001974944,0.00040167302,0.00059317704,0.0006511922,0.0006475232,0.00068485667,0.0022880698],"category_scores_gemma":[0.0025664724,0.00039695814,0.0030903895,0.0009125855,0.0008802665,0.00036148267,0.000321868,0.0008390329,0.0001835219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85779124,0.004586998,0.08632662,0.0015816664,0.0073633203,0.000113290305,0.0003177146,0.0004986366,0.0054992163,0.000077255434,0.0010440218,0.03480003],"study_design_scores_gemma":[0.26471332,0.12280073,0.599536,0.00016227161,0.008034863,0.00024022568,0.00029480061,0.0010278109,0.0011398244,0.00008666131,0.0018432599,0.00012022475],"about_ca_topic_score_codex":0.099450424,"about_ca_topic_score_gemma":0.1694856,"teacher_disagreement_score":0.099450424,"about_ca_system_score_codex":0.0039152326,"about_ca_system_score_gemma":0.0052659977,"threshold_uncertainty_score":0.19774306},"labels":[],"label_agreement":null},{"id":"W1983997227","doi":"10.1185/03007990802333167","title":"Comparison of allergy rates in glaucoma patients receiving brimonidine 0.2% monotherapy versus fixed-combination brimonidine 0.2%–timolol 0.5% therapy","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"American Glaucoma Society","keywords":"Brimonidine; Medicine; Timolol; Allergy; Incidence (geometry); Glaucoma; Ophthalmology; Anesthesia; Immunology","score_opus":0.12444064569903891,"score_gpt":0.44489863135242963,"score_spread":0.32045798565339073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983997227","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996321,0.00016460723,0.000018154284,0.0000046644514,0.0000028662378,0.000007057851,0.000036940943,9.890747e-7,0.0001326881],"genre_scores_gemma":[0.99977845,0.00004810104,0.00003027183,0.000010399295,0.000008359113,0.000008840408,0.00007923165,5.4233294e-7,0.000035760488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914014,0.00029687225,0.0000968697,0.0001833757,0.0001904672,0.00009229604],"domain_scores_gemma":[0.99723095,0.0007972499,0.0014325947,0.00010924282,0.00017304608,0.00025682437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075610995,0.00020034176,0.0005238341,0.00052836124,0.00017893325,0.00034620147,0.00021169372,0.0004683917,0.0011530678],"category_scores_gemma":[0.0022783473,0.0002222351,0.000648563,0.00033949627,0.00022590927,0.00032092826,0.00020060343,0.00034418644,0.00014458239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005994415,0.00026327497,0.98775613,0.000046810314,0.00023507116,0.00019442826,0.00006692025,0.00009106666,0.0017830556,0.000013118544,0.000060745624,0.0034950376],"study_design_scores_gemma":[0.00018342106,0.0036503542,0.995025,0.0000059816603,0.00010089539,0.0004281769,0.000057189292,0.00021514497,0.00026836985,0.0000060439565,0.000053563523,0.0000058713317],"about_ca_topic_score_codex":0.0005052208,"about_ca_topic_score_gemma":0.00050323026,"teacher_disagreement_score":0.0011530678,"about_ca_system_score_codex":0.00020927202,"about_ca_system_score_gemma":0.00015589641,"threshold_uncertainty_score":0.0039987564},"labels":[],"label_agreement":null},{"id":"W1985001841","doi":"10.1185/03007990802417713","title":"A retrospective study of cholinesterase inhibitors for Alzheimer's disease: cerebrovascular disease as a predictor of patient outcomes","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal","funders":"","keywords":"Medicine; Galantamine; Dementia; Retrospective cohort study; Disease; Internal medicine; Rivastigmine; Cholinesterase; Clinical endpoint; Medical prescription; Cohort study; Donepezil; Clinical trial; Pharmacology","score_opus":0.07044938587892123,"score_gpt":0.42364789333172326,"score_spread":0.353198507452802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985001841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977648,0.00035619867,0.00010089812,0.00003203007,0.000007940582,0.000034683333,0.0013049163,0.0000037351765,0.00039480708],"genre_scores_gemma":[0.99861264,0.00014747969,0.00008643952,0.000046905145,0.000011689261,0.000035821195,0.00094336376,0.0000023014072,0.00011328114],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866617,0.00026297345,0.00018390818,0.0003728905,0.0003242356,0.00018978804],"domain_scores_gemma":[0.99704856,0.0003515928,0.0012925667,0.0003028204,0.0005212231,0.00048324312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013602833,0.00032354196,0.0004993232,0.0010693388,0.0008089183,0.0007123119,0.0005330304,0.0005010634,0.001019735],"category_scores_gemma":[0.0026068948,0.00049343426,0.0005580617,0.0023728136,0.00038165157,0.00048545835,0.0005817394,0.0006944775,0.00026790623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007284213,0.000015599127,0.99943656,0.000006200959,0.000036428308,0.000046338955,0.000035163506,0.000009849306,0.00004784435,0.0000063883845,0.000062722145,0.00022404091],"study_design_scores_gemma":[0.0000123197715,0.00011772151,0.99922407,0.000006310683,0.00003492635,0.00019929692,0.00011022586,0.00007667675,0.000022663246,0.00000870763,0.00018325263,0.0000038835633],"about_ca_topic_score_codex":0.05148068,"about_ca_topic_score_gemma":0.0600243,"teacher_disagreement_score":0.05148068,"about_ca_system_score_codex":0.0011347331,"about_ca_system_score_gemma":0.0013689727,"threshold_uncertainty_score":0.10236204},"labels":[],"label_agreement":null},{"id":"W1985859384","doi":"10.1185/03007995.2014.915801","title":"Weekly risk of venous thromboembolism recurrence in patients receiving oral anticoagulants","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Venous thromboembolism; Hazard ratio; Medical prescription; Internal medicine; Proportional hazards model; Anticoagulant; Risk assessment; Emergency medicine; Pediatrics; Confidence interval; Thrombosis","score_opus":0.06389392541402902,"score_gpt":0.398267381692557,"score_spread":0.334373456278528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985859384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736553,0.00083048095,0.00029420594,0.00010012574,0.000006332603,0.000011701035,0.0008907666,0.000009517085,0.00049128383],"genre_scores_gemma":[0.99891603,0.00016492033,0.00017814446,0.000022878572,0.00001502785,0.000010098519,0.00060468976,0.000001913684,0.00008627707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987697,0.00030620722,0.00022467985,0.00023595004,0.00035131365,0.000112115755],"domain_scores_gemma":[0.98857504,0.0015854031,0.008746631,0.00032174695,0.0003821073,0.0003890581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015164295,0.00015653572,0.00037939142,0.0011587859,0.00017426595,0.00060424843,0.00044603104,0.0003591613,0.0011376321],"category_scores_gemma":[0.0064555393,0.00016817357,0.00068202306,0.0014006284,0.0001253662,0.0003364102,0.00037902,0.0006072544,0.00017465588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015181825,0.000017109145,0.99733174,0.000018198594,0.00008610221,0.00004197295,0.000025677009,0.000100262616,0.000056840272,0.000017114447,0.00010717228,0.002046048],"study_design_scores_gemma":[0.00001145075,0.00011539498,0.99816257,0.00001576827,0.00005655312,0.0005148494,0.000035462166,0.0007061122,0.00007661779,0.00004811796,0.00025174578,0.0000053855524],"about_ca_topic_score_codex":0.002236132,"about_ca_topic_score_gemma":0.0019921693,"teacher_disagreement_score":0.002236132,"about_ca_system_score_codex":0.00036660268,"about_ca_system_score_gemma":0.00029378288,"threshold_uncertainty_score":0.008019745},"labels":[],"label_agreement":null},{"id":"W1986062673","doi":"10.1185/03007995.2014.936553","title":"Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Citalopram; Depression (economics); Serotonin reuptake inhibitor; Rating scale; Major depressive disorder; Prospective cohort study; Physical therapy; Quality of life (healthcare); Internal medicine; Psychiatry; Antidepressant; Psychology; Anxiety; Mood","score_opus":0.16244814332232327,"score_gpt":0.5014510710942178,"score_spread":0.33900292777189456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986062673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96903104,0.0026598168,0.0011912482,0.0002209507,0.00009324617,0.002380676,0.020492649,0.00005260356,0.0038777597],"genre_scores_gemma":[0.98465085,0.00029656873,0.000542553,0.00015533215,0.00008538476,0.0016777313,0.011691733,0.000017763723,0.00088224595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949079,0.002277373,0.0007673954,0.00069216086,0.0009683179,0.00038693816],"domain_scores_gemma":[0.9903286,0.0022681071,0.0044398173,0.00056193664,0.0018059025,0.00059563474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061913496,0.0006230242,0.0017947074,0.0011425638,0.0003932377,0.00087705115,0.000649709,0.00063460425,0.0039796988],"category_scores_gemma":[0.009276914,0.00019377292,0.0040983795,0.0012161847,0.0003393453,0.0006928589,0.0009603258,0.00093020446,0.0005526024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12344131,0.0026026776,0.79429865,0.0042557623,0.015163054,0.00016764685,0.00026686487,0.0014117166,0.0012758644,0.0002851924,0.005714759,0.051116552],"study_design_scores_gemma":[0.005642393,0.01524314,0.97095585,0.0002242688,0.003445789,0.0001972634,0.00010101234,0.00094077695,0.0006229748,0.00018653755,0.0023924091,0.000047584203],"about_ca_topic_score_codex":0.0013905646,"about_ca_topic_score_gemma":0.00234553,"teacher_disagreement_score":0.0061913496,"about_ca_system_score_codex":0.0008000828,"about_ca_system_score_gemma":0.00095311983,"threshold_uncertainty_score":0.032743335},"labels":[],"label_agreement":null},{"id":"W1986288498","doi":"10.1185/030079902125000246","title":"Lipids and Diabetes Mellitus: A Review of Therapeutic Options","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Internal medicine; Lipid profile; Disease; Type 2 Diabetes Mellitus; Intensive care medicine; Endocrinology","score_opus":0.19730840211574024,"score_gpt":0.46749184992438086,"score_spread":0.2701834478086406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986288498","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007782111,0.998381,0.00008537421,0.00031269804,0.00026995924,0.000005571108,0.000009682949,0.000006685915,0.00085112086],"genre_scores_gemma":[0.00031436209,0.9983564,0.00024121761,0.00024053834,0.00036375702,0.000008223254,0.000017378768,0.0000011062689,0.00045700037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966395,0.00007183723,0.00005556204,0.00004412185,0.00014286158,0.000021626998],"domain_scores_gemma":[0.9996176,0.00019687322,0.00005252564,0.000014761634,0.000077613506,0.000040660845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006832819,0.0014259932,0.002113199,0.0033703474,0.0004866328,0.0013097099,0.0011862365,0.00150185,0.006341208],"category_scores_gemma":[0.00094046205,0.00036871285,0.0006556076,0.0033254246,0.0005436292,0.0018149907,0.0007111717,0.0020999538,0.003493262],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009718358,0.00015331204,0.00014356503,0.0111098075,0.00007741061,0.0005431347,0.0000787353,0.00028013397,0.0008015192,0.0018046529,0.037047192,0.9478634],"study_design_scores_gemma":[0.00006728989,0.0001538798,0.0010886121,0.009432206,0.00016068004,0.004464929,0.00014915493,0.000097695694,0.00020740545,0.0025546048,0.9815949,0.000028577042],"about_ca_topic_score_codex":0.0010404771,"about_ca_topic_score_gemma":0.0020772803,"teacher_disagreement_score":0.006341208,"about_ca_system_score_codex":0.0006516926,"about_ca_system_score_gemma":0.0010743922,"threshold_uncertainty_score":0.021213472},"labels":[],"label_agreement":null},{"id":"W1987970762","doi":"10.1185/03007995.2010.515900","title":"Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institutes of Health; National Institute of Mental Health; Institut National de la Santé et de la Recherche Médicale; Eli Lilly and Company","keywords":"Discontinuation; Medicine; Concordance; Antipsychotic; Adverse effect; Schizophrenia (object-oriented programming); Clinical endpoint; Continuation; Psychiatry; Clinical trial; Antipsychotic drug; Pediatrics; Internal medicine","score_opus":0.08885910751449391,"score_gpt":0.4495784966865421,"score_spread":0.36071938917204815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987970762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887856,0.005163197,0.0008579811,0.0019463006,0.000059932503,0.00018203534,0.0006163417,0.000020696065,0.002367924],"genre_scores_gemma":[0.9962081,0.0011221869,0.0016665652,0.00023036893,0.00005907123,0.000108185624,0.00034321303,0.0000063279567,0.0002559944],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98795056,0.006561516,0.0018961086,0.00042274466,0.002718678,0.00045044624],"domain_scores_gemma":[0.93936485,0.023697047,0.02988169,0.00052755204,0.0046645254,0.0018642619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009688897,0.00028627214,0.00062159484,0.0019757478,0.0006157626,0.0013368535,0.00038508896,0.00076978427,0.0016737754],"category_scores_gemma":[0.038774572,0.00024098935,0.0012278628,0.0010231829,0.00036267875,0.0009711592,0.001040892,0.0009519772,0.00020786287],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081473443,0.00011616598,0.95402485,0.0004758469,0.00032183595,0.00025371605,0.0036842313,0.00015521306,0.0003302553,0.00012229841,0.0012103238,0.038490515],"study_design_scores_gemma":[0.00009742216,0.0003389502,0.98910505,0.00059082854,0.00016471434,0.0015067642,0.0040638275,0.00061656965,0.0002902586,0.00022656408,0.0029439772,0.00005505922],"about_ca_topic_score_codex":0.001584931,"about_ca_topic_score_gemma":0.0057190405,"teacher_disagreement_score":0.009688897,"about_ca_system_score_codex":0.0013811686,"about_ca_system_score_gemma":0.0026963945,"threshold_uncertainty_score":0.051240385},"labels":[],"label_agreement":null},{"id":"W1993235173","doi":"10.1185/03007995.2012.709837","title":"An evaluation of patient and physician satisfaction with controlled-release oxybutynin 15 mg as a one-step daily dose in elderly and non-elderly patients with overactive bladder: results of the STOP study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); Guelph General Hospital; Hôpital Charles-Le Moyne","funders":"","keywords":"Medicine; Overactive bladder; Nocturia; Oxybutynin; Tolterodine; Anticholinergic; Adverse effect; Patient satisfaction; Delirium; Urinary incontinence; Internal medicine; Urology; Urinary system; Surgery; Intensive care medicine","score_opus":0.05188406553823979,"score_gpt":0.4027806970838807,"score_spread":0.3508966315456409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993235173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99881953,0.00026919582,0.00008428117,0.000027241902,0.000005354619,0.00014392534,0.00032150134,0.0000040476875,0.0003249033],"genre_scores_gemma":[0.9984535,0.0001816756,0.0002554739,0.00007732524,0.000022371694,0.00016037769,0.00057999295,0.0000020424056,0.0002672254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990146,0.0005245195,0.000109877335,0.00007870948,0.00020639267,0.00006585611],"domain_scores_gemma":[0.99670106,0.0009037176,0.0014767381,0.000088795634,0.00030278385,0.0005268908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023031489,0.0003518478,0.00083332724,0.00027442642,0.00021998254,0.00042107588,0.00028372533,0.00046463162,0.0019767429],"category_scores_gemma":[0.0025839182,0.00018031233,0.0011656537,0.00037828845,0.00021884282,0.00041595547,0.0003193436,0.00049607566,0.00025232453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08412361,0.006723174,0.87033266,0.00048076402,0.0018202756,0.00010802847,0.0004904422,0.00033270125,0.0028764284,0.00003832241,0.0006660152,0.03200765],"study_design_scores_gemma":[0.009660539,0.0519978,0.9349945,0.000038826518,0.0005862174,0.00023936061,0.00024248623,0.0010954208,0.00054593734,0.000015161229,0.0005581501,0.000025475465],"about_ca_topic_score_codex":0.0005125864,"about_ca_topic_score_gemma":0.00074243604,"teacher_disagreement_score":0.0023031489,"about_ca_system_score_codex":0.00024551645,"about_ca_system_score_gemma":0.00022742382,"threshold_uncertainty_score":0.012180388},"labels":[],"label_agreement":null},{"id":"W1993770917","doi":"10.1185/03007990903210066","title":"Tadalafil therapy and health-related quality of life in pulmonary arterial hypertension","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Tadalafil; Medicine; Tolerability; Placebo; Quality of life (healthcare); Pulmonary hypertension; Physical therapy; Internal medicine; Erectile dysfunction; Cardiology; Adverse effect; Alternative medicine","score_opus":0.29839008884754364,"score_gpt":0.4725349696551922,"score_spread":0.17414488080764856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993770917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942044,0.05265233,0.00021006985,0.00081108056,0.000108598295,0.00006335413,0.000380412,0.000011860963,0.0037183214],"genre_scores_gemma":[0.99496377,0.004188462,0.0001821177,0.00018205745,0.00010314715,0.000022891909,0.00016162239,9.2589056e-7,0.00019500924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954295,0.00025783846,0.000044325094,0.000024552897,0.00009689258,0.000033541528],"domain_scores_gemma":[0.9982645,0.0008056879,0.0006150747,0.00003018221,0.00009226872,0.0001923071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001075863,0.00013276971,0.00032665618,0.00020874533,0.00017921926,0.00040144852,0.0001443098,0.00039406779,0.0016268734],"category_scores_gemma":[0.0020466002,0.000068405905,0.00039985107,0.00034837818,0.00017419584,0.0001856586,0.0001683653,0.00057253265,0.00010063662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016933635,0.003918857,0.8183026,0.0018832042,0.0021286895,0.00031044465,0.0003320327,0.0010836585,0.005016392,0.00034845012,0.0016295846,0.14811246],"study_design_scores_gemma":[0.0005385301,0.0041467506,0.99231404,0.00008103016,0.00051031855,0.00018401559,0.000047374127,0.00058336987,0.00032698846,0.00012637512,0.0011337991,0.0000073752735],"about_ca_topic_score_codex":0.0005280486,"about_ca_topic_score_gemma":0.00069258496,"teacher_disagreement_score":0.0016268734,"about_ca_system_score_codex":0.00020579694,"about_ca_system_score_gemma":0.00017101802,"threshold_uncertainty_score":0.0056898},"labels":[],"label_agreement":null},{"id":"W1995103418","doi":"10.1185/030079908x280725","title":"In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70  mg) and in vivo implications","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Alendronic acid; Immediate release; Dissolution; Pharmacology; Dosage form; Bisphosphonate; Internal medicine; Chemistry; Osteoporosis","score_opus":0.1915947261061282,"score_gpt":0.4885672652288719,"score_spread":0.2969725391227437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995103418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546486,0.0027408064,0.0009904463,0.000027134049,0.000015501646,0.000029839684,0.00016220902,0.000011572633,0.0005576685],"genre_scores_gemma":[0.9943229,0.0014808888,0.0023809178,0.000025283716,0.00001210543,0.000021900627,0.00046686397,0.000010391469,0.0012788157],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99953747,0.00011483743,0.000048658214,0.000070639326,0.00017553153,0.000052999836],"domain_scores_gemma":[0.9996519,0.0001077002,0.000109718036,0.00003964148,0.00006624077,0.00002469554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043205512,0.0003300344,0.0003494081,0.00023286283,0.00015745922,0.0002610957,0.00015379378,0.00029035623,0.0011093583],"category_scores_gemma":[0.0006906396,0.00015233688,0.000350396,0.0002714681,0.00024160015,0.00017548067,0.0001004059,0.00035769303,0.0002483094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016605655,0.00025066736,0.0031858406,0.00015463034,0.000054507826,0.00018570157,0.000104099134,0.000232152,0.9870047,0.000026877644,0.000059083326,0.007081263],"study_design_scores_gemma":[0.0001222031,0.012992955,0.061528992,0.00001742508,0.00018737548,0.0013355763,0.00012790468,0.0020796193,0.9192866,0.000024348608,0.002278009,0.000019022578],"about_ca_topic_score_codex":0.0035075843,"about_ca_topic_score_gemma":0.0034096797,"teacher_disagreement_score":0.0035075843,"about_ca_system_score_codex":0.00041467827,"about_ca_system_score_gemma":0.00030689136,"threshold_uncertainty_score":0.0069743395},"labels":[],"label_agreement":null},{"id":"W1997452386","doi":"10.1185/03007995.2014.915212","title":"Use of 5% lidocaine medicated plasters for the treatment of pain in routine hospital practice: patient reported pain, functioning and satisfaction","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pharma Medica Research (Canada)","funders":"","keywords":"Medicine; Discontinuation; Lidocaine; Physical therapy; Pain relief; Patient satisfaction; Pain score; Anesthesia; Surgery","score_opus":0.10884867224092692,"score_gpt":0.4085421352218908,"score_spread":0.2996934629809639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997452386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889296,0.0004479129,0.000039810926,0.00009441232,0.0000027846322,0.000014107638,0.000039140035,0.000002519124,0.00046644203],"genre_scores_gemma":[0.9995454,0.00020633679,0.000079504025,0.00004356536,0.000006074878,0.000007832739,0.00002826842,6.246689e-7,0.000082411105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982539,0.0009175779,0.00017200426,0.00008738351,0.00038191996,0.00018734936],"domain_scores_gemma":[0.9941255,0.0020747418,0.002833938,0.000090736874,0.00029068437,0.00058445765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013690444,0.00010036292,0.00024830797,0.0002853571,0.0002043876,0.00048408407,0.00017474299,0.00024637117,0.0030434248],"category_scores_gemma":[0.0067904657,0.00011173297,0.0002213459,0.0003795345,0.00028317486,0.00029131284,0.0003273305,0.00027826751,0.00027024074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008881004,0.00048972905,0.9516827,0.00021993811,0.000079528865,0.0004269414,0.0010061591,0.00010463607,0.0016833701,0.000016020207,0.00048166042,0.04292115],"study_design_scores_gemma":[0.00004688255,0.0028657282,0.9944859,0.00004913441,0.000027749535,0.001049385,0.00071821205,0.00016267863,0.00022504182,0.000006761064,0.0003542563,0.000008232519],"about_ca_topic_score_codex":0.0010410289,"about_ca_topic_score_gemma":0.002429699,"teacher_disagreement_score":0.0030434248,"about_ca_system_score_codex":0.00044906046,"about_ca_system_score_gemma":0.00038754355,"threshold_uncertainty_score":0.010181248},"labels":[],"label_agreement":null},{"id":"W1999059326","doi":"10.1185/030079904125003467","title":"The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":587,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Bayer Corporation","keywords":"Medicine; Erectile dysfunction; Demography; Dyslipidemia; Depression (economics); Population; Gerontology; Prevalence; Disease; Psychiatry; Internal medicine; Environmental health","score_opus":0.15866864211484244,"score_gpt":0.5006145562333871,"score_spread":0.3419459141185447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999059326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597794,0.00033725705,0.00011032746,0.00014089595,0.000017734637,0.000162445,0.0023614676,0.000005803636,0.0008862411],"genre_scores_gemma":[0.99377066,0.00047243637,0.00043072348,0.0002707768,0.000098924116,0.00039942644,0.0033701432,0.0000063213056,0.001180466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999037,0.0005628247,0.000057433357,0.00009840098,0.00014301251,0.00010132995],"domain_scores_gemma":[0.99879646,0.00014386782,0.00048541153,0.00014149667,0.0001182815,0.0003145084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025064775,0.0006977092,0.0004956581,0.00080838974,0.0006942135,0.00061020313,0.0005345953,0.0006358478,0.0012135226],"category_scores_gemma":[0.0015325332,0.00057601766,0.00086421287,0.00082020595,0.0003879725,0.000609302,0.0013027883,0.00077717565,0.0004005521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027597576,0.00018696708,0.996406,0.00002083654,0.000098935816,0.00003463488,0.00026669752,0.000016842305,0.00014424277,0.000018470331,0.00040123152,0.0021290607],"study_design_scores_gemma":[0.000054613723,0.00031762396,0.99874324,0.000010062734,0.00004358698,0.000069198526,0.0002856388,0.000029138902,0.00004546875,0.000004983586,0.0003930962,0.0000033476535],"about_ca_topic_score_codex":0.008593989,"about_ca_topic_score_gemma":0.012867241,"teacher_disagreement_score":0.008593989,"about_ca_system_score_codex":0.00036604688,"about_ca_system_score_gemma":0.0005006209,"threshold_uncertainty_score":0.017087936},"labels":[],"label_agreement":null},{"id":"W2000588978","doi":"10.1185/030079907x226087","title":"Health-related quality of life (HRQOL) among patients with Generalised Anxiety Disorder: evaluation conducted alongside an escitalopram relapse prevention trial","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Escitalopram; Quality of life (healthcare); Visual analogue scale; Anxiety; Placebo; Population; Randomization; Physical therapy; Internal medicine; Randomized controlled trial; Psychiatry; Alternative medicine","score_opus":0.21006950467039445,"score_gpt":0.5130317131532052,"score_spread":0.30296220848281075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000588978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508625,0.0021644873,0.00010514023,0.00021874957,0.000039636256,0.0013521862,0.00055955315,0.00001889544,0.00045510073],"genre_scores_gemma":[0.99410784,0.0014560674,0.00052947877,0.0002158744,0.00013156982,0.0022140276,0.0009609834,0.0000058716964,0.0003782724],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99751854,0.0016232942,0.00016975189,0.00026058016,0.00020251489,0.0002252786],"domain_scores_gemma":[0.9971205,0.0005151849,0.0009757118,0.00027265277,0.00030010633,0.00081575796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005679403,0.0010750863,0.0031925743,0.00039332727,0.0006527366,0.0010360695,0.00073881535,0.0013991711,0.0021626584],"category_scores_gemma":[0.0035208028,0.00048340144,0.0025554115,0.00079708954,0.0008784633,0.00067391584,0.0007131134,0.0018889578,0.00041450773],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93533427,0.01380112,0.014733,0.0008108387,0.0033296053,0.00009038841,0.00017711932,0.00039717497,0.001963367,0.00005233785,0.00060219277,0.02870859],"study_design_scores_gemma":[0.63167536,0.27007917,0.09160743,0.00012643683,0.0041458607,0.00017347635,0.00013457333,0.00057343533,0.0004842982,0.000068101544,0.00088723295,0.000044656972],"about_ca_topic_score_codex":0.0023857516,"about_ca_topic_score_gemma":0.0036256278,"teacher_disagreement_score":0.005679403,"about_ca_system_score_codex":0.0009426676,"about_ca_system_score_gemma":0.0016617664,"threshold_uncertainty_score":0.030035913},"labels":[],"label_agreement":null},{"id":"W2001583411","doi":"10.1185/03007995.2014.908828","title":"Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; GlaxoSmithKline (Canada); McMaster University","funders":"GlaxoSmithKline","keywords":"Medicine; COPD; Salmeterol; Fluticasone propionate; Medical prescription; Internal medicine; Odds ratio; Cohort; Emergency department; Fluticasone; Intensive care medicine; Emergency medicine; Corticosteroid; Pharmacology","score_opus":0.04927786246417121,"score_gpt":0.40540056299820315,"score_spread":0.35612270053403194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001583411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974004,0.0009781227,0.00003984287,0.0003061189,0.000013970539,0.000016747994,0.00062597793,0.0000037165858,0.00061515],"genre_scores_gemma":[0.9992519,0.00012146688,0.00005569433,0.00007657153,0.000011285504,0.000006112449,0.0003375264,9.746511e-7,0.00013840396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779934,0.0006297504,0.000252925,0.0002520793,0.00074267446,0.00032320092],"domain_scores_gemma":[0.9941387,0.00090869755,0.0030991905,0.00018354242,0.0008182089,0.0008517224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019782186,0.00019454418,0.000406219,0.0004934368,0.0005557127,0.00073327584,0.0005204992,0.00069372373,0.001156214],"category_scores_gemma":[0.008215519,0.00016472662,0.0007320024,0.000867025,0.00021891063,0.00029823952,0.00037837322,0.00078025856,0.00013710262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109582244,0.00008272435,0.99760276,0.000012390211,0.000108275926,0.000017325188,0.000029763474,0.00005035822,0.00003640571,0.0000053963786,0.0001061592,0.0018388922],"study_design_scores_gemma":[0.0000068579366,0.000059668626,0.99957806,0.000009319289,0.000020373785,0.000025605803,0.000033936445,0.0001846007,0.000009082657,0.0000030959495,0.00006759716,0.0000017341514],"about_ca_topic_score_codex":0.16466838,"about_ca_topic_score_gemma":0.21241088,"teacher_disagreement_score":0.16466838,"about_ca_system_score_codex":0.001843283,"about_ca_system_score_gemma":0.0018393997,"threshold_uncertainty_score":0.32741982},"labels":[],"label_agreement":null},{"id":"W2001783668","doi":"10.1185/030079908x291912","title":"Functionality and health-status benefits associated with reduction of osteoarthritis pain","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; WOMAC; Osteoarthritis; Physical therapy; Placebo; Visual analogue scale; Tramadol; Intensity (physics); Randomized controlled trial; Internal medicine; Analgesic; Anesthesia; Alternative medicine","score_opus":0.1429188671685779,"score_gpt":0.39378362470936584,"score_spread":0.25086475754078796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001783668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988282,0.0095123295,0.00015519177,0.00037464133,0.000031455358,0.00008391599,0.00017366122,0.000017787926,0.0013690367],"genre_scores_gemma":[0.9980642,0.0012136445,0.00017445332,0.00012776357,0.00009427688,0.00004029844,0.00013541838,0.0000011687359,0.00014886918],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99940133,0.0003021994,0.000056438977,0.000046546153,0.00012597497,0.00006750623],"domain_scores_gemma":[0.9975885,0.0010919531,0.00093674456,0.000039606577,0.000097185366,0.00024607143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009119423,0.0003842159,0.0006047532,0.00023997863,0.00013100656,0.00031102952,0.00025228944,0.00053190195,0.0025770308],"category_scores_gemma":[0.0035083648,0.00015664085,0.00058338273,0.00015647261,0.000447466,0.00024923251,0.0002265689,0.00064570183,0.00017135458],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3448211,0.019575732,0.21640609,0.0071608527,0.0064084325,0.0004914307,0.00025184557,0.002429913,0.05367344,0.00030334602,0.0015025478,0.34697518],"study_design_scores_gemma":[0.028265558,0.1089733,0.8541747,0.00017234193,0.002052328,0.00082795275,0.00006866719,0.0010255184,0.0030104544,0.00017611035,0.001218654,0.00003445409],"about_ca_topic_score_codex":0.0001845891,"about_ca_topic_score_gemma":0.00032142707,"teacher_disagreement_score":0.0025770308,"about_ca_system_score_codex":0.00015979624,"about_ca_system_score_gemma":0.0002244476,"threshold_uncertainty_score":0.008621037},"labels":[],"label_agreement":null},{"id":"W2001950185","doi":"10.1185/030079906x132749","title":"A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD:the EXTEND Study","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Alberta Hospital Edmonton; University of Alberta Hospital; Douglas Mental Health University Institute","funders":"","keywords":"Rivastigmine; Medicine; Observational study; Clinical Global Impression; Internal medicine; Dementia; Adverse effect; Disease; Donepezil; Alternative medicine","score_opus":0.13386145888034318,"score_gpt":0.4850007915149414,"score_spread":0.35113933263459823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001950185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999265,0.000133304,0.00006294913,0.00002858838,0.0000064904543,0.00010760422,0.00019590982,0.000003957343,0.00019623348],"genre_scores_gemma":[0.99800783,0.0001786745,0.00028672875,0.00014412939,0.00003896739,0.0001964681,0.0007032788,0.0000056229956,0.00043830898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989235,0.0005999138,0.000072827446,0.00018688168,0.00013081527,0.00008589161],"domain_scores_gemma":[0.9981535,0.00037859875,0.00041558043,0.00032990854,0.00017812684,0.0005441947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031796426,0.00091323745,0.0011911581,0.00045486412,0.0012840837,0.00073817425,0.0005047866,0.00088302523,0.0012046174],"category_scores_gemma":[0.002692413,0.00066886103,0.0008622244,0.00045081935,0.00066468416,0.0008774725,0.0006928952,0.0010122157,0.00057463633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034974143,0.0151852025,0.93090445,0.00023714593,0.0012933925,0.0012197312,0.002419838,0.00012305526,0.004828899,0.00009326299,0.0010761571,0.007644612],"study_design_scores_gemma":[0.003943807,0.011968534,0.98048156,0.000023892639,0.0003255008,0.00090937864,0.00077158725,0.00022248724,0.00016570376,0.000078086894,0.0010644344,0.000045135337],"about_ca_topic_score_codex":0.00355933,"about_ca_topic_score_gemma":0.005707043,"teacher_disagreement_score":0.00355933,"about_ca_system_score_codex":0.0003000517,"about_ca_system_score_gemma":0.00050155923,"threshold_uncertainty_score":0.016815722},"labels":[],"label_agreement":null},{"id":"W2006353383","doi":"10.1185/030079904x4644","title":"Montelukast in asthmatic patients 6 years–14 years old with an FEV<sub>1</sub>&gt; 75%","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Montelukast; Medicine; Placebo; Asthma; Leukotriene receptor; Clinical endpoint; Internal medicine; Clinical trial; Leukotriene; Anesthesia; Antagonist; Receptor","score_opus":0.04360183958872483,"score_gpt":0.3726995768612552,"score_spread":0.3290977372725304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006353383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633235,0.0030709186,0.000048575694,0.00010855507,0.000030443147,0.00010934514,0.00006508526,0.00000344643,0.00023136956],"genre_scores_gemma":[0.99782443,0.001228213,0.00018901963,0.0002251784,0.00010478012,0.00009961641,0.00016038185,0.0000014333152,0.00016696457],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99937004,0.00028679223,0.00009247491,0.00009178187,0.00006697637,0.00009197727],"domain_scores_gemma":[0.9991974,0.0002737611,0.00022339767,0.00003635907,0.00004904813,0.00021994849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013687987,0.0004432113,0.0017095194,0.00022875954,0.00042289754,0.0004406529,0.00018892423,0.000825425,0.0009392617],"category_scores_gemma":[0.0017257129,0.00027680423,0.0015760214,0.00029151898,0.0002867141,0.0004226114,0.00022741276,0.000724322,0.00016971827],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5110648,0.0077033034,0.37148815,0.0016131102,0.0038730653,0.001472098,0.0005625818,0.00093526207,0.024917964,0.00015358687,0.0012974264,0.07491872],"study_design_scores_gemma":[0.11080792,0.32947445,0.5442102,0.00022609992,0.0042838436,0.0018317194,0.00033945925,0.0011328579,0.004166289,0.0001912312,0.0032724978,0.00006344483],"about_ca_topic_score_codex":0.0007525331,"about_ca_topic_score_gemma":0.0018178705,"teacher_disagreement_score":0.0017095194,"about_ca_system_score_codex":0.00030885794,"about_ca_system_score_gemma":0.0006850874,"threshold_uncertainty_score":0.0072390437},"labels":[],"label_agreement":null},{"id":"W2008055993","doi":"10.1185/030079904125003403","title":"Cost effectiveness of oral triptan therapy: a trans-national comparison based on a meta-analysis of randomised controlled trials","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sumatriptan; Medicine; Triptans; Rizatriptan; Number needed to treat; Migraine; Cost effectiveness; Placebo; Zolmitriptan; Meta-analysis; Randomized controlled trial; Intensive care medicine; Confidence interval; Physical therapy; Relative risk; Anesthesia; Internal medicine; Alternative medicine","score_opus":0.7514765241341359,"score_gpt":0.6330354176853634,"score_spread":0.11844110644877248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008055993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.092288725,0.88274944,0.0137104085,0.0013879724,0.0016257014,0.002718345,0.0033733053,0.00016195061,0.001984167],"genre_scores_gemma":[0.8105362,0.16574872,0.013540787,0.0012084411,0.0006508795,0.0046352926,0.0028964789,0.00013645088,0.00064666476],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9280106,0.055302143,0.008403969,0.003545453,0.004118359,0.0006195486],"domain_scores_gemma":[0.9412627,0.045984007,0.007425573,0.0022857133,0.0025280425,0.00051398907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04959758,0.0036543438,0.025772452,0.009630668,0.00054020644,0.004612185,0.0024835875,0.0027435056,0.00455662],"category_scores_gemma":[0.08444489,0.0018000423,0.06562252,0.006896898,0.0009414742,0.0032520692,0.0023365116,0.003319191,0.000277165],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019582555,0.000048616585,0.0031390633,0.042318754,0.92501587,0.000089052955,0.00004481307,0.0024904523,0.00020391756,0.0002874851,0.0002701291,0.0065092733],"study_design_scores_gemma":[0.007675245,0.0010153464,0.0034971687,0.0040443176,0.9802336,0.0001167184,0.00005972683,0.0017863631,0.00013382253,0.000713747,0.0006836459,0.000040204497],"about_ca_topic_score_codex":0.0032526348,"about_ca_topic_score_gemma":0.0037884617,"teacher_disagreement_score":0.04959758,"about_ca_system_score_codex":0.003276997,"about_ca_system_score_gemma":0.0019192136,"threshold_uncertainty_score":0.2623002},"labels":[],"label_agreement":null},{"id":"W2009077238","doi":"10.1185/030079905x38169","title":"Association between corneal thickness, mean intraocular pressure, disease stability and severity, and cost of treatment in glaucoma: a Canadian analysis","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; PharmIdeas (Canada); Brock University","funders":"","keywords":"Medicine; Glaucoma; Intraocular pressure; Ophthalmology; Disease; Visual field; Severity of illness; Internal medicine","score_opus":0.06771134620846002,"score_gpt":0.3820534541385429,"score_spread":0.3143421079300829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009077238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99252534,0.0008842143,0.0001223482,0.00028218137,0.00000964871,0.000026885968,0.0046189977,0.000009907117,0.0015203326],"genre_scores_gemma":[0.9963135,0.0005097513,0.0002033299,0.000059992424,0.000007475957,0.000009567512,0.002636415,0.0000055911537,0.0002542281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893683,0.00010573598,0.000084187755,0.00015514327,0.0004439111,0.00027419472],"domain_scores_gemma":[0.99692863,0.00022622905,0.0006728956,0.00010411872,0.0014328898,0.00063529855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010489399,0.00057242654,0.00056025054,0.0020537924,0.0023034895,0.0012541423,0.0012025835,0.0004431426,0.002573678],"category_scores_gemma":[0.0032241757,0.00045348215,0.001231556,0.0052098325,0.00071383617,0.000334481,0.00085460284,0.0008719516,0.00019357496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103572616,0.00001813838,0.996646,0.000030647265,0.00010098105,0.0000848544,0.00011150434,0.00011548852,0.00008333277,0.00004671336,0.0005852048,0.002073499],"study_design_scores_gemma":[0.0000110642595,0.000018459656,0.99873286,0.000016616583,0.000052314554,0.00013158175,0.00015158318,0.0004104997,0.000032133936,0.000013548084,0.0004200635,0.000009402643],"about_ca_topic_score_codex":0.98184884,"about_ca_topic_score_gemma":0.9834367,"teacher_disagreement_score":0.018151164,"about_ca_system_score_codex":0.01636029,"about_ca_system_score_gemma":0.016439492,"threshold_uncertainty_score":0.11870277},"labels":[],"label_agreement":null},{"id":"W2010268134","doi":"10.1185/03007995.2014.898140","title":"A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Dalhousie University","funders":"","keywords":"Belatacept; Medicine; Tacrolimus; Immunosuppression; Meta-analysis; Renal function; Kidney transplantation; Randomized controlled trial; Transplantation; Internal medicine; Urology; Kidney transplant","score_opus":0.2729114025688503,"score_gpt":0.5037379700726837,"score_spread":0.2308265675038334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010268134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062338307,0.9260715,0.0065904474,0.0010232792,0.0005470278,0.00059166655,0.0015745193,0.0001279011,0.001135277],"genre_scores_gemma":[0.82627285,0.15918079,0.009627655,0.00093335076,0.00032381734,0.0011512996,0.0017780561,0.00006874937,0.0006632987],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.977811,0.0165914,0.002558583,0.0015763121,0.0011381183,0.00032460986],"domain_scores_gemma":[0.9720933,0.023131149,0.00230995,0.0010094378,0.0011359464,0.0003201097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026946152,0.0031592308,0.012513988,0.007388753,0.0006092254,0.0032732063,0.0019582831,0.0021351948,0.0026539355],"category_scores_gemma":[0.04739305,0.0013479956,0.044176314,0.0047753467,0.00051374023,0.0016943106,0.0014981591,0.0023413317,0.00029297455],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049386593,0.00003736389,0.005230984,0.034546077,0.94477093,0.00011601897,0.000040642997,0.0031258224,0.0002147922,0.00017174118,0.00031112492,0.006495925],"study_design_scores_gemma":[0.00091369916,0.00027840646,0.002803271,0.0017165224,0.991651,0.00006476667,0.000014980771,0.0016184242,0.000083823725,0.0003392325,0.00049801194,0.00001786384],"about_ca_topic_score_codex":0.008342285,"about_ca_topic_score_gemma":0.010929202,"teacher_disagreement_score":0.026946152,"about_ca_system_score_codex":0.0028912164,"about_ca_system_score_gemma":0.0022736737,"threshold_uncertainty_score":0.1425066},"labels":[],"label_agreement":null},{"id":"W2010436565","doi":"10.1185/03007990802430518","title":"Naturalistic evaluation of entacapone in patients with signs and symptoms of<scp>L</scp>-dopa wearing-off","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Calgary; Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre","funders":"","keywords":"Entacapone; Medicine; Levodopa; Quality of life (healthcare); Clinical Global Impression; Observational study; Parkinson's disease; Rating scale; Open label; Physical therapy; Internal medicine; Prospective cohort study; Clinical trial; Disease; Psychology; Alternative medicine","score_opus":0.08985375168669918,"score_gpt":0.39372623525140216,"score_spread":0.303872483564703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010436565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953985,0.000092026945,0.000037663187,0.000015262765,0.0000019677964,0.00006523684,0.00005002927,0.0000020540733,0.00019589512],"genre_scores_gemma":[0.999241,0.000087471584,0.0002784004,0.00006968324,0.000007040208,0.00007286261,0.00014057542,8.029316e-7,0.000102211794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995455,0.0002450053,0.000037566475,0.000066621295,0.000065084714,0.00004019585],"domain_scores_gemma":[0.99855465,0.000285962,0.0006506917,0.000066486355,0.0001776971,0.00026455088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008328969,0.00024389492,0.0004210325,0.00023131008,0.0006448412,0.0003301263,0.00021729732,0.00037471953,0.0007594404],"category_scores_gemma":[0.002444189,0.00020326761,0.00031903354,0.00014816673,0.00033272922,0.00027252903,0.0002542274,0.00030527147,0.0001536091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015672693,0.009665869,0.9402491,0.00035371573,0.00021735317,0.0017112528,0.0019661398,0.0002356839,0.009328148,0.000047405956,0.00063258514,0.019920092],"study_design_scores_gemma":[0.0012309422,0.025519088,0.9672985,0.000029006913,0.000077764416,0.0025401071,0.0009375422,0.00056685664,0.00070540805,0.000048207126,0.0010104836,0.00003604547],"about_ca_topic_score_codex":0.0029024126,"about_ca_topic_score_gemma":0.006445485,"teacher_disagreement_score":0.0029024126,"about_ca_system_score_codex":0.00045817092,"about_ca_system_score_gemma":0.0005033178,"threshold_uncertainty_score":0.0057709813},"labels":[],"label_agreement":null},{"id":"W2011186711","doi":"10.1185/030079905x75069","title":"Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etoricoxib; Tolerability; Diclofenac; Low back pain; Discontinuation; Randomized controlled trial; Clinical endpoint; Visual analogue scale; Physical therapy; Analgesic; Anesthesia; Adverse effect; Internal medicine","score_opus":0.05000715325874751,"score_gpt":0.38057945519416736,"score_spread":0.33057230193541987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011186711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942747,0.003527799,0.0002701623,0.00017459133,0.00009529472,0.0008998619,0.00029229373,0.000034438268,0.0004309041],"genre_scores_gemma":[0.9932915,0.0021998298,0.0012130877,0.0005312111,0.00024478778,0.0012686264,0.0005047862,0.000011984322,0.0007342307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99813205,0.0010601259,0.00020217482,0.00024351566,0.00019904628,0.00016304819],"domain_scores_gemma":[0.99756515,0.00082953455,0.0007241404,0.00022695413,0.00017964287,0.00047462844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042081345,0.0011475458,0.0035430943,0.00055497425,0.0004273515,0.00086640485,0.0009951352,0.0015463582,0.0031946825],"category_scores_gemma":[0.002921031,0.0009151363,0.0020968197,0.00058237993,0.001201608,0.0010813386,0.00043734274,0.0019994513,0.00049977127],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95202583,0.013820059,0.0022148045,0.00056228496,0.0019126524,0.000024085328,0.000063601496,0.00031137108,0.0042705117,0.000031559393,0.00020670597,0.024556525],"study_design_scores_gemma":[0.8710339,0.11839106,0.008397815,0.000026176956,0.00095871347,0.000029401494,0.000016201842,0.0002895761,0.0005140815,0.000027731769,0.00029617717,0.00001909],"about_ca_topic_score_codex":0.0010053411,"about_ca_topic_score_gemma":0.0020230513,"teacher_disagreement_score":0.0042081345,"about_ca_system_score_codex":0.0010062333,"about_ca_system_score_gemma":0.0013967901,"threshold_uncertainty_score":0.022255003},"labels":[],"label_agreement":null},{"id":"W2011227046","doi":"10.1185/03007995.2013.867842","title":"Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Takeda Pharmaceuticals International","keywords":"Medicine; COPD; Exacerbation; Pulmonary rehabilitation; Quality of life (healthcare); Physical therapy; Disease management; Intensive care medicine; Pulmonary disease; Disease; Internal medicine; Nursing","score_opus":0.07687313663596963,"score_gpt":0.40245613765280114,"score_spread":0.3255830010168315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011227046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907148,0.0009520211,0.00017277908,0.0020040725,0.000025338562,0.000121288154,0.0036948384,0.000009006054,0.0023058201],"genre_scores_gemma":[0.9959449,0.00063582545,0.00031297348,0.00081810623,0.000042067964,0.00012904519,0.0019108802,0.0000048604174,0.0002014052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958733,0.0024687548,0.0005138241,0.00025809952,0.0005350349,0.00035105317],"domain_scores_gemma":[0.99334466,0.0017934756,0.002625187,0.00022961586,0.0009147056,0.0010923492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041634697,0.00023691112,0.00045187198,0.00093809725,0.0003859994,0.0008872392,0.00026654496,0.0008392316,0.00066433364],"category_scores_gemma":[0.009464411,0.00020181072,0.00043418928,0.001709206,0.00033808014,0.0010242464,0.0019204225,0.0007021246,0.00019031622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072973016,0.00007197019,0.98493075,0.00015640569,0.000047918256,0.00010992327,0.0036922502,0.00008013288,0.00017121134,0.000051267387,0.002322503,0.008292642],"study_design_scores_gemma":[0.000015559106,0.00016533615,0.9922873,0.00006810894,0.000015727324,0.00020707998,0.0045732963,0.00015228009,0.000035101693,0.00003760253,0.0024332467,0.0000094017705],"about_ca_topic_score_codex":0.004394038,"about_ca_topic_score_gemma":0.007448588,"teacher_disagreement_score":0.004394038,"about_ca_system_score_codex":0.00062791054,"about_ca_system_score_gemma":0.00066923816,"threshold_uncertainty_score":0.02201879},"labels":[],"label_agreement":null},{"id":"W2013186052","doi":"10.1185/03007995.2011.626760","title":"Blood glucose and subsequent cardiovascular disease: update of a meta-analysis","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Postprandial; Diabetes mellitus; Myocardial infarction; Stroke (engine); Meta-analysis; Internal medicine; Poisson regression; Relative risk; Confidence interval; Population; Endocrinology; Environmental health","score_opus":0.3009077740967583,"score_gpt":0.44256426945082544,"score_spread":0.14165649535406716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013186052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010809235,0.9946898,0.0018705213,0.0011277149,0.0005039253,0.00011556199,0.00035495835,0.0000492563,0.00020731034],"genre_scores_gemma":[0.065713495,0.91495734,0.011852232,0.0033509359,0.0018125762,0.0009150736,0.0009312235,0.0001351296,0.0003320082],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.947731,0.03195334,0.0108471885,0.0034712737,0.0054208688,0.0005763961],"domain_scores_gemma":[0.8771553,0.09701867,0.010995277,0.006587902,0.007571018,0.0006717584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07653892,0.0042786878,0.021164827,0.015460002,0.00069427834,0.006931518,0.003997879,0.0036398738,0.0033716322],"category_scores_gemma":[0.16305447,0.002451192,0.054538492,0.013319112,0.0010735758,0.0038268424,0.0028107585,0.0042732083,0.0005933051],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018494306,0.000025695528,0.0067970185,0.16740717,0.7732114,0.00020036189,0.00013306222,0.0013434374,0.0002439724,0.00060276047,0.0044465372,0.043739174],"study_design_scores_gemma":[0.0007723875,0.00018199562,0.004958828,0.041623466,0.9418509,0.00021838974,0.000047384165,0.00055121194,0.00015871474,0.0015248767,0.008039242,0.000072562616],"about_ca_topic_score_codex":0.006985358,"about_ca_topic_score_gemma":0.012808897,"teacher_disagreement_score":0.07653892,"about_ca_system_score_codex":0.0041139736,"about_ca_system_score_gemma":0.004521462,"threshold_uncertainty_score":0.40478134},"labels":[],"label_agreement":null},{"id":"W2014301715","doi":"10.1185/03007990212500093","title":"Cardiovascular Properties of the Kallikrein-Kinin System","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Kinin; Myocardial infarction; Kallikrein; Heart failure; Cardiology; Diabetes mellitus; Left ventricular hypertrophy; Internal medicine; Infarction; Bradykinin; Endocrinology; Blood pressure; Receptor","score_opus":0.29251122512116917,"score_gpt":0.4267279343491331,"score_spread":0.13421670922796392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014301715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006310385,0.99559987,0.000332066,0.000211165,0.00016174963,0.0000045146503,0.000011210103,0.0000083922805,0.0030399351],"genre_scores_gemma":[0.0047119325,0.9918493,0.00037243127,0.00013877326,0.00031695343,0.0000070682045,0.000021858837,0.0000012349225,0.0025803961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999064,0.00001607391,0.000010909331,0.000016715272,0.000041582476,0.000008231638],"domain_scores_gemma":[0.99992204,0.000029529683,0.000011084176,0.000002975906,0.000025700794,0.000008584462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000245177,0.00048212512,0.00075034896,0.00089675986,0.0002340066,0.0007036803,0.00038920352,0.0005843376,0.0022491864],"category_scores_gemma":[0.00022637156,0.00010784225,0.00018870279,0.00066654885,0.00032260315,0.0007621592,0.00027837392,0.0006944862,0.0015674536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009585539,0.00007152216,0.00033103005,0.00788491,0.00005703136,0.0008651427,0.00009767524,0.0003346781,0.013457862,0.004673216,0.0134215895,0.95870954],"study_design_scores_gemma":[0.00002060124,0.00016094597,0.002398238,0.0008875859,0.00007016386,0.0052074487,0.00007718487,0.00014017062,0.0034010534,0.0028306993,0.9847857,0.000020298816],"about_ca_topic_score_codex":0.00062231056,"about_ca_topic_score_gemma":0.00069036614,"teacher_disagreement_score":0.0022491864,"about_ca_system_score_codex":0.00035281244,"about_ca_system_score_gemma":0.00047361926,"threshold_uncertainty_score":0.007524252},"labels":[],"label_agreement":null},{"id":"W2014337472","doi":"10.1185/030079906x148265","title":"Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trials","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Quetiapine; Medicine; Bipolar disorder; Olanzapine; Mania; Clinical trial; Psychiatry; Emergency medicine; Lithium (medication); Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.11719718238809285,"score_gpt":0.5276035133286752,"score_spread":0.4104063309405823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014337472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7883516,0.020885011,0.13010536,0.010962611,0.000564544,0.004934554,0.005344136,0.00022016838,0.038631987],"genre_scores_gemma":[0.9841175,0.002618789,0.009721526,0.00041809052,0.00007686954,0.0011919847,0.0006869152,0.0000215577,0.0011467601],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9828463,0.0153753115,0.00039008143,0.00031091121,0.0006243398,0.00045304061],"domain_scores_gemma":[0.94420713,0.05052813,0.0028484492,0.0006192824,0.0009242905,0.0008727612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023606366,0.001529921,0.0023809648,0.0018619203,0.00048227407,0.0030359193,0.001095534,0.0017017744,0.004283467],"category_scores_gemma":[0.07384165,0.0008372874,0.0031829008,0.001981883,0.0009144102,0.001929833,0.0013153603,0.0020219437,0.00015174915],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032606816,0.00032037112,0.009463017,0.00060222397,0.0013656087,0.00028357792,0.000064131505,0.9532104,0.00018256703,0.01488816,0.0013730509,0.014986223],"study_design_scores_gemma":[0.0013618338,0.00145168,0.005951485,0.00049502193,0.0014402772,0.0002021012,0.00019491365,0.9700244,0.0002898466,0.015645837,0.0028780366,0.00006456555],"about_ca_topic_score_codex":0.009078648,"about_ca_topic_score_gemma":0.004217564,"teacher_disagreement_score":0.023606366,"about_ca_system_score_codex":0.006048161,"about_ca_system_score_gemma":0.004844474,"threshold_uncertainty_score":0.124843836},"labels":[],"label_agreement":null},{"id":"W2014755596","doi":"10.1185/03007995.2013.838154","title":"The impact of knowledge, attitudes and beliefs on the engagement of primary and community-based healthcare professionals in cancer care: a literature review","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cancer Australia","keywords":"Medicine; Grey literature; Intervention (counseling); Primary care; Health professionals; Health care; Family medicine; Nursing; MEDLINE","score_opus":0.4713188435233936,"score_gpt":0.6194994241723552,"score_spread":0.14818058064896156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014755596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019146386,0.9964126,0.00009121454,0.0003850845,0.00009242487,0.00012025218,0.00027350942,0.000003852465,0.0007065773],"genre_scores_gemma":[0.009659319,0.98936146,0.000266734,0.00025813698,0.00006224127,0.00016756238,0.00015053162,0.0000028052211,0.00007126014],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902857,0.0027839474,0.003982593,0.0006594123,0.0019367595,0.00035169022],"domain_scores_gemma":[0.9122129,0.073339835,0.008104935,0.0005488128,0.005239576,0.0005538813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011582438,0.0010776243,0.004847797,0.021689717,0.000943009,0.004779042,0.0020369678,0.002365541,0.004782343],"category_scores_gemma":[0.052230623,0.0009927531,0.0045372318,0.026965627,0.0011838282,0.0043986277,0.0019148052,0.0012560555,0.0005426022],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001413161,0.000055212073,0.0031133825,0.8586031,0.0025099488,0.00031848185,0.001924193,0.00009101891,0.000110059074,0.00058987143,0.0025453155,0.12999816],"study_design_scores_gemma":[0.0000432336,0.00011538672,0.009841232,0.9489364,0.011929635,0.00074478384,0.0022811845,0.000051084757,0.00011772998,0.00031043642,0.025593117,0.00003572026],"about_ca_topic_score_codex":0.010505184,"about_ca_topic_score_gemma":0.021870136,"teacher_disagreement_score":0.021689717,"about_ca_system_score_codex":0.0046819844,"about_ca_system_score_gemma":0.014554963,"threshold_uncertainty_score":0.0612545},"labels":[],"label_agreement":null},{"id":"W2016190330","doi":"10.1185/03007995.2010.525475","title":"Meta-analysis of a partially hydrolysed 100%-whey infant formula vs. extensively hydrolysed infant formulas in the prevention of atopic dermatitis","year":2010,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Medicine; Atopic dermatitis; Incidence (geometry); Infant formula; Milk allergy; Casein; Relative risk; Randomized controlled trial; Meta-analysis; Cumulative incidence; Pediatrics; Internal medicine; Allergy; Confidence interval; Food allergy; Food science; Dermatology; Immunology; Mathematics","score_opus":0.26968374150559316,"score_gpt":0.4874502259053778,"score_spread":0.21776648439978463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016190330","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07199183,0.9196554,0.0040859943,0.000638069,0.00091975124,0.0005758495,0.0009155515,0.00014039365,0.0010770834],"genre_scores_gemma":[0.8497617,0.14196913,0.004396019,0.0010642542,0.00039062143,0.000782315,0.00077404256,0.000073709954,0.0007881899],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9807047,0.014647538,0.001839692,0.0015093898,0.00096099335,0.0003376695],"domain_scores_gemma":[0.9812077,0.015273739,0.0017440787,0.000784762,0.00068621035,0.0003034236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023272699,0.0031009524,0.015968688,0.0039115916,0.00054033054,0.0033535871,0.0018261524,0.0027264291,0.0031542717],"category_scores_gemma":[0.028529491,0.0014243821,0.06571465,0.0033189466,0.00060565874,0.0012741467,0.0012539518,0.002588222,0.0002852434],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014318461,0.000047912145,0.0024429834,0.02077595,0.9559735,0.00009539424,0.000019166675,0.0017702577,0.00026803775,0.00009915733,0.00016579208,0.0040233703],"study_design_scores_gemma":[0.0017831592,0.00065990025,0.001822785,0.0010196882,0.9934105,0.000043919248,0.000012606691,0.0006276487,0.000116335425,0.00014461206,0.00034833446,0.0000104774],"about_ca_topic_score_codex":0.005211202,"about_ca_topic_score_gemma":0.0065553403,"teacher_disagreement_score":0.023272699,"about_ca_system_score_codex":0.0020409643,"about_ca_system_score_gemma":0.0016318122,"threshold_uncertainty_score":0.12307924},"labels":[],"label_agreement":null},{"id":"W2017304854","doi":"10.1185/030079906x80242","title":"Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Celecoxib; Medicine; Placebo; WOMAC; Osteoarthritis; Clinical endpoint; Internal medicine; Adverse effect; Anesthesia; Randomized controlled trial; Cyclooxygenase","score_opus":0.09109603477984789,"score_gpt":0.4542389730617358,"score_spread":0.3631429382818879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017304854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840269,0.0124782,0.0006055028,0.00020816672,0.00028208343,0.0011210252,0.00036317474,0.00003730847,0.0008776165],"genre_scores_gemma":[0.9944564,0.0026250966,0.0008007177,0.00031445525,0.00026242493,0.00072034454,0.00045652917,0.0000059477616,0.00035802284],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99408495,0.004196582,0.00058475824,0.0004536609,0.0004752673,0.0002047459],"domain_scores_gemma":[0.994009,0.0023896059,0.0017885471,0.0004857708,0.00058327446,0.0007438562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007154147,0.0011228599,0.0030554363,0.00081857643,0.00038213615,0.0011270827,0.0010946034,0.002164602,0.0026215643],"category_scores_gemma":[0.007657804,0.00070736354,0.003012806,0.00054870406,0.0009447788,0.0007390629,0.00045341512,0.0017364565,0.00042954736],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92250526,0.015329399,0.0066531976,0.0017891066,0.007290069,0.00013966442,0.00018029161,0.00037906985,0.016382966,0.00012681844,0.00036102018,0.028863115],"study_design_scores_gemma":[0.5466025,0.41868415,0.022430982,0.00013299099,0.006297256,0.00022440916,0.000066629276,0.0004281133,0.0036975762,0.00012458117,0.0012540176,0.000056852616],"about_ca_topic_score_codex":0.0005449041,"about_ca_topic_score_gemma":0.0010675188,"teacher_disagreement_score":0.007154147,"about_ca_system_score_codex":0.000688158,"about_ca_system_score_gemma":0.0009952172,"threshold_uncertainty_score":0.03783524},"labels":[],"label_agreement":null},{"id":"W2018780010","doi":"10.1185/030079902125001029","title":"Functional, Cognitive and Behavioral Effects of Donepezil in Patients with Moderate Alzheimer's Disease","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; McGill University","funders":"Pfizer","keywords":"Donepezil; Medicine; Alzheimer's disease; Disease; Cognition; Dementia; Psychiatry; Internal medicine","score_opus":0.09042586568861398,"score_gpt":0.4050831020880094,"score_spread":0.3146572363993954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018780010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924225,0.006531932,0.00005639481,0.00012039742,0.000050945113,0.00015273123,0.00013735099,0.000012318821,0.00051537115],"genre_scores_gemma":[0.99751306,0.0015293716,0.0001533534,0.00018066344,0.00009888274,0.00013902025,0.00020700293,0.0000013102183,0.0001773045],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965584,0.00012273563,0.00005568699,0.00005241576,0.000056044053,0.000057373323],"domain_scores_gemma":[0.9993999,0.00017497508,0.00020112522,0.000021451597,0.000037964204,0.00016458298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008833135,0.0006712836,0.0018394856,0.00027695947,0.00032823673,0.0004358154,0.00038302533,0.00068060955,0.0012480726],"category_scores_gemma":[0.001391054,0.0002583737,0.0008912096,0.00023671468,0.00037834005,0.0003007955,0.0001637377,0.00057481247,0.00017716375],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8420953,0.012615705,0.03552679,0.0024495162,0.0039035385,0.0003470194,0.00020207575,0.0004783833,0.0105970185,0.00005788441,0.0008893903,0.090837434],"study_design_scores_gemma":[0.5071476,0.2903259,0.19259998,0.00018689458,0.0034188284,0.0007818432,0.00016965918,0.0008508433,0.0023135974,0.00017091795,0.0019870677,0.000046811063],"about_ca_topic_score_codex":0.00076161104,"about_ca_topic_score_gemma":0.002401867,"teacher_disagreement_score":0.0018394856,"about_ca_system_score_codex":0.0003636419,"about_ca_system_score_gemma":0.00046689413,"threshold_uncertainty_score":0.0046714544},"labels":[],"label_agreement":null},{"id":"W2019045699","doi":"10.1185/03007995.2014.901941","title":"US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada)","funders":"American Pain Society","keywords":"Medicine; Dosing; Medical prescription; Pharmacy; Buprenorphine; Opioid; Emergency medicine; Family medicine; Internal medicine; Pharmacology","score_opus":0.06090701486458457,"score_gpt":0.375056298115606,"score_spread":0.3141492832510214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019045699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990595,0.00014618889,0.000029771423,0.00005511744,0.0000020351401,0.000008965315,0.00035166618,0.00000232319,0.0003444691],"genre_scores_gemma":[0.9993229,0.00013076565,0.0000703495,0.000040309533,0.00000515392,0.000008703592,0.0002968532,0.0000010330789,0.0001240072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995012,0.00008626547,0.00011424516,0.00009273436,0.00014021593,0.000065238804],"domain_scores_gemma":[0.99707925,0.0003656248,0.0021541591,0.00005826725,0.00012666897,0.00021606256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043543478,0.00010576832,0.00022472556,0.00057890505,0.00025757213,0.00042574352,0.00019853278,0.0003468121,0.0025461053],"category_scores_gemma":[0.0029854632,0.00018852096,0.00030268208,0.00089107413,0.00013331624,0.00043235565,0.00027753387,0.0003883718,0.00029452832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026015694,0.00004075872,0.99888474,0.0000060875836,0.00001583097,0.000038524387,0.000069365065,0.000024568619,0.00009660087,0.000006173079,0.00006509841,0.00072611927],"study_design_scores_gemma":[0.0000033926763,0.00007900809,0.999178,0.0000071356512,0.0000069963676,0.00029418568,0.00016697163,0.00011642712,0.000027821283,0.0000036357026,0.00011462285,0.0000018044763],"about_ca_topic_score_codex":0.0067458237,"about_ca_topic_score_gemma":0.011860831,"teacher_disagreement_score":0.0067458237,"about_ca_system_score_codex":0.00038428218,"about_ca_system_score_gemma":0.00035854787,"threshold_uncertainty_score":0.013413072},"labels":[],"label_agreement":null},{"id":"W2020989669","doi":"10.1185/03007991003771338","title":"Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma","year":2010,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Research in Astrophysics of Québec","funders":"","keywords":"Omalizumab; Medicine; Placebo; Asthma; Exacerbation; Adverse effect; Immunoglobulin E; Randomized controlled trial; Rate ratio; Internal medicine; Corticosteroid; Anesthesia; Gastroenterology; Confidence interval; Immunology; Antibody","score_opus":0.03495446278182664,"score_gpt":0.372221480296493,"score_spread":0.33726701751466637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020989669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9501876,0.047517043,0.0004066146,0.00054146216,0.000110840534,0.00036152327,0.00017197715,0.00003652227,0.0006663212],"genre_scores_gemma":[0.9880108,0.009163978,0.0012213504,0.0004969408,0.00018667558,0.0004076751,0.0002520999,0.0000086180125,0.00025182017],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987503,0.0007847354,0.00012714388,0.0001178256,0.000118466596,0.00010152176],"domain_scores_gemma":[0.9984218,0.0007631987,0.0005001093,0.000072779345,0.000037210393,0.00020480498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019383924,0.00044769357,0.0021019892,0.00025831113,0.00022377026,0.00041679555,0.00047079276,0.0008563465,0.001195458],"category_scores_gemma":[0.0026797557,0.00024806897,0.0012212557,0.00034993296,0.00060728163,0.00042644114,0.00030500474,0.0011577731,0.00018359296],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.592464,0.0067557404,0.08906513,0.008061314,0.0039492417,0.0015143936,0.0003852888,0.0014310757,0.017893728,0.00067286805,0.0028112207,0.27499598],"study_design_scores_gemma":[0.4572517,0.28704253,0.22300228,0.0008539013,0.004563405,0.0054986803,0.00022258698,0.0016225989,0.007424426,0.00047529142,0.011991683,0.0000508863],"about_ca_topic_score_codex":0.00069811125,"about_ca_topic_score_gemma":0.0010235313,"teacher_disagreement_score":0.0021019892,"about_ca_system_score_codex":0.00040540216,"about_ca_system_score_gemma":0.00070164725,"threshold_uncertainty_score":0.010251284},"labels":[],"label_agreement":null},{"id":"W2021278088","doi":"10.1185/030079902125001128","title":"A Double-blind, Randomised Comparative Trial of Amisulpride Versus Olanzapine in the Treatment of Schizophrenia: Short-term Results at Two Months","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alzheimer Society of Canada","funders":"","keywords":"Amisulpride; Olanzapine; Medicine; Brief Psychiatric Rating Scale; Extrapyramidal symptoms; Schizophrenia (object-oriented programming); Adverse effect; Internal medicine; Psychiatry; Psychosis; Antipsychotic","score_opus":0.33400150161970055,"score_gpt":0.48912254988820697,"score_spread":0.15512104826850642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021278088","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98805666,0.0040716985,0.00061723264,0.00041268198,0.000816928,0.0044405847,0.0006254031,0.000097469,0.0008612071],"genre_scores_gemma":[0.97901237,0.0034900748,0.0025907604,0.0008864148,0.0011213063,0.009613803,0.0008087831,0.000026948086,0.0024495095],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975726,0.0014649911,0.00028366502,0.0002999379,0.00018797471,0.00019076996],"domain_scores_gemma":[0.9968664,0.001034685,0.00088569353,0.00023674317,0.00021833653,0.0007581148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035771145,0.0021754869,0.0046020844,0.0007196097,0.0005862058,0.0012694062,0.0012746686,0.0030148935,0.007801448],"category_scores_gemma":[0.0050352416,0.0011670742,0.0021765097,0.0006229969,0.002061817,0.0015479538,0.0005744417,0.0021619566,0.0012037205],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99405813,0.0019908017,0.00011798551,0.00021311018,0.00021014766,0.000009812964,0.00001710607,0.000051933752,0.0006174613,0.000016523009,0.00006223919,0.002634758],"study_design_scores_gemma":[0.95814914,0.040716495,0.00053014955,0.00001608413,0.00015847376,0.000011262186,0.000009788853,0.00014203641,0.0001212647,0.000033755594,0.00010402047,0.000007582651],"about_ca_topic_score_codex":0.0008775615,"about_ca_topic_score_gemma":0.0017806236,"teacher_disagreement_score":0.007801448,"about_ca_system_score_codex":0.00082217396,"about_ca_system_score_gemma":0.0015736913,"threshold_uncertainty_score":0.02609843},"labels":[],"label_agreement":null},{"id":"W2021917132","doi":"10.1185/030079904x15165","title":"Measuring symptom response to pharmacological interventions in patients with COPD: a review of instruments used in clinical trials","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Social Innovation; Centre for Global Health Research","funders":"","keywords":"Medicine; COPD; Psychological intervention; Clinical trial; Intensive care medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.4908715463316888,"score_gpt":0.5965045688036081,"score_spread":0.10563302247191936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021917132","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000335747,0.9987569,0.00019525897,0.000163911,0.00008420696,0.00023539187,0.00006516709,0.000005695606,0.00015764775],"genre_scores_gemma":[0.0051431283,0.99223715,0.0015552372,0.00026937193,0.00006175698,0.0006090257,0.000070598944,0.000004170209,0.0000495298],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9607271,0.016994072,0.013710342,0.0016312681,0.006603748,0.000333386],"domain_scores_gemma":[0.874369,0.1004531,0.016366085,0.0012949678,0.006982531,0.0005342492],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038235616,0.0020318492,0.012201998,0.011075011,0.0006818209,0.0034993242,0.0026363742,0.00273234,0.0028280483],"category_scores_gemma":[0.12236587,0.0012738791,0.0049563674,0.015754536,0.0017348108,0.0032433742,0.0013843963,0.0013929656,0.00045188534],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068290735,0.000048534144,0.000753746,0.7425878,0.0045073004,0.00007885183,0.00020124116,0.000169054,0.00022845493,0.0004700129,0.0016634476,0.24860862],"study_design_scores_gemma":[0.0013208853,0.0012851236,0.009030143,0.8871639,0.046491746,0.00077033037,0.00048270557,0.00026990744,0.00071257807,0.0009841227,0.05138936,0.00009921152],"about_ca_topic_score_codex":0.0020956853,"about_ca_topic_score_gemma":0.0050668227,"teacher_disagreement_score":0.9617644,"about_ca_system_score_codex":0.0037910398,"about_ca_system_score_gemma":0.007357446,"threshold_uncertainty_score":0.20221168},"labels":[],"label_agreement":null},{"id":"W2022069934","doi":"10.1185/03007995.2011.621416","title":"Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes","year":2011,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Education","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Glycemic; Hypoglycemia; Intensive care medicine; Insulin; Type 2 diabetes; Diabetes mellitus; Diabetes management; Internal medicine; Endocrinology","score_opus":0.09655757236718554,"score_gpt":0.39005797805382925,"score_spread":0.2935004056866437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022069934","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011404514,0.9621923,0.00040408628,0.022421254,0.0003910746,0.000038435064,0.0002681577,0.0000063417347,0.0028738107],"genre_scores_gemma":[0.19419195,0.7949355,0.0013488138,0.007921988,0.0008337794,0.00015923599,0.00028759765,0.000010445736,0.00031066767],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9864292,0.0070365323,0.0026540542,0.00080867426,0.002682218,0.00038930605],"domain_scores_gemma":[0.9017699,0.07648775,0.015767558,0.00074413675,0.004237001,0.0009936197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016562564,0.00041049093,0.0018527295,0.0029373167,0.0008521959,0.005293565,0.0010890025,0.0021484657,0.0027529632],"category_scores_gemma":[0.068667606,0.0004599375,0.0021067655,0.006587737,0.0016225707,0.0038992576,0.0019560766,0.0032489426,0.0001991537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007628061,0.00016314989,0.097381175,0.25786585,0.0076171057,0.0014195947,0.00794453,0.00051119004,0.00020374927,0.009161922,0.023028238,0.5939407],"study_design_scores_gemma":[0.00031358007,0.00066610106,0.17206034,0.6059338,0.016954737,0.00503627,0.018807957,0.0009135793,0.00038621438,0.023202928,0.15542956,0.00029490926],"about_ca_topic_score_codex":0.010580373,"about_ca_topic_score_gemma":0.016542314,"teacher_disagreement_score":0.016562564,"about_ca_system_score_codex":0.0025123928,"about_ca_system_score_gemma":0.0056391675,"threshold_uncertainty_score":0.087592244},"labels":[],"label_agreement":null},{"id":"W2024791905","doi":"10.1185/03007995.2015.1019608","title":"Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; European Society of Cardiology; University of Cincinnati","keywords":"Medicine; Atrial fibrillation; Guideline; Warfarin; Antithrombotic; Stroke (engine); Intensive care medicine; Anticoagulant therapy; Anticoagulant; Decision analysis; Psychological intervention; Surgery; Internal medicine; Nursing","score_opus":0.7270205726613163,"score_gpt":0.6477190679370661,"score_spread":0.07930150472425013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024791905","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056406986,0.00070611824,0.8546367,0.010509823,0.0006701453,0.004573942,0.0076978495,0.03797177,0.026826551],"genre_scores_gemma":[0.07968909,0.00022903844,0.91138065,0.0009877938,0.000075766206,0.0015423368,0.0034544333,0.00062406616,0.002016869],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.991774,0.004673086,0.0009636728,0.00061656587,0.0016866805,0.00028601833],"domain_scores_gemma":[0.9694009,0.022583408,0.001410307,0.001992923,0.0036108748,0.0010015811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012797421,0.0016642737,0.00077575125,0.0021068729,0.000804601,0.004354383,0.002214939,0.0020675627,0.014737135],"category_scores_gemma":[0.054678537,0.0006703371,0.0019655686,0.0010951108,0.00047316935,0.0031117704,0.003306768,0.0023331817,0.0030287865],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001054983,0.0014767253,0.016749233,0.0023561516,0.00071739766,0.0016902601,0.0032062107,0.05470531,0.0059291665,0.027384236,0.12324034,0.76149005],"study_design_scores_gemma":[0.0019794048,0.0013085686,0.0055156252,0.003244303,0.00056365225,0.0020724942,0.0019862708,0.63990927,0.013311806,0.089909606,0.23964806,0.0005509695],"about_ca_topic_score_codex":0.0023725124,"about_ca_topic_score_gemma":0.0038891141,"teacher_disagreement_score":0.014737135,"about_ca_system_score_codex":0.0011777477,"about_ca_system_score_gemma":0.0035472398,"threshold_uncertainty_score":0.06768},"labels":[],"label_agreement":null},{"id":"W2026240770","doi":"10.1185/03007990802426813","title":"Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Travoprost; Latanoprost; Evening; Morning; Dosing; Glaucoma; Open angle glaucoma; Ophthalmology; Internal medicine","score_opus":0.10709904824102029,"score_gpt":0.4203581562258453,"score_spread":0.31325910798482504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026240770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730057,0.001990498,0.00008275546,0.000067913395,0.000066620865,0.000058076173,0.00006858641,0.000009271455,0.00035579564],"genre_scores_gemma":[0.99863654,0.0005108829,0.0002633609,0.00008942255,0.00011141741,0.000043291562,0.00009922624,0.000002933854,0.00024290307],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933714,0.00030369931,0.00007972905,0.00009613848,0.0001350291,0.000048301463],"domain_scores_gemma":[0.9977239,0.0010667255,0.00058042427,0.00010976196,0.00008653588,0.00043260888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001048663,0.00036257744,0.0015113206,0.00021611998,0.00020795545,0.00046970596,0.00031647916,0.00060162746,0.0013467951],"category_scores_gemma":[0.0024772943,0.00028944633,0.00077929074,0.00025440368,0.0003392921,0.00048973435,0.00014473978,0.0008389417,0.00021917754],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.871164,0.007620415,0.034644578,0.0007372852,0.0012582705,0.00017698354,0.00022935304,0.0004328524,0.01857701,0.000075959055,0.00038592002,0.064697355],"study_design_scores_gemma":[0.12605424,0.66099,0.20289199,0.000069090696,0.0018242579,0.00043613644,0.0002799433,0.0019221965,0.0045006736,0.00014348756,0.00081503903,0.00007290121],"about_ca_topic_score_codex":0.00044881096,"about_ca_topic_score_gemma":0.0013993364,"teacher_disagreement_score":0.0015113206,"about_ca_system_score_codex":0.0003246249,"about_ca_system_score_gemma":0.00043374125,"threshold_uncertainty_score":0.005545974},"labels":[],"label_agreement":null},{"id":"W2026341154","doi":"10.1185/03007995.2014.916159","title":"Is rivaroxaban associated with lower inpatient costs compared to warfarin among patients with non-valvular atrial fibrillation?","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Rivaroxaban; Medicine; Warfarin; Atrial fibrillation; Propensity score matching; Internal medicine; Stroke (engine); Emergency medicine","score_opus":0.08631108257162853,"score_gpt":0.4082514394110455,"score_spread":0.321940356839417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026341154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633336,0.001769768,0.00004385373,0.00086382776,0.000036903726,0.000006195941,0.00036312535,0.0000018646556,0.0005810457],"genre_scores_gemma":[0.99897194,0.00044383737,0.00004252218,0.0001309291,0.00004787865,0.0000047291996,0.00030127465,0.0000013086755,0.000055554403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986852,0.0004464281,0.00020190698,0.00024303076,0.00023356064,0.00018992166],"domain_scores_gemma":[0.99484694,0.0009148641,0.0033769866,0.00018129474,0.00027633578,0.00040355013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091062725,0.00021071281,0.0006726605,0.00068205164,0.00031081104,0.0011901383,0.00046353054,0.0007233349,0.0029069893],"category_scores_gemma":[0.00841464,0.00022614114,0.0015254893,0.0014583902,0.00023176818,0.0006090704,0.00032481342,0.0006359494,0.00018942912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005744117,0.000059769452,0.9951953,0.00004013875,0.00043405927,0.00008187071,0.000027971064,0.00006316453,0.00004337138,0.00005439979,0.00024764723,0.0031779483],"study_design_scores_gemma":[0.000056067,0.0001463285,0.9985746,0.000020665591,0.00019544762,0.00029286993,0.00012908262,0.00027005075,0.000022643462,0.00009853259,0.00018847547,0.0000053493154],"about_ca_topic_score_codex":0.0034826149,"about_ca_topic_score_gemma":0.004214157,"teacher_disagreement_score":0.0034826149,"about_ca_system_score_codex":0.0006557148,"about_ca_system_score_gemma":0.0005757092,"threshold_uncertainty_score":0.009724796},"labels":[],"label_agreement":null},{"id":"W2026692964","doi":"10.1185/030079904x12951","title":"Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lidocaine; Neuropathic pain; Analgesic; Adverse effect; Osteoarthritis; Anesthesia; Visual analogue scale; Population; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.23042993751117313,"score_gpt":0.48560950754814897,"score_spread":0.25517957003697583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026692964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99689317,0.00131718,0.0004073602,0.0001015122,0.000045283527,0.00070757675,0.00013717714,0.000019827994,0.00037092442],"genre_scores_gemma":[0.9948284,0.0014311045,0.0013894307,0.0002527122,0.00026890144,0.0006868374,0.00029155618,0.000015019487,0.00083604414],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989164,0.0006175365,0.000086268796,0.00012401682,0.00012949393,0.00012645464],"domain_scores_gemma":[0.9981658,0.0007040666,0.00038558996,0.0001642965,0.00018328216,0.00039695596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028415665,0.0009832161,0.0019391268,0.0003858112,0.000399869,0.0006493995,0.0008311131,0.0009134106,0.0027297477],"category_scores_gemma":[0.002011208,0.00051723723,0.0011925611,0.00032925408,0.0011925204,0.0011623169,0.00035771824,0.0020703587,0.00042152428],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5996327,0.22625431,0.004600567,0.0011857897,0.001087483,0.00024639352,0.00047631827,0.00070089306,0.09333798,0.00010165077,0.00063107756,0.07174488],"study_design_scores_gemma":[0.10096599,0.88364655,0.011300458,0.000020864629,0.00030957762,0.00008777135,0.00005669879,0.00028356453,0.0029624144,0.00002974877,0.00032092415,0.00001546254],"about_ca_topic_score_codex":0.00076651294,"about_ca_topic_score_gemma":0.0018584444,"teacher_disagreement_score":0.0028415665,"about_ca_system_score_codex":0.0003297828,"about_ca_system_score_gemma":0.00085007586,"threshold_uncertainty_score":0.015027821},"labels":[],"label_agreement":null},{"id":"W2029158492","doi":"10.1185/03007995.2014.952367","title":"Re: Marchington JM, Burd GP. Author attitudes to professional medical writing support. Curr Med Res Opin 2014 Jul 9:1-6","year":2014,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Academic integrity and plagiarism","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Medical writing; Medical education; Family medicine; Nursing","score_opus":0.15935537919502707,"score_gpt":0.5178399436591414,"score_spread":0.35848456446411436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029158492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022938628,0.002303021,0.00007417745,0.97775966,0.0136988945,0.0000075392545,0.00007261041,0.000046320096,0.00580841],"genre_scores_gemma":[0.00881532,0.005546119,0.0003660468,0.9187558,0.03568673,0.000051064617,0.00009479779,0.00007424305,0.030609826],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99574727,0.0008181428,0.0007143881,0.00042321347,0.0019805324,0.00031650029],"domain_scores_gemma":[0.95876294,0.017232042,0.0029145428,0.0014221792,0.016384589,0.0032837281],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0036174706,0.0008611415,0.0012959624,0.0017620183,0.0061064465,0.00517379,0.0022436748,0.032782435,0.03395959],"category_scores_gemma":[0.076032355,0.0007488953,0.0009888442,0.0016158657,0.002915954,0.006381829,0.0019536214,0.0345606,0.039294884],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014260013,0.000008234532,0.00025924577,0.000026341031,0.0000034564207,0.0006308941,0.00008987261,0.00000909853,0.00004213333,0.0004201933,0.9934767,0.0050196135],"study_design_scores_gemma":[0.000085333995,0.000038441118,0.0019766914,0.0013277429,0.000028786455,0.008776176,0.0015223817,0.00019713458,0.0003462698,0.006267413,0.97936755,0.000066109824],"about_ca_topic_score_codex":0.013602911,"about_ca_topic_score_gemma":0.024094349,"teacher_disagreement_score":0.96721756,"about_ca_system_score_codex":0.004866235,"about_ca_system_score_gemma":0.006147428,"threshold_uncertainty_score":0.113606155},"labels":[],"label_agreement":null},{"id":"W2030138403","doi":"10.1185/03007995.2011.633989","title":"Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University","funders":"","keywords":"Cetuximab; Medicine; Radiation therapy; Head and neck cancer; Oncology; Cisplatin; Internal medicine; Hazard ratio; Head and neck squamous-cell carcinoma; Dosing; Randomized controlled trial; Meta-analysis; Confidence interval; Cancer; Chemotherapy; Colorectal cancer","score_opus":0.26108924597764915,"score_gpt":0.49318848902548784,"score_spread":0.2320992430478387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030138403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1395279,0.839186,0.006412004,0.0011064241,0.0019833033,0.003979596,0.00299548,0.00011631446,0.004692921],"genre_scores_gemma":[0.8982027,0.086772144,0.0072658206,0.0011399746,0.00084354304,0.0031538808,0.0012674438,0.00006134428,0.0012931447],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95206374,0.03689496,0.0061290697,0.0020723185,0.0025203908,0.00031954783],"domain_scores_gemma":[0.8724051,0.110800065,0.011564124,0.0023735978,0.00239001,0.00046703217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04699751,0.002531156,0.00910808,0.003714336,0.00027198833,0.002853286,0.001636959,0.0019662816,0.005584873],"category_scores_gemma":[0.11205824,0.0010281692,0.02300466,0.002906406,0.0011044871,0.001614507,0.0014534952,0.002534793,0.00044446552],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08765536,0.00024631305,0.007161412,0.19407022,0.6733578,0.00015090057,0.00018000543,0.0024205393,0.00095464825,0.0007148117,0.0005481134,0.032539867],"study_design_scores_gemma":[0.03958558,0.011148811,0.012298056,0.013966315,0.91378635,0.0002678459,0.000099336714,0.0014645049,0.0015019343,0.002253804,0.0035447022,0.000082742234],"about_ca_topic_score_codex":0.0016036234,"about_ca_topic_score_gemma":0.0022182874,"teacher_disagreement_score":0.04699751,"about_ca_system_score_codex":0.0023501038,"about_ca_system_score_gemma":0.0020253526,"threshold_uncertainty_score":0.24854952},"labels":[],"label_agreement":null},{"id":"W2030898895","doi":"10.1185/030079905x38123","title":"Quality of structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association: a 10-year follow-up study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Family medicine; Medical journal; Consistency (knowledge bases); MEDLINE; Quality Score","score_opus":0.6294144850314811,"score_gpt":0.6092852695994536,"score_spread":0.020129215432027503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030898895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9684137,0.024945922,0.00051537395,0.0009499947,0.00016714343,0.0009873307,0.0026607167,0.000039228846,0.0013205179],"genre_scores_gemma":[0.99162674,0.0039228285,0.0011862752,0.00021653702,0.00015688906,0.00053911563,0.001999212,0.000017107424,0.00033539702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9110341,0.019121066,0.0337026,0.0040529785,0.030607333,0.0014819652],"domain_scores_gemma":[0.43836358,0.110564284,0.3184803,0.009984234,0.11190846,0.01069915],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.074914426,0.00087362406,0.0028858671,0.0231549,0.001986437,0.004870668,0.0013175888,0.0017221294,0.0014935682],"category_scores_gemma":[0.36975846,0.0011056687,0.0036238884,0.017971797,0.0019165102,0.0037903772,0.0038951098,0.0012261425,0.00034502006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004821451,0.00058624113,0.9479309,0.006559981,0.0038302874,0.00032618092,0.007162942,0.00022965632,0.00083127205,0.00006682271,0.0012916783,0.02636251],"study_design_scores_gemma":[0.00047411086,0.0015541547,0.9914684,0.0007989253,0.0011178394,0.0005008743,0.0017819133,0.00019259212,0.00039283565,0.00008595824,0.0015265477,0.00010588523],"about_ca_topic_score_codex":0.009878335,"about_ca_topic_score_gemma":0.012818244,"teacher_disagreement_score":0.92508554,"about_ca_system_score_codex":0.007162351,"about_ca_system_score_gemma":0.006801741,"threshold_uncertainty_score":0.3961901},"labels":[],"label_agreement":null},{"id":"W2031040803","doi":"10.1185/03007995.2013.779876","title":"The fundamental role of inflammation in tendon injury","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Tendon Structure and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Inflammation; Tendon; Ultimate tensile strength; Inflammatory response; Surgery; Immunology; Composite material","score_opus":0.045199280963502994,"score_gpt":0.4247034206302917,"score_spread":0.3795041396667887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031040803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03775685,0.9217981,0.0052158777,0.018360298,0.005021982,0.00006772815,0.00037293282,0.000095708594,0.011310559],"genre_scores_gemma":[0.41770506,0.54942715,0.002932296,0.0067254324,0.013250257,0.00012569316,0.0002287791,0.00003190155,0.009573446],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991749,0.00022039936,0.00008564115,0.00013538921,0.0002356537,0.00014804819],"domain_scores_gemma":[0.99916327,0.00022169981,0.00025503334,0.00005447582,0.00015942585,0.0001461373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011108641,0.00084510894,0.0010027139,0.0008199,0.0006993595,0.0020035736,0.00062343373,0.002044376,0.0036206255],"category_scores_gemma":[0.0013613106,0.00026176145,0.00035612463,0.00050074834,0.0022355204,0.00183312,0.0014314627,0.0026980117,0.0012602048],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003053707,0.0010229062,0.014441841,0.019550407,0.0002462936,0.0059238262,0.0028689126,0.0018333168,0.20692235,0.17112549,0.055964388,0.51704645],"study_design_scores_gemma":[0.0003761585,0.0043779477,0.07508538,0.009376846,0.00047751522,0.013644299,0.004684662,0.0023778551,0.04752054,0.21109892,0.6306831,0.00029676894],"about_ca_topic_score_codex":0.00041861585,"about_ca_topic_score_gemma":0.00044818697,"teacher_disagreement_score":0.0036206255,"about_ca_system_score_codex":0.0006561314,"about_ca_system_score_gemma":0.0011500003,"threshold_uncertainty_score":0.0121122},"labels":[],"label_agreement":null},{"id":"W2036440924","doi":"10.1185/03007995.2013.856287","title":"Statin–fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low","year":2013,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Fibrate; Medicine; Cardiovascular event; Statin; Lipid profile; Dyslipidemia; Cardiology; Internal medicine; Intensive care medicine; Pharmacology; Cholesterol; Disease","score_opus":0.05354596407779159,"score_gpt":0.3889355457778891,"score_spread":0.33538958170009747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036440924","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037492877,0.004021033,0.0004192053,0.9607523,0.017706446,0.000023281977,0.000055880602,0.00007860861,0.013193963],"genre_scores_gemma":[0.04103081,0.006032688,0.0017525562,0.84103537,0.09633936,0.000057863013,0.00008573958,0.00005646562,0.013609123],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988242,0.0002989979,0.00022204344,0.000121418474,0.0003659666,0.00016730775],"domain_scores_gemma":[0.9969234,0.0016482689,0.0003007196,0.00010578665,0.00055893935,0.00046289817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011391692,0.0007627092,0.0016804609,0.00049612386,0.001978051,0.0022740655,0.00077024073,0.023532275,0.0040581212],"category_scores_gemma":[0.012147673,0.00036208902,0.0012016194,0.00056931906,0.001279756,0.0015630041,0.0005378751,0.019087894,0.0035920304],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005335026,0.00033178448,0.005217674,0.0002526878,0.00014236303,0.04701459,0.00016902162,0.00026580133,0.0010693697,0.0045006364,0.8682949,0.07220768],"study_design_scores_gemma":[0.0012506453,0.00075702986,0.011784764,0.0009101155,0.0002941058,0.07571548,0.0005018361,0.0022112653,0.001266778,0.018250793,0.88690096,0.00015630898],"about_ca_topic_score_codex":0.0026107794,"about_ca_topic_score_gemma":0.007515826,"teacher_disagreement_score":0.023532275,"about_ca_system_score_codex":0.0026835138,"about_ca_system_score_gemma":0.0016533037,"threshold_uncertainty_score":0.019470394},"labels":[],"label_agreement":null},{"id":"W2036471103","doi":"10.1185/030079905x56402","title":"Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada","funders":"","keywords":"Medicine; Mometasone furoate; Evening; Placebo; Asthma; Inhalation; Morning; Corticosteroid; Inhaler; Dry-powder inhaler; Clinical endpoint; Dosing; Anesthesia; Internal medicine; Randomized controlled trial","score_opus":0.05810863186133086,"score_gpt":0.37454886046167923,"score_spread":0.31644022860034837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036471103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952407,0.0037224817,0.00013041716,0.00013453639,0.000057801557,0.00012033766,0.00008163999,0.000021433661,0.00049069134],"genre_scores_gemma":[0.9981573,0.00084262254,0.00024316397,0.00018662708,0.00013545282,0.000106456435,0.00009940627,0.0000032049988,0.00022574923],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99943954,0.00029671803,0.000056624605,0.00006989959,0.00008242815,0.000054835153],"domain_scores_gemma":[0.998607,0.0005824658,0.00038586563,0.000084388776,0.000076017175,0.00026424826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013920963,0.00048286558,0.0016442499,0.00026520249,0.0003825254,0.0005766741,0.00038179115,0.0010083301,0.0014837048],"category_scores_gemma":[0.0021408908,0.0003496852,0.00091383664,0.00024330406,0.0005500207,0.00042446947,0.00019287413,0.0011953731,0.00029192367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7627366,0.016008172,0.03829237,0.0015318656,0.0016071951,0.00041541483,0.00025412135,0.00062958896,0.045140356,0.00006850545,0.00087873364,0.13243707],"study_design_scores_gemma":[0.28066012,0.5435309,0.1646038,0.00014613266,0.0016501611,0.0006146832,0.00014550853,0.0011145175,0.005805576,0.00010216298,0.001584904,0.00004152676],"about_ca_topic_score_codex":0.0003675559,"about_ca_topic_score_gemma":0.00054434506,"teacher_disagreement_score":0.0016442499,"about_ca_system_score_codex":0.00034404802,"about_ca_system_score_gemma":0.00042123307,"threshold_uncertainty_score":0.007362187},"labels":[],"label_agreement":null},{"id":"W2040005083","doi":"10.1185/03007995.2012.657302","title":"Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Rosuvastatin; Medicine; Tolerability; Internal medicine; Statin; Adverse effect; Simvastatin; Atorvastatin; Rosuvastatin Calcium; Gastroenterology; Diabetes mellitus; Endocrinology","score_opus":0.33369323085718666,"score_gpt":0.49896020723159556,"score_spread":0.1652669763744089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040005083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994286,0.00028465714,0.000027248898,0.000021460375,0.000003295028,0.000011774386,0.00011381351,9.545446e-7,0.000108199776],"genre_scores_gemma":[0.99939346,0.00015199347,0.00008296789,0.000059735947,0.000013362108,0.000016446635,0.00022681263,8.1154525e-7,0.00005449653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989686,0.0003397187,0.00017126041,0.0002052702,0.00017571224,0.00013943305],"domain_scores_gemma":[0.9969304,0.00049862626,0.0018327925,0.00013508934,0.00013752034,0.00046560797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010138091,0.00026583055,0.0008718449,0.00045807747,0.00057473197,0.0006658492,0.00032857206,0.00065442274,0.0014338864],"category_scores_gemma":[0.002730194,0.00042382418,0.000712735,0.001065021,0.0002480614,0.00053356367,0.0003443133,0.00069596997,0.00026061994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013208798,0.00025408625,0.9964959,0.000041490075,0.00014860435,0.0001217091,0.00010664708,0.000015662694,0.00015471356,0.000008687086,0.000069155954,0.0012623789],"study_design_scores_gemma":[0.0002136248,0.0019479133,0.9965203,0.000021744847,0.00011817378,0.00050532597,0.00026778792,0.00013870467,0.000035491412,0.000013336635,0.00020864891,0.000008967723],"about_ca_topic_score_codex":0.0027016953,"about_ca_topic_score_gemma":0.0037604442,"teacher_disagreement_score":0.0027016953,"about_ca_system_score_codex":0.00039954527,"about_ca_system_score_gemma":0.00043637017,"threshold_uncertainty_score":0.005371928},"labels":[],"label_agreement":null},{"id":"W2041031356","doi":"10.1185/030079906x112561","title":"Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Louis-H Lafontaine; AstraZeneca (Canada); Université de Montréal","funders":"","keywords":"Quetiapine; Medicine; Psychiatry; Schizophrenia (object-oriented programming); Extrapyramidal symptoms; Craving; Substance abuse; Clozapine; Cannabis; Psychosis; Addiction; Antipsychotic","score_opus":0.10499089369123789,"score_gpt":0.4098819037209551,"score_spread":0.30489101002971725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041031356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98972285,0.006265497,0.00028872298,0.00043748895,0.00020570465,0.0011604797,0.0006657798,0.00011653355,0.0011369756],"genre_scores_gemma":[0.9928018,0.0032421919,0.00062079757,0.00038241013,0.0003043378,0.00076688314,0.0007274684,0.000011928732,0.0011423737],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99963117,0.00014945808,0.000032776683,0.00006471113,0.000044924614,0.00007697883],"domain_scores_gemma":[0.99910223,0.00025606883,0.00019291062,0.000059938313,0.00006771554,0.00032107264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00103554,0.0013259086,0.002394626,0.00047842195,0.0004635321,0.0008412696,0.0007860681,0.0015554427,0.004644098],"category_scores_gemma":[0.0014230995,0.00036714756,0.0012649911,0.0005781066,0.0009816806,0.0008295039,0.00025876937,0.0017379018,0.0006566985],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93835884,0.009169172,0.0027883225,0.0011535352,0.0013065713,0.00027342935,0.00013537645,0.0004384407,0.006459176,0.00011819021,0.0010107171,0.03878828],"study_design_scores_gemma":[0.9473564,0.046290874,0.0044652233,0.00003801349,0.00028920698,0.00011782214,0.000031785792,0.00047016,0.0004092807,0.00006113949,0.0004547917,0.000015280268],"about_ca_topic_score_codex":0.002443166,"about_ca_topic_score_gemma":0.0067715594,"teacher_disagreement_score":0.004644098,"about_ca_system_score_codex":0.0012273957,"about_ca_system_score_gemma":0.0014746716,"threshold_uncertainty_score":0.01553607},"labels":[],"label_agreement":null},{"id":"W2041216910","doi":"10.1185/03007995.2013.786692","title":"Predictors of achieving HbA<sub>1c</sub> &lt;7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"Novo Nordisk; Bristol-Myers Squibb","keywords":"Medicine; Insulin aspart; Postprandial; Internal medicine; Diabetes mellitus; Insulin; Type 2 diabetes; Hypoglycemia; Observational study; Incidence (geometry); Regimen; Cohort; Endocrinology","score_opus":0.02573497210367938,"score_gpt":0.3233318535809332,"score_spread":0.2975968814772538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041216910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981864,0.0007603482,0.000052278352,0.000089935034,0.000016270158,0.000030205418,0.0003800795,0.0000043275986,0.0004801723],"genre_scores_gemma":[0.9982621,0.00027091973,0.0001009357,0.000102008016,0.000060282437,0.000029973658,0.00096801476,0.0000033756435,0.00020228236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991708,0.0002966187,0.00009461355,0.00014385517,0.00014651447,0.00014767148],"domain_scores_gemma":[0.99604756,0.000975336,0.0016605112,0.00024727426,0.00024636992,0.00082289154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021723176,0.00043980143,0.001151037,0.00040378107,0.00037471487,0.0009791054,0.000586236,0.00095086,0.0012869573],"category_scores_gemma":[0.0035584758,0.00040772898,0.0013494664,0.0007738213,0.00026671172,0.00062058464,0.00056294136,0.001555062,0.00018875263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010815589,0.00046218786,0.9844891,0.00007453733,0.00045490538,0.000084933825,0.000065044806,0.00022937296,0.00035342554,0.000035111272,0.00040107447,0.0025347432],"study_design_scores_gemma":[0.00091084314,0.0026445475,0.9946242,0.000023619074,0.0005111087,0.00012310297,0.00009655408,0.00068746833,0.0000793441,0.000041955238,0.00024212954,0.00001517233],"about_ca_topic_score_codex":0.0016765321,"about_ca_topic_score_gemma":0.0023039347,"teacher_disagreement_score":0.0021723176,"about_ca_system_score_codex":0.00030172497,"about_ca_system_score_gemma":0.00043104187,"threshold_uncertainty_score":0.011488497},"labels":[],"label_agreement":null},{"id":"W2044581275","doi":"10.1185/03007995.2013.795139","title":"Comparison of gastrointestinal safety and tolerability of aceclofenac with diclofenac: a multicenter, randomized, double-blind study in patients with knee osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diclofenac; Tolerability; Aceclofenac; Osteoarthritis; Adverse effect; Discontinuation; Internal medicine; Placebo; Anesthesia; Gastroenterology","score_opus":0.053062289657115694,"score_gpt":0.3960141481509415,"score_spread":0.3429518584938258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044581275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378055,0.0033488024,0.00049589796,0.00015703798,0.00016167054,0.0014675976,0.00022258275,0.000033940705,0.00033177895],"genre_scores_gemma":[0.9935011,0.0017720343,0.0016185361,0.0003758887,0.00045391926,0.0014339817,0.00037727406,0.000010841483,0.00045634105],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99783415,0.0012341543,0.00027172535,0.0002864165,0.00021949972,0.00015419774],"domain_scores_gemma":[0.99695325,0.00075049273,0.0010049745,0.00022510649,0.0002731369,0.00079305377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035766046,0.0012346279,0.0037663528,0.0005604305,0.0005753167,0.0009256358,0.000889963,0.0017544482,0.0036664736],"category_scores_gemma":[0.0035009691,0.0009081907,0.0020118828,0.0006111096,0.0014453729,0.0011542883,0.00046815933,0.0015355948,0.00058347394],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9643097,0.013414223,0.0018963905,0.00070611574,0.0009149685,0.00004294551,0.00007511354,0.00012475975,0.0077204527,0.000036795576,0.00012207954,0.010636544],"study_design_scores_gemma":[0.6995602,0.2940197,0.0044713067,0.000023463499,0.00058355497,0.000055338227,0.000033507113,0.00022855698,0.0007689934,0.000025707706,0.00021461013,0.0000149901125],"about_ca_topic_score_codex":0.00049337494,"about_ca_topic_score_gemma":0.0010199448,"teacher_disagreement_score":0.0037663528,"about_ca_system_score_codex":0.00053826004,"about_ca_system_score_gemma":0.0012539547,"threshold_uncertainty_score":0.018915117},"labels":[],"label_agreement":null},{"id":"W2047601746","doi":"10.1185/03007990903512396","title":"Undertreatment of hypercholesterolemia","year":2009,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.1455126765897489,"score_gpt":0.4490897593131414,"score_spread":0.30357708272339246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047601746","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054615815,0.0067666085,0.00030435756,0.95765996,0.018412463,0.000019335417,0.00006082161,0.0000355467,0.011279385],"genre_scores_gemma":[0.08157559,0.009777831,0.0004577372,0.8119532,0.08642842,0.00003426144,0.000053443422,0.00002382014,0.009695728],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984598,0.0006819238,0.00015512806,0.00020823245,0.00030867467,0.00018636434],"domain_scores_gemma":[0.9966618,0.0019839287,0.00044089995,0.00011145571,0.00046256138,0.00033947057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014345823,0.00047148843,0.0008065231,0.00040731582,0.0013285669,0.0011725979,0.00065079634,0.011870928,0.0032037331],"category_scores_gemma":[0.011283743,0.00023188267,0.0004935688,0.00045395465,0.0012831789,0.00091670925,0.00045046952,0.008840508,0.002016316],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018069094,0.00009718372,0.011952623,0.00034927882,0.00007416892,0.07200004,0.00059885456,0.00013145094,0.00097357144,0.0055720676,0.8444742,0.06359582],"study_design_scores_gemma":[0.00040703616,0.00031841168,0.026354013,0.002149684,0.00021090695,0.23778756,0.0013316768,0.0015145744,0.0012130898,0.0210765,0.7075456,0.00009097739],"about_ca_topic_score_codex":0.0027744742,"about_ca_topic_score_gemma":0.005023168,"teacher_disagreement_score":0.011870928,"about_ca_system_score_codex":0.0019433128,"about_ca_system_score_gemma":0.0010470215,"threshold_uncertainty_score":0.014099836},"labels":[],"label_agreement":null},{"id":"W2048088264","doi":"10.1185/03007995.2014.919908","title":"Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Genome British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Classifier (UML); Internal medicine; Prostatectomy; Cancer; Artificial intelligence","score_opus":0.08400146609774921,"score_gpt":0.44386760837072586,"score_spread":0.35986614227297664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048088264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924207,0.00011116274,0.000115013674,0.00008897363,0.0000059565887,0.0000091785305,0.0001027124,0.0000031180166,0.0003218973],"genre_scores_gemma":[0.99961877,0.000033015203,0.00013196788,0.0000297101,0.0000091201155,0.0000068268673,0.00010440565,0.0000016977169,0.000064373635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99594116,0.0027425468,0.00021168187,0.0003134969,0.0006660519,0.00012505689],"domain_scores_gemma":[0.95469856,0.029910814,0.010393747,0.0014605268,0.0017443972,0.0017919956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052191205,0.00024363553,0.00026896116,0.00035828908,0.00028970724,0.0009403528,0.00035298115,0.00044100906,0.0009670855],"category_scores_gemma":[0.0328098,0.00017599057,0.00053846504,0.000534447,0.0003481899,0.00054591545,0.00034752503,0.0007518521,0.00016310909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014471832,0.00018429742,0.9942813,0.000015770054,0.00019082597,0.000028228444,0.00012277943,0.00031175575,0.000058883707,0.000019827523,0.00014582477,0.003193418],"study_design_scores_gemma":[0.00007533016,0.0012487076,0.9940625,0.000012010977,0.0001763809,0.00013890714,0.00028849283,0.003382601,0.00016856725,0.00006176577,0.00037185784,0.00001273757],"about_ca_topic_score_codex":0.002233068,"about_ca_topic_score_gemma":0.0023374956,"teacher_disagreement_score":0.0052191205,"about_ca_system_score_codex":0.0003533404,"about_ca_system_score_gemma":0.0005463108,"threshold_uncertainty_score":0.02760166},"labels":[],"label_agreement":null},{"id":"W2048521093","doi":"10.1185/030079906x120968","title":"Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Dosing; Darbepoetin alfa; Cumulative dose; Erythropoietin; Internal medicine; Cancer","score_opus":0.034716047231888626,"score_gpt":0.38251526016441106,"score_spread":0.3477992129325224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048521093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990345,0.00036995483,0.000058561793,0.00009925945,0.000002095571,0.000008516438,0.00025177043,0.0000024833364,0.00017284762],"genre_scores_gemma":[0.99928015,0.00013093514,0.00014043324,0.00004169573,0.00001177394,0.000009745182,0.00034174914,0.0000011571924,0.000042271844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858034,0.0005281602,0.00023780973,0.00017586871,0.0003519282,0.00012592814],"domain_scores_gemma":[0.9917508,0.0016042904,0.0058709513,0.00011380414,0.00035243767,0.00030772336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081447104,0.00015289438,0.00031940878,0.0008297181,0.00025700743,0.000577366,0.00028627596,0.00046561615,0.00072488416],"category_scores_gemma":[0.008187325,0.00021276783,0.00043615059,0.0014637553,0.00015835754,0.0004598121,0.000290626,0.00038404888,0.000082920065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006433158,0.00003316085,0.9981628,0.0000068152012,0.000044159955,0.000038198417,0.000030655032,0.000096665826,0.00003632038,0.00000969567,0.000085012085,0.0013922084],"study_design_scores_gemma":[0.000014046053,0.00010918603,0.99835736,0.000010151758,0.00003478667,0.0003013507,0.000108456974,0.00085561693,0.00004334778,0.000018275481,0.00014455435,0.0000027458816],"about_ca_topic_score_codex":0.0061876746,"about_ca_topic_score_gemma":0.007517085,"teacher_disagreement_score":0.0061876746,"about_ca_system_score_codex":0.0007834003,"about_ca_system_score_gemma":0.00033376398,"threshold_uncertainty_score":0.012303293},"labels":[],"label_agreement":null},{"id":"W2050347354","doi":"10.1185/030079904125004006","title":"Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014)","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Abacavir; Lamivudine; Indinavir; Zidovudine; Regimen; Tolerability; Population; Internal medicine; Viral load; Intention-to-treat analysis; Gastroenterology; Randomized controlled trial; Immunology; Adverse effect; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus","score_opus":0.18496230111015938,"score_gpt":0.4390745304334409,"score_spread":0.25411222932328154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050347354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995719,0.0022197815,0.00016834747,0.00023023848,0.00014686707,0.00047117774,0.0002606805,0.000031424748,0.0007525042],"genre_scores_gemma":[0.9960866,0.0010920673,0.0006090115,0.00038962747,0.00022148916,0.00048303822,0.00039985494,0.0000082866845,0.0007101106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99895513,0.00068528333,0.00007368628,0.00013745498,0.0000625204,0.00008584372],"domain_scores_gemma":[0.9984755,0.00048250728,0.00036898185,0.0001024144,0.000089265595,0.00048128987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015780027,0.0009829552,0.0028453292,0.00029678218,0.0002858393,0.0008010665,0.0008826859,0.0014237163,0.004866385],"category_scores_gemma":[0.0023623742,0.00040933973,0.001235346,0.00031576908,0.0009054431,0.00091876544,0.00036930607,0.00237307,0.0005554254],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9708547,0.0056417705,0.0006909337,0.00033943367,0.00066647184,0.000022006347,0.000043746153,0.00015051063,0.001895657,0.000048458984,0.0002739603,0.019372372],"study_design_scores_gemma":[0.83569884,0.15746973,0.004663594,0.000040079787,0.0006238751,0.000049014518,0.00003024804,0.00055764563,0.00045579567,0.00011306689,0.00028440577,0.000013733364],"about_ca_topic_score_codex":0.0008531827,"about_ca_topic_score_gemma":0.0013091841,"teacher_disagreement_score":0.004866385,"about_ca_system_score_codex":0.0005173908,"about_ca_system_score_gemma":0.0006049117,"threshold_uncertainty_score":0.016279697},"labels":[],"label_agreement":null},{"id":"W2052628556","doi":"10.1185/03007995.2013.874992","title":"Efficacy and safety of the adjustable gastric band – pooled interim analysis of the APEX and HERO studies at 48 weeks","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; HERO; Apex (geometry); Adjustable gastric band; Interim analysis; Internal medicine; Surgery; Clinical trial; Weight loss; Anatomy; Obesity; Gastric bypass","score_opus":0.10793692970021856,"score_gpt":0.4211310819086208,"score_spread":0.31319415220840224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052628556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91580737,0.05854091,0.0053088274,0.0004409756,0.00044738926,0.0018893199,0.012401641,0.00016736795,0.0049962243],"genre_scores_gemma":[0.9854134,0.0034756945,0.0021748277,0.00036439678,0.0003826218,0.0013118759,0.005296572,0.00004926791,0.0015314787],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909428,0.0049641556,0.0012347125,0.0009864595,0.0014272935,0.00044469113],"domain_scores_gemma":[0.979498,0.009312087,0.0073046633,0.001831957,0.0015409656,0.0005122256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015820054,0.0013694812,0.005039586,0.0010749567,0.00024421533,0.0018417755,0.00060576125,0.0010276757,0.0028682004],"category_scores_gemma":[0.015676638,0.0006695157,0.011824481,0.0008780433,0.00036277625,0.001268522,0.0009522439,0.0015632398,0.00035488466],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66935855,0.001024557,0.087786615,0.0096526565,0.17348477,0.0002103244,0.00015895996,0.0023645414,0.005298999,0.00019044222,0.0025559058,0.04791366],"study_design_scores_gemma":[0.07999543,0.11888914,0.47695053,0.0014476972,0.30076295,0.0008742082,0.00035085191,0.0050238078,0.006793261,0.0007708624,0.0078817,0.00025954365],"about_ca_topic_score_codex":0.00023176044,"about_ca_topic_score_gemma":0.00050482893,"teacher_disagreement_score":0.015820054,"about_ca_system_score_codex":0.00037259754,"about_ca_system_score_gemma":0.00063255057,"threshold_uncertainty_score":0.08366543},"labels":[],"label_agreement":null},{"id":"W2054439906","doi":"10.1185/030079902125000651","title":"GABA Agonist: Clomethiazole","year":2002,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Agonist; Glutamate receptor; Neuroprotection; Pharmacology; Anesthesia; Depolarization; Neurotransmitter; Neuroscience; NMDA receptor; Central nervous system; Internal medicine; Receptor; Biology","score_opus":0.4875499766340358,"score_gpt":0.5270043245140522,"score_spread":0.039454347880016394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054439906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008491602,0.9929229,0.00030716058,0.00046688516,0.0003493528,0.000021533608,0.00004228744,0.000037754835,0.005002986],"genre_scores_gemma":[0.007585692,0.98206574,0.00053330854,0.0006328419,0.0003435267,0.00003125619,0.000101949925,0.0000056131576,0.008699993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999286,0.000015936768,0.000009257192,0.00001607997,0.000022061664,0.000008034884],"domain_scores_gemma":[0.99994504,0.000012658383,0.000017320184,0.0000020849525,0.000014954788,0.00000803379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014404749,0.0009697547,0.0009159589,0.0011338751,0.0002079971,0.000456175,0.00060757453,0.0008855023,0.008056434],"category_scores_gemma":[0.00018818676,0.00012425521,0.00022017202,0.0009526699,0.0002511899,0.000393566,0.00028382085,0.0007111843,0.0058652353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030715403,0.00011151618,0.00014588375,0.015250647,0.00006851206,0.0012078881,0.000053981476,0.00018158367,0.012836082,0.0014550181,0.031661056,0.93672067],"study_design_scores_gemma":[0.00014361541,0.0002677098,0.0013636439,0.0016620761,0.00009803542,0.0059095807,0.000076399,0.00006824494,0.0044595776,0.000586235,0.9853512,0.000013784508],"about_ca_topic_score_codex":0.0012694745,"about_ca_topic_score_gemma":0.002969804,"teacher_disagreement_score":0.008056434,"about_ca_system_score_codex":0.00038620457,"about_ca_system_score_gemma":0.00037973843,"threshold_uncertainty_score":0.026951432},"labels":[],"label_agreement":null},{"id":"W2056290188","doi":"10.1185/030079904125004051","title":"Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Medicine; Abacavir; Regimen; Lamivudine; Internal medicine; Zidovudine; Indinavir; Randomized controlled trial; Population; Viral load; Dosing; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus","score_opus":0.08232951022776082,"score_gpt":0.39161202277814156,"score_spread":0.30928251255038075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056290188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997192,0.00011661867,0.000015399604,0.00002619144,0.0000022295803,0.0000061254755,0.000030044157,7.4114257e-7,0.00008336372],"genre_scores_gemma":[0.9997929,0.000040584448,0.00003619625,0.000019361045,0.000007137305,0.000004769885,0.00006090077,4.4426793e-7,0.000037633727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961096,0.0001582025,0.000055075387,0.00004747637,0.00008165918,0.00004673149],"domain_scores_gemma":[0.9983216,0.00057119597,0.00061675865,0.0000497003,0.00009245237,0.00034830885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007614252,0.00020157149,0.0004017002,0.00024049722,0.00029156875,0.00038258324,0.0001798067,0.0005301802,0.0010680616],"category_scores_gemma":[0.0028613515,0.0001960596,0.00035804202,0.0003688879,0.00017940954,0.00027075858,0.00018335207,0.00058018015,0.00011973254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011460681,0.0002175439,0.9961902,0.000010950186,0.00008315783,0.000041115458,0.00003788951,0.000089682966,0.00020443044,0.000007986353,0.000051384177,0.0019196252],"study_design_scores_gemma":[0.00016544617,0.0013170069,0.99695456,0.000008903358,0.00007194639,0.00018738926,0.00007665764,0.001048854,0.0000722676,0.000018507291,0.00007459476,0.0000037191428],"about_ca_topic_score_codex":0.0012215106,"about_ca_topic_score_gemma":0.001284239,"teacher_disagreement_score":0.0012215106,"about_ca_system_score_codex":0.00016257125,"about_ca_system_score_gemma":0.00019115607,"threshold_uncertainty_score":0.00402683},"labels":[],"label_agreement":null},{"id":"W2057332288","doi":"10.1185/03007995.2013.837817","title":"Early use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in Type 2 diabetes","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Canadian Diabetes Association","keywords":"Medicine; Exenatide; Liraglutide; Metformin; Type 2 diabetes; Incretin; Hypoglycemia; Glucagon-like peptide 1 receptor; Diabetes mellitus; Internal medicine; Glycemic; Clinical trial; Pharmacology; Endocrinology; Agonist; Receptor","score_opus":0.22692591207380713,"score_gpt":0.45767175723437686,"score_spread":0.23074584516056973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057332288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.041390423,0.95241797,0.00031581265,0.001407605,0.00048061166,0.0004705866,0.00061847124,0.000013047632,0.0028853866],"genre_scores_gemma":[0.30993214,0.68074805,0.002457803,0.0033893173,0.001387959,0.0007106353,0.000699102,0.000013631457,0.00066130277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922868,0.0037236435,0.0018879146,0.00047289755,0.0014048875,0.00022383714],"domain_scores_gemma":[0.97336775,0.017396053,0.0062951297,0.00034108153,0.0020201649,0.0005798878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010378686,0.0005496259,0.002566603,0.0019168722,0.00026767544,0.0022990708,0.0008871209,0.0019520238,0.0047032423],"category_scores_gemma":[0.020019634,0.00037345832,0.002676242,0.002720839,0.0004808334,0.0018732259,0.00076081854,0.0012382352,0.00046456076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041890815,0.0020188317,0.021442555,0.37943953,0.0063502765,0.0011042847,0.0006167738,0.00030544892,0.0034208414,0.0006461684,0.0037378622,0.5390266],"study_design_scores_gemma":[0.045575075,0.069531165,0.17284691,0.48782107,0.052206088,0.0065617515,0.0016275104,0.00075297855,0.008810736,0.0023048702,0.15162943,0.00033248423],"about_ca_topic_score_codex":0.0009481536,"about_ca_topic_score_gemma":0.0020886092,"teacher_disagreement_score":0.010378686,"about_ca_system_score_codex":0.0008303018,"about_ca_system_score_gemma":0.0020394265,"threshold_uncertainty_score":0.054888427},"labels":[],"label_agreement":null},{"id":"W2058758881","doi":"10.1185/03007990802484234","title":"The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Respiratory viral infections research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; St. Joseph’s Healthcare Hamilton; McMaster University; McMaster Children's Hospital; Toronto Rehabilitation Institute; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Gestational age; Respiratory system; Pediatrics; Bronchopulmonary dysplasia; Pregnancy; Internal medicine","score_opus":0.14225546417479512,"score_gpt":0.45932642881124514,"score_spread":0.31707096463645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058758881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8580132,0.02258106,0.006233757,0.0032205654,0.00015405561,0.0024240315,0.08791992,0.00011737674,0.019336008],"genre_scores_gemma":[0.9736311,0.0064079696,0.0043327324,0.0003280157,0.000033155044,0.00039486168,0.012660742,0.00003611819,0.0021753085],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9970402,0.00094867917,0.00017358,0.0002750024,0.0007886909,0.0007738043],"domain_scores_gemma":[0.9943047,0.0024611587,0.00068492995,0.00018459673,0.0017189031,0.0006455508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045580408,0.0019336876,0.0028667701,0.0039498955,0.0010879429,0.0024654486,0.0034530673,0.0014956611,0.0054184077],"category_scores_gemma":[0.011514933,0.0010867749,0.0100728795,0.0069914763,0.00073008094,0.0006383066,0.0013139071,0.0023490621,0.00027022965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01398007,0.0007854379,0.14887695,0.0067518665,0.027929977,0.0011045359,0.0003171972,0.7384442,0.0011628069,0.013083655,0.017405976,0.030157385],"study_design_scores_gemma":[0.006929912,0.001946867,0.25345954,0.0021868078,0.027871724,0.001035256,0.0011231769,0.6815009,0.0011512337,0.004846905,0.017264603,0.0006830595],"about_ca_topic_score_codex":0.9774196,"about_ca_topic_score_gemma":0.9615385,"teacher_disagreement_score":0.08409303,"about_ca_system_score_codex":0.08409303,"about_ca_system_score_gemma":0.06571468,"threshold_uncertainty_score":0.61014044},"labels":[],"label_agreement":null},{"id":"W2058810731","doi":"10.1185/03007995.2013.867843","title":"Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation?","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Propensity score matching; Internal medicine; Cohort; Stroke (engine); Retrospective cohort study; Emergency medicine","score_opus":0.0679400469636449,"score_gpt":0.38356245780021464,"score_spread":0.3156224108365697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058810731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972293,0.0014488733,0.00006107326,0.00046734486,0.00003127357,0.0000046170585,0.00039217013,0.0000024319472,0.00036288163],"genre_scores_gemma":[0.99903023,0.00028699456,0.000044704193,0.00007484723,0.00005191586,0.000004398026,0.00045131487,0.0000018680897,0.000053706764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989046,0.00026732244,0.0002024305,0.00026040748,0.00020067883,0.00016458346],"domain_scores_gemma":[0.992239,0.0011352766,0.0052254037,0.00019599711,0.00039080318,0.0008134577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011634893,0.0002475841,0.00054969214,0.00091088796,0.00034291894,0.001107252,0.0006662139,0.00084331987,0.0022781303],"category_scores_gemma":[0.006380547,0.00019874207,0.0014375672,0.0018969706,0.00033672032,0.00084620155,0.0004623463,0.00089879497,0.00020940098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024885722,0.000021880427,0.9984995,0.000019146793,0.00015412069,0.000037616417,0.000026485544,0.000027684255,0.000040626444,0.000018218983,0.00009181866,0.0008140546],"study_design_scores_gemma":[0.000013571027,0.000099192315,0.9990988,0.000013580154,0.0000869049,0.00016899445,0.00016235618,0.00018547245,0.000021418153,0.000039834435,0.00010483482,0.0000051705347],"about_ca_topic_score_codex":0.0028728573,"about_ca_topic_score_gemma":0.0032702363,"teacher_disagreement_score":0.0028728573,"about_ca_system_score_codex":0.0005540031,"about_ca_system_score_gemma":0.0005526749,"threshold_uncertainty_score":0.00762105},"labels":[],"label_agreement":null},{"id":"W2059079195","doi":"10.1185/03007995.2015.1027185","title":"Single-pill combination therapy for type 2 diabetes mellitus: linagliptin plus empagliflozin","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Linagliptin; Empagliflozin; Medicine; Metformin; Type 2 diabetes; Type 2 Diabetes Mellitus; Pill; Glycemic; Diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Internal medicine; Endocrinology","score_opus":0.36926063485675414,"score_gpt":0.5114607009127419,"score_spread":0.14220006605598773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059079195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037153042,0.98738146,0.00049410516,0.0010639232,0.00039086115,0.00041770533,0.0016799421,0.000033543693,0.004823155],"genre_scores_gemma":[0.04414178,0.9414562,0.004459363,0.0030862677,0.0010735448,0.0012214246,0.0023826358,0.000019119307,0.0021596856],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975873,0.0007601553,0.00076978613,0.00022955152,0.00059469003,0.000058514954],"domain_scores_gemma":[0.9941631,0.0033736,0.0019059095,0.000079417296,0.00037576465,0.00010220729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033091058,0.00044036756,0.0024141564,0.0047738627,0.0002479387,0.0013990846,0.0006075919,0.00095779245,0.017278204],"category_scores_gemma":[0.0063071405,0.00024107,0.0024838499,0.0067250566,0.00032708218,0.0015416304,0.0006000389,0.0005817445,0.0020686316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020299593,0.00012505232,0.001737639,0.49214613,0.0037026913,0.00029202533,0.00014047438,0.00009159578,0.0008995185,0.0007350357,0.017011488,0.48108837],"study_design_scores_gemma":[0.0068368255,0.002520975,0.026816024,0.55330443,0.03327453,0.005081851,0.00046629077,0.00050511735,0.0016556119,0.0028845253,0.3665143,0.00013945387],"about_ca_topic_score_codex":0.00062597194,"about_ca_topic_score_gemma":0.002225225,"teacher_disagreement_score":0.017278204,"about_ca_system_score_codex":0.0006581578,"about_ca_system_score_gemma":0.0016019944,"threshold_uncertainty_score":0.057801306},"labels":[],"label_agreement":null},{"id":"W2059142294","doi":"10.1185/03007995.2012.748654","title":"Major depressive disorder severity and the frequency of painful physical symptoms: a pooled analysis of observational studies","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Observational study; Medicine; Depression (economics); Major depressive disorder; Anxiety; Logistic regression; Physical therapy; Longitudinal study; Odds ratio; Post-hoc analysis; Internal medicine; Psychiatry; Mood","score_opus":0.13270354148571759,"score_gpt":0.4601563853263587,"score_spread":0.3274528438406411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059142294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5701673,0.4071762,0.007992547,0.00038077324,0.00042090737,0.00071828347,0.01212962,0.000098921824,0.00091550266],"genre_scores_gemma":[0.97334516,0.020231472,0.002330247,0.00016201875,0.00019033448,0.00049841485,0.003107521,0.00001948683,0.000115461095],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.966475,0.018308336,0.0087781865,0.0036231128,0.0023217062,0.00049373484],"domain_scores_gemma":[0.9263893,0.04216399,0.022880549,0.004751286,0.003111671,0.0007031763],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.030557131,0.001212831,0.005469677,0.0052985363,0.00032242268,0.0022213832,0.0009180252,0.0009269834,0.00096898444],"category_scores_gemma":[0.046230804,0.0009019155,0.017824104,0.0053472943,0.0004156146,0.000878663,0.0015024587,0.0006578975,0.00011328525],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005115512,0.000035915655,0.46979842,0.011492665,0.5052059,0.00016121767,0.00010538937,0.0007207488,0.00046652486,0.000102394704,0.00047320765,0.0063221413],"study_design_scores_gemma":[0.00135372,0.0013101617,0.5481033,0.0027946436,0.44113863,0.0006504465,0.000301993,0.0016655797,0.00036369995,0.00032947658,0.0019118333,0.00007657414],"about_ca_topic_score_codex":0.0018998854,"about_ca_topic_score_gemma":0.0020134547,"teacher_disagreement_score":0.9945303,"about_ca_system_score_codex":0.00056556077,"about_ca_system_score_gemma":0.000761291,"threshold_uncertainty_score":0.16160345},"labels":[],"label_agreement":null},{"id":"W2062448901","doi":"10.1185/03007995.2014.944973","title":"Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nilotinib; Imatinib; Internal medicine; Adverse effect; Incidence (geometry); Imatinib mesylate; Quality of life (healthcare); Chronic myelogenous leukemia; Philadelphia chromosome; Bosutinib; Tyrosine-kinase inhibitor; Myeloid leukemia; Gastroenterology; Leukemia; Cancer","score_opus":0.09152452362728754,"score_gpt":0.45543503688559417,"score_spread":0.36391051325830664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062448901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986106,0.00073021173,0.00008640019,0.00005863858,0.000004853714,0.0000132837185,0.00029396397,0.0000016033885,0.00020033719],"genre_scores_gemma":[0.99942774,0.00009114899,0.00006245102,0.00002734582,0.0000067159754,0.000009050398,0.0003278003,4.2529453e-7,0.00004731698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874973,0.0006913634,0.0001522307,0.0001042075,0.00019416533,0.00010826207],"domain_scores_gemma":[0.995503,0.0016142773,0.0022885387,0.00008512381,0.0002170599,0.0002920913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021466631,0.00017647132,0.00045038402,0.00028665806,0.00015317748,0.0004485905,0.00015124933,0.00021573498,0.001160325],"category_scores_gemma":[0.004994089,0.00007250842,0.00077802705,0.00046442947,0.0001400608,0.00032536697,0.0003184853,0.00045622024,0.000082824445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013215722,0.000083976,0.9918356,0.00006205327,0.0002808029,0.000033290067,0.00001792733,0.00024641515,0.00016739593,0.000009998456,0.00009253011,0.005848376],"study_design_scores_gemma":[0.000062672494,0.00072540937,0.99827886,0.0000113989545,0.00013441841,0.00010553823,0.000025394624,0.00043176766,0.00008936896,0.00001499262,0.000117613745,0.0000026362184],"about_ca_topic_score_codex":0.00053744076,"about_ca_topic_score_gemma":0.0013412904,"teacher_disagreement_score":0.0021466631,"about_ca_system_score_codex":0.00021411853,"about_ca_system_score_gemma":0.00021272786,"threshold_uncertainty_score":0.0113527775},"labels":[],"label_agreement":null},{"id":"W2062482109","doi":"10.1185/030079908x297231","title":"Chondroitin sulphate for symptomatic osteoarthritis: critical appraisal of meta-analyses","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Proteoglycans and glycosaminoglycans research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"Pfizer","keywords":"Medicine; Tolerability; Placebo; Meta-analysis; Osteoarthritis; Acetaminophen; Internal medicine; Clinical trial; Analgesic; Chondroitin sulphate; Randomized controlled trial; Dosing; Physical therapy; Adverse effect; Anesthesia; Alternative medicine; Pathology","score_opus":0.3959808938835189,"score_gpt":0.581649663551936,"score_spread":0.1856687696684171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062482109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052991835,0.99058366,0.0016393646,0.00033321913,0.00029122087,0.00096697017,0.0005432463,0.00005641532,0.00028666487],"genre_scores_gemma":[0.30425826,0.6784097,0.00875571,0.0012654595,0.00069715,0.0048745205,0.001210854,0.00009406908,0.00043425232],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.96178883,0.02678125,0.005967805,0.0020328537,0.002931402,0.0004979286],"domain_scores_gemma":[0.9321016,0.05390123,0.008679516,0.0017074232,0.0030146048,0.0005956305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04313645,0.0043247845,0.027136771,0.008516817,0.0006991839,0.0034206274,0.0037292284,0.0028987247,0.0042606923],"category_scores_gemma":[0.08408034,0.0022371174,0.056789786,0.007921208,0.0011602046,0.0021759174,0.0019163998,0.002702334,0.00035102526],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035674714,0.000025750629,0.001834938,0.18625067,0.80025214,0.0000850797,0.00005529203,0.0008783707,0.000108961576,0.00010324277,0.00040557134,0.006432518],"study_design_scores_gemma":[0.0016290767,0.0003038526,0.0021313936,0.0132689215,0.98081803,0.00006922331,0.000035703757,0.0004361394,0.00009867266,0.00030163585,0.0008809859,0.000026372685],"about_ca_topic_score_codex":0.006035121,"about_ca_topic_score_gemma":0.00920974,"teacher_disagreement_score":0.04313645,"about_ca_system_score_codex":0.00422935,"about_ca_system_score_gemma":0.0034514943,"threshold_uncertainty_score":0.22813004},"labels":[],"label_agreement":null},{"id":"W2063443588","doi":"10.1185/03007995.2013.802230","title":"Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer’s disease: the EMBRACE study","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Toronto; Université de Montréal; McGill University","funders":"","keywords":"Medicine; Tolerability; Rivastigmine; Internal medicine; Transdermal patch; Quality of life (healthcare); Adverse effect; Dementia; Disease; Transdermal; Donepezil; Pharmacology","score_opus":0.055553451928397106,"score_gpt":0.3999487300846192,"score_spread":0.34439527815622206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063443588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999233,0.0003294424,0.000032547963,0.000019935374,0.000003267867,0.0000501147,0.00014275247,0.0000021774918,0.00018682872],"genre_scores_gemma":[0.9989661,0.00024478504,0.00013254318,0.000057129277,0.000020946412,0.00004566286,0.00033618973,0.0000011432128,0.00019555501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999485,0.00020229466,0.00004842051,0.00007647211,0.00014124802,0.00004665605],"domain_scores_gemma":[0.9986437,0.0002352218,0.0006514582,0.0000743075,0.00014850499,0.00024690395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014835134,0.00043414027,0.00087664806,0.00014689642,0.00026106433,0.0004630889,0.0002596071,0.00037171683,0.00080143876],"category_scores_gemma":[0.0017906048,0.00020107874,0.0007121124,0.0002843498,0.00030828547,0.00043711314,0.00019700086,0.000505125,0.0001694778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18905784,0.010972358,0.7312068,0.000521779,0.0023381046,0.0004550111,0.00081788085,0.0006679692,0.009959054,0.000043537602,0.00081396487,0.053145684],"study_design_scores_gemma":[0.013858371,0.06471756,0.9168119,0.000028509508,0.0006984724,0.0006298694,0.00019460318,0.0006701384,0.001235715,0.000024207751,0.0010912846,0.00003927676],"about_ca_topic_score_codex":0.0038850745,"about_ca_topic_score_gemma":0.00650414,"teacher_disagreement_score":0.0038850745,"about_ca_system_score_codex":0.0005873711,"about_ca_system_score_gemma":0.000551621,"threshold_uncertainty_score":0.0078457},"labels":[],"label_agreement":null},{"id":"W2063984158","doi":"10.1185/030079908x280545","title":"Efficacy and tolerability of intramuscular interferon beta-1a compared with subcutaneous interferon beta-1a in relapsing MS: results from PROOF","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Tolerability; Interferon beta-1a; Intramuscular injection; BETA (programming language); Interferon; Adverse effect; Interferon beta; Pharmacology; Internal medicine; Immunology","score_opus":0.17177108392703672,"score_gpt":0.4099728827756343,"score_spread":0.2382017988485976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063984158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910727,0.007899737,0.00030962203,0.00007030679,0.000029655292,0.00012064072,0.00017242119,0.000015194067,0.0003096548],"genre_scores_gemma":[0.99670106,0.0019648387,0.0006433261,0.000071387345,0.00010020113,0.000076112265,0.00022862628,0.000008348178,0.00020618843],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979956,0.0013136875,0.00022254413,0.00014625887,0.00024081492,0.00008102935],"domain_scores_gemma":[0.9925811,0.0037194341,0.002571699,0.00039573386,0.00033396622,0.00039811982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045599844,0.0005104175,0.0012122691,0.0003016367,0.00013580512,0.0005301223,0.0004714693,0.0005693335,0.0016864464],"category_scores_gemma":[0.0051730904,0.0002566876,0.0016594905,0.00020898528,0.0006486786,0.00067651237,0.00034030573,0.0008671717,0.0002600959],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7727979,0.008851129,0.03229877,0.002299939,0.003038118,0.00014911957,0.00038855578,0.0005828848,0.022726553,0.00015190632,0.00053118524,0.15618402],"study_design_scores_gemma":[0.05975157,0.80141324,0.119427375,0.00023929562,0.0034469664,0.00076433347,0.00016249623,0.0010032941,0.012170679,0.00015752844,0.0014160926,0.00004714824],"about_ca_topic_score_codex":0.00018886804,"about_ca_topic_score_gemma":0.00017296214,"teacher_disagreement_score":0.0045599844,"about_ca_system_score_codex":0.00026275113,"about_ca_system_score_gemma":0.00031574862,"threshold_uncertainty_score":0.024115741},"labels":[],"label_agreement":null},{"id":"W2064266976","doi":"10.1185/03007995.2015.1013625","title":"Six-minute walk test in Chinese adults with clinically stable bronchiectasis: association with clinical indices and determinants","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Infection and Immunity","keywords":"Bronchiectasis; Medicine; Spirometry; DLCO; Internal medicine; Quality of life (healthcare); Diffusing capacity; Physical therapy; Pediatrics; Lung; Lung function; Asthma","score_opus":0.08031396074731945,"score_gpt":0.4720257132296111,"score_spread":0.3917117524822917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064266976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99932003,0.000262525,0.000019488514,0.00004622983,0.0000035772925,0.000006016465,0.00007849842,0.000001336943,0.00026223075],"genre_scores_gemma":[0.99977416,0.000047886082,0.00001654168,0.000014654669,0.0000046336813,0.0000031483817,0.000096131174,2.8855698e-7,0.000042574717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976104,0.000032773627,0.000037747977,0.000052061718,0.000060002098,0.000056398694],"domain_scores_gemma":[0.9992805,0.00009998885,0.00027566345,0.000036814236,0.000101989346,0.00020503745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038794422,0.00030526042,0.0003577462,0.0005999577,0.00043623606,0.0003478412,0.00024777398,0.00041081585,0.0011285018],"category_scores_gemma":[0.0011526166,0.0001419948,0.00030689896,0.0006826863,0.00029913028,0.00024169324,0.0002516372,0.00038152534,0.000127192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042527805,0.000012545289,0.9993593,0.0000063871294,0.0000140315915,0.00006259456,0.000023283297,0.000012075091,0.00010542881,0.000005454632,0.000023520488,0.0003329549],"study_design_scores_gemma":[0.0000020913794,0.0000399512,0.9996927,0.0000020502264,0.000010206201,0.000092714,0.000047042646,0.00006737738,0.000013216741,0.000005791741,0.000025927464,8.909384e-7],"about_ca_topic_score_codex":0.011588182,"about_ca_topic_score_gemma":0.012799306,"teacher_disagreement_score":0.011588182,"about_ca_system_score_codex":0.0003648696,"about_ca_system_score_gemma":0.0005000705,"threshold_uncertainty_score":0.023041487},"labels":[],"label_agreement":null},{"id":"W2064799289","doi":"10.1185/030079905x75087","title":"The economic burden of schizophrenia in Canada in 2004","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"National Institute of Mental Health","keywords":"Medicine; Schizophrenia (object-oriented programming); Government (linguistics); Productivity; Indirect costs; Health care; Unemployment; Economic cost; Psychiatry; MEDLINE; Environmental health; Gerontology; Demography; Economic growth; Business; Accounting","score_opus":0.0509386803591048,"score_gpt":0.3887010100075109,"score_spread":0.3377623296484061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064799289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67946357,0.097202845,0.002941391,0.016599096,0.0004380248,0.0010336031,0.16692355,0.0002579625,0.03513998],"genre_scores_gemma":[0.9228135,0.041348938,0.005443623,0.0011018333,0.00010991544,0.00031699648,0.022164391,0.00002859342,0.006672236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823606,0.00022378142,0.00013258724,0.00008625502,0.00095787743,0.0003634396],"domain_scores_gemma":[0.9962597,0.00019629518,0.0006758057,0.000030551328,0.0025023937,0.0003354014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015561242,0.00096175104,0.00065193675,0.00753917,0.0019568345,0.0025222672,0.0010400678,0.00052050286,0.0020630548],"category_scores_gemma":[0.0062358254,0.0003707107,0.0013562345,0.010134826,0.0005291944,0.00056317536,0.00087408157,0.0006466756,0.00022218151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095615385,0.00014275285,0.7966708,0.0038306206,0.0017797414,0.0013811447,0.0012325464,0.029197328,0.0005073242,0.0055236467,0.044653136,0.114124805],"study_design_scores_gemma":[0.00018702533,0.00013633778,0.93553144,0.0017283694,0.00097370724,0.000597417,0.002233037,0.013108369,0.0005348334,0.0012497677,0.043585483,0.00013412679],"about_ca_topic_score_codex":0.99647325,"about_ca_topic_score_gemma":0.99685776,"teacher_disagreement_score":0.13316298,"about_ca_system_score_codex":0.13316298,"about_ca_system_score_gemma":0.12995057,"threshold_uncertainty_score":0.96616954},"labels":[],"label_agreement":null},{"id":"W2067585939","doi":"10.1185/03007995.2015.1027183","title":"Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Osteoarthritis; Medicine; Rheumatology; Drug class; Interpretation (philosophy); Physical therapy; Alternative medicine; Osteoporosis; Intensive care medicine; Internal medicine; Drug; Pathology; Psychiatry","score_opus":0.2891479671736384,"score_gpt":0.4439503389713015,"score_spread":0.1548023717976631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067585939","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016754358,0.002426794,0.00038877482,0.9260229,0.06997709,0.000023310009,0.00010584652,0.00003518401,0.00085256225],"genre_scores_gemma":[0.0020315123,0.0017106952,0.00072949193,0.93935704,0.055010617,0.000043304823,0.000045735123,0.000043856377,0.0010276664],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.94929904,0.017539266,0.012806451,0.0036019983,0.014701205,0.0020520906],"domain_scores_gemma":[0.7498099,0.16007797,0.017801827,0.006044092,0.059242293,0.0070238146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050866097,0.0014105231,0.0024043908,0.0026014203,0.0037187394,0.0052809655,0.008566702,0.05625266,0.0052789147],"category_scores_gemma":[0.27852735,0.0015136235,0.004499796,0.0028201698,0.008680063,0.006151715,0.0037914196,0.065233946,0.0070212875],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012291186,0.000020285244,0.0003101394,0.00037435468,0.00005747845,0.0005984023,0.0004124577,0.000100065394,0.00018080766,0.0028792256,0.9857137,0.009230188],"study_design_scores_gemma":[0.00014610155,0.00008066032,0.0009974816,0.0021735006,0.00012490973,0.0014062393,0.00075642066,0.00028016834,0.0005872533,0.006698765,0.9866175,0.00013100343],"about_ca_topic_score_codex":0.006555738,"about_ca_topic_score_gemma":0.005949022,"teacher_disagreement_score":0.05625266,"about_ca_system_score_codex":0.0069940793,"about_ca_system_score_gemma":0.0067302026,"threshold_uncertainty_score":0.26900887},"labels":[],"label_agreement":null},{"id":"W2070555238","doi":"10.1185/030079907x182202","title":"Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Otsuka Pharmaceutical; Otsuka America; Otsuka America Pharmaceutical","keywords":"Duloxetine; Duloxetine Hydrochloride; Medicine; Placebo; Nausea; Internal medicine; Adverse effect; Clinical endpoint; Anxiety; Clinical trial; Generalized anxiety disorder; Randomized controlled trial; Escitalopram; Psychiatry; Antidepressant","score_opus":0.382866705017147,"score_gpt":0.6069214512962262,"score_spread":0.22405474627907923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070555238","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13033175,0.8554898,0.0032690242,0.0007124727,0.00042409278,0.0023964788,0.0050001354,0.00025198536,0.0021242632],"genre_scores_gemma":[0.80545735,0.18096662,0.0033431503,0.0010831094,0.0005288066,0.0027324993,0.0052288636,0.00012331965,0.00053638854],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9734504,0.015471633,0.005788612,0.0023301237,0.0023965137,0.0005626442],"domain_scores_gemma":[0.9733655,0.01397935,0.0086885635,0.0015671074,0.0019179791,0.00048162934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02053711,0.002915757,0.0166693,0.0041413046,0.0004487081,0.0035344886,0.0010799577,0.0019557814,0.002847848],"category_scores_gemma":[0.03421338,0.001263705,0.033200074,0.0048585427,0.0007108505,0.0012907806,0.0015904148,0.001198121,0.00034730442],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049626235,0.000106115906,0.009168327,0.034066536,0.87493104,0.00013937808,0.000098321034,0.00093602453,0.00085020857,0.000064934946,0.00094937073,0.029063508],"study_design_scores_gemma":[0.022238309,0.0029824376,0.030720105,0.0031847714,0.9374349,0.00025482167,0.00006957951,0.00045195688,0.0003898407,0.00020706287,0.001994287,0.000072043746],"about_ca_topic_score_codex":0.001402889,"about_ca_topic_score_gemma":0.0029963497,"teacher_disagreement_score":0.02053711,"about_ca_system_score_codex":0.0016560969,"about_ca_system_score_gemma":0.0017649889,"threshold_uncertainty_score":0.10861188},"labels":[],"label_agreement":null},{"id":"W2071657833","doi":"10.1185/03007995.2013.835715","title":"Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland; Waypoint Centre for Mental Health Care","funders":"","keywords":"Medicine; Dosing; Olanzapine; Confidence interval; Anesthesia; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.24317243608566128,"score_gpt":0.48304835078294195,"score_spread":0.23987591469728067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071657833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974717,0.00022265015,0.00014483328,0.0001381454,0.0000064877095,0.000021615286,0.0015187694,0.00000829645,0.00046741162],"genre_scores_gemma":[0.9982566,0.0001750383,0.00018269151,0.00006371567,0.0000070008437,0.000016479913,0.0012381992,0.000003909152,0.000056261437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764,0.0009915773,0.0004917838,0.00038467356,0.0003541311,0.00013782798],"domain_scores_gemma":[0.9867856,0.0024624623,0.008815722,0.00037134514,0.001149664,0.00041528363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021119467,0.00020837206,0.00027183435,0.0010849026,0.0002629975,0.000867725,0.000510025,0.00041314907,0.0010524397],"category_scores_gemma":[0.0087014865,0.00022482243,0.00047255773,0.0016880609,0.00030569846,0.00072634046,0.00042113048,0.000506515,0.00019125688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020881134,0.00006184271,0.99608696,0.000021862703,0.00010923463,0.00003426211,0.000118830045,0.00022195463,0.00006427737,0.000027683553,0.00034361077,0.002700567],"study_design_scores_gemma":[0.000013852654,0.00012698551,0.9972886,0.000026404728,0.000044905802,0.00021017775,0.0005371875,0.0013035723,0.00009950302,0.000027827553,0.0003082529,0.000012735378],"about_ca_topic_score_codex":0.026278637,"about_ca_topic_score_gemma":0.03194662,"teacher_disagreement_score":0.026278637,"about_ca_system_score_codex":0.0012280933,"about_ca_system_score_gemma":0.00081012637,"threshold_uncertainty_score":0.0522514},"labels":[],"label_agreement":null},{"id":"W2072117854","doi":"10.1185/03007995.2012.681035","title":"Extended-release tramadol/paracetamol in moderate-to-severe pain: a randomized, placebo-controlled study in patients with acute low back pain","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeshore General Hospital; McGill University; Manna Research","funders":"","keywords":"Medicine; Placebo; Anesthesia; Tramadol; Double blind; Randomized controlled trial; Clinical endpoint; Clinical trial; Placebo-controlled study; Low back pain; Analgesic; Surgery; Internal medicine","score_opus":0.07394208201321233,"score_gpt":0.4115539855001807,"score_spread":0.33761190348696835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072117854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874843,0.0046539605,0.00078499643,0.00027656433,0.00041200928,0.005289222,0.000400533,0.000082046005,0.0006163494],"genre_scores_gemma":[0.98508644,0.0038170652,0.0026263143,0.0006354462,0.0009635758,0.0050727655,0.00048507558,0.00001854799,0.0012949122],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848527,0.0007893971,0.00016710351,0.00022492818,0.00017860916,0.00015465975],"domain_scores_gemma":[0.9983157,0.00051679777,0.0004161993,0.0001528095,0.00015447325,0.00044409645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031081648,0.001307898,0.004009297,0.00069445604,0.00059806596,0.0010022469,0.0013148698,0.0017348299,0.0047235293],"category_scores_gemma":[0.0022385013,0.0008462274,0.0019182091,0.00085133844,0.0017904806,0.0010805638,0.00048055206,0.002149747,0.0007010451],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95783556,0.02100255,0.000592906,0.00089778623,0.00065986096,0.0000584346,0.000065449574,0.0001367611,0.0062262104,0.000048258895,0.0001833399,0.012292987],"study_design_scores_gemma":[0.87115973,0.12656713,0.0012608987,0.000018787396,0.00025857185,0.000028727602,0.000016794593,0.00014425893,0.00033823683,0.000019263876,0.0001781851,0.00000940463],"about_ca_topic_score_codex":0.0007055058,"about_ca_topic_score_gemma":0.0016840196,"teacher_disagreement_score":0.0047235293,"about_ca_system_score_codex":0.00052113313,"about_ca_system_score_gemma":0.0015059406,"threshold_uncertainty_score":0.01643771},"labels":[],"label_agreement":null},{"id":"W2073695555","doi":"10.1185/03007995.2013.812961","title":"Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Atomoxetine; Medicine; Methylphenidate; Attention deficit hyperactivity disorder; Psychiatry; Stimulant; MEDLINE; Population; European union; Epidemiology; Pediatrics; Pathology","score_opus":0.3117459813348096,"score_gpt":0.5198673718540309,"score_spread":0.2081213905192213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073695555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022773089,0.9522462,0.00090792275,0.009917735,0.00040859642,0.00015587453,0.006024493,0.0000717786,0.00749436],"genre_scores_gemma":[0.23869328,0.7345891,0.0070087016,0.006921046,0.00073717016,0.0006420353,0.010404037,0.000037511225,0.0009671067],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938433,0.0014363347,0.0031837923,0.0005039792,0.00086371583,0.0001689327],"domain_scores_gemma":[0.9885234,0.0045381957,0.003724496,0.00013998925,0.0028304276,0.00024350912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006850101,0.00039070478,0.0011399791,0.0061210664,0.00031230215,0.0015231486,0.0011088289,0.001511304,0.002553413],"category_scores_gemma":[0.020353716,0.0002688494,0.0010569561,0.009770299,0.00036724313,0.0018881434,0.00063189084,0.0005839126,0.00062324246],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032232012,0.0002433168,0.29859725,0.06070894,0.0014879318,0.0010945303,0.0018005986,0.0005498719,0.00037839383,0.002240099,0.09894412,0.53363264],"study_design_scores_gemma":[0.00020956561,0.00022961601,0.715892,0.118985884,0.0027227472,0.0062193493,0.003995444,0.00076288794,0.0003833423,0.002725449,0.14778046,0.000093293354],"about_ca_topic_score_codex":0.0095454585,"about_ca_topic_score_gemma":0.010938875,"teacher_disagreement_score":0.0095454585,"about_ca_system_score_codex":0.0010867096,"about_ca_system_score_gemma":0.0029457423,"threshold_uncertainty_score":0.036227286},"labels":[],"label_agreement":null},{"id":"W2074206824","doi":"10.1185/03007995.2014.907140","title":"Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":185,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Hazard ratio; Propensity score matching; Internal medicine; Stroke (engine); Confidence interval; Pulmonary embolism; Cardiology","score_opus":0.14760869087517217,"score_gpt":0.47262164088784175,"score_spread":0.3250129500126696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074206824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966732,0.001571271,0.00029373378,0.00014669787,0.00002350481,0.000060279664,0.00083415594,0.000004089899,0.00039308402],"genre_scores_gemma":[0.9983992,0.00024378487,0.0001856998,0.000060317343,0.000027943184,0.00005289447,0.0009955626,0.0000012749748,0.000033278553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9850256,0.009791511,0.0017511487,0.0013172068,0.0017311731,0.0003833497],"domain_scores_gemma":[0.9608585,0.0177717,0.016992124,0.0021697006,0.0010037316,0.0012042471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01562141,0.00029850466,0.0008406802,0.0008875424,0.00026759965,0.00143398,0.0006615609,0.0007433773,0.0019546787],"category_scores_gemma":[0.033073626,0.00022907952,0.0019588275,0.0011260578,0.0005826056,0.0010253896,0.0007290783,0.00064520637,0.00020603806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03874879,0.0010819343,0.9295321,0.00045719402,0.010090556,0.00014159738,0.00019587886,0.0017424445,0.00033205128,0.00036936408,0.0005684307,0.016739555],"study_design_scores_gemma":[0.005721243,0.016017424,0.9667227,0.00013090788,0.0030209648,0.0005485157,0.0002695601,0.004894703,0.00064106483,0.0008419293,0.001132216,0.000058766018],"about_ca_topic_score_codex":0.0005774375,"about_ca_topic_score_gemma":0.0005182635,"teacher_disagreement_score":0.01562141,"about_ca_system_score_codex":0.00079733564,"about_ca_system_score_gemma":0.0005935056,"threshold_uncertainty_score":0.0826149},"labels":[],"label_agreement":null},{"id":"W2076944326","doi":"10.1185/030079908x260853","title":"An economic evaluation of sevelamer in patients new to dialysis","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Sevelamer; Dialysis; Intensive care medicine; Internal medicine; Kidney disease; Hyperphosphatemia","score_opus":0.21261200673001632,"score_gpt":0.5082672745175829,"score_spread":0.29565526778756657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076944326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96360415,0.010651171,0.009127336,0.0022471838,0.00017508637,0.0018682953,0.002210849,0.00005047024,0.010065465],"genre_scores_gemma":[0.99553585,0.0012405751,0.0018294374,0.00011544154,0.00002730037,0.00031959446,0.00040505457,0.0000052959167,0.00052143465],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9939984,0.0049723377,0.00017042231,0.00015350309,0.00036671135,0.00033861864],"domain_scores_gemma":[0.9880683,0.009540781,0.0010678822,0.0001708608,0.00045189538,0.0007003035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008410186,0.0010520683,0.0014618636,0.001140273,0.0004317346,0.0025834108,0.0009366428,0.0013613247,0.005701686],"category_scores_gemma":[0.021890296,0.0004898125,0.0032722077,0.0010812666,0.0006285599,0.0014644238,0.0014079992,0.0017539631,0.00019137381],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070439026,0.0027707813,0.038872857,0.003951825,0.005067942,0.00072572945,0.00031624988,0.79766977,0.001056533,0.013042852,0.0023787369,0.06370777],"study_design_scores_gemma":[0.018331133,0.039358,0.029112844,0.0020080802,0.005005942,0.0008876943,0.0011256085,0.8836684,0.0015052381,0.010124923,0.008651419,0.00022078109],"about_ca_topic_score_codex":0.007053545,"about_ca_topic_score_gemma":0.005060836,"teacher_disagreement_score":0.008410186,"about_ca_system_score_codex":0.0068904534,"about_ca_system_score_gemma":0.004280927,"threshold_uncertainty_score":0.04999405},"labels":[],"label_agreement":null},{"id":"W2079424502","doi":"10.1185/030079908x273011","title":"The impact of a medical food containing gammalinolenic and eicosapentaenoic acids on asthma management and the quality of life of adult asthma patients","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Moncton","funders":"","keywords":"Medicine; Asthma; Placebo; Quality of life (healthcare); Eicosapentaenoic acid; Internal medicine; Randomized controlled trial; Gastroenterology; Fatty acid; Polyunsaturated fatty acid","score_opus":0.08993296323244858,"score_gpt":0.43529647497093354,"score_spread":0.34536351173848495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079424502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963504,0.002890974,0.000025338897,0.00013303808,0.00002726487,0.00008861519,0.00008561736,0.0000025709726,0.00039613672],"genre_scores_gemma":[0.9981213,0.00096612645,0.00019989825,0.00018856571,0.00004770476,0.00011807233,0.00015834562,0.0000010067267,0.00019889876],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99959415,0.00022009121,0.00003773851,0.000049994353,0.000050359853,0.000047592523],"domain_scores_gemma":[0.99914896,0.00033744916,0.00024032925,0.000024956717,0.000043690226,0.00020457296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010692512,0.0003351593,0.0008474458,0.00013171879,0.00029269396,0.00043171013,0.00020620352,0.00067341287,0.0022394026],"category_scores_gemma":[0.0016099963,0.0001470304,0.00086847943,0.00018827434,0.00030487566,0.00031878878,0.00023630269,0.0008188308,0.00010510664],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70889246,0.037181295,0.08634427,0.0028223076,0.0037892328,0.00013130916,0.00024150115,0.0007882127,0.014053402,0.00011057972,0.0010330378,0.14461234],"study_design_scores_gemma":[0.10382502,0.57721704,0.31037864,0.00023797156,0.0031688584,0.00018814029,0.00018096794,0.000680288,0.0023463075,0.00009838644,0.0016483621,0.000030101783],"about_ca_topic_score_codex":0.0004516685,"about_ca_topic_score_gemma":0.0008436474,"teacher_disagreement_score":0.0022394026,"about_ca_system_score_codex":0.00028977933,"about_ca_system_score_gemma":0.00035401102,"threshold_uncertainty_score":0.0074915886},"labels":[],"label_agreement":null},{"id":"W2081028045","doi":"10.1185/03007995.2012.728524","title":"Comparison of quetiapine and risperidone in Chinese Han patients with schizophrenia: results of a single-blind, randomized study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Quetiapine; Risperidone; Tolerability; Extrapyramidal symptoms; Medicine; Positive and Negative Syndrome Scale; Clinical Global Impression; Internal medicine; Adverse effect; Quetiapine Fumarate; Somnolence; Psychiatry; Schizophrenia (object-oriented programming); Atypical antipsychotic; Antipsychotic; Psychosis; Placebo","score_opus":0.09370925198373438,"score_gpt":0.448551174275721,"score_spread":0.35484192229198663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081028045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961295,0.001725742,0.00023065037,0.00012403817,0.00011360791,0.0010386799,0.00021600956,0.000040411567,0.0003813459],"genre_scores_gemma":[0.9961144,0.0011044096,0.0006951746,0.0002556688,0.00023884054,0.00081364426,0.00028241987,0.000006817788,0.0004886027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99870026,0.000673897,0.00014914529,0.00018784759,0.00016399084,0.0001248962],"domain_scores_gemma":[0.998365,0.0005884193,0.00038432144,0.00012634072,0.00013363622,0.00040231223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020480969,0.0009977473,0.0031186442,0.0005720878,0.00046939313,0.0005072257,0.0006418956,0.0011219259,0.0032539757],"category_scores_gemma":[0.002533301,0.0005125607,0.0013605127,0.00043757964,0.00089046167,0.00064049306,0.0002548584,0.00073974184,0.0003404733],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97418344,0.0050340747,0.0015794355,0.0003089253,0.0012868377,0.00004174769,0.00006372681,0.00015382576,0.003043169,0.00003818101,0.00017957899,0.014087127],"study_design_scores_gemma":[0.8748069,0.11344157,0.009168561,0.000014643697,0.0010487048,0.00003949009,0.000031785512,0.00052445894,0.00057198806,0.00005296441,0.00027379967,0.00002512449],"about_ca_topic_score_codex":0.0022508104,"about_ca_topic_score_gemma":0.0054415376,"teacher_disagreement_score":0.0032539757,"about_ca_system_score_codex":0.0009946878,"about_ca_system_score_gemma":0.0015045295,"threshold_uncertainty_score":0.010885596},"labels":[],"label_agreement":null},{"id":"W2081208043","doi":"10.1185/0300799009117014","title":"Dose Response and Safety of Cizolirtine Citrate (E-4018) in Patients with Pain Following Extraction of Third Molars","year":2000,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Molar; Extraction (chemistry); Dentistry; Anesthesia; Chromatography","score_opus":0.03720159257238333,"score_gpt":0.3832386857286012,"score_spread":0.3460370931562179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081208043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99531436,0.0036692834,0.00017043843,0.00010473355,0.00004976796,0.00028450912,0.00006317558,0.000016348637,0.00032752514],"genre_scores_gemma":[0.9966589,0.0017836315,0.00054223556,0.00019596731,0.00014377228,0.00019054963,0.00010982271,0.00000518355,0.00036991923],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987326,0.00068304467,0.00019855272,0.00009202255,0.00020886859,0.00008483135],"domain_scores_gemma":[0.9977181,0.0011269354,0.0007286218,0.00012888963,0.00014248671,0.00015498856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013458867,0.00046686496,0.0017030305,0.00032994442,0.00017058985,0.00042307132,0.00040733133,0.001006204,0.0017924937],"category_scores_gemma":[0.0040724035,0.00034340066,0.00068554556,0.00033626045,0.0004590901,0.00043763194,0.00020339341,0.0009142307,0.00030157054],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7615214,0.01124691,0.016264768,0.0021980202,0.0011528439,0.00033353156,0.0003107925,0.00080757565,0.06164043,0.000090418565,0.00039621678,0.14403714],"study_design_scores_gemma":[0.17671601,0.71882856,0.087073445,0.00012152769,0.00094543234,0.00063640805,0.00022860839,0.0009352795,0.012257234,0.0001051575,0.0020886487,0.00006370501],"about_ca_topic_score_codex":0.0002504197,"about_ca_topic_score_gemma":0.00044119195,"teacher_disagreement_score":0.0017924937,"about_ca_system_score_codex":0.00028043307,"about_ca_system_score_gemma":0.00031876628,"threshold_uncertainty_score":0.007117808},"labels":[],"label_agreement":null},{"id":"W2082548427","doi":"10.1185/030079905x36396","title":"Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Blepharospasm; Cervical dystonia; Medicine; Hemifacial spasm; Botulinum toxin; Anesthesia; Dystonia; Focal dystonia; Visual analogue scale; Surgery; Facial nerve","score_opus":0.02722865630179253,"score_gpt":0.3876719189177403,"score_spread":0.3604432626159477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082548427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994968,0.00029964672,0.00002641302,0.0000052480364,0.0000033561016,0.000024471747,0.00002034811,0.0000028274446,0.00012087752],"genre_scores_gemma":[0.99964654,0.000101702244,0.000056184166,0.000020844425,0.000014935261,0.000023691522,0.000059227314,9.761794e-7,0.000075993914],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991009,0.00039813388,0.00008810821,0.00012322924,0.00017836154,0.00011124058],"domain_scores_gemma":[0.99821824,0.0006596123,0.0006455865,0.00012055378,0.00009661,0.00025939086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013114979,0.0003649251,0.0008272877,0.00033838922,0.00025559985,0.00036472167,0.00023344727,0.0005588892,0.0010458884],"category_scores_gemma":[0.0025236078,0.0002065599,0.0006409312,0.0001859605,0.0003783963,0.00033787248,0.0001795076,0.00047502742,0.00015551514],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45487726,0.017261125,0.23956263,0.0006519336,0.002105724,0.0008819134,0.0008849705,0.0012303096,0.093223006,0.00007573572,0.0004120025,0.1888334],"study_design_scores_gemma":[0.018911565,0.53661877,0.4318015,0.000034123223,0.0009528308,0.0011619029,0.0002042107,0.000992392,0.008873613,0.000042809374,0.00037213674,0.000034327055],"about_ca_topic_score_codex":0.00033616702,"about_ca_topic_score_gemma":0.0004944314,"teacher_disagreement_score":0.0013114979,"about_ca_system_score_codex":0.0003290548,"about_ca_system_score_gemma":0.0002189745,"threshold_uncertainty_score":0.006935954},"labels":[],"label_agreement":null},{"id":"W2084667022","doi":"10.1185/030079906x112642","title":"Single-day famciclovir therapy for recurrent genital herpes","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institutes of Health; GlaxoSmithKline","keywords":"Medicine; Famciclovir; Clinical trial; Internal medicine; Pediatrics; Placebo; Immunology; Virus; Pathology; Alternative medicine","score_opus":0.14092265418949607,"score_gpt":0.44978677706090353,"score_spread":0.30886412287140746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084667022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82467175,0.16231285,0.0020520615,0.0033169119,0.0008267261,0.0005330655,0.00020746245,0.00011875134,0.0059603318],"genre_scores_gemma":[0.97603196,0.019567084,0.0015656532,0.0009957973,0.00061828573,0.00014394279,0.00013713051,0.00000795292,0.000932234],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996729,0.0001396136,0.000052289888,0.00003277439,0.00006724427,0.000035169338],"domain_scores_gemma":[0.9991248,0.00040755788,0.00020772532,0.00003971106,0.000046773217,0.0001733805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083110604,0.00024999553,0.0012331548,0.00037129532,0.00027936616,0.00020010998,0.000468044,0.00095562404,0.004318918],"category_scores_gemma":[0.0018440236,0.00009665826,0.0006090126,0.00022494979,0.00020119188,0.00032189747,0.0001785876,0.00078075426,0.0004149588],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01722724,0.0031440093,0.010958255,0.003988837,0.00090997573,0.0023132658,0.00030496388,0.00053493644,0.013627082,0.00023303254,0.005825891,0.94093263],"study_design_scores_gemma":[0.081812076,0.37970194,0.29458293,0.0048394105,0.0034731568,0.09696402,0.0007509688,0.004216052,0.043819774,0.0019002774,0.08773125,0.00020811056],"about_ca_topic_score_codex":0.00037591063,"about_ca_topic_score_gemma":0.0011015991,"teacher_disagreement_score":0.004318918,"about_ca_system_score_codex":0.00033838712,"about_ca_system_score_gemma":0.0003630797,"threshold_uncertainty_score":0.0144482255},"labels":[],"label_agreement":null},{"id":"W2088551446","doi":"10.1185/03007990902784459","title":"Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Manitoba","keywords":"Medicine; Erythropoietin; Epoetin alfa; Observational study; Clinical trial; Anemia; Erythropoiesis; Clinical Practice; Internal medicine; Physical therapy","score_opus":0.08632463025427674,"score_gpt":0.494633193862878,"score_spread":0.4083085636086013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088551446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995235,0.002755618,0.00024952574,0.00012432382,0.000024058949,0.00033321904,0.0003478143,0.000015944726,0.0009145313],"genre_scores_gemma":[0.9977144,0.00077094295,0.0004011267,0.00020948127,0.00007949109,0.00015921443,0.00048736267,0.000006172406,0.0001718292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98719853,0.008412262,0.00082645396,0.0011560174,0.0020851388,0.0003215957],"domain_scores_gemma":[0.9802539,0.0051544993,0.010293153,0.0014917072,0.0013544987,0.0014522386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01565028,0.00056566886,0.0012570112,0.0006735316,0.00023099559,0.00095151016,0.0005829406,0.0012119187,0.0014989411],"category_scores_gemma":[0.0181668,0.00031414372,0.0013976663,0.000829675,0.00088336185,0.0009659556,0.0012117686,0.00067420944,0.0002544903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33532497,0.013870572,0.4820829,0.0019525938,0.009225,0.00021870462,0.0006574508,0.0015522841,0.0023491278,0.00041253312,0.0033077374,0.14904611],"study_design_scores_gemma":[0.06352021,0.113861695,0.8121678,0.0003224822,0.0030984462,0.0008527917,0.00021906204,0.0015463992,0.001018687,0.00016586843,0.0031466961,0.00007981759],"about_ca_topic_score_codex":0.0007046403,"about_ca_topic_score_gemma":0.00060778507,"teacher_disagreement_score":0.01565028,"about_ca_system_score_codex":0.0010494206,"about_ca_system_score_gemma":0.0011674017,"threshold_uncertainty_score":0.082767606},"labels":[],"label_agreement":null},{"id":"W2091516800","doi":"10.1185/030079905x75104","title":"Cost-minimization analysis of treprostinil vs. epoprostenol as an alternate to oral therapy non-responders for the treatment of pulmonary arterial hypertension","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; PharmIdeas (Canada); Brock University","funders":"United Therapeutics Corporation","keywords":"Treprostinil; Medicine; Dosing; Adverse effect; Bosentan; Pulmonary hypertension; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.20181207033086745,"score_gpt":0.47038349871434565,"score_spread":0.2685714283834782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091516800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637552,0.0022044517,0.019004552,0.0024360016,0.00007315783,0.000921763,0.0014888501,0.00009396393,0.010022031],"genre_scores_gemma":[0.9948949,0.00027787132,0.0027762577,0.00016369333,0.000012494845,0.00019585567,0.00025386875,0.000009567951,0.0014154586],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99852437,0.001038433,0.000033679004,0.000104498235,0.000116132345,0.00018290615],"domain_scores_gemma":[0.9944007,0.0044263364,0.0004598583,0.00008716891,0.0002744675,0.00035154208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00400272,0.0014757183,0.0018899839,0.0013114373,0.0003979994,0.0015252271,0.0016064246,0.0016171109,0.0043169335],"category_scores_gemma":[0.008363451,0.0009851181,0.0030783054,0.0007421987,0.0006754311,0.0010221063,0.000877513,0.001462261,0.00018374427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024385566,0.00029914282,0.0015735318,0.00012848807,0.0003693759,0.00009916127,0.000018120334,0.99021435,0.0002687613,0.0011881165,0.00030659302,0.0030958215],"study_design_scores_gemma":[0.0010357909,0.0017267356,0.0024248653,0.0000735123,0.0008351453,0.000073276635,0.000057025954,0.99137914,0.00039257127,0.0015498166,0.00042450012,0.000027661685],"about_ca_topic_score_codex":0.016927954,"about_ca_topic_score_gemma":0.0073185125,"teacher_disagreement_score":0.016927954,"about_ca_system_score_codex":0.0058029722,"about_ca_system_score_gemma":0.0039987187,"threshold_uncertainty_score":0.042103708},"labels":[],"label_agreement":null},{"id":"W2093173165","doi":"10.1185/03007995.2013.784191","title":"Comparison of safety outcomes among Caucasian, Hispanic, Black, and Asian patients in duloxetine studies of chronic painful conditions","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Medicine; Duloxetine; Placebo; Adverse effect; Internal medicine; Discontinuation; Nausea; Subgroup analysis; Physical therapy; Confidence interval","score_opus":0.10204924964318275,"score_gpt":0.4715952761652065,"score_spread":0.3695460265220238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093173165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959698,0.032737065,0.0027058863,0.0002664915,0.00015692438,0.0008052773,0.0015075728,0.000025720457,0.0020970406],"genre_scores_gemma":[0.9964809,0.0013838446,0.0006812795,0.00013239274,0.00008778669,0.00045523467,0.000607858,0.0000073064552,0.00016347416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9762211,0.016716294,0.0032231426,0.0014161129,0.001976657,0.0004467839],"domain_scores_gemma":[0.9757111,0.015452586,0.0057920325,0.0011311674,0.0015831696,0.0003298937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021845842,0.0005570854,0.0020956704,0.0014967902,0.00040496644,0.00077736157,0.00043515122,0.0005797769,0.0020523602],"category_scores_gemma":[0.022596741,0.0002132152,0.005764093,0.0012300014,0.00030409652,0.0005317516,0.00058921275,0.0004458831,0.00011052672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21422762,0.00049942516,0.46528456,0.008362076,0.23642185,0.00035824624,0.0006498221,0.0011418435,0.007964423,0.00034462128,0.0008213119,0.06392417],"study_design_scores_gemma":[0.013633405,0.030985689,0.858375,0.00080632546,0.086970344,0.00045861487,0.0005577817,0.0017852597,0.0024867726,0.00058085454,0.0032984582,0.00006145454],"about_ca_topic_score_codex":0.00053076673,"about_ca_topic_score_gemma":0.0011543982,"teacher_disagreement_score":0.021845842,"about_ca_system_score_codex":0.0002931852,"about_ca_system_score_gemma":0.000551232,"threshold_uncertainty_score":0.11553329},"labels":[],"label_agreement":null},{"id":"W2094364524","doi":"10.1185/03007995.2014.973939","title":"A multiplicity of targets: evaluating composite endpoint studies of the GLP-1 receptor agonists in type 2 diabetes","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Canada","keywords":"Medicine; Liraglutide; Metformin; Type 2 diabetes; Clinical endpoint; Exenatide; Glycemic; Clinical trial; Internal medicine; Glucagon-like peptide 1 receptor; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin; Agonist; Receptor","score_opus":0.29486009570304916,"score_gpt":0.5409420813016502,"score_spread":0.24608198559860106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094364524","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005901067,0.9811164,0.0052031437,0.0015985039,0.00050706934,0.002287092,0.0009891002,0.00003947529,0.0023581441],"genre_scores_gemma":[0.24925467,0.6575901,0.06517043,0.005551806,0.0021823957,0.016824143,0.002302087,0.00014060557,0.0009836907],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7776461,0.1504015,0.051093675,0.00563625,0.014641296,0.00058113027],"domain_scores_gemma":[0.6502806,0.29228643,0.038449965,0.006372227,0.011376451,0.0012343286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16622512,0.002076136,0.010653627,0.011235371,0.0007927479,0.008790315,0.0024063452,0.002819714,0.0042614667],"category_scores_gemma":[0.22111543,0.0011587699,0.016768217,0.013808039,0.0013235694,0.0049327933,0.0031812584,0.0023719098,0.00050210574],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047623366,0.00011527278,0.008287982,0.678206,0.15131207,0.00019658553,0.000531806,0.0009311126,0.00082212884,0.0025331369,0.0016272907,0.15067428],"study_design_scores_gemma":[0.00758974,0.0061176014,0.026395766,0.44056934,0.44900963,0.0008470399,0.0011941424,0.0019821494,0.0019779091,0.015396218,0.04856339,0.00035718858],"about_ca_topic_score_codex":0.00085883227,"about_ca_topic_score_gemma":0.0029914218,"teacher_disagreement_score":0.16622512,"about_ca_system_score_codex":0.0022400569,"about_ca_system_score_gemma":0.0055420357,"threshold_uncertainty_score":0.879093},"labels":[],"label_agreement":null},{"id":"W2095313483","doi":"10.1185/03007995.2014.915211","title":"Systematic review of long-acting injectables versus oral atypical antipsychotics on hospitalization in schizophrenia","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Meta-analysis; Schizophrenia (object-oriented programming); Pediatrics; Random effects model; Internal medicine; Emergency medicine; Psychiatry","score_opus":0.17038784938800458,"score_gpt":0.507362570092788,"score_spread":0.3369747207047834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095313483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025556558,0.99623907,0.0001766284,0.00014665355,0.00013406601,0.00027392455,0.00027826583,0.000010489261,0.00018520192],"genre_scores_gemma":[0.058235582,0.93867016,0.0011598497,0.00053521025,0.00019621185,0.00067848276,0.00034001705,0.000010395952,0.00017418173],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98994,0.0049433736,0.002939042,0.0006545203,0.0012616653,0.00026136942],"domain_scores_gemma":[0.98241353,0.011782784,0.0038011342,0.00028097176,0.0014759738,0.00024559975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0116042895,0.0023092413,0.013896811,0.0066239187,0.000636096,0.0023017928,0.0016839388,0.0017474863,0.0032019308],"category_scores_gemma":[0.032314617,0.0011393093,0.02286036,0.00626042,0.00067528494,0.0014675019,0.0012396637,0.0012385513,0.00021299881],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013266822,0.000030214254,0.0015349503,0.8184611,0.15932444,0.00012541364,0.00009405436,0.00027717822,0.00025529615,0.00011299706,0.0006922695,0.017765312],"study_design_scores_gemma":[0.0010701414,0.00063178584,0.0051924405,0.20981337,0.77781844,0.00020810019,0.00011454874,0.00018552304,0.0002632702,0.00021824068,0.0044479356,0.000036111727],"about_ca_topic_score_codex":0.0076281046,"about_ca_topic_score_gemma":0.021347325,"teacher_disagreement_score":0.013896811,"about_ca_system_score_codex":0.003621562,"about_ca_system_score_gemma":0.007032583,"threshold_uncertainty_score":0.061370134},"labels":[],"label_agreement":null},{"id":"W2097410402","doi":"10.1185/030079903125002955","title":"Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Purdue Pharma (Canada); University Health Network","funders":"Purdue Pharma","keywords":"Oxybutynin; Medicine; Urination; Urinary incontinence; Adverse effect; Urology; Anesthesia; Urinary system; Internal medicine; Overactive bladder","score_opus":0.1711520587863129,"score_gpt":0.486737151901993,"score_spread":0.3155850931156801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097410402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993299,0.00363194,0.0012065733,0.00016646781,0.000094990806,0.0008125053,0.00016013053,0.000045172146,0.000583212],"genre_scores_gemma":[0.9908399,0.0026534472,0.0037029285,0.00031367195,0.00015941178,0.00062821887,0.0005457417,0.000020720163,0.0011358777],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99960834,0.00017182455,0.000037190293,0.00005972702,0.00006310646,0.00005981931],"domain_scores_gemma":[0.999619,0.0001308572,0.000081567836,0.000024864523,0.000048846443,0.000094729956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011364726,0.0007103582,0.0009953442,0.00019857877,0.00017819177,0.0005510999,0.0008410677,0.00070983,0.0019844228],"category_scores_gemma":[0.0008134223,0.00024315425,0.00064599083,0.00014364766,0.0004663844,0.00048485416,0.00019044454,0.0011800111,0.00031389465],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12542747,0.039670374,0.004061484,0.0034136225,0.00064780284,0.0009422577,0.00060334,0.00092630036,0.61540926,0.0002290798,0.0010583738,0.20761059],"study_design_scores_gemma":[0.078393854,0.8518619,0.016317442,0.00009227033,0.0004872863,0.0008674648,0.00011273094,0.0012708551,0.046250746,0.00003736113,0.004268483,0.00003961857],"about_ca_topic_score_codex":0.0004601225,"about_ca_topic_score_gemma":0.0009358891,"teacher_disagreement_score":0.0019844228,"about_ca_system_score_codex":0.00022062635,"about_ca_system_score_gemma":0.0003672953,"threshold_uncertainty_score":0.006638527},"labels":[],"label_agreement":null},{"id":"W2097411741","doi":"10.1185/030079906x80314","title":"Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: the APEX Study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Montreal General Hospital; McGill University","funders":"","keywords":"Medicine; Apex (geometry); Venlafaxine; Depression (economics); Internal medicine; Gerontology; Psychiatry; Physical therapy; Antidepressant; Anxiety","score_opus":0.09141584852667184,"score_gpt":0.4406190705037754,"score_spread":0.3492032219771036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097411741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97634435,0.00068598124,0.00014331771,0.00048493608,0.00001057495,0.00007762351,0.020072535,0.000014498613,0.0021661762],"genre_scores_gemma":[0.99008405,0.00038184132,0.00026925746,0.0000886695,0.000009952949,0.000043702363,0.0084822485,0.000005617488,0.0006347568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877495,0.00021806489,0.00008623503,0.00013316634,0.0005038454,0.00028378842],"domain_scores_gemma":[0.99632037,0.0003245125,0.0010510003,0.00012430496,0.0016081587,0.0005717041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012016755,0.00036477382,0.0005957332,0.0016501232,0.001273543,0.0010355193,0.0011975238,0.00038782257,0.0021772874],"category_scores_gemma":[0.005344675,0.00034825,0.0009765653,0.0045864405,0.00029012794,0.00030056934,0.00079915393,0.0006299669,0.00017168414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028939484,0.000033500524,0.9938345,0.000035971403,0.00012643616,0.000039657512,0.000105180145,0.00048079592,0.00003572798,0.0001296418,0.0019284373,0.002960893],"study_design_scores_gemma":[0.0000457161,0.000029452674,0.99785197,0.000015578049,0.00003429275,0.000027811693,0.00014275707,0.0011166749,0.000029036097,0.00001319915,0.00068712735,0.000006425333],"about_ca_topic_score_codex":0.99165326,"about_ca_topic_score_gemma":0.99000436,"teacher_disagreement_score":0.96652335,"about_ca_system_score_codex":0.033476677,"about_ca_system_score_gemma":0.023006575,"threshold_uncertainty_score":0.24289143},"labels":[],"label_agreement":null},{"id":"W2097624585","doi":"10.1185/03007995.2013.803057","title":"Effects of demographics on the antihypertensive efficacy of triple therapy with amlodipine, valsartan, and hydrochlorothiazide for moderate to severe hypertension","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Omron Healthcare; Novartis Pharmaceuticals Corporation","keywords":"Medicine; Hydrochlorothiazide; Amlodipine; Valsartan; Blood pressure; Internal medicine; Placebo; Combination therapy; Randomized controlled trial; Urology; Cardiology","score_opus":0.09806040910206085,"score_gpt":0.37090220348313224,"score_spread":0.27284179438107137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097624585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952148,0.0038447347,0.000100142875,0.000117160314,0.00006879628,0.00009526283,0.000101289326,0.00000778436,0.00044999938],"genre_scores_gemma":[0.99861646,0.00070416153,0.00017310299,0.000096723874,0.00008398388,0.00006764958,0.000085161424,0.000002173423,0.00017072998],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99895394,0.0005373102,0.00016476419,0.00012233685,0.00012497848,0.000096656404],"domain_scores_gemma":[0.9980876,0.00088693626,0.00043920497,0.00010804739,0.00007628315,0.00040198263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016992651,0.00045487168,0.0019313792,0.0001995774,0.00019747515,0.00047902885,0.0002833496,0.00069443585,0.0024833772],"category_scores_gemma":[0.0029715383,0.00027044074,0.0016735173,0.00020243766,0.0003359304,0.00042908677,0.00029182402,0.0008978474,0.00015789283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9357871,0.002910401,0.0084528485,0.00059381116,0.004042226,0.000046188583,0.000047863145,0.0003831753,0.0075345095,0.000045305456,0.00019516294,0.03996145],"study_design_scores_gemma":[0.38651899,0.4254425,0.16418765,0.00028513602,0.014248756,0.00032409577,0.00015610688,0.0017539898,0.0055186,0.00024260081,0.0012591211,0.0000624295],"about_ca_topic_score_codex":0.00040882186,"about_ca_topic_score_gemma":0.00095405744,"teacher_disagreement_score":0.0024833772,"about_ca_system_score_codex":0.00024702222,"about_ca_system_score_gemma":0.00037616747,"threshold_uncertainty_score":0.0089867115},"labels":[],"label_agreement":null},{"id":"W2097933001","doi":"10.1185/030079903125003125","title":"Efficacy of risedronate on clinical vertebral fractures within six months","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Procter and Gamble","keywords":"Medicine; Osteoporosis; Placebo; Incidence (geometry); Surgery; Internal medicine","score_opus":0.16601880925933565,"score_gpt":0.5405479117058117,"score_spread":0.3745291024464761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097933001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749346,0.021628452,0.00023703957,0.0002654902,0.00006557046,0.00009199418,0.00027814327,0.000031351847,0.0024673522],"genre_scores_gemma":[0.99690944,0.002158993,0.00015554737,0.000070205104,0.000050991148,0.000020647269,0.00018853048,0.0000018212145,0.00044384066],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999166,0.00037604873,0.00006370277,0.00007027127,0.00027415928,0.000049728154],"domain_scores_gemma":[0.99855334,0.0006602448,0.0005099724,0.000055354947,0.00010796151,0.000113168375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012216066,0.00024400237,0.0004902969,0.00022359111,0.00010274879,0.00024907052,0.00025547197,0.00041466602,0.0011026543],"category_scores_gemma":[0.0036642796,0.000109882436,0.0006334296,0.00017716408,0.00017033644,0.000103269886,0.00013375095,0.00042046278,0.00011737186],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21648577,0.0066241445,0.24099384,0.003429069,0.009121717,0.00036211725,0.00028172124,0.0032796054,0.044059902,0.0004184616,0.0017963969,0.47314727],"study_design_scores_gemma":[0.014168179,0.13960235,0.825257,0.00039977342,0.003340708,0.0010113491,0.00009252086,0.0014568073,0.009183397,0.00025156976,0.0052052494,0.00003104776],"about_ca_topic_score_codex":0.00092234096,"about_ca_topic_score_gemma":0.0018003029,"teacher_disagreement_score":0.0012216066,"about_ca_system_score_codex":0.00019139188,"about_ca_system_score_gemma":0.00027619107,"threshold_uncertainty_score":0.006460607},"labels":[],"label_agreement":null},{"id":"W2097938982","doi":"10.1185/030079903125002090","title":"An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"UCB Pharma","keywords":"Medicine; WOMAC; Osteoarthritis; Tolerability; Visual analogue scale; Physical therapy; Knee pain; Analgesic; Randomized controlled trial; Surgery; Anesthesia; Adverse effect; Internal medicine","score_opus":0.11669649382085101,"score_gpt":0.43189280560074567,"score_spread":0.31519631177989466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097938982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940871,0.0011516883,0.00048385526,0.00011328538,0.0001869526,0.002988258,0.00031068432,0.000043328906,0.0006347124],"genre_scores_gemma":[0.986302,0.0012277634,0.001839994,0.00058275275,0.00064551353,0.006570243,0.0007744215,0.000014776175,0.002042569],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99924797,0.00031500665,0.000055430442,0.00013410822,0.0001000621,0.00014741752],"domain_scores_gemma":[0.99843377,0.00047045908,0.0003414208,0.00015247047,0.00009122688,0.0005106154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018457077,0.0015960338,0.0031397003,0.0005626257,0.0005570305,0.0008181429,0.0012213687,0.0018632786,0.0051874584],"category_scores_gemma":[0.0014792341,0.0006527064,0.0012347332,0.00039708288,0.0013998257,0.0011206291,0.00037460396,0.002785634,0.00092681876],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.778188,0.17736955,0.0022242393,0.0005781956,0.0004323412,0.00016740723,0.00014894563,0.00041616705,0.013020195,0.000108031614,0.0004774053,0.026869688],"study_design_scores_gemma":[0.36881486,0.62624127,0.0034480535,0.000013107688,0.00008728958,0.000076894365,0.000022201191,0.00024134194,0.00059469196,0.000025914887,0.00042127745,0.000013173681],"about_ca_topic_score_codex":0.0004905814,"about_ca_topic_score_gemma":0.0010294719,"teacher_disagreement_score":0.0051874584,"about_ca_system_score_codex":0.0005403573,"about_ca_system_score_gemma":0.0009588115,"threshold_uncertainty_score":0.017353773},"labels":[],"label_agreement":null},{"id":"W2099652899","doi":"10.1185/030079904x2051","title":"Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":234,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"AstraZeneca","keywords":"Budesonide; Formoterol; Medicine; Budesonide/formoterol; Inhaler; Exacerbation; Asthma; Corticosteroid; Anesthesia; Terbutaline; Internal medicine","score_opus":0.10602572009709625,"score_gpt":0.41532322922396603,"score_spread":0.30929750912686976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099652899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965089,0.0025948102,0.00008976078,0.00010671603,0.00011137275,0.00015267877,0.00006151384,0.0000079973615,0.00036626463],"genre_scores_gemma":[0.9980787,0.00075213396,0.0002708219,0.0001717366,0.0002637946,0.00015906717,0.00010684398,0.0000022766485,0.0001947057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99882835,0.0007084509,0.00013499794,0.00012748456,0.00011348079,0.00008724671],"domain_scores_gemma":[0.9978326,0.0010823248,0.00046555177,0.000110276735,0.00007991975,0.0004292741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018849676,0.0004753479,0.0021723753,0.0001766321,0.00022171045,0.00056906464,0.00045167498,0.0009697127,0.0021619136],"category_scores_gemma":[0.0023023218,0.00026720882,0.0011967181,0.00018651916,0.0007222171,0.00048238898,0.00024379634,0.0013439059,0.0003297218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9317528,0.0096209,0.0064488235,0.0008159014,0.00096842926,0.0000734529,0.00008477023,0.0004774244,0.01255974,0.00005577631,0.00025863093,0.036883235],"study_design_scores_gemma":[0.33013216,0.63792986,0.027794657,0.000057464316,0.00079380546,0.00018024712,0.000046037967,0.00050614844,0.0017689515,0.00006271034,0.0007045828,0.000023394248],"about_ca_topic_score_codex":0.0002484728,"about_ca_topic_score_gemma":0.0005001621,"teacher_disagreement_score":0.0021723753,"about_ca_system_score_codex":0.00035665836,"about_ca_system_score_gemma":0.00045362895,"threshold_uncertainty_score":0.009968758},"labels":[],"label_agreement":null},{"id":"W2099955896","doi":"10.1185/030079904125003566","title":"Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; University of Calgary","funders":"Procter and Gamble","keywords":"Medicine; Tolerability; Osteoporosis; Postmenopausal women; Postmenopausal osteoporosis; Internal medicine; Bone mineral; Adverse effect","score_opus":0.09070662429593646,"score_gpt":0.4395590446284275,"score_spread":0.34885242033249103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099955896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965495,0.002512994,0.00012887405,0.00010371223,0.000047368536,0.00019447526,0.00014413567,0.000021076588,0.00029779397],"genre_scores_gemma":[0.9975611,0.00075800775,0.00028218207,0.00025362466,0.00013146686,0.00020911018,0.00035158946,0.0000034017667,0.0004495397],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993098,0.0003405855,0.00006177847,0.00009432516,0.00011604671,0.0000774391],"domain_scores_gemma":[0.9990062,0.0003048635,0.00038087516,0.000055365952,0.00006749873,0.00018521913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020797667,0.0005620431,0.0011178086,0.00033257384,0.00026251952,0.0003923727,0.00040001003,0.001077885,0.0012662477],"category_scores_gemma":[0.002265001,0.00035084458,0.0010160431,0.00021912885,0.0003520531,0.00042409048,0.00017743322,0.0009815725,0.00024034479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7816207,0.032248456,0.038479023,0.00084805314,0.002070488,0.0002753412,0.00025745638,0.00086166145,0.02470178,0.00004931043,0.0007699772,0.117817804],"study_design_scores_gemma":[0.18575926,0.6614604,0.14635704,0.000049491402,0.001156303,0.00027831923,0.00006824716,0.00072683644,0.0027013454,0.000058645463,0.0013450657,0.000038916776],"about_ca_topic_score_codex":0.00061473466,"about_ca_topic_score_gemma":0.0013985484,"teacher_disagreement_score":0.0020797667,"about_ca_system_score_codex":0.00034025704,"about_ca_system_score_gemma":0.00037966348,"threshold_uncertainty_score":0.010999024},"labels":[],"label_agreement":null},{"id":"W2101407866","doi":"10.1185/030079906x104722","title":"Efficacy and safety of aceclofenac in the treatment of osteoarthritis: a randomized double-blind comparative clinical trial versus diclofenac – an Indian experience","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Aceclofenac; Tolerability; Diclofenac; Osteoarthritis; Adverse effect; WOMAC; Randomized controlled trial; Population; Visual analogue scale; Internal medicine; Anesthesia; Alternative medicine","score_opus":0.27134232502661093,"score_gpt":0.5309749352035308,"score_spread":0.25963261017691985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101407866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98016226,0.0084880665,0.0010804908,0.0004576329,0.0006824963,0.007213635,0.00048519924,0.00008335967,0.0013468621],"genre_scores_gemma":[0.97925305,0.0067500244,0.0027519488,0.0010374737,0.0013657484,0.006429598,0.00055006886,0.000023339642,0.001838854],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9979081,0.0012079909,0.00025132424,0.00025920742,0.00018913375,0.00018420743],"domain_scores_gemma":[0.99753463,0.0007285958,0.00064831803,0.00021946983,0.00028097723,0.0005879403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035916548,0.001345756,0.004774554,0.00090433133,0.0007252873,0.0010072648,0.0012545993,0.0020118447,0.006388303],"category_scores_gemma":[0.0029468532,0.00081386545,0.0026805867,0.0010524166,0.0022224456,0.0012362631,0.0004632134,0.0020569419,0.0007559417],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9713949,0.013815865,0.0004285361,0.0010133862,0.00067742495,0.000042178217,0.000062220985,0.000087697954,0.0034010888,0.000073971736,0.0001347969,0.008867892],"study_design_scores_gemma":[0.8627943,0.133482,0.0016652122,0.00004494163,0.0008117798,0.000036161447,0.000036011155,0.00018499348,0.00052787137,0.00005893898,0.00033644307,0.000021347912],"about_ca_topic_score_codex":0.00074796344,"about_ca_topic_score_gemma":0.0013397288,"teacher_disagreement_score":0.006388303,"about_ca_system_score_codex":0.0005933043,"about_ca_system_score_gemma":0.0015655071,"threshold_uncertainty_score":0.021371007},"labels":[],"label_agreement":null},{"id":"W2101760942","doi":"10.1185/030079906x80341","title":"Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Etanercept; Rheumatoid arthritis; Internal medicine; Infliximab; Discontinuation; Rheumatology; Combination therapy; Physical therapy; Disease","score_opus":0.11525694431924108,"score_gpt":0.4334376229740263,"score_spread":0.3181806786547853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101760942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860518,0.0018287514,0.00041090188,0.00024937865,0.000031176507,0.00046199336,0.009940445,0.000022474022,0.0010029699],"genre_scores_gemma":[0.98838496,0.00085355487,0.001413369,0.00024933898,0.000103113285,0.0004895333,0.0077798995,0.000018068653,0.0007081545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99309677,0.0043328158,0.00074999296,0.0009361546,0.0005927475,0.00029147562],"domain_scores_gemma":[0.9935335,0.0009872952,0.0034767175,0.0006696977,0.00058727886,0.00074542256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052697007,0.00084662583,0.0012355602,0.0005089862,0.00056869973,0.001283762,0.00089236937,0.0009869472,0.0017411594],"category_scores_gemma":[0.006042772,0.0010097245,0.001289394,0.0010441049,0.00047857204,0.0010254103,0.0015152091,0.0011549311,0.00093134044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017937565,0.001367254,0.9640305,0.00056690635,0.003338554,0.00018021591,0.0005153483,0.00067322823,0.0008780623,0.00020017718,0.003874481,0.006437785],"study_design_scores_gemma":[0.006737899,0.004569522,0.97704893,0.00020370475,0.0025564146,0.00097162183,0.0005535273,0.0012769761,0.00042778763,0.0001057726,0.0054510557,0.00009677216],"about_ca_topic_score_codex":0.0067877104,"about_ca_topic_score_gemma":0.009859097,"teacher_disagreement_score":0.0067877104,"about_ca_system_score_codex":0.0005711088,"about_ca_system_score_gemma":0.0008773763,"threshold_uncertainty_score":0.027869225},"labels":[],"label_agreement":null},{"id":"W2103796156","doi":"10.1185/030079902125000282","title":"Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial","year":2002,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Etoricoxib; Osteoarthritis; Placebo; Randomized controlled trial; Clinical trial; Internal medicine; Anesthesia; Adverse effect; Alternative medicine","score_opus":0.08160137811245635,"score_gpt":0.37390564270905796,"score_spread":0.29230426459660164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103796156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811639,0.008836961,0.00081513537,0.0006824833,0.00033448968,0.004943289,0.0011636117,0.00013703415,0.0019230607],"genre_scores_gemma":[0.98395973,0.0036317594,0.0018124039,0.0012131111,0.00072373054,0.005532918,0.0011732226,0.00002138296,0.0019316007],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987494,0.00071562367,0.00012271968,0.00018735943,0.00011818572,0.00010666799],"domain_scores_gemma":[0.998533,0.0003564311,0.00047315372,0.00011827084,0.00011837578,0.0004008422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030470875,0.0014293697,0.003342586,0.00041792088,0.0004632028,0.0010716792,0.0010438926,0.0026378753,0.0049313707],"category_scores_gemma":[0.0027097953,0.0006865364,0.0014312201,0.00046960457,0.0012013275,0.0010870912,0.00033137118,0.002084087,0.0010064226],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9742799,0.0074628275,0.00062028616,0.0005477956,0.00049821316,0.000030388657,0.000031645468,0.00015702011,0.0023902154,0.00003600252,0.00037419083,0.013571475],"study_design_scores_gemma":[0.9585126,0.038952984,0.0015355202,0.0000191389,0.00020984969,0.000028537337,0.000007444409,0.00016185644,0.00025472508,0.00003073753,0.00027880273,0.000007738945],"about_ca_topic_score_codex":0.00037717272,"about_ca_topic_score_gemma":0.0007763466,"teacher_disagreement_score":0.0049313707,"about_ca_system_score_codex":0.00050827855,"about_ca_system_score_gemma":0.00090792327,"threshold_uncertainty_score":0.016497016},"labels":[],"label_agreement":null},{"id":"W2104243240","doi":"10.1185/03007995.2012.689956","title":"Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"American Diabetes Association","keywords":"Medicine; Canagliflozin; Sitagliptin; Metformin; Internal medicine; Placebo; Type 2 diabetes; Sitagliptin Phosphate; Urinary system; Creatinine; Gastroenterology; Glycemic; Diabetes mellitus; Renal function; Endocrinology; Urology","score_opus":0.04561111091520502,"score_gpt":0.39865473916015326,"score_spread":0.3530436282449482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104243240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965508,0.0010592622,0.00018153217,0.0001534008,0.000098157405,0.001148668,0.00027527637,0.000030744977,0.0005021278],"genre_scores_gemma":[0.9924533,0.0012137353,0.0012701413,0.0006996121,0.00039702744,0.0018378936,0.00078600633,0.000013536515,0.0013288294],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99892163,0.0005989038,0.000069589136,0.0001590452,0.000116759235,0.00013406342],"domain_scores_gemma":[0.9984659,0.00040592684,0.0003246455,0.00013879336,0.0001355958,0.00052916136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035672532,0.001684857,0.0026135447,0.0004416685,0.0005586444,0.0008711448,0.000831064,0.0018866612,0.0028724282],"category_scores_gemma":[0.0021442692,0.00086858,0.0019173494,0.00032522588,0.0007301651,0.0009034232,0.0003806901,0.00238059,0.0004530052],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89157796,0.07353278,0.0043956935,0.00042588759,0.0010445303,0.000053252505,0.00007217112,0.00025798904,0.007641721,0.000019848496,0.00046471966,0.020513425],"study_design_scores_gemma":[0.527124,0.4523893,0.018147903,0.000023935498,0.00053783046,0.000042669883,0.000020015992,0.00032663354,0.0010830191,0.000025728214,0.00026158622,0.000017469167],"about_ca_topic_score_codex":0.0008553251,"about_ca_topic_score_gemma":0.0020521062,"teacher_disagreement_score":0.0035672532,"about_ca_system_score_codex":0.0005724718,"about_ca_system_score_gemma":0.0013370189,"threshold_uncertainty_score":0.018865645},"labels":[],"label_agreement":null},{"id":"W2104819398","doi":"10.1185/03007990152005405","title":"Eprosartan Provides Safe and Effective Long-term Maintenance of Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension","year":2001,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hydrochlorothiazide; Blood pressure; Adverse effect; Candesartan; Incidence (geometry); Placebo; Internal medicine; Diuretic; Peripheral edema; Essential hypertension; Angiotensin II; Cardiology","score_opus":0.037067750166443134,"score_gpt":0.3484559406893169,"score_spread":0.31138819052287375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104819398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996777,0.0009929409,0.00029691102,0.00008369027,0.0000301337,0.0009378397,0.00013688869,0.000024283152,0.00072023814],"genre_scores_gemma":[0.9958687,0.00092320825,0.0009310136,0.00020088338,0.00009435079,0.00110548,0.0002757291,0.0000041654657,0.00059639296],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991447,0.00055052765,0.00008157361,0.000067254,0.00006330293,0.000092649825],"domain_scores_gemma":[0.999073,0.00032722866,0.00022808279,0.00008937252,0.000036611455,0.0002457249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012586634,0.00033582284,0.0013182221,0.00020703944,0.0002667753,0.000350094,0.00041745862,0.00067826867,0.002493604],"category_scores_gemma":[0.0019332155,0.00024983255,0.0006447238,0.00027554904,0.0006208677,0.00039148904,0.00033096707,0.0007385577,0.0004119174],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78189343,0.024604842,0.019919688,0.0009963741,0.0006295314,0.00021971903,0.00033659613,0.00049375766,0.015853276,0.0001359815,0.0010315595,0.15388529],"study_design_scores_gemma":[0.4411598,0.39409643,0.15869825,0.00010986053,0.0003958143,0.00038426215,0.0001256009,0.0006598944,0.0022730844,0.00011759682,0.0019395126,0.00003999779],"about_ca_topic_score_codex":0.0006975237,"about_ca_topic_score_gemma":0.0014455733,"teacher_disagreement_score":0.002493604,"about_ca_system_score_codex":0.00026504602,"about_ca_system_score_gemma":0.0007265132,"threshold_uncertainty_score":0.008341908},"labels":[],"label_agreement":null},{"id":"W2106728901","doi":"10.1185/030079905x65547","title":"Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Tolerability; Viscosupplementation; Osteoarthritis; WOMAC; Sodium hyaluronate; Adverse effect; Clinical endpoint; Hyaluronic acid; Knee pain; Surgery; Internal medicine; Anesthesia; Randomized controlled trial; Intra articular","score_opus":0.061442415981732376,"score_gpt":0.38317129679134504,"score_spread":0.32172888080961265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106728901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948842,0.0043167705,0.00030690207,0.00004970695,0.000016576276,0.000052999385,0.00007537431,0.0000129390755,0.00028454026],"genre_scores_gemma":[0.9983872,0.000807648,0.00023717854,0.00006558619,0.000052792788,0.000041674568,0.00013164163,0.000003809231,0.00027239192],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994097,0.000286901,0.000066953486,0.000049463313,0.00014208429,0.000044829714],"domain_scores_gemma":[0.99912995,0.0002490796,0.00038238405,0.00004119638,0.00008942707,0.00010795897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010386513,0.0002744811,0.00069464,0.00015605199,0.00013906551,0.00026922108,0.00019233952,0.000312443,0.0010969876],"category_scores_gemma":[0.0011072968,0.0001155655,0.00060361763,0.00018968432,0.0001972202,0.000273646,0.00012494695,0.00048639587,0.00019226818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23609948,0.013897597,0.09265866,0.002684693,0.0023443871,0.0008369281,0.00062568794,0.0018270027,0.27243322,0.000088206565,0.000786909,0.37571725],"study_design_scores_gemma":[0.0160816,0.58320683,0.3695457,0.000116291754,0.0018529244,0.0019416156,0.00032557256,0.0021603648,0.022140766,0.0000665846,0.0025170934,0.000044659242],"about_ca_topic_score_codex":0.00023057398,"about_ca_topic_score_gemma":0.0004704868,"teacher_disagreement_score":0.0010969876,"about_ca_system_score_codex":0.00013343757,"about_ca_system_score_gemma":0.00017833743,"threshold_uncertainty_score":0.0054929852},"labels":[],"label_agreement":null},{"id":"W2108680897","doi":"10.1185/030079904125004376","title":"Nursing home-acquired pneumonia: an emergency department treatment algorithm","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Emergency department; Pneumonia; Emergency medicine; Intensive care medicine; Algorithm; Medical emergency; Nursing; Internal medicine","score_opus":0.23041544399512015,"score_gpt":0.533487597536195,"score_spread":0.30307215354107486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108680897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019636223,0.861482,0.054620817,0.026426306,0.002772613,0.0052139717,0.0026991956,0.0010785764,0.0260703],"genre_scores_gemma":[0.09386259,0.5817493,0.2951738,0.005628718,0.0014801896,0.004542165,0.0113050155,0.00007878929,0.006179468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988292,0.0004021843,0.000273655,0.00010268896,0.00035337007,0.000038964365],"domain_scores_gemma":[0.9984182,0.0004766592,0.00031678352,0.000024735828,0.000678565,0.000085071384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018968866,0.0010401247,0.0024612984,0.002340158,0.0003195812,0.0011122333,0.0021978072,0.0011257667,0.0028798732],"category_scores_gemma":[0.005007024,0.0003983676,0.00090519246,0.0022192409,0.00022853324,0.0014665645,0.000543277,0.0011247091,0.0016110697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020384962,0.0003064162,0.006289369,0.010810525,0.00046731828,0.00047639714,0.00010464018,0.003968061,0.0003843201,0.0020088165,0.07789941,0.8970809],"study_design_scores_gemma":[0.002436151,0.0018342584,0.09078234,0.06323045,0.0051871547,0.021388935,0.0010955354,0.05157495,0.0023480465,0.02132856,0.7384495,0.0003441464],"about_ca_topic_score_codex":0.002409581,"about_ca_topic_score_gemma":0.0041495333,"teacher_disagreement_score":0.0028798732,"about_ca_system_score_codex":0.0015277831,"about_ca_system_score_gemma":0.0032463537,"threshold_uncertainty_score":0.011084914},"labels":[],"label_agreement":null},{"id":"W2109156797","doi":"10.1185/030079903125002469","title":"A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Etoricoxib; Medicine; Tolerability; Diclofenac; Osteoarthritis; WOMAC; Clinical endpoint; Anesthesia; Clinical trial; Physical therapy; Adverse effect; Internal medicine","score_opus":0.059623230907279924,"score_gpt":0.4094679379635202,"score_spread":0.34984470705624027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109156797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607475,0.012349093,0.00018494965,0.00010400839,0.000082523606,0.0002862216,0.0001702954,0.000008365358,0.00073989737],"genre_scores_gemma":[0.99644357,0.002117959,0.00041733513,0.00018957454,0.00016728444,0.0001608033,0.0002658546,0.0000021168423,0.0002355885],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9982526,0.0009864225,0.0002409068,0.00015612204,0.00028209641,0.00008190408],"domain_scores_gemma":[0.9973859,0.0011164732,0.0008336057,0.000115988216,0.00018368276,0.00036436677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030884554,0.00044245293,0.0020379557,0.00041436055,0.00021350227,0.000519214,0.00033104216,0.00080038025,0.0017427996],"category_scores_gemma":[0.0038002874,0.00033160156,0.001024609,0.00038169778,0.00047290087,0.0007280889,0.00029057084,0.00071240356,0.00023791434],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8726254,0.007208279,0.023158832,0.0018152181,0.002616417,0.00012500506,0.00014977435,0.00043922354,0.013618922,0.00008219232,0.0003172443,0.07784342],"study_design_scores_gemma":[0.24836802,0.63288987,0.11089211,0.00014194328,0.0020281742,0.00040631572,0.0001388187,0.0007740563,0.0026704024,0.00010205964,0.0015445615,0.000043777905],"about_ca_topic_score_codex":0.00021460498,"about_ca_topic_score_gemma":0.0004249403,"teacher_disagreement_score":0.0030884554,"about_ca_system_score_codex":0.00033348758,"about_ca_system_score_gemma":0.00041390202,"threshold_uncertainty_score":0.01633352},"labels":[],"label_agreement":null},{"id":"W2109883415","doi":"10.1185/030079906x80279","title":"Response to rivastigmine or donepezil in Alzheimer's patients with symptoms suggestive of concomitant Lewy body pathology","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Donepezil; Rivastigmine; Medicine; Concomitant; Internal medicine; Lewy body; Dementia with Lewy bodies; Adverse effect; Dementia; Population; Alzheimer's disease; Disease","score_opus":0.05331040456414979,"score_gpt":0.4222077054324689,"score_spread":0.36889730086831907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109883415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958561,0.0030391421,0.000113610746,0.00007400601,0.00006248356,0.00031526262,0.00018815858,0.000018172275,0.00033313362],"genre_scores_gemma":[0.9981511,0.0007731587,0.00018477191,0.0001329846,0.00009040653,0.00028077734,0.00021783871,0.0000024343672,0.00016633605],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992526,0.00033408433,0.00012115032,0.00012641304,0.00007065126,0.00009506722],"domain_scores_gemma":[0.9990501,0.0003311396,0.00032607757,0.000057993864,0.000052994103,0.00018173284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014314777,0.000692315,0.0024530932,0.00032769362,0.00025111757,0.00053983607,0.00040845544,0.00088254333,0.0017357128],"category_scores_gemma":[0.001563688,0.00038281817,0.0013109354,0.0002654838,0.00041373202,0.00039798653,0.00018684685,0.0008155392,0.00031803775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9524117,0.0054203547,0.012952648,0.0006474878,0.0016749172,0.00012929925,0.000066471606,0.00027574663,0.004082557,0.000029626928,0.00027534482,0.022033969],"study_design_scores_gemma":[0.73656774,0.20274772,0.056077197,0.000069124995,0.0013664514,0.00036548468,0.000045161538,0.0007038005,0.0013646568,0.000085797714,0.000580406,0.000026479613],"about_ca_topic_score_codex":0.00028655806,"about_ca_topic_score_gemma":0.00065488723,"teacher_disagreement_score":0.0024530932,"about_ca_system_score_codex":0.00035157416,"about_ca_system_score_gemma":0.00045365357,"threshold_uncertainty_score":0.007570505},"labels":[],"label_agreement":null},{"id":"W2110411269","doi":"10.1185/03007990802695037","title":"Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada); McGill University","funders":"","keywords":"Medicine; Amiodarone; Implantable cardioverter-defibrillator; Sudden cardiac death; Primary prevention; Cardiology; Internal medicine; Intensive care medicine; Ventricular fibrillation; Sudden death; Atrial fibrillation; Disease","score_opus":0.13160721765674607,"score_gpt":0.4207621936664989,"score_spread":0.2891549760097528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110411269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637637,0.003437475,0.003417577,0.0028007776,0.00009796644,0.0012663354,0.011718558,0.00009157141,0.013405968],"genre_scores_gemma":[0.9944595,0.0006974448,0.0012767096,0.00016344218,0.000011172644,0.00012935359,0.0019439083,0.0000076152237,0.0013108868],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99810153,0.0007533378,0.00006904658,0.00017117933,0.00032624553,0.000578735],"domain_scores_gemma":[0.9946173,0.002384817,0.00051153894,0.00012362153,0.0015660556,0.0007967609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030628897,0.0011069687,0.0016468334,0.0015764785,0.001107184,0.0015036229,0.0022032463,0.0010865306,0.004954444],"category_scores_gemma":[0.012290785,0.00070371124,0.0024198338,0.0020119615,0.0008964873,0.00060377154,0.0009901809,0.0012485053,0.00016861642],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007103235,0.0005783415,0.041648056,0.00067005475,0.0013538525,0.00046883855,0.00009447173,0.9212662,0.0004505189,0.008724956,0.004848716,0.012792739],"study_design_scores_gemma":[0.0052725426,0.0017320651,0.045732126,0.00020342307,0.0017702077,0.00019690153,0.0003648368,0.9372981,0.000491965,0.003421058,0.0033834805,0.00013327826],"about_ca_topic_score_codex":0.9399153,"about_ca_topic_score_gemma":0.8950735,"teacher_disagreement_score":0.06858305,"about_ca_system_score_codex":0.06858305,"about_ca_system_score_gemma":0.049703956,"threshold_uncertainty_score":0.49760717},"labels":[],"label_agreement":null},{"id":"W2112485792","doi":"10.1185/030079907x233269","title":"Reviewing CATIE for clinicians:balancing benefit and risk using evidence-based medicine tools","year":2007,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto East General Hospital; Eli Lilly (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Intensive care medicine; Evidence-based medicine; Alternative medicine; MEDLINE; Pathology","score_opus":0.6920178167274026,"score_gpt":0.6105946113727778,"score_spread":0.08142320535462477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112485792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011052764,0.6117592,0.07960241,0.22993082,0.011528679,0.02163673,0.009847418,0.001290753,0.02335121],"genre_scores_gemma":[0.14850114,0.22488788,0.505865,0.068737075,0.008999601,0.035827097,0.004998274,0.0007640412,0.0014199635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.38656008,0.36694002,0.1770163,0.00955533,0.057998743,0.0019295174],"domain_scores_gemma":[0.0947111,0.75075424,0.049554214,0.014730989,0.08690681,0.0033426536],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.37746567,0.00287051,0.0147041455,0.03783141,0.002526512,0.02309611,0.010182116,0.007592287,0.00614541],"category_scores_gemma":[0.81274873,0.0031965584,0.010330205,0.022738088,0.0045323586,0.012879282,0.009284425,0.010608984,0.0016730003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072240055,0.00022958126,0.011873541,0.27898508,0.018985232,0.00077649415,0.0063929097,0.003222779,0.00042434823,0.015405083,0.13625227,0.5267303],"study_design_scores_gemma":[0.0012079054,0.00060695864,0.011007925,0.68239963,0.020187646,0.001149992,0.006206321,0.0063333847,0.0009581137,0.059344724,0.20992087,0.000676573],"about_ca_topic_score_codex":0.0065572346,"about_ca_topic_score_gemma":0.014184457,"teacher_disagreement_score":0.37746567,"about_ca_system_score_codex":0.014629892,"about_ca_system_score_gemma":0.035819482,"threshold_uncertainty_score":0.76769567},"labels":[],"label_agreement":null},{"id":"W2112514785","doi":"10.1185/030079905x56484","title":"Cost effectiveness of duloxetine compared with venlafaxine‐XR in the treatment of major depressive disorder","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Venlafaxine; Duloxetine; Medicine; Liberian dollar; Major depressive disorder; Internal medicine; Psychiatry; Antidepressant; Economics; Finance; Anxiety; Mood","score_opus":0.2201016283113629,"score_gpt":0.5184016880465453,"score_spread":0.29830005973518237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112514785","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457528,0.03806128,0.004663271,0.0019719442,0.0003001774,0.0010295279,0.0014629919,0.00007505259,0.0066827964],"genre_scores_gemma":[0.9942749,0.0030383356,0.0016391882,0.00019769686,0.000026310354,0.00014101941,0.000281876,0.000005803733,0.00039481287],"study_design_codex":"simulation_or_modeling","study_design_gemma":"systematic_review","domain_scores_codex":[0.99648225,0.0026770954,0.00018901793,0.00014439215,0.000334709,0.0001724881],"domain_scores_gemma":[0.9953898,0.0036182888,0.00055883924,0.0000666824,0.0001927055,0.00017355896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037245438,0.00070144905,0.0016199773,0.0008628988,0.00021745171,0.0010620331,0.0006720143,0.00088288734,0.0034154868],"category_scores_gemma":[0.013828315,0.00043814522,0.0034929817,0.0008015045,0.00035812584,0.00081954035,0.00046691726,0.0009685091,0.000088897636],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2319428,0.0020715117,0.04657858,0.009882519,0.03282173,0.00042079476,0.00025789172,0.38859266,0.001873203,0.00545537,0.0030461247,0.2770568],"study_design_scores_gemma":[0.06761009,0.05685446,0.117961004,0.0053112623,0.06840593,0.0010675197,0.0008060728,0.65831524,0.003910638,0.012578539,0.006822918,0.0003563345],"about_ca_topic_score_codex":0.018787023,"about_ca_topic_score_gemma":0.01946829,"teacher_disagreement_score":0.018787023,"about_ca_system_score_codex":0.004702635,"about_ca_system_score_gemma":0.002869881,"threshold_uncertainty_score":0.037355363},"labels":[],"label_agreement":null},{"id":"W2115498839","doi":"10.1185/03007995.2013.874988","title":"Asenapine treatment and health-related quality of life in patients experiencing bipolar I disorder with mixed episodes: post-hoc analyses of pivotal trials","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Asenapine; Medicine; Olanzapine; Placebo; Bipolar I disorder; Post-hoc analysis; Quality of life (healthcare); Population; Internal medicine; Atypical antipsychotic; Clinical trial; Randomized controlled trial; Bipolar disorder; Antipsychotic; Psychiatry; Schizophrenia (object-oriented programming); Mania; Lithium (medication)","score_opus":0.272580436939632,"score_gpt":0.5029290711515391,"score_spread":0.23034863421190704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115498839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107975,0.0784316,0.0017245065,0.00076485914,0.00070220686,0.002867847,0.0021388272,0.00011295582,0.002459765],"genre_scores_gemma":[0.98343843,0.0103863515,0.0013077904,0.00039203657,0.0004552527,0.0018635879,0.0013967728,0.000033007564,0.0007267294],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99212974,0.0058546257,0.0009141168,0.00043776183,0.00035052508,0.0003132128],"domain_scores_gemma":[0.9889311,0.0062026456,0.002728239,0.0008456133,0.000723519,0.00056896074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012052058,0.0018113719,0.0049692593,0.000660806,0.00037277627,0.0023020906,0.000961943,0.0010677284,0.0033606295],"category_scores_gemma":[0.012594398,0.00063284463,0.0091679245,0.00094826205,0.000683362,0.0012954286,0.0008688155,0.0019361647,0.000316672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9163484,0.001147285,0.0052735116,0.0036262467,0.051210787,0.000068339104,0.000101122394,0.0005798285,0.00190456,0.00008527086,0.0007720964,0.018882588],"study_design_scores_gemma":[0.6931745,0.14753237,0.056438193,0.00076680334,0.09308098,0.00027550478,0.0003175297,0.0019936662,0.0016868758,0.00042656652,0.004167056,0.00013999596],"about_ca_topic_score_codex":0.000681727,"about_ca_topic_score_gemma":0.0021529908,"teacher_disagreement_score":0.012052058,"about_ca_system_score_codex":0.0008337783,"about_ca_system_score_gemma":0.0009842513,"threshold_uncertainty_score":0.06373817},"labels":[],"label_agreement":null},{"id":"W2116370794","doi":"10.1185/03007995.2011.604672","title":"A practical, evidence-based guide to the use of adalimumab in Crohn’s disease","year":2011,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Internal medicine; Maintenance therapy; Crohn's disease; Disease; Inflammatory bowel disease; Randomized controlled trial; MEDLINE; Intensive care medicine; Chemotherapy","score_opus":0.4129539309395999,"score_gpt":0.5245469099389666,"score_spread":0.11159297899936665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116370794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025856926,0.35984877,0.13659254,0.3441888,0.040834136,0.011271535,0.012972157,0.0065642693,0.08514208],"genre_scores_gemma":[0.008383692,0.23828124,0.59188694,0.09316928,0.012356895,0.010526708,0.007256038,0.0010028421,0.03713638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9812578,0.007030236,0.006335343,0.00068338943,0.0043447725,0.00034837707],"domain_scores_gemma":[0.9569489,0.01760272,0.00497072,0.0010099545,0.017634507,0.0018332512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015531949,0.0033617907,0.004351211,0.018010566,0.0014162536,0.004522679,0.006511622,0.008392369,0.020404339],"category_scores_gemma":[0.04852621,0.0019372228,0.0031910706,0.011352982,0.0021929513,0.007546034,0.0031748053,0.0098170405,0.025347129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015979097,0.00030469662,0.00060134113,0.008483788,0.00013989082,0.00090365927,0.00036539108,0.0006083748,0.001164853,0.002559284,0.77448785,0.2102211],"study_design_scores_gemma":[0.00032070818,0.00023453309,0.002216663,0.020145515,0.00018478771,0.0021872963,0.0004082479,0.0012161494,0.00037236273,0.011237525,0.9613561,0.00012011174],"about_ca_topic_score_codex":0.0039049215,"about_ca_topic_score_gemma":0.009126685,"teacher_disagreement_score":0.020404339,"about_ca_system_score_codex":0.0028196173,"about_ca_system_score_gemma":0.010226251,"threshold_uncertainty_score":0.08214176},"labels":[],"label_agreement":null},{"id":"W2117216433","doi":"10.1185/030079905x59102","title":"Statins and LDL‐cholesterol lowering: an overview","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"European Society of Cardiology; University of Waterloo; Merck KGaA","keywords":"Medicine; Ldl cholesterol; Cholesterol; Cholesterol lowering; Ezetimibe; Pharmacology; Atorvastatin; Statin; Internal medicine","score_opus":0.4106502170329484,"score_gpt":0.5698913529223524,"score_spread":0.15924113588940397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117216433","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012895997,0.9977639,0.00009897394,0.0009661356,0.0002650929,0.000008841487,0.000023975645,0.000008184762,0.00073589216],"genre_scores_gemma":[0.00039628433,0.9978758,0.00019521774,0.00046946493,0.0006666311,0.00001264892,0.00003853855,0.000001676345,0.00034370366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995264,0.00010616477,0.00008944378,0.000072968556,0.0001498393,0.00005517639],"domain_scores_gemma":[0.99928445,0.00032118143,0.0000904418,0.000020488764,0.0001851967,0.00009826047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011996352,0.0011616378,0.0017791366,0.003249148,0.00039592266,0.0017605049,0.0009485011,0.0022584456,0.003794643],"category_scores_gemma":[0.001094371,0.0004938669,0.0010012201,0.0026049018,0.00045746416,0.00200038,0.000922827,0.0030092401,0.002717609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040112803,0.0002739229,0.00059318764,0.018478233,0.00020594682,0.0003004595,0.000079421385,0.0002661675,0.0011939511,0.0038819327,0.053165354,0.9211603],"study_design_scores_gemma":[0.00007448948,0.0004402701,0.0022721293,0.0075222817,0.00027977373,0.0013993591,0.000065217646,0.0001411649,0.00029476703,0.0029878041,0.98448586,0.00003694674],"about_ca_topic_score_codex":0.0018336951,"about_ca_topic_score_gemma":0.0022017488,"teacher_disagreement_score":0.003794643,"about_ca_system_score_codex":0.000927222,"about_ca_system_score_gemma":0.0016766159,"threshold_uncertainty_score":0.012694359},"labels":[],"label_agreement":null},{"id":"W2118328023","doi":"10.1185/03007995.2012.756808","title":"Impact of sevelamer versus calcium-based binders on hospitalizations and missed in-center dialysis treatments among CKD patients on dialysis: a modeled analysis","year":2012,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Humber River Regional Hospital","funders":"","keywords":"Medicine; Dialysis; Sevelamer; Dialysis adequacy; End stage renal disease; Intensive care medicine; Hemodialysis; Emergency medicine; Internal medicine; Kidney disease; Hyperphosphatemia","score_opus":0.12389662635742724,"score_gpt":0.4597669767169544,"score_spread":0.33587035035952717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118328023","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990542,0.00017987029,0.0046392344,0.00054950727,0.000026042962,0.00008897477,0.0016713769,0.00006582818,0.0022370433],"genre_scores_gemma":[0.9956957,0.00012898349,0.0015887857,0.00010290348,0.000015470103,0.000075160904,0.0008421641,0.0000124732205,0.0015384785],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99900454,0.0003952179,0.0000409125,0.00016456102,0.00008278215,0.00031199347],"domain_scores_gemma":[0.9937238,0.004137565,0.00094115944,0.00018558014,0.00048078728,0.000530979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027887602,0.0011831846,0.0016124677,0.0011829237,0.00083586725,0.001832573,0.002665144,0.0025480823,0.0039689033],"category_scores_gemma":[0.0065281596,0.00091392116,0.002595065,0.0010041638,0.0008486346,0.0010290227,0.0010235406,0.0018956078,0.00027249136],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029227554,0.0002594802,0.016005347,0.000024532683,0.0001522988,0.00016098833,0.000029705448,0.98076963,0.00017063277,0.00091670506,0.00034402954,0.0008743108],"study_design_scores_gemma":[0.00010401203,0.00020915824,0.004362029,0.000011782168,0.00009501043,0.000043663527,0.000075147174,0.99438286,0.000099298486,0.00043947485,0.00016180618,0.000015758103],"about_ca_topic_score_codex":0.07545485,"about_ca_topic_score_gemma":0.034995206,"teacher_disagreement_score":0.07545485,"about_ca_system_score_codex":0.0048937625,"about_ca_system_score_gemma":0.0037759047,"threshold_uncertainty_score":0.15003133},"labels":[],"label_agreement":null},{"id":"W2120807296","doi":"10.1185/030079907x233160","title":"Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Tolerability; Overactive bladder; Discontinuation; Placebo; Adverse effect; Constipation; Solifenacin; Internal medicine; Anesthesia","score_opus":0.17753468286716914,"score_gpt":0.5006003412852479,"score_spread":0.32306565841807877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120807296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975804,0.0016918486,0.000120281344,0.000023739844,0.00001233677,0.00011607557,0.00032301355,0.0000064191627,0.00012584969],"genre_scores_gemma":[0.99674135,0.0006592503,0.00029502372,0.00013758164,0.00006966867,0.00019242632,0.0017329605,0.0000040418167,0.00016766429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977768,0.0010911905,0.00027814388,0.000293073,0.0004013037,0.0001594774],"domain_scores_gemma":[0.99190134,0.0029813747,0.002936442,0.0006606947,0.0006172643,0.000902899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064868806,0.00067575945,0.002050645,0.00066817994,0.00035921606,0.0009071036,0.00041133724,0.0008417769,0.0011323537],"category_scores_gemma":[0.0055677406,0.00037227818,0.0026619367,0.00069030956,0.00047626224,0.00065597135,0.00058246905,0.00084066385,0.000208578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3080573,0.004944771,0.62516,0.0013041504,0.010261263,0.000680483,0.00052446127,0.0007864076,0.006801042,0.000053277086,0.0005028017,0.040924102],"study_design_scores_gemma":[0.021015434,0.064207464,0.90771323,0.00010504912,0.0034917183,0.0006613746,0.00013312166,0.0007239039,0.00063372665,0.00003850734,0.0012153367,0.00006108796],"about_ca_topic_score_codex":0.0005461351,"about_ca_topic_score_gemma":0.00091830606,"teacher_disagreement_score":0.0064868806,"about_ca_system_score_codex":0.00052161067,"about_ca_system_score_gemma":0.0006459443,"threshold_uncertainty_score":0.034306288},"labels":[],"label_agreement":null},{"id":"W2122016047","doi":"10.1185/030079906x162809","title":"Quetiapine augmentation of treatment-resistant depression: a comparison with lithium","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine; AstraZeneca (Canada)","funders":"","keywords":"Quetiapine; Lithium (medication); Medicine; Antidepressant; Rating scale; Quetiapine Fumarate; Depression (economics); Internal medicine; Bipolar disorder; Lithium carbonate; Anesthesia; Psychiatry; Antipsychotic; Atypical antipsychotic; Psychology; Schizophrenia (object-oriented programming)","score_opus":0.1272281207290876,"score_gpt":0.48260314132262894,"score_spread":0.3553750205935413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122016047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98743546,0.0107274465,0.00014234697,0.00021850893,0.00009632302,0.00015054307,0.00008278381,0.000026386395,0.0011200985],"genre_scores_gemma":[0.9948225,0.0038484512,0.00030908978,0.0001269585,0.00022127749,0.00008678409,0.00013177081,0.000004386855,0.00044891113],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99917895,0.00050466007,0.00007788695,0.0000656412,0.000098907236,0.00007400099],"domain_scores_gemma":[0.998985,0.00046248766,0.0002530392,0.00005774484,0.000042622738,0.00019908266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010903525,0.00040962506,0.0015157625,0.00035932122,0.00017303605,0.00055951276,0.00059246004,0.0008005423,0.002614399],"category_scores_gemma":[0.0019307,0.00019245013,0.0010211699,0.00029797808,0.00052962283,0.00057832786,0.00018930253,0.0008982123,0.00027772496],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8522741,0.007424813,0.003950073,0.0012003257,0.0017401357,0.00023096261,0.00018061078,0.00040366218,0.014923478,0.00027238377,0.000354943,0.11704455],"study_design_scores_gemma":[0.39488083,0.5500089,0.04018524,0.00028793962,0.0024947417,0.0007072531,0.00019022348,0.002156806,0.004300283,0.0002846723,0.0044350205,0.00006798805],"about_ca_topic_score_codex":0.0007151391,"about_ca_topic_score_gemma":0.0023432607,"teacher_disagreement_score":0.002614399,"about_ca_system_score_codex":0.0005307179,"about_ca_system_score_gemma":0.0003864648,"threshold_uncertainty_score":0.008746088},"labels":[],"label_agreement":null},{"id":"W2123003746","doi":"10.1185/030079904125003430","title":"Managing acute exacerbations of schizophrenia: focus on quetiapine","year":2004,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Medicine; Quetiapine; Schizophrenia (object-oriented programming); Psychiatry; Quetiapine Fumarate; Focus (optics); Intensive care medicine; Atypical antipsychotic; Antipsychotic","score_opus":0.15210424749362153,"score_gpt":0.4848616602917703,"score_spread":0.33275741279814874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123003746","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022759095,0.65522325,0.001493967,0.30648038,0.020614754,0.00003700126,0.000029505518,0.000063260624,0.01378193],"genre_scores_gemma":[0.025135526,0.6865752,0.0027046215,0.15362065,0.12397507,0.000054843767,0.000051920433,0.00006758082,0.007814585],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99890137,0.0003575603,0.00015026605,0.00011156744,0.00033630643,0.00014295123],"domain_scores_gemma":[0.9958781,0.0019596855,0.0004568922,0.00006697124,0.0009179117,0.0007203611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019295196,0.00046689145,0.0007140988,0.0006773459,0.0007054425,0.0021788047,0.0010223449,0.0038975484,0.0030381773],"category_scores_gemma":[0.0055639567,0.00017352859,0.000573413,0.000570936,0.0011361338,0.0029689525,0.0014405889,0.0051284176,0.0007829906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016218684,0.00008799054,0.0013064839,0.0043245726,0.000053794614,0.008059925,0.0016851284,0.00032598182,0.0017400483,0.008379721,0.33025768,0.6436164],"study_design_scores_gemma":[0.00006126237,0.00016734605,0.001987782,0.0048540737,0.000057705653,0.010029446,0.0015249068,0.00018267636,0.00030522182,0.0029784732,0.97780186,0.00004930444],"about_ca_topic_score_codex":0.003707674,"about_ca_topic_score_gemma":0.012641835,"teacher_disagreement_score":0.0038975484,"about_ca_system_score_codex":0.0019391757,"about_ca_system_score_gemma":0.0024877505,"threshold_uncertainty_score":0.014069796},"labels":[],"label_agreement":null},{"id":"W2124466636","doi":"10.1185/030079907x188198","title":"Prescriptions for vitamin Damong patients taking antiresorptive agents in Canada","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); University of Calgary","funders":"","keywords":"Medicine; Vitamin D and neurology; Medical prescription; Raloxifene; Alfacalcidol; Calcitriol receptor; Ergocalciferol; Internal medicine; Denosumab; Osteoporosis; Cholecalciferol; Pharmacology; Breast cancer; Bone mineral; Cancer","score_opus":0.164496793056832,"score_gpt":0.46485279143798475,"score_spread":0.30035599838115273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124466636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892413,0.0010803574,0.000056017045,0.0003391348,0.000009124929,0.00006467642,0.006427435,0.000013709226,0.0027682097],"genre_scores_gemma":[0.9964128,0.0009273409,0.00011577421,0.00017629702,0.000006961453,0.000022415681,0.0016356695,0.0000033247916,0.0006994037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991248,0.000042613257,0.00008380128,0.000106643485,0.00039627776,0.0002458082],"domain_scores_gemma":[0.99797565,0.0001292733,0.00080934976,0.000038527596,0.0006010853,0.0004461937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030685565,0.00018939984,0.00031932472,0.0013482234,0.001325415,0.0008770633,0.00076094794,0.00035701832,0.0022840719],"category_scores_gemma":[0.0016601827,0.00033309136,0.0004122348,0.0040447167,0.0003261384,0.00021857921,0.00047503557,0.0005572599,0.00019611213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049474813,0.000025303287,0.9949825,0.00004004358,0.000019653538,0.00014481683,0.00019762728,0.0000399275,0.000098771394,0.000026669892,0.00062370783,0.0037515287],"study_design_scores_gemma":[0.000008410306,0.000025766527,0.9982274,0.000029813427,0.000014436616,0.00017685961,0.0003696667,0.00016085521,0.00005871365,0.000007827941,0.0009151625,0.0000051521697],"about_ca_topic_score_codex":0.9684257,"about_ca_topic_score_gemma":0.97788006,"teacher_disagreement_score":0.03157431,"about_ca_system_score_codex":0.013767846,"about_ca_system_score_gemma":0.016144903,"threshold_uncertainty_score":0.09989315},"labels":[],"label_agreement":null},{"id":"W2127101106","doi":"10.1185/030079906x80323","title":"Treatment patterns for women with new episodes of uterine myomas in an insured population in the US","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Waterloo","keywords":"Medicine; Population; Gynecology; Obstetrics; Environmental health","score_opus":0.12372607828550747,"score_gpt":0.4669350017645471,"score_spread":0.34320892347903964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127101106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988159,0.00019782757,0.000031979802,0.00011691724,0.000002114174,0.000006236011,0.0005921604,0.000003455067,0.00023332736],"genre_scores_gemma":[0.9991837,0.00011488013,0.00006411384,0.000051532443,0.0000051228617,0.000007027429,0.00050506205,0.000001137239,0.0000674353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995859,0.000092413866,0.000061526334,0.000099233286,0.000097631666,0.000063325504],"domain_scores_gemma":[0.9986505,0.00021219558,0.0008374253,0.000051325675,0.0000976697,0.00015096854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003864812,0.000095153686,0.00017590668,0.0008822427,0.00027255007,0.00032842986,0.0002872112,0.00031573928,0.0011874676],"category_scores_gemma":[0.002230662,0.00016382952,0.0002722854,0.0009938263,0.0001744939,0.00028429207,0.00029852855,0.00027171825,0.00013497206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017976625,0.000014126426,0.9989002,0.0000027409494,0.000011098815,0.000030792224,0.00003701909,0.00002202729,0.000051014777,0.0000060181364,0.00009828481,0.0008087376],"study_design_scores_gemma":[0.0000031713562,0.000026424026,0.9993318,0.0000049335163,0.000008078364,0.00018982707,0.00011858475,0.00018754398,0.000024967498,0.000008894847,0.000094067786,0.0000017329736],"about_ca_topic_score_codex":0.018214725,"about_ca_topic_score_gemma":0.024274696,"teacher_disagreement_score":0.018214725,"about_ca_system_score_codex":0.00058736466,"about_ca_system_score_gemma":0.00034317223,"threshold_uncertainty_score":0.03621745},"labels":[],"label_agreement":null},{"id":"W2128057975","doi":"10.1185/03007995.2013.763779","title":"Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; McMaster University; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Denosumab; Medicine; Teriparatide; Osteoporosis; Discontinuation; Raloxifene; Adverse effect; Osteonecrosis of the jaw; Bisphosphonate; Internal medicine; Placebo; Bone mineral; Tamoxifen; Breast cancer; Alternative medicine; Cancer","score_opus":0.35256512639565313,"score_gpt":0.5813298030249506,"score_spread":0.2287646766292975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128057975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010548851,0.98047596,0.0004115712,0.010383351,0.0014670492,0.000029458093,0.00007730119,0.00002037949,0.0060800333],"genre_scores_gemma":[0.010151919,0.9727778,0.0017136862,0.008173917,0.0025664924,0.000042901374,0.00014193272,0.0000065247655,0.0044247913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996307,0.00007392523,0.000050117436,0.000044526343,0.0001768291,0.000023809971],"domain_scores_gemma":[0.9995759,0.00014608017,0.00009890011,0.000009082005,0.00012944973,0.000040624967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008160069,0.00027965102,0.00045440276,0.0012107977,0.00024946075,0.0008876561,0.0003792475,0.001061936,0.0054436983],"category_scores_gemma":[0.0011800977,0.00012037798,0.00047131427,0.001001835,0.00031939626,0.00093758793,0.00039451075,0.0011883649,0.0019421837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026043205,0.00013202435,0.0009133133,0.010239214,0.00013549812,0.001137924,0.00017043593,0.00008608605,0.0047786217,0.00477147,0.084596716,0.8927783],"study_design_scores_gemma":[0.00026467803,0.00026531893,0.0020012415,0.0026197382,0.0002595033,0.002619161,0.0001069853,0.000112358866,0.00071511685,0.0018411237,0.98917985,0.000015020523],"about_ca_topic_score_codex":0.00099225,"about_ca_topic_score_gemma":0.00401744,"teacher_disagreement_score":0.0054436983,"about_ca_system_score_codex":0.00048249523,"about_ca_system_score_gemma":0.0010400643,"threshold_uncertainty_score":0.018210948},"labels":[],"label_agreement":null},{"id":"W2128667657","doi":"10.1185/03007995.2015.1082989","title":"A primer on the hormone-free interval for combined oral contraceptives","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Calgary General Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Dosing; Discontinuation; Estrogen; Follicular phase; Family planning; Progestin; Population; Gynecology; Internal medicine; Environmental health","score_opus":0.4227601636236631,"score_gpt":0.558261526390508,"score_spread":0.13550136276684488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128667657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004129466,0.71605086,0.0031029359,0.21889071,0.045073953,0.00010366512,0.0001343105,0.000073787865,0.016156899],"genre_scores_gemma":[0.003981025,0.673924,0.006496726,0.2333224,0.065725796,0.0002567158,0.00016082969,0.0000896619,0.016042884],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973463,0.0014394191,0.00024025302,0.00022242183,0.0006312258,0.00012039334],"domain_scores_gemma":[0.99365497,0.004796503,0.00035934465,0.00009837956,0.00077323907,0.00031753405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003703178,0.00085222715,0.0009244714,0.0012180668,0.0007923186,0.0022581546,0.0014522278,0.0059963237,0.010760649],"category_scores_gemma":[0.008351607,0.00045808972,0.0011189907,0.0009713748,0.002169861,0.0064126896,0.0014774527,0.01254358,0.004829392],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014484626,0.00010880696,0.00025320824,0.0041426197,0.000037028356,0.00053865387,0.0009008263,0.00015570398,0.0009157481,0.032827374,0.6232685,0.3367067],"study_design_scores_gemma":[0.000010663468,0.000052087216,0.00009730886,0.0016408286,0.000010077836,0.0006137582,0.00010104027,0.000024899631,0.00006244211,0.0028277154,0.99455124,0.000007841916],"about_ca_topic_score_codex":0.0012506924,"about_ca_topic_score_gemma":0.0018082295,"teacher_disagreement_score":0.010760649,"about_ca_system_score_codex":0.0017306034,"about_ca_system_score_gemma":0.0020394807,"threshold_uncertainty_score":0.035997927},"labels":[],"label_agreement":null},{"id":"W2129869980","doi":"10.1185/030079904x2754","title":"Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Analgesic; WOMAC; Tramadol; Lidocaine; Adverse effect; Anesthesia; Hyperalgesia; Duloxetine; Brief Pain Inventory; Physical therapy; Chronic pain; Internal medicine; Nociception","score_opus":0.1506651205344753,"score_gpt":0.44258410425849315,"score_spread":0.2919189837240178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129869980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90791905,0.073497996,0.010809266,0.0012759442,0.00036091983,0.00039333437,0.00009283599,0.00018257032,0.0054679764],"genre_scores_gemma":[0.9797381,0.015475482,0.0024748917,0.0003965453,0.00029078132,0.00009291386,0.000059649632,0.0000068420445,0.0014647021],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99987054,0.000039013466,0.000011345233,0.000021314023,0.000028261926,0.000029526978],"domain_scores_gemma":[0.9999106,0.000027633896,0.0000373486,0.0000055851583,0.0000089568275,0.000009925998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033108573,0.00021494777,0.00049402035,0.0001494252,0.000115895906,0.0004167934,0.00029298765,0.00040326544,0.0021293072],"category_scores_gemma":[0.0002563706,0.0000977086,0.00047330698,0.000089915586,0.00025643,0.0003438552,0.0001191068,0.00052439637,0.00023673003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045656273,0.0014188742,0.0024059245,0.0021019378,0.00010906877,0.0010744834,0.0000954489,0.00036666205,0.81648254,0.0012386056,0.0009459753,0.16919482],"study_design_scores_gemma":[0.008805227,0.18183473,0.08991636,0.0010307487,0.0018996052,0.011984498,0.00069901766,0.009658515,0.6387057,0.0022949695,0.05305491,0.00011582186],"about_ca_topic_score_codex":0.00031328146,"about_ca_topic_score_gemma":0.000987329,"teacher_disagreement_score":0.0021293072,"about_ca_system_score_codex":0.00016968932,"about_ca_system_score_gemma":0.00024305366,"threshold_uncertainty_score":0.0071232915},"labels":[],"label_agreement":null},{"id":"W2129945276","doi":"10.1185/030079905x43677","title":"Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel","year":2005,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Metabolic syndrome; Position paper; Diabetes mellitus; Type 2 diabetes; Position (finance); Consensus conference; Intensive care medicine; Internal medicine; Endocrinology; Pathology","score_opus":0.11074684889550147,"score_gpt":0.39118636971840426,"score_spread":0.2804395208229028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129945276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010728562,0.8121815,0.0026409065,0.14026695,0.03399658,0.00059761805,0.00064673467,0.00010911556,0.008487789],"genre_scores_gemma":[0.0109748235,0.87019145,0.014583612,0.068557516,0.018396998,0.0012376931,0.002559822,0.000098484634,0.013399615],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959417,0.0013901003,0.00085123925,0.00036694852,0.0010638969,0.00038606385],"domain_scores_gemma":[0.99413836,0.0014658283,0.00078879745,0.00012111861,0.0026443147,0.00084155647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012102922,0.0014261982,0.0027599668,0.0018503714,0.00080055295,0.002853701,0.0050486373,0.00902636,0.0027269062],"category_scores_gemma":[0.00922018,0.00061282876,0.0031035126,0.001672407,0.00088056177,0.0019050328,0.0023215043,0.008334608,0.002331402],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055331364,0.000246151,0.000879979,0.015798023,0.00068500324,0.00060402456,0.00030581662,0.00069437956,0.0013357763,0.0033054096,0.49175844,0.48383367],"study_design_scores_gemma":[0.0006182797,0.00023873957,0.002355645,0.026903128,0.0009048134,0.000709753,0.00021585874,0.00033715292,0.0005316159,0.0029953977,0.9641271,0.00006250832],"about_ca_topic_score_codex":0.0072047897,"about_ca_topic_score_gemma":0.0093877865,"teacher_disagreement_score":0.012102922,"about_ca_system_score_codex":0.0027927826,"about_ca_system_score_gemma":0.008791362,"threshold_uncertainty_score":0.0640071},"labels":[],"label_agreement":null},{"id":"W2129953844","doi":"10.1185/03007990802622726","title":"Escitalopram in the treatment of major depressive disorder: A meta-analysis","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Escitalopram; Citalopram; Duloxetine; Venlafaxine; Major depressive disorder; Sertraline; Medicine; Internal medicine; Antidepressant; Paroxetine; Fluoxetine; Rating scale; Meta-analysis; Hamilton Rating Scale for Depression; Depression (economics); Psychiatry; Psychology; Serotonin","score_opus":0.37284286152732893,"score_gpt":0.5338162859527834,"score_spread":0.16097342442545448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129953844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019161465,0.9787248,0.0005413829,0.0002865411,0.00025866917,0.0002278869,0.00040502468,0.000039263527,0.00035512054],"genre_scores_gemma":[0.45159972,0.5420215,0.0027078348,0.0012515738,0.00044375594,0.0006993809,0.0008250102,0.000033181735,0.00041803936],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9927128,0.0042047873,0.0013999138,0.00073350134,0.0007609762,0.00018799],"domain_scores_gemma":[0.9935288,0.0043637366,0.001242692,0.00019903583,0.0005078279,0.00015789688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01010472,0.0024462952,0.01508755,0.0037322117,0.00045448614,0.002544092,0.0016270874,0.001968848,0.0027543672],"category_scores_gemma":[0.0154788345,0.0012614982,0.030848427,0.0040653874,0.0005373532,0.0009944513,0.000920009,0.0014236966,0.00020700252],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009628924,0.000052632862,0.0027626874,0.06588438,0.9087261,0.000076953875,0.000029682484,0.00082748523,0.00026851756,0.0000759676,0.00033760993,0.011329037],"study_design_scores_gemma":[0.004102121,0.0005500152,0.0031697964,0.006188376,0.98453784,0.000078806734,0.000021591522,0.0003506325,0.00011533893,0.00011189815,0.0007602811,0.000013276828],"about_ca_topic_score_codex":0.005305744,"about_ca_topic_score_gemma":0.010469881,"teacher_disagreement_score":0.01508755,"about_ca_system_score_codex":0.0020074483,"about_ca_system_score_gemma":0.001545072,"threshold_uncertainty_score":0.053439498},"labels":[],"label_agreement":null},{"id":"W2131442583","doi":"10.1185/03007990802381364","title":"Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine","year":2008,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Diclofenac; Intensive care medicine; Pharmacology; Traditional medicine","score_opus":0.27508731710275125,"score_gpt":0.5253570267360547,"score_spread":0.2502697096333034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131442583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029476229,0.9985989,0.00010675684,0.0001223951,0.00016771839,0.000009333496,0.000055775894,0.000006129626,0.0006382297],"genre_scores_gemma":[0.0014726996,0.9970989,0.00031895566,0.00021133597,0.00020937742,0.000011447366,0.000102815466,0.0000020949783,0.00057237875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999561,0.00006116221,0.0001440381,0.00006198984,0.00015316553,0.000018636083],"domain_scores_gemma":[0.9992224,0.00031076872,0.0001752556,0.00001751793,0.00023223109,0.00004184896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057024363,0.0007674467,0.001449021,0.0041849418,0.00030634497,0.0009725365,0.00081561814,0.0007886716,0.004674495],"category_scores_gemma":[0.0010547718,0.00029475585,0.0007260588,0.0052196453,0.00031556352,0.0012799937,0.00036647706,0.0007196863,0.0016720106],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023799033,0.00015055179,0.0004930555,0.11307743,0.00038530873,0.0006498378,0.0001369039,0.00032640577,0.005041745,0.0009034425,0.039429866,0.8391674],"study_design_scores_gemma":[0.0000437937,0.0004407428,0.004767909,0.017045816,0.0009735744,0.0043112733,0.00013265415,0.0001600635,0.0018144068,0.0005245268,0.969749,0.000036299018],"about_ca_topic_score_codex":0.0014526788,"about_ca_topic_score_gemma":0.0023461895,"teacher_disagreement_score":0.004674495,"about_ca_system_score_codex":0.00049833255,"about_ca_system_score_gemma":0.0015816815,"threshold_uncertainty_score":0.015637755},"labels":[],"label_agreement":null},{"id":"W2131806746","doi":"10.1185/030079904125004178","title":"Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":97,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Migraine; Medicine; Zolmitriptan; Menstruation; Physical therapy; Migraine treatment; Pediatrics; Psychiatry; Internal medicine","score_opus":0.194414882329176,"score_gpt":0.5139342092231748,"score_spread":0.31951932689399876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131806746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890275,0.0009968276,0.00014025284,0.00027185451,0.000014819098,0.0009863095,0.006919019,0.000014025436,0.001629351],"genre_scores_gemma":[0.9846281,0.0012744808,0.00064476277,0.00044493913,0.000060638027,0.0012967177,0.01085308,0.000007144384,0.00079011853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990767,0.00042277572,0.00010540402,0.000061924606,0.00021545855,0.000117740536],"domain_scores_gemma":[0.99842596,0.00016967491,0.0009820326,0.00004805727,0.00015531019,0.00021892872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001705164,0.00038184627,0.0006156857,0.00039833286,0.00027687842,0.0003840502,0.0003856386,0.00045194285,0.0009964112],"category_scores_gemma":[0.0023020643,0.00019182872,0.000988523,0.00067068567,0.00015952556,0.00028915785,0.00048450116,0.00036563654,0.0003113256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007171066,0.0011065836,0.9663107,0.00031809654,0.0007523061,0.00008606157,0.00015801394,0.00040440224,0.00043756783,0.00003190175,0.0024835244,0.020739708],"study_design_scores_gemma":[0.0010492573,0.0015826543,0.99557424,0.000044241147,0.00013610297,0.0001239966,0.00007005039,0.00014227522,0.00008347036,0.000017196358,0.0011679219,0.0000086510045],"about_ca_topic_score_codex":0.0050984663,"about_ca_topic_score_gemma":0.010228554,"teacher_disagreement_score":0.0050984663,"about_ca_system_score_codex":0.00062985433,"about_ca_system_score_gemma":0.0008209363,"threshold_uncertainty_score":0.010137558},"labels":[],"label_agreement":null},{"id":"W2133195352","doi":"10.1185/030079907x219643","title":"Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Hydromorphone; Oxycodone; Medicine; Opioid; Anesthesia; Morphine; Chronic pain; Adverse effect; Osteoarthritis; Extended release; Physical therapy; Pharmacology; Internal medicine","score_opus":0.07536041559794104,"score_gpt":0.4218867078261125,"score_spread":0.34652629222817144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133195352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857357,0.00058891304,0.003619386,0.0011860195,0.000051597715,0.00022080955,0.0024593298,0.000033275854,0.0061049215],"genre_scores_gemma":[0.99601823,0.00022915199,0.0012949094,0.000104978986,0.000009027148,0.00009822188,0.000491465,0.0000064061473,0.0017476719],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989518,0.00055885315,0.000037945043,0.000119487035,0.00006697823,0.0002649851],"domain_scores_gemma":[0.99310064,0.0053754463,0.0006673095,0.0001300618,0.00037380555,0.000352703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022476674,0.0014019281,0.0011745911,0.0010598353,0.00054172444,0.001853302,0.0017887435,0.0026307518,0.0039502783],"category_scores_gemma":[0.007513724,0.0008618836,0.0021213938,0.0010948995,0.0010173547,0.001021531,0.0010407076,0.0015611472,0.00018223243],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031503206,0.00012266733,0.0047054715,0.000042800468,0.000083797495,0.000117716285,0.000018897812,0.9923339,0.000058093232,0.0012574121,0.00021172893,0.00073263387],"study_design_scores_gemma":[0.00032175853,0.00032402985,0.0045281984,0.000046608686,0.00016198936,0.0000369857,0.00018953832,0.99263895,0.00014641623,0.0011628082,0.00041502644,0.00002766244],"about_ca_topic_score_codex":0.14681524,"about_ca_topic_score_gemma":0.06341378,"teacher_disagreement_score":0.14681524,"about_ca_system_score_codex":0.0071249325,"about_ca_system_score_gemma":0.0036398014,"threshold_uncertainty_score":0.29192138},"labels":[],"label_agreement":null},{"id":"W2135648839","doi":"10.1185/030079903125002405","title":"Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":158,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"AstraZeneca","keywords":"Rosuvastatin; Medicine; Pravastatin; Atorvastatin; Simvastatin; Pharmacology; Statin; Rosuvastatin Calcium; Internal medicine; Cholesterol","score_opus":0.17612580238412012,"score_gpt":0.47144030552235,"score_spread":0.2953145031382299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135648839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871749,0.008430252,0.00048815896,0.00059860444,0.00035612436,0.0005807077,0.00066496286,0.00004049352,0.0016657081],"genre_scores_gemma":[0.9912816,0.0035125602,0.0008726285,0.00073315384,0.00053455174,0.0006268707,0.0013065686,0.00002243318,0.0011095013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.996093,0.00296829,0.00029163292,0.00022824894,0.00023512477,0.000183678],"domain_scores_gemma":[0.9974439,0.0010714708,0.0005532528,0.0002464404,0.00013750933,0.00054741325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064465594,0.0012117132,0.0036243172,0.00039129297,0.00023598455,0.00097123923,0.0006627552,0.0013688175,0.003206861],"category_scores_gemma":[0.004244881,0.00042380777,0.0035193693,0.00035285918,0.00097485847,0.00088169856,0.00054335804,0.002250274,0.00062452414],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9887495,0.0011800517,0.0009146124,0.00031598183,0.0016949176,0.000014890714,0.000034375164,0.00015196785,0.0008600859,0.00008206014,0.00025177014,0.0057497644],"study_design_scores_gemma":[0.9089318,0.08071899,0.0055413684,0.00007829743,0.0024828496,0.000049826387,0.000051333533,0.00064767455,0.00055239006,0.0003098403,0.0006160329,0.000019603689],"about_ca_topic_score_codex":0.00038360723,"about_ca_topic_score_gemma":0.00068780687,"teacher_disagreement_score":0.0064465594,"about_ca_system_score_codex":0.0003916811,"about_ca_system_score_gemma":0.00072124315,"threshold_uncertainty_score":0.034093022},"labels":[],"label_agreement":null},{"id":"W2136459019","doi":"10.1185/03007995.2013.803462","title":"Venous thromboembolism management: where do novel anticoagulants fit?","year":2013,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; Hamilton Health Sciences; McMaster University","funders":"","keywords":"Medicine; Venous thromboembolism; Dabigatran; Intensive care medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Internal medicine; Thrombosis","score_opus":0.28757096000421317,"score_gpt":0.5060240680105191,"score_spread":0.21845310800630596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136459019","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022478367,0.99575424,0.00006758376,0.0033733908,0.0003225988,0.000022254793,0.000024842317,0.0000021723872,0.00020822127],"genre_scores_gemma":[0.0054376456,0.9886107,0.00057301193,0.0037090646,0.0013962219,0.000067782916,0.000050183447,0.0000039797974,0.00015138417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99281114,0.0024731033,0.0026320599,0.00059670315,0.0012984304,0.00018850845],"domain_scores_gemma":[0.9742649,0.015157488,0.0063903746,0.00022761647,0.0036083912,0.0003512615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009001608,0.0010326416,0.0055565974,0.0037593977,0.0005851321,0.0043756007,0.0015686615,0.0038623891,0.0040548653],"category_scores_gemma":[0.037029486,0.000597632,0.0022333805,0.0056193247,0.0012622206,0.0079569835,0.0010241518,0.0022249403,0.00083207834],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084254175,0.0000758148,0.0040257447,0.47511706,0.0030035977,0.00041459393,0.0005098749,0.0004573072,0.0004647188,0.0056733787,0.02130127,0.48811412],"study_design_scores_gemma":[0.0005158814,0.00046184906,0.005132298,0.82960474,0.006216966,0.001818227,0.0011621176,0.00036422934,0.00019692408,0.005927128,0.14854406,0.000055552457],"about_ca_topic_score_codex":0.0020855444,"about_ca_topic_score_gemma":0.0057017454,"teacher_disagreement_score":0.009001608,"about_ca_system_score_codex":0.0032107853,"about_ca_system_score_gemma":0.006579039,"threshold_uncertainty_score":0.047605634},"labels":[],"label_agreement":null},{"id":"W2136897350","doi":"10.1185/03007995.2015.1092127","title":"Two placebo-controlled, randomized withdrawal studies to evaluate the fentanyl 1 day patch in opioid-naïve patients with chronic pain","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Placebo; Fentanyl; Discontinuation; Visual analogue scale; Adverse effect; Anesthesia; Opioid; Chronic pain; Clinical endpoint; Randomized controlled trial; McGill Pain Questionnaire; Physical therapy; Internal medicine","score_opus":0.07340315948754632,"score_gpt":0.4373179433196166,"score_spread":0.36391478383207027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136897350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95163995,0.011892674,0.00230236,0.00081318343,0.0013675648,0.029233864,0.0011902096,0.00014646511,0.0014137648],"genre_scores_gemma":[0.9340891,0.0068226005,0.006727676,0.0024116307,0.0016409578,0.043700837,0.001397315,0.000047104862,0.0031627575],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9960821,0.0023524186,0.00049098406,0.00049209874,0.00032707554,0.00025521955],"domain_scores_gemma":[0.9947627,0.0016382384,0.0015267258,0.00052682945,0.00064696954,0.0008984711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064761243,0.0017568099,0.005314113,0.0008136267,0.00081139564,0.0009910177,0.0014717766,0.0030242314,0.00509593],"category_scores_gemma":[0.0072576157,0.0011629864,0.002488773,0.00072233065,0.0018001881,0.0016262479,0.0005562267,0.0027579004,0.0007225629],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9707107,0.0119652655,0.0005050736,0.0010862934,0.0008085679,0.000030763753,0.00007496627,0.00007566421,0.0032128475,0.000049552902,0.00027204418,0.011208284],"study_design_scores_gemma":[0.9246118,0.07381425,0.00079462415,0.000024867315,0.0002208814,0.000013672753,0.000011400102,0.000054411543,0.00020401653,0.000029095805,0.00021344179,0.000007588965],"about_ca_topic_score_codex":0.00054808677,"about_ca_topic_score_gemma":0.0020079988,"teacher_disagreement_score":0.0064761243,"about_ca_system_score_codex":0.00082414236,"about_ca_system_score_gemma":0.0018716992,"threshold_uncertainty_score":0.034249425},"labels":[],"label_agreement":null},{"id":"W2137919051","doi":"10.1185/030079906x89685","title":"Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Donepezil; Tolerability; Rivastigmine; Internal medicine; Butyrylcholinesterase; Acetylcholinesterase; Population; Adverse effect; Cholinesterase; Oncology; Dementia; Disease; Aché","score_opus":0.04012341822008597,"score_gpt":0.4254921382347489,"score_spread":0.38536872001466294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137919051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958996,0.0030837303,0.000057547004,0.00007017835,0.000029250616,0.000026962764,0.00016516443,0.0000041387952,0.0006633535],"genre_scores_gemma":[0.9993037,0.0002894447,0.000048910824,0.00006636076,0.000035120724,0.000016820026,0.0001573511,0.000001182909,0.000081096805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928635,0.000325355,0.00009997933,0.00010866997,0.000095494055,0.000084108375],"domain_scores_gemma":[0.99656796,0.001563234,0.001172705,0.00012182637,0.0001424292,0.00043180696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017683828,0.00037342968,0.0010109267,0.00026593448,0.0002009281,0.00043539432,0.0002493055,0.0005515161,0.00091973774],"category_scores_gemma":[0.0047030663,0.00015178259,0.0010197447,0.00033855005,0.00025015266,0.0003783462,0.00024590534,0.00046242346,0.00015255087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18002069,0.0011843761,0.7845443,0.00031567446,0.002083223,0.00029568258,0.0001921348,0.0006730414,0.0027176389,0.000058587633,0.00040858652,0.027506113],"study_design_scores_gemma":[0.0025141349,0.016415386,0.9784359,0.000035891047,0.000972514,0.00029101642,0.000077095116,0.0004440247,0.00033433296,0.00008181726,0.00038152336,0.000016445476],"about_ca_topic_score_codex":0.00048122066,"about_ca_topic_score_gemma":0.00069054373,"teacher_disagreement_score":0.0017683828,"about_ca_system_score_codex":0.00025579685,"about_ca_system_score_gemma":0.00020053593,"threshold_uncertainty_score":0.009352207},"labels":[],"label_agreement":null},{"id":"W2138234348","doi":"10.1080/03007995.2017.1292446","title":"Corrections to: Once-daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study","year":2017,"lang":"en","type":"erratum","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Pfizer","keywords":"Medicine; Pregabalin; Fibromyalgia; Placebo; Double blind; Anesthesia; Randomized controlled trial; Placebo-controlled study; Physical therapy; Internal medicine; Alternative medicine","score_opus":0.07000949703835077,"score_gpt":0.4312884633059609,"score_spread":0.36127896626761014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138234348","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054933527,0.003917245,0.0009665803,0.06810168,0.9196299,0.00027428532,0.0019576591,0.00040614407,0.004197286],"genre_scores_gemma":[0.021871239,0.015472362,0.014713624,0.3579862,0.294067,0.0015056471,0.004222223,0.0020883896,0.28807324],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995494,0.0012038797,0.0011104821,0.00037979754,0.0015556958,0.00025610797],"domain_scores_gemma":[0.9618505,0.012606208,0.003264047,0.0017596075,0.019293448,0.0012262199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064195567,0.001692777,0.0018738725,0.0018998671,0.0016123664,0.0017971309,0.00223975,0.0040369253,0.05285979],"category_scores_gemma":[0.057154156,0.00079061865,0.002385124,0.0014233916,0.0011317455,0.0013299304,0.00073065166,0.006534394,0.017760165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042844986,0.000044239845,0.00011878599,0.00044302357,0.00003468546,0.00018653918,0.000033380074,0.000037749585,0.00013353086,0.00044166666,0.98282856,0.015269321],"study_design_scores_gemma":[0.0018907778,0.00030358686,0.0028404556,0.0012810436,0.00025209913,0.000620609,0.000104837796,0.00033071285,0.0010088967,0.0012245364,0.9900593,0.00008315432],"about_ca_topic_score_codex":0.010327275,"about_ca_topic_score_gemma":0.01724294,"teacher_disagreement_score":0.05285979,"about_ca_system_score_codex":0.0020116302,"about_ca_system_score_gemma":0.0048791505,"threshold_uncertainty_score":0.17683357},"labels":[],"label_agreement":null},{"id":"W2139218479","doi":"10.1185/03007995.2010.507492","title":"Clinical development of onercept, a tumor necrosis factor binding protein, in psoriasis","year":2010,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Discontinuation; Tumor necrosis factor alpha; Clinical trial; Psoriatic arthritis; Systemic inflammatory response syndrome; Sepsis; Internal medicine; Arthritis; Etiology; Placebo; Dermatology; Pathology","score_opus":0.2546228500833358,"score_gpt":0.4820121677577306,"score_spread":0.2273893176743948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139218479","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8837428,0.062260326,0.014818532,0.005878019,0.0009965225,0.009665947,0.00075136573,0.0005613262,0.021325123],"genre_scores_gemma":[0.965712,0.017100241,0.008450782,0.002754521,0.00064119365,0.002123306,0.0008719626,0.000049527356,0.002296332],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99818796,0.0009973395,0.00017804805,0.00020409883,0.00026423085,0.00016829766],"domain_scores_gemma":[0.99772424,0.0005377528,0.0003565009,0.00021357776,0.00045179023,0.0007161744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006860574,0.0004845566,0.0009326933,0.00048323628,0.0006150778,0.001107001,0.000834599,0.0010774574,0.0023948126],"category_scores_gemma":[0.0032879391,0.00023631238,0.00078527036,0.00036254374,0.00082465657,0.00062419835,0.00050427637,0.0021300055,0.0007535061],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04576892,0.020675505,0.009664668,0.0030542922,0.00036244697,0.0017615545,0.0008812902,0.001678798,0.11580244,0.001798848,0.009637856,0.78891337],"study_design_scores_gemma":[0.1591435,0.56683475,0.041608315,0.0014989859,0.0013177535,0.016028289,0.00036377728,0.0040130937,0.09630263,0.0018564012,0.11092551,0.00010699501],"about_ca_topic_score_codex":0.00032946287,"about_ca_topic_score_gemma":0.0005647121,"teacher_disagreement_score":0.006860574,"about_ca_system_score_codex":0.0010215002,"about_ca_system_score_gemma":0.0025629678,"threshold_uncertainty_score":0.0362826},"labels":[],"label_agreement":null},{"id":"W2139848588","doi":"10.1185/030079904125004484","title":"Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre","funders":"American Heart Association","keywords":"Atorvastatin; Medicine; Quartile; Internal medicine; Coronary heart disease; National Cholesterol Education Program; Cholesterol; Guideline; Cardiology; Metabolic syndrome; Confidence interval","score_opus":0.4358632798930135,"score_gpt":0.5607694194324756,"score_spread":0.12490613953946211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139848588","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971245,0.0008183385,0.00013090612,0.00020230944,0.000019824312,0.00012209963,0.00085242087,0.0000051933653,0.00072437467],"genre_scores_gemma":[0.996896,0.0002735375,0.00026244673,0.00021493864,0.000029789797,0.00011494944,0.001871262,0.000004420061,0.00033249895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770564,0.0014451828,0.00016623485,0.00029474022,0.00023094505,0.0001572687],"domain_scores_gemma":[0.9966276,0.00092329923,0.0010660662,0.00048861024,0.00030345123,0.0005909636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005058424,0.0006730138,0.0015039266,0.00040603668,0.00028248507,0.0007814822,0.0005265496,0.0011685075,0.0012032327],"category_scores_gemma":[0.0048387144,0.00030448817,0.001048774,0.00083315093,0.00048545812,0.0004409567,0.00094300625,0.0012225977,0.00018408027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05900551,0.0013128567,0.9249514,0.0002700541,0.003375702,0.0002687046,0.00021732862,0.0006810439,0.0013129375,0.00020932424,0.0011666398,0.007228442],"study_design_scores_gemma":[0.0070568193,0.004069218,0.9859132,0.000054772157,0.00097094954,0.00018206668,0.00011900323,0.00061442325,0.00018206149,0.00021854212,0.00059726974,0.000021583488],"about_ca_topic_score_codex":0.0025148557,"about_ca_topic_score_gemma":0.003420335,"teacher_disagreement_score":0.005058424,"about_ca_system_score_codex":0.00054659107,"about_ca_system_score_gemma":0.0007549396,"threshold_uncertainty_score":0.026751816},"labels":[],"label_agreement":null},{"id":"W2140719894","doi":"10.1185/030079905x56565","title":"Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novartis Pharma; Novartis","keywords":"Rivastigmine; Donepezil; Tolerability; Medicine; Adverse effect; Discontinuation; Cholinesterase; Internal medicine; Dementia; Population; Randomized controlled trial; Disease","score_opus":0.14255179854658334,"score_gpt":0.45086080174606846,"score_spread":0.3083090031994851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140719894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851135,0.01194472,0.00024319552,0.00018776623,0.0002376276,0.001029281,0.00032135443,0.00003035594,0.0008922861],"genre_scores_gemma":[0.99401736,0.0030066457,0.00043689442,0.0003089262,0.0002259049,0.0010748365,0.00038750906,0.000003358262,0.00053863914],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9975128,0.0013801269,0.00034022768,0.0003448076,0.00021568763,0.00020626979],"domain_scores_gemma":[0.9984249,0.000375827,0.0006964749,0.000108569766,0.00007956386,0.0003147241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030969002,0.00067351497,0.0032411583,0.00050713867,0.00029072157,0.00058590254,0.00062397117,0.0011772441,0.001792195],"category_scores_gemma":[0.0033542472,0.00037863408,0.0021090927,0.0005301784,0.0005521886,0.0006325075,0.00040949837,0.000979823,0.0002631613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93955266,0.00825487,0.0037788483,0.0016999255,0.0027277463,0.00007833674,0.00008922624,0.00027567564,0.0027093028,0.00005768818,0.00048764193,0.040288188],"study_design_scores_gemma":[0.7324785,0.22490034,0.03902769,0.00013532524,0.0013546012,0.0001187622,0.00003395074,0.00030059463,0.00066613394,0.00010819476,0.0008509423,0.000024989768],"about_ca_topic_score_codex":0.0007645845,"about_ca_topic_score_gemma":0.001760664,"teacher_disagreement_score":0.0032411583,"about_ca_system_score_codex":0.0007549648,"about_ca_system_score_gemma":0.00087490736,"threshold_uncertainty_score":0.016378105},"labels":[],"label_agreement":null},{"id":"W2143632543","doi":"10.1185/030079906x104614","title":"Improving the global management of the neurogenic bladder patient: part II.Future treatment strategies","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"Allergan; Ipsen","keywords":"Medicine; Overactive bladder; Urinary incontinence; Reimbursement; Intensive care medicine; Dosing; Population; Disease; Urinary system; Urinary bladder; Urology; Internal medicine; Health care; Alternative medicine; Pathology","score_opus":0.13997246888930823,"score_gpt":0.4645990195552691,"score_spread":0.3246265506659609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143632543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013232276,0.99607384,0.00022049893,0.0021476496,0.00032779475,0.000020446516,0.000012127569,0.000009459834,0.0010559575],"genre_scores_gemma":[0.0009715093,0.9966983,0.0006125503,0.0007892641,0.00037699423,0.000041389336,0.00002210937,0.0000015905256,0.00048625245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999569,0.00016503916,0.00006011347,0.00005164778,0.00011358238,0.000040746872],"domain_scores_gemma":[0.9995783,0.00017549115,0.0000942061,0.000013345195,0.000092509006,0.000046149788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012340259,0.0011847814,0.0019589094,0.0021100654,0.00036501366,0.0011280833,0.0012902976,0.002552449,0.0051357895],"category_scores_gemma":[0.001425243,0.00031711947,0.0006888959,0.0018263211,0.0007353135,0.0022022275,0.00064908987,0.0017425125,0.0022187436],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000618,0.00013466203,0.0003216571,0.015380404,0.000082686805,0.00032938865,0.000102035076,0.00057725876,0.0005106704,0.002542841,0.032571122,0.9473855],"study_design_scores_gemma":[0.00015091874,0.00046278085,0.008309696,0.03815946,0.00028760295,0.006270917,0.00074893393,0.00068013417,0.0005255073,0.007882558,0.9364569,0.00006443039],"about_ca_topic_score_codex":0.001958832,"about_ca_topic_score_gemma":0.0028192687,"teacher_disagreement_score":0.0051357895,"about_ca_system_score_codex":0.0011983538,"about_ca_system_score_gemma":0.0018054207,"threshold_uncertainty_score":0.01718098},"labels":[],"label_agreement":null},{"id":"W2144528397","doi":"10.1185/03007995.2014.975786","title":"The current landscape of treatment options for venous thromboembolism: a focus on novel oral anticoagulants","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Edoxaban; Dabigatran; Apixaban; Rivaroxaban; Intensive care medicine; Direct thrombin inhibitor; Clinical trial; Pulmonary embolism; Pharmacodynamics; Adverse effect; Warfarin; Pharmacokinetics; Pharmacology; Internal medicine; Atrial fibrillation","score_opus":0.2514164696356102,"score_gpt":0.5098408109641079,"score_spread":0.25842434132849773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144528397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025591432,0.98821604,0.00027128897,0.009958166,0.0003851307,0.0000066343046,0.000033481112,0.000010654365,0.0008627555],"genre_scores_gemma":[0.002214431,0.9916082,0.000771249,0.0038419422,0.0012662875,0.000018337516,0.000058951082,0.000005452819,0.00021522402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766505,0.000771534,0.00048118274,0.0003018761,0.0006730453,0.000107303014],"domain_scores_gemma":[0.9848838,0.010649701,0.0015057556,0.00021341784,0.0022856302,0.000461616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005497986,0.0007423278,0.0021237594,0.00407416,0.0005522667,0.002756174,0.0014599256,0.0027250266,0.006670925],"category_scores_gemma":[0.009061137,0.00030433404,0.0014197971,0.0038187853,0.00126161,0.005610691,0.0013279313,0.0034385566,0.0011626009],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001901715,0.0001003432,0.00088154606,0.039671507,0.00025615105,0.0003528596,0.00024239156,0.00047278526,0.000789583,0.012276546,0.041445892,0.9033203],"study_design_scores_gemma":[0.000093815725,0.00041120267,0.0031687052,0.06801155,0.0007929106,0.0026682601,0.0008401267,0.0005111169,0.0003017557,0.015112664,0.9080048,0.00008305852],"about_ca_topic_score_codex":0.0012610015,"about_ca_topic_score_gemma":0.0028163749,"teacher_disagreement_score":0.006670925,"about_ca_system_score_codex":0.0016003577,"about_ca_system_score_gemma":0.0043944307,"threshold_uncertainty_score":0.029076517},"labels":[],"label_agreement":null},{"id":"W2145546237","doi":"10.1185/030079906x132631","title":"Economic implications of growth hormone use in patients with short bowel syndrome","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Short bowel syndrome; Parenteral nutrition; Somatropin; Malabsorption; Pediatrics; Growth hormone deficiency; Surgery; Growth hormone; Intensive care medicine; Internal medicine; Hormone","score_opus":0.06444060966351599,"score_gpt":0.39155649114533275,"score_spread":0.32711588148181675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145546237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687395,0.0030206055,0.011110528,0.00487083,0.000095724135,0.0002987532,0.001923894,0.00005098767,0.00988913],"genre_scores_gemma":[0.9983011,0.0003774005,0.00057991326,0.000144302,0.000007005103,0.000031897907,0.00021374875,0.00000245019,0.00034225328],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9976872,0.0017112648,0.00007156402,0.00009784385,0.000201142,0.00023092538],"domain_scores_gemma":[0.99270093,0.005846499,0.00079114403,0.00009694154,0.0002397469,0.00032475486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030738774,0.00063235173,0.00054188014,0.00046649398,0.00036632616,0.0013335611,0.0006383382,0.0009847414,0.004074785],"category_scores_gemma":[0.01607794,0.0003748174,0.0013736051,0.0005721767,0.00050566334,0.0007717502,0.0009480597,0.0012052342,0.0001655563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021070386,0.00030167587,0.06003308,0.0002059412,0.0006240705,0.00096830324,0.00006149332,0.9193562,0.00033029326,0.003844468,0.0008822536,0.011285191],"study_design_scores_gemma":[0.0011624955,0.0022944354,0.04041165,0.00032893845,0.00084059767,0.0009906135,0.00037594605,0.9406069,0.00086677336,0.008840962,0.0032082596,0.00007244308],"about_ca_topic_score_codex":0.01777711,"about_ca_topic_score_gemma":0.007883197,"teacher_disagreement_score":0.01777711,"about_ca_system_score_codex":0.0042841504,"about_ca_system_score_gemma":0.0025292737,"threshold_uncertainty_score":0.035347283},"labels":[],"label_agreement":null},{"id":"W2146473798","doi":"10.1185/030079907x210444","title":"The Barthel Index and modified Rankin Scale as prognostic tools for long-term outcomes after stroke: a qualitative review of the literature","year":2007,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Stroke Rehabilitation and Recovery","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"AstraZeneca","keywords":"Medicine; Modified Rankin Scale; Barthel index; Stroke (engine); Term (time); Scale (ratio); Physical therapy; Index (typography); Physical medicine and rehabilitation; Intensive care medicine; Internal medicine; Activities of daily living; Ischemic stroke","score_opus":0.20580107981137316,"score_gpt":0.5485744398505992,"score_spread":0.342773360039226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146473798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021778315,0.9637407,0.0017650203,0.006343381,0.00031893115,0.0021666249,0.0014401617,0.000014447183,0.0024324213],"genre_scores_gemma":[0.17313406,0.8072162,0.008766239,0.0037538426,0.00018937251,0.0056069666,0.00060022256,0.00002111617,0.0007119779],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95277303,0.032153044,0.009314269,0.0011269547,0.0039153327,0.0007174021],"domain_scores_gemma":[0.7996717,0.1748716,0.011911498,0.00087238685,0.0121163055,0.000556596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058304895,0.001018632,0.0033117237,0.021341389,0.0014500397,0.0045110043,0.0018563035,0.0017144759,0.0023473385],"category_scores_gemma":[0.14712082,0.0009351564,0.0019033491,0.021664204,0.0028014823,0.0058356905,0.0026244835,0.0010724989,0.00025941263],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056246785,0.000062168234,0.007771678,0.68807477,0.0018206803,0.0014045615,0.10011771,0.000492317,0.0016012127,0.006100365,0.007825924,0.18416604],"study_design_scores_gemma":[0.00022220683,0.00054279534,0.013594666,0.7270616,0.0045197266,0.0017791016,0.17134623,0.00038814958,0.000927053,0.003285331,0.07613407,0.00019911467],"about_ca_topic_score_codex":0.006563267,"about_ca_topic_score_gemma":0.010060235,"teacher_disagreement_score":0.058304895,"about_ca_system_score_codex":0.009202907,"about_ca_system_score_gemma":0.015675055,"threshold_uncertainty_score":0.30834943},"labels":[],"label_agreement":null},{"id":"W2146626244","doi":"10.1185/030079906x158066","title":"Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain","year":2006,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; PharmIdeas (Canada)","funders":"Bayer Canada; Bayer HealthCare","keywords":"Medicine; Neuropathic pain; Multiple sclerosis; Cannabis; Meta-analysis; Cannabidiol; Psychiatry; Internal medicine; Anesthesia","score_opus":0.4307523687674539,"score_gpt":0.48561267720592605,"score_spread":0.05486030843847217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146626244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008972174,0.9880525,0.000881617,0.00034505985,0.00040049755,0.00027762775,0.0006472505,0.000059646904,0.0003636159],"genre_scores_gemma":[0.4045123,0.5840219,0.0048281667,0.001493833,0.0007789676,0.0017998721,0.0016497917,0.00010314975,0.00081208185],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98066527,0.012584305,0.0031752572,0.0015290399,0.0016573521,0.00038881533],"domain_scores_gemma":[0.96985424,0.0234306,0.0034415396,0.0011673102,0.0016786086,0.000427701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01911845,0.0036114273,0.021910045,0.0072015906,0.00086067925,0.0037326103,0.0024651238,0.002515119,0.0048356885],"category_scores_gemma":[0.047913577,0.0013943133,0.054776218,0.007054651,0.000711921,0.0014566433,0.0016184526,0.0022083898,0.00033923177],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027264499,0.000019385747,0.0019563579,0.045907315,0.9443793,0.00004535054,0.000021590751,0.00038574106,0.000085708176,0.00006821864,0.0003007193,0.0041038124],"study_design_scores_gemma":[0.00081302907,0.00019752105,0.0023241495,0.0034791247,0.9920738,0.000046674773,0.00001779691,0.00018634868,0.000067468616,0.0001773523,0.00060524413,0.000011539284],"about_ca_topic_score_codex":0.007439543,"about_ca_topic_score_gemma":0.0118670305,"teacher_disagreement_score":0.021910045,"about_ca_system_score_codex":0.0026511564,"about_ca_system_score_gemma":0.002845743,"threshold_uncertainty_score":0.10110921},"labels":[],"label_agreement":null},{"id":"W2147759467","doi":"10.1185/030079906x132541","title":"Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Epoetin alfa; Kidney disease; Hemoglobin; Anemia; Internal medicine; Erythropoietin; Quality of life (healthcare); Intensive care medicine; Gastroenterology","score_opus":0.16099891755677606,"score_gpt":0.4227268406957679,"score_spread":0.26172792313899185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147759467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996519,0.00012520482,0.000059165868,0.000020838774,0.0000019217148,0.0000034850134,0.000058824247,0.0000010714188,0.00007762683],"genre_scores_gemma":[0.99975103,0.000028076902,0.0000717152,0.000011270851,0.00000365213,0.0000040390482,0.00010461134,3.6143228e-7,0.000025185738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949014,0.00024135593,0.00006463108,0.000053346506,0.00010482469,0.000045719546],"domain_scores_gemma":[0.9966234,0.0015313615,0.0011512791,0.0001024964,0.00031033604,0.00028118302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012428287,0.00015525837,0.00027891027,0.0004858692,0.00020339788,0.0003976547,0.00015420993,0.0002726166,0.0008288331],"category_scores_gemma":[0.004753873,0.00011026134,0.0003058101,0.00048064094,0.00015374832,0.0003307046,0.00021675043,0.00049850217,0.00006373037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030639317,0.00008325615,0.99799037,0.0000069178054,0.00009256698,0.000020652871,0.000025271916,0.00010768518,0.00010944984,0.0000074980003,0.000031802792,0.0012182742],"study_design_scores_gemma":[0.00003699824,0.0006022154,0.99809283,0.0000041316634,0.000053136097,0.00012632099,0.000051350802,0.0008912725,0.00006062768,0.000019580255,0.000058304013,0.0000032015964],"about_ca_topic_score_codex":0.0010739225,"about_ca_topic_score_gemma":0.0009796984,"teacher_disagreement_score":0.0012428287,"about_ca_system_score_codex":0.00018767464,"about_ca_system_score_gemma":0.00018209156,"threshold_uncertainty_score":0.006572783},"labels":[],"label_agreement":null},{"id":"W2147817551","doi":"10.1185/030079904125004358","title":"Association between mean intraocular pressure, disease stability and cost of treating glaucoma in Canada","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Brock University; PharmIdeas (Canada)","funders":"","keywords":"Medicine; Intraocular pressure; Glaucoma; Ophthalmology; Christian ministry; Spearman's rank correlation coefficient","score_opus":0.04839776097522691,"score_gpt":0.36496399491088904,"score_spread":0.31656623393566213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147817551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533045,0.0006900842,0.000058840193,0.0002773627,0.0000054074076,0.00001708763,0.0025806995,0.000005411421,0.0010346713],"genre_scores_gemma":[0.99864596,0.0002646013,0.000063002,0.00004760591,0.000004508705,0.0000054680972,0.000781818,0.0000015779328,0.00018546743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988883,0.000088874476,0.00013969201,0.00012379803,0.0005457513,0.0002136765],"domain_scores_gemma":[0.9951774,0.00039974856,0.0014812563,0.00007931082,0.0021492762,0.00071303535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005220581,0.00014992087,0.00026127725,0.0012425529,0.0012912995,0.0008380118,0.0006821592,0.00031631626,0.001527949],"category_scores_gemma":[0.0042963517,0.00023436452,0.00035474956,0.0029712203,0.0005406569,0.00024967158,0.0005364709,0.00048143356,0.00009318894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019814746,0.0000063691455,0.9985337,0.000010466362,0.000016382086,0.000056776455,0.000039255658,0.00004753778,0.000025073017,0.000017011182,0.00019678677,0.0010307808],"study_design_scores_gemma":[0.0000019602896,0.000010214039,0.999418,0.000007089823,0.000008788491,0.00011077157,0.00009355546,0.00014915329,0.000015507292,0.000006725793,0.00017574217,0.0000025761817],"about_ca_topic_score_codex":0.9561726,"about_ca_topic_score_gemma":0.96052545,"teacher_disagreement_score":0.043827415,"about_ca_system_score_codex":0.01269539,"about_ca_system_score_gemma":0.014123045,"threshold_uncertainty_score":0.092111886},"labels":[],"label_agreement":null},{"id":"W2147866356","doi":"10.1185/030079904125003197","title":"Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Checklist; Meta-analysis; Kappa; MEDLINE; Randomized controlled trial; Internal medicine; Population; Major depressive disorder; Cochrane Library; Pharmacotherapy; Physical therapy; Psychology","score_opus":0.9331273537804017,"score_gpt":0.7443359877222335,"score_spread":0.18879136605816815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147866356","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047615618,0.8850173,0.04633813,0.0030853404,0.0017918631,0.0102516245,0.003631241,0.00036769308,0.0019012428],"genre_scores_gemma":[0.7228374,0.14008185,0.10259957,0.0016322567,0.0016479007,0.027568357,0.0029131023,0.00024146815,0.000478143],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.4069418,0.35208002,0.1944302,0.011266591,0.0342277,0.0010536815],"domain_scores_gemma":[0.23695195,0.608187,0.108197674,0.017504528,0.027893849,0.001265041],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.40922067,0.0038705529,0.020871496,0.027758697,0.0019280985,0.008833797,0.004314829,0.0034460006,0.0017961524],"category_scores_gemma":[0.6547482,0.0028845556,0.04413544,0.018568454,0.0037851052,0.0041566133,0.005411536,0.002659487,0.00021046144],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061340495,0.000083395294,0.069093354,0.28466362,0.58445394,0.00025225407,0.0012413262,0.0028063215,0.00061295956,0.00093041325,0.0017727731,0.04795563],"study_design_scores_gemma":[0.0043731416,0.0015067278,0.0585588,0.071967565,0.8426924,0.0007500233,0.0004988957,0.0051119914,0.001539795,0.0060892114,0.0065840418,0.0003274057],"about_ca_topic_score_codex":0.0035013168,"about_ca_topic_score_gemma":0.0048041684,"teacher_disagreement_score":0.5907793,"about_ca_system_score_codex":0.006915133,"about_ca_system_score_gemma":0.006182437,"threshold_uncertainty_score":0.7285361},"labels":[],"label_agreement":null},{"id":"W2148461943","doi":"10.1185/030079904x2114","title":"Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Cilag","keywords":"Medicine; Fentanyl; Adverse effect; Cancer pain; Somnolence; Morphine; Constipation; Transdermal; Chronic pain; Internal medicine; Randomized controlled trial; Cancer; Anesthesia; Incidence (geometry); Physical therapy; Pharmacology","score_opus":0.03037748228040237,"score_gpt":0.37276218749624807,"score_spread":0.3423847052158457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148461943","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4041297,0.59043354,0.00084503694,0.0006157447,0.00019660854,0.0010472902,0.0013219521,0.000030235436,0.0013798479],"genre_scores_gemma":[0.94919217,0.047424447,0.0009737158,0.0004827095,0.00037651416,0.0005462009,0.0007993265,0.000009105488,0.00019596849],"study_design_codex":"meta_analysis","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9875201,0.0072030965,0.002804879,0.0007464553,0.0015015599,0.00022392739],"domain_scores_gemma":[0.9880327,0.0060704686,0.004670047,0.000325281,0.00069240696,0.00020906996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012283928,0.0008658564,0.0043420214,0.002038983,0.00022290974,0.0014578418,0.0007115266,0.0010903156,0.0013287485],"category_scores_gemma":[0.019326663,0.00049209676,0.008236156,0.0016436644,0.00062988914,0.0008749953,0.0007880842,0.00080911606,0.000100945035],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24909966,0.0013560455,0.054366626,0.0923076,0.3713272,0.00019811753,0.00036229787,0.0018718614,0.004263647,0.00025943608,0.0008444449,0.22374308],"study_design_scores_gemma":[0.13139068,0.122127846,0.2467606,0.012425048,0.4721193,0.0012692546,0.00042312077,0.00200568,0.003662448,0.0005636434,0.007088072,0.00016437926],"about_ca_topic_score_codex":0.0008187559,"about_ca_topic_score_gemma":0.0021748038,"teacher_disagreement_score":0.012283928,"about_ca_system_score_codex":0.0010229406,"about_ca_system_score_gemma":0.00088066753,"threshold_uncertainty_score":0.064964354},"labels":[],"label_agreement":null},{"id":"W2150556712","doi":"10.1185/030079906x104786","title":"Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Glimepiride; Pioglitazone; Medicine; Metformin; Type 2 diabetes; Rosiglitazone; Hypoglycemia; Internal medicine; Diabetes mellitus; Randomized controlled trial; Clinical endpoint; Urology; Endocrinology","score_opus":0.1340628565789854,"score_gpt":0.4469974842120171,"score_spread":0.3129346276330317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150556712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901239,0.006174859,0.00025566146,0.00042842622,0.00035947474,0.0014360667,0.00039028432,0.000048518446,0.0007826397],"genre_scores_gemma":[0.9914106,0.0032712694,0.00081940676,0.0006736025,0.0006506905,0.0017638248,0.00064033584,0.000014399117,0.00075579673],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99810743,0.0012098224,0.00018511729,0.00023114383,0.00012995419,0.00013651799],"domain_scores_gemma":[0.99698097,0.0012469743,0.0007090168,0.00021014117,0.00017451879,0.00067834527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031616795,0.0014205592,0.005011185,0.00051025645,0.00045592285,0.0012185931,0.0010582397,0.0020446642,0.0046853144],"category_scores_gemma":[0.0041051623,0.0007968871,0.00251849,0.0006291584,0.0010276429,0.00094654615,0.0004210351,0.0017818512,0.0006902529],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9912179,0.0026205182,0.00064929156,0.00019729325,0.0007157659,0.00001339215,0.000013526798,0.000054506134,0.00040405328,0.000010808102,0.000090607224,0.004012489],"study_design_scores_gemma":[0.93489194,0.06064339,0.0028500503,0.000029191138,0.0010035125,0.000018187837,0.000016776812,0.00021671972,0.0001446952,0.000032695487,0.00014392464,0.000008958084],"about_ca_topic_score_codex":0.00079537206,"about_ca_topic_score_gemma":0.0014806935,"teacher_disagreement_score":0.005011185,"about_ca_system_score_codex":0.00069124304,"about_ca_system_score_gemma":0.001091957,"threshold_uncertainty_score":0.016720772},"labels":[],"label_agreement":null},{"id":"W2150557505","doi":"10.1185/030079906x100032","title":"Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"AstraZeneca","keywords":"GERD; Medicine; Medical prescription; Asymptomatic; Disease; Reflux; Telephone interview; Internal medicine; Medical record; Physical therapy; Family medicine; Pediatrics; Nursing","score_opus":0.0778253260323295,"score_gpt":0.41520244817145957,"score_spread":0.33737712213913007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150557505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974981,0.00038633397,0.00005736354,0.0006432084,0.000009370585,0.000041517942,0.00041667727,0.0000020001648,0.0009453758],"genre_scores_gemma":[0.998958,0.00025070316,0.00008346095,0.00030729448,0.000018153933,0.000040700685,0.00024944943,0.0000014646246,0.00009076957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598503,0.0022749158,0.00056400936,0.00019491493,0.00061286247,0.00036828255],"domain_scores_gemma":[0.99074626,0.0031386565,0.003592362,0.00024135833,0.0012575531,0.0010238084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003405746,0.00014544521,0.00049271586,0.00088936544,0.0005899733,0.0011603849,0.00039003807,0.0014250089,0.002103361],"category_scores_gemma":[0.015872711,0.0003586019,0.00058737915,0.0018997054,0.00037382165,0.0017686295,0.0007689617,0.00074125966,0.0004956869],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010556851,0.00021276205,0.99340665,0.00013505791,0.00007412557,0.000078809615,0.002125353,0.000030488889,0.00007812528,0.00002440719,0.00038290647,0.003345808],"study_design_scores_gemma":[0.000017503617,0.00042912914,0.99236286,0.00004645604,0.000026065843,0.00018345217,0.0059694024,0.00014164814,0.000014627218,0.000013138679,0.000786637,0.000009014731],"about_ca_topic_score_codex":0.0057557863,"about_ca_topic_score_gemma":0.008048347,"teacher_disagreement_score":0.0057557863,"about_ca_system_score_codex":0.0005834269,"about_ca_system_score_gemma":0.0007271629,"threshold_uncertainty_score":0.01801157},"labels":[],"label_agreement":null},{"id":"W2150762958","doi":"10.1185/030079906x96245","title":"Estimation of symptom-free days in generalized anxiety disorder","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Medicine; Placebo; Anxiety; Population; Generalized anxiety disorder; Venlafaxine; Internal medicine; Quartile; Major depressive disorder; Randomized controlled trial; Physical therapy; Psychiatry; Mood; Confidence interval; Antidepressant","score_opus":0.07676903180071445,"score_gpt":0.4581342199479335,"score_spread":0.3813651881472191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150762958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8161801,0.16435455,0.009808213,0.00028312608,0.00012072958,0.0008401154,0.0061096973,0.00017337357,0.0021299694],"genre_scores_gemma":[0.98473144,0.0075454246,0.004718884,0.00007755811,0.00008418018,0.00049571815,0.0020850508,0.000014185722,0.00024763224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990244,0.006583826,0.0012306324,0.0007457148,0.0010577993,0.0001381075],"domain_scores_gemma":[0.9855555,0.006765027,0.0060562394,0.000572463,0.00084720564,0.00020360936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012162737,0.0010766874,0.001941319,0.0026243648,0.00013394954,0.0006846556,0.00067850243,0.00048029862,0.0011082898],"category_scores_gemma":[0.019386496,0.00037728474,0.0029896435,0.0014487471,0.0003664947,0.00048009166,0.00070384634,0.0004847241,0.00013035249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064771794,0.0006541209,0.49352366,0.019297209,0.1130907,0.00022321427,0.0004916715,0.0071940334,0.009665031,0.0004273521,0.0024429488,0.28821826],"study_design_scores_gemma":[0.003984668,0.016639415,0.94341695,0.0008198576,0.024474386,0.0008753729,0.00019519175,0.002750539,0.0026731824,0.0005820601,0.0034733103,0.00011499391],"about_ca_topic_score_codex":0.0005338246,"about_ca_topic_score_gemma":0.00083712384,"teacher_disagreement_score":0.012162737,"about_ca_system_score_codex":0.0004027871,"about_ca_system_score_gemma":0.00023861337,"threshold_uncertainty_score":0.064323425},"labels":[],"label_agreement":null},{"id":"W2153070704","doi":"10.1185/03007995.2014.918029","title":"Diagnosis, comorbidities, and management of restless legs syndrome","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Restless Legs Syndrome Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Restless legs syndrome; Comorbidity; Anxiety; Depression (economics); Disease; Psychiatry; Differential diagnosis; Pediatrics; Physical therapy; Insomnia; Internal medicine; Pathology","score_opus":0.3307372617754096,"score_gpt":0.5471310927163142,"score_spread":0.21639383094090464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153070704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008238638,0.99666435,0.00014167372,0.0008156812,0.00027103198,0.000011118364,0.00007712524,0.000005933923,0.0011891888],"genre_scores_gemma":[0.019553319,0.9774279,0.0005888819,0.0009643839,0.0008977365,0.00002641899,0.00023064611,0.0000028667082,0.00030783872],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994492,0.00013542779,0.00016169339,0.00007494641,0.00014095187,0.000037750135],"domain_scores_gemma":[0.9989711,0.0006107352,0.00025420878,0.000012120359,0.00012294619,0.000028930213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054263655,0.0005197092,0.00078815105,0.0015846625,0.00026417134,0.0010072648,0.00047451246,0.00078912306,0.0023111964],"category_scores_gemma":[0.0040621394,0.00015608949,0.0007950451,0.001239979,0.00032777048,0.0008227265,0.00046620524,0.0008601812,0.0003869632],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021581259,0.000047000554,0.007515454,0.100513674,0.00077509,0.0038991203,0.00045771713,0.00042309298,0.0010112652,0.0030637237,0.03808169,0.84399635],"study_design_scores_gemma":[0.00018945962,0.00032943953,0.04109148,0.27007693,0.002937747,0.050074972,0.0013894268,0.00058581715,0.001003699,0.0064890226,0.6257251,0.00010691053],"about_ca_topic_score_codex":0.0020785728,"about_ca_topic_score_gemma":0.002782794,"teacher_disagreement_score":0.0023111964,"about_ca_system_score_codex":0.00059366063,"about_ca_system_score_gemma":0.0012763956,"threshold_uncertainty_score":0.0077317357},"labels":[],"label_agreement":null},{"id":"W2153769961","doi":"10.1185/030079904125003250","title":"Generic replacement of clozapine: a simple decision model from a Canadian perspective","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Royal Ottawa Mental Health Centre","funders":"","keywords":"Clozapine; Medicine; Schizophrenia (object-oriented programming); Incidence (geometry); Psychiatry","score_opus":0.22165207092856176,"score_gpt":0.4459791323805348,"score_spread":0.22432706145197306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153769961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68577516,0.00612622,0.1568399,0.020998154,0.0007894134,0.003165011,0.018969472,0.00054159143,0.10679508],"genre_scores_gemma":[0.9484731,0.0026105253,0.024395695,0.0007569905,0.00018129367,0.00090269884,0.002346572,0.00003837088,0.020294767],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99792933,0.00084349967,0.000055072,0.00032285607,0.0002317044,0.0006174625],"domain_scores_gemma":[0.99510914,0.0033246307,0.00031675238,0.0000596182,0.0007283661,0.00046144633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031642623,0.0022079432,0.002497134,0.0018374511,0.0015835885,0.0042137285,0.0028365958,0.0033112406,0.01329746],"category_scores_gemma":[0.007702073,0.0012882517,0.00238936,0.0020900618,0.0015602346,0.0013020991,0.0013467086,0.0026649258,0.0006738089],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005598183,0.000081512575,0.0022223284,0.00010323305,0.00011292588,0.000197587,0.00004517287,0.98184925,0.000089796216,0.008184737,0.0018727306,0.0046809204],"study_design_scores_gemma":[0.00035708823,0.00011316536,0.001056016,0.00003626664,0.00017598362,0.000046899764,0.0000673812,0.9927954,0.000038732607,0.004063781,0.0012161251,0.0000331988],"about_ca_topic_score_codex":0.69039255,"about_ca_topic_score_gemma":0.4864464,"teacher_disagreement_score":0.97594863,"about_ca_system_score_codex":0.024051392,"about_ca_system_score_gemma":0.024605224,"threshold_uncertainty_score":0.62286156},"labels":[],"label_agreement":null},{"id":"W2155011514","doi":"10.1185/030079905x43712","title":"Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale","year":2005,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Nicotine withdrawal; Craving; Irritability; Clinical psychology; Confirmatory factor analysis; Varenicline; Exploratory factor analysis; Mood; Anxiety; Psychiatry; Anger; Construct validity; Anhedonia; Medicine; Psychology; Smoking cessation; Psychometrics; Nicotine; Addiction; Structural equation modeling; Schizophrenia (object-oriented programming)","score_opus":0.0761572998217576,"score_gpt":0.4341971350825373,"score_spread":0.3580398352607797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155011514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7395541,0.004908263,0.22595714,0.0052927686,0.00020532255,0.0017534372,0.0016495779,0.00024897623,0.020430464],"genre_scores_gemma":[0.90041834,0.0010372485,0.09602503,0.00024030302,0.000042208187,0.00085054495,0.00066499255,0.000013799092,0.0007074703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969162,0.0017629628,0.00026665296,0.00018946487,0.0007560973,0.00010862696],"domain_scores_gemma":[0.99725443,0.0011018462,0.000553192,0.00016575435,0.000759488,0.00016529986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005293826,0.0004993289,0.00034093324,0.0015991331,0.00046228443,0.0011591795,0.00048777112,0.00027843312,0.0007780015],"category_scores_gemma":[0.012350401,0.0002117975,0.0006191116,0.0009376831,0.00080005237,0.0009720701,0.0016998928,0.00082397077,0.0001225142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023899302,0.00026668416,0.5448226,0.0010597274,0.00048988103,0.0007110743,0.014907098,0.0045721717,0.0062518083,0.043623287,0.005321106,0.37773556],"study_design_scores_gemma":[0.00010361104,0.0008205489,0.88442886,0.0014480787,0.00016562713,0.0013957309,0.007155543,0.024165688,0.0012510249,0.057769142,0.021165319,0.00013080261],"about_ca_topic_score_codex":0.0049138577,"about_ca_topic_score_gemma":0.011316405,"teacher_disagreement_score":0.005293826,"about_ca_system_score_codex":0.0011976059,"about_ca_system_score_gemma":0.0024735734,"threshold_uncertainty_score":0.027996778},"labels":[],"label_agreement":null},{"id":"W2155850242","doi":"10.1185/03007990903069249","title":"Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada","year":2009,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":132,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; The Scarborough Hospital","funders":"Temple University","keywords":"Medicine; Internal medicine; Creatinine; Uric acid; Placebo; Kidney disease; Blood urea nitrogen; Gastroenterology; Probiotic; Clinical trial; Crossover study; Renal function; Randomized controlled trial","score_opus":0.03312535570918103,"score_gpt":0.3632865502161355,"score_spread":0.33016119450695447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155850242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876659,0.0040527694,0.00021136332,0.00085582724,0.00011619115,0.004539096,0.0009358726,0.000027155551,0.001595814],"genre_scores_gemma":[0.99018645,0.0030976774,0.0011259604,0.00078126404,0.00012378213,0.0020130577,0.00089756976,0.000006894873,0.001767241],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99907494,0.00036597459,0.000054802236,0.00008371435,0.00014503827,0.00027549505],"domain_scores_gemma":[0.9983341,0.0001126169,0.00023040635,0.000054056807,0.00042963677,0.00083923433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001889437,0.00073196815,0.0018877203,0.00029026793,0.0016766966,0.0007017901,0.00075059826,0.0009943614,0.0030810295],"category_scores_gemma":[0.0014809677,0.00035737635,0.001533972,0.00088884356,0.0008613852,0.00031570529,0.0005172377,0.0012080721,0.00023439717],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8437448,0.036150873,0.032919206,0.0022399297,0.0021527812,0.00032809263,0.0006661378,0.00067382614,0.0062215496,0.0001567901,0.0035630635,0.07118294],"study_design_scores_gemma":[0.6295751,0.21334495,0.14940478,0.0002725259,0.001623936,0.000103930404,0.0003455804,0.000699551,0.00072903547,0.000095329255,0.0037487792,0.000056506255],"about_ca_topic_score_codex":0.47978735,"about_ca_topic_score_gemma":0.6977337,"teacher_disagreement_score":0.52021265,"about_ca_system_score_codex":0.008658655,"about_ca_system_score_gemma":0.026034515,"threshold_uncertainty_score":0.9539893},"labels":[],"label_agreement":null},{"id":"W2155860297","doi":"10.1185/030079904x10142","title":"Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey – phase IV*","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton","funders":"AstraZeneca","keywords":"Triptans; Medicine; Migraine; Pharmacy; Migraine treatment; Zolmitriptan; Rizatriptan; Family medicine; Sumatriptan; Psychiatry; Internal medicine","score_opus":0.3178509980921958,"score_gpt":0.5624532324101766,"score_spread":0.24460223431798084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155860297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9520968,0.00095457176,0.00035490753,0.001045713,0.000039638,0.0019567471,0.038127802,0.000048924372,0.0053749694],"genre_scores_gemma":[0.94554096,0.0011654289,0.0014903112,0.0015230479,0.00011742591,0.003578325,0.04282285,0.000029518942,0.003732092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998489,0.0007004986,0.00029078347,0.00008767843,0.00026386578,0.0001680919],"domain_scores_gemma":[0.99741626,0.00030479947,0.0015523727,0.00009010765,0.00028865374,0.000347777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018723871,0.00032613342,0.000511476,0.0007617409,0.00017183925,0.0004350842,0.0004384381,0.00067060575,0.0022432266],"category_scores_gemma":[0.0035661247,0.00032558385,0.00062536757,0.0012040576,0.00022349434,0.00069694204,0.0008045661,0.0005066231,0.0010715552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021804196,0.000623877,0.9665443,0.00037636512,0.0002485127,0.00008522793,0.0002508053,0.00032775284,0.0002895475,0.00008069681,0.012309653,0.016682755],"study_design_scores_gemma":[0.00027949348,0.0005749899,0.9951279,0.000035905934,0.000028217772,0.00008704103,0.00009728732,0.00012108572,0.000048976835,0.00002232518,0.0035697918,0.000006937779],"about_ca_topic_score_codex":0.0040272377,"about_ca_topic_score_gemma":0.0062579825,"teacher_disagreement_score":0.0040272377,"about_ca_system_score_codex":0.00058214384,"about_ca_system_score_gemma":0.0005142713,"threshold_uncertainty_score":0.009902239},"labels":[],"label_agreement":null},{"id":"W2156774389","doi":"10.1185/030079904125003610","title":"Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Zoo","funders":"","keywords":"Telithromycin; Medicine; Clarithromycin; Clinical endpoint; Internal medicine; Population; Community-acquired pneumonia; Pneumonia; Respiratory tract infections; Antibacterial agent; Randomized controlled trial; Antibiotics; Helicobacter pylori; Respiratory system","score_opus":0.14107474568794162,"score_gpt":0.4651035068709187,"score_spread":0.3240287611829771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156774389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993451,0.00034826086,0.000028658375,0.000014053583,0.00000782949,0.000033495387,0.000077385426,0.0000016617298,0.00014352602],"genre_scores_gemma":[0.9993518,0.00012531999,0.00007770528,0.00003286761,0.0000122064375,0.00006205162,0.0002459745,9.517027e-7,0.00009116293],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99851984,0.0007401239,0.00019467495,0.0002327751,0.00020009789,0.00011256139],"domain_scores_gemma":[0.997241,0.0010156942,0.0010431453,0.00016393967,0.00014839727,0.0003878143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021600164,0.00033591664,0.0009482016,0.00031499844,0.000133029,0.00040727967,0.0003770257,0.0007794574,0.0013333877],"category_scores_gemma":[0.0030200377,0.00028711127,0.0011637632,0.00025740985,0.00026760498,0.00036100656,0.0002398988,0.0005820195,0.00014033644],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38143724,0.0059031053,0.56520504,0.0007412886,0.004152098,0.00019282108,0.00023523686,0.0009095659,0.0054077907,0.00007084209,0.00044507443,0.03529996],"study_design_scores_gemma":[0.019757723,0.06965555,0.9054088,0.00006684627,0.0015497112,0.00031020655,0.00017220777,0.001357105,0.0012151827,0.00006697235,0.00040391195,0.00003573787],"about_ca_topic_score_codex":0.0005437435,"about_ca_topic_score_gemma":0.00085126254,"teacher_disagreement_score":0.0021600164,"about_ca_system_score_codex":0.0004225091,"about_ca_system_score_gemma":0.00045239175,"threshold_uncertainty_score":0.011423349},"labels":[],"label_agreement":null},{"id":"W2157403060","doi":"10.1185/03007990802563706","title":"Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation; Bayer (Canada)","funders":"","keywords":"Sorafenib; Medicine; Hepatocellular carcinoma; Internal medicine; Placebo; Christian ministry; Oncology; Economic evaluation; Pathology; Alternative medicine","score_opus":0.3126463337726336,"score_gpt":0.4002029687421255,"score_spread":0.0875566349694919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157403060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87116385,0.035975523,0.011432059,0.013149313,0.00025289727,0.0038451091,0.0143788215,0.00018543343,0.049617063],"genre_scores_gemma":[0.9923821,0.003090269,0.0019816316,0.00029207306,0.000018773022,0.00024564663,0.0010497468,0.000012387495,0.00092730427],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9938783,0.0039177677,0.00016732352,0.00020483222,0.0011338862,0.0006979531],"domain_scores_gemma":[0.99082243,0.005507083,0.0009355637,0.00019394973,0.0018791523,0.0006618648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071322364,0.0010468737,0.0012857701,0.0013946181,0.001175536,0.0022443186,0.0015466197,0.00093990494,0.0031366274],"category_scores_gemma":[0.026506191,0.00058617565,0.0018997742,0.0023593723,0.0010159662,0.00070945604,0.0010773337,0.0014719443,0.00009481638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008088435,0.00048203042,0.02004938,0.002264122,0.0023181867,0.0003607111,0.00014912667,0.90687793,0.00042083274,0.015852118,0.0066314023,0.036505733],"study_design_scores_gemma":[0.0050537908,0.0017692237,0.036044426,0.0010637176,0.002256719,0.0002599739,0.00051643857,0.93156594,0.00072969764,0.009161844,0.011387635,0.00019054319],"about_ca_topic_score_codex":0.9110651,"about_ca_topic_score_gemma":0.86681783,"teacher_disagreement_score":0.90442467,"about_ca_system_score_codex":0.09557531,"about_ca_system_score_gemma":0.07836662,"threshold_uncertainty_score":0.6934507},"labels":[],"label_agreement":null},{"id":"W2158832244","doi":"10.1185/030079903125002108","title":"Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up","year":2003,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Memorial University of Newfoundland; Eli Lilly and Company","keywords":"Medicine; Olanzapine; Schizoaffective disorder; Schizophrenia (object-oriented programming); Open label; Psychiatry; Atypical antipsychotic; Open label study; Pediatrics; Internal medicine; Psychosis; Antipsychotic; Clinical trial; Adverse effect","score_opus":0.08683636340195997,"score_gpt":0.41204852826089233,"score_spread":0.32521216485893234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158832244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988018,0.00023854488,0.0001107582,0.000034338686,0.00002904085,0.00045275202,0.00014526659,0.000010898506,0.00017653071],"genre_scores_gemma":[0.9968786,0.00026858025,0.00039354223,0.00022024439,0.00012396807,0.00077917834,0.0008698586,0.0000043348373,0.00046166923],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99815243,0.0006572537,0.00021674423,0.00035747304,0.0002773502,0.00033869388],"domain_scores_gemma":[0.99481153,0.0009339957,0.0014935753,0.00056383846,0.00049932866,0.0016977084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004530083,0.0013946985,0.0026522812,0.0011337817,0.0014991745,0.0013644978,0.0009973819,0.0018985502,0.0018708329],"category_scores_gemma":[0.0038664585,0.00078800076,0.0024700572,0.0007983065,0.001535961,0.0023302566,0.00093078415,0.0024823532,0.0006315007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.498331,0.20546271,0.23380297,0.00056592096,0.0022362093,0.0007872797,0.0017470736,0.0013661237,0.00729252,0.00009818798,0.0008326612,0.047477346],"study_design_scores_gemma":[0.07940423,0.6967897,0.2178625,0.00006177771,0.0008629155,0.00026688317,0.00056881673,0.0018504652,0.0013357489,0.00010974998,0.0007452224,0.00014202797],"about_ca_topic_score_codex":0.0033308372,"about_ca_topic_score_gemma":0.0031332595,"teacher_disagreement_score":0.004530083,"about_ca_system_score_codex":0.0013850742,"about_ca_system_score_gemma":0.0014713025,"threshold_uncertainty_score":0.02395767},"labels":[],"label_agreement":null},{"id":"W2160686867","doi":"10.1185/03007990802537122","title":"Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Tolterodine; Medicine; Overactive bladder; Urology; Urinary bladder","score_opus":0.04857267151701749,"score_gpt":0.4073395634564596,"score_spread":0.3587668919394421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160686867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944406,0.0047038123,0.00011943327,0.00008439287,0.000040250783,0.00014999715,0.00013266079,0.000018573128,0.00031015082],"genre_scores_gemma":[0.9973115,0.00144239,0.0003999616,0.00011347066,0.0000868419,0.00018316686,0.00012529334,0.000003185895,0.00033428194],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992199,0.00045853513,0.0000717663,0.000088164175,0.000108260276,0.000053449246],"domain_scores_gemma":[0.99763155,0.0012433337,0.00067137,0.0000905249,0.00006566154,0.00029756286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013744358,0.0004276604,0.0016636264,0.00018426677,0.00013529057,0.00035379696,0.00030984977,0.00062791444,0.0026849997],"category_scores_gemma":[0.0031108535,0.0002224594,0.0005849801,0.00017019034,0.00033058738,0.00048464185,0.00024450052,0.0006569981,0.00016551999],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8320318,0.011600941,0.008603782,0.0019501153,0.0014976341,0.00007469501,0.00016760506,0.0006536171,0.016771732,0.000030773048,0.00030437295,0.12631293],"study_design_scores_gemma":[0.17473572,0.6774769,0.1406561,0.000205185,0.0013744789,0.00023245318,0.0001338216,0.0010662435,0.0030445664,0.00007766005,0.00094722124,0.000049653492],"about_ca_topic_score_codex":0.00021377848,"about_ca_topic_score_gemma":0.000433112,"teacher_disagreement_score":0.0026849997,"about_ca_system_score_codex":0.00015396399,"about_ca_system_score_gemma":0.00019878338,"threshold_uncertainty_score":0.008982241},"labels":[],"label_agreement":null},{"id":"W2161354785","doi":"10.1185/03007995.2015.1107534","title":"Burden of symptomatic uterine fibroids in Canadian women: a cohort study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université Laval","funders":"","keywords":"Medicine; Quality of life (healthcare); Cohort; Cohort study; Physical therapy; Internal medicine; Pediatrics","score_opus":0.09225413330101942,"score_gpt":0.4494602623844802,"score_spread":0.35720612908346083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161354785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926099,0.00056959456,0.00007421397,0.0002798635,0.000012286627,0.000076204364,0.005061122,0.0000056190347,0.0013111718],"genre_scores_gemma":[0.99606186,0.0007974628,0.0001839731,0.00011161628,0.0000107312235,0.00004001376,0.0023083575,0.0000028697752,0.0004832027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993224,0.000051369712,0.000037735448,0.00011295201,0.0002624553,0.00021305602],"domain_scores_gemma":[0.99907553,0.000040198873,0.00023324006,0.000051772262,0.0003690575,0.0002301324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007628106,0.00041051678,0.00039045513,0.0012651272,0.0023772968,0.0007825777,0.00079313864,0.00044738452,0.0017096269],"category_scores_gemma":[0.0016896928,0.0004215339,0.00060132996,0.003445667,0.00042533563,0.00041327492,0.0007287796,0.00059015333,0.00020658571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006694641,0.000029250823,0.9966012,0.000026548552,0.000051746785,0.00006679877,0.0004312413,0.000025957384,0.00011337319,0.00003820936,0.0007294829,0.0018192612],"study_design_scores_gemma":[0.000010546432,0.000026929205,0.99869305,0.000020744425,0.000021942451,0.00007178601,0.0005160134,0.00009384518,0.000013864254,0.000010076143,0.00051456,0.000006803193],"about_ca_topic_score_codex":0.97676325,"about_ca_topic_score_gemma":0.9778997,"teacher_disagreement_score":0.023236752,"about_ca_system_score_codex":0.009906407,"about_ca_system_score_gemma":0.011264932,"threshold_uncertainty_score":0.07187641},"labels":[],"label_agreement":null},{"id":"W2165140611","doi":"10.1185/030079906x162674","title":"Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy","year":2006,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"McGill University","keywords":"Medicine; Tramadol; Acetaminophen; Peripheral neuropathy; Placebo; Randomized controlled trial; Peripheral; Diabetic neuropathy; Anesthesia; Internal medicine; Diabetes mellitus; Analgesic","score_opus":0.09226693513633698,"score_gpt":0.4176050997037606,"score_spread":0.3253381645674236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165140611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95543873,0.01440618,0.0014367297,0.0012942896,0.003098133,0.018231792,0.0014240372,0.0003356559,0.0043344866],"genre_scores_gemma":[0.9631851,0.0077275713,0.003294312,0.0017655427,0.0016774797,0.016781814,0.0007667402,0.00003814845,0.004763212],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978017,0.0013708819,0.00021058651,0.00022125206,0.00017615462,0.00021943984],"domain_scores_gemma":[0.99738616,0.0011639453,0.000494639,0.00013374684,0.00022319869,0.00059836655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003121569,0.001608713,0.005598315,0.0010694335,0.0007100824,0.001429175,0.0016998063,0.0026765803,0.01207867],"category_scores_gemma":[0.0041601793,0.0009814061,0.001789155,0.0007999807,0.0016974445,0.001205348,0.00056188426,0.0030590976,0.0012698645],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98762,0.0041732006,0.00011334169,0.0005693216,0.00036981318,0.000020850952,0.00001807479,0.00006760465,0.0006551096,0.00005184412,0.00015149607,0.006189445],"study_design_scores_gemma":[0.95532644,0.04354354,0.0003493335,0.000026391806,0.00021485904,0.000011175473,0.00001117752,0.00012295737,0.00012905287,0.000046315705,0.0002137446,0.000004998701],"about_ca_topic_score_codex":0.0013970673,"about_ca_topic_score_gemma":0.0024224229,"teacher_disagreement_score":0.01207867,"about_ca_system_score_codex":0.0008058118,"about_ca_system_score_gemma":0.0017233659,"threshold_uncertainty_score":0.04040718},"labels":[],"label_agreement":null},{"id":"W2167248921","doi":"10.1185/030079906x167381","title":"Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes","year":2007,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Pfizer; Eli Lilly and Company","keywords":"Medicine; Insulin; Diabetes mellitus; Crossover study; Insulin glargine; Context (archaeology); Type 2 diabetes; Insulin pen; Internal medicine; Type 1 diabetes; Endocrinology; Pediatrics; Placebo","score_opus":0.06424815007399848,"score_gpt":0.39263409689443585,"score_spread":0.32838594682043737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167248921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977252,0.0016568464,0.00008006493,0.000079867874,0.000019941333,0.000050713155,0.00009538461,0.0000035959004,0.0002884217],"genre_scores_gemma":[0.99896646,0.00037686824,0.00027234806,0.00010704115,0.000030851555,0.00005712145,0.000118562086,0.0000012114715,0.00006956398],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977755,0.0015119667,0.00019673018,0.00015419252,0.00026777972,0.00009387446],"domain_scores_gemma":[0.9941758,0.0035039731,0.001680953,0.00015884881,0.00010049176,0.0003799405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002723318,0.00034542754,0.0010613222,0.0001857011,0.00017349467,0.0006110368,0.00023683454,0.00066150894,0.0021038335],"category_scores_gemma":[0.0076313103,0.00019567712,0.0010651113,0.0003695262,0.00031420632,0.00046154583,0.00022893693,0.0006950539,0.00012696358],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5348287,0.008158799,0.31183794,0.0013666793,0.0041884007,0.00014598167,0.00032862514,0.0014674414,0.0026009297,0.00011050847,0.0006285265,0.13433744],"study_design_scores_gemma":[0.07757715,0.25579095,0.6556239,0.00024584017,0.0025171668,0.0006984475,0.00043491434,0.0041504866,0.0016532135,0.00029106217,0.0009061411,0.00011067414],"about_ca_topic_score_codex":0.00034296926,"about_ca_topic_score_gemma":0.00047183977,"teacher_disagreement_score":0.002723318,"about_ca_system_score_codex":0.00029936136,"about_ca_system_score_gemma":0.00026739025,"threshold_uncertainty_score":0.014402449},"labels":[],"label_agreement":null},{"id":"W2167525817","doi":"10.1185/03007995.2014.982246","title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","year":2014,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ulipristal acetate; Hysterectomy; Uterine artery embolization; Uterine fibroids; Leiomyoma; Endometrial ablation; Cochrane Library; Systematic review; Watchful waiting; Review article; Intensive care medicine; General surgery; MEDLINE; Surgery; Randomized controlled trial; Population; Internal medicine; Family planning; Pathology; Cancer","score_opus":0.22801679799897245,"score_gpt":0.5297126304550334,"score_spread":0.3016958324560609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167525817","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093863804,0.9989913,0.000040822084,0.000567015,0.00008757491,0.0000029460514,0.00000639826,0.0000017531484,0.00020824972],"genre_scores_gemma":[0.0011161242,0.99793833,0.00019039109,0.00040068408,0.00029182207,0.0000071853665,0.00001199951,7.615102e-7,0.000042681262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985367,0.0004326596,0.00036820263,0.00017346874,0.00041073505,0.00007821087],"domain_scores_gemma":[0.9951792,0.0032335457,0.00084094005,0.00005470262,0.0005838136,0.00010793473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024464978,0.0008408753,0.0016332966,0.003989875,0.0004515344,0.0019441433,0.0009208021,0.0015962314,0.0030037402],"category_scores_gemma":[0.005289411,0.00033341924,0.0012077009,0.0036108764,0.0010042761,0.0030139906,0.0009410904,0.0015976377,0.00039688076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015107298,0.000088963294,0.0010401027,0.1814317,0.00044110915,0.0006386028,0.0003915436,0.0004169264,0.00066002103,0.005260835,0.017475646,0.7920035],"study_design_scores_gemma":[0.00011438657,0.00041154292,0.007722994,0.3187098,0.0023063319,0.0071935602,0.0018348687,0.00046703464,0.0004846063,0.0063457796,0.65430915,0.000099927514],"about_ca_topic_score_codex":0.0016578796,"about_ca_topic_score_gemma":0.0034236037,"teacher_disagreement_score":0.003989875,"about_ca_system_score_codex":0.0015146075,"about_ca_system_score_gemma":0.0031121727,"threshold_uncertainty_score":0.012938499},"labels":[],"label_agreement":null},{"id":"W2169369869","doi":"10.1185/030079907x199655","title":"Comment on: The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease","year":2007,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; PharmIdeas (Canada)","funders":"Amgen","keywords":"Medicine; Darbepoetin alfa; Epoetin alfa; Dosing; Kidney disease; Internal medicine; Erythropoietin","score_opus":0.23062913471945348,"score_gpt":0.4338414552437033,"score_spread":0.20321232052424984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169369869","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003077382,0.00054736156,0.00007282405,0.9807319,0.016157987,0.000014682811,0.00015280009,0.000018317229,0.0019964196],"genre_scores_gemma":[0.0017159543,0.0003135161,0.00009614791,0.97044635,0.024078477,0.000024284232,0.000032012387,0.000015568981,0.0032776494],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933215,0.0016417914,0.0011359729,0.0009818869,0.0016790351,0.0012398831],"domain_scores_gemma":[0.97903377,0.0141286105,0.001538181,0.0003809337,0.0030108467,0.0019075661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007566753,0.0010635154,0.0027263684,0.0011224508,0.004413789,0.0048742127,0.0038178149,0.1220867,0.009089932],"category_scores_gemma":[0.045277018,0.0012267564,0.0026840025,0.0017416644,0.0038498715,0.0031426016,0.002139452,0.06386197,0.007584947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011600708,0.000018033972,0.00050804595,0.000056919936,0.000029618404,0.00088057696,0.00012079578,0.00008629765,0.000086403146,0.0027025614,0.99254817,0.0028465928],"study_design_scores_gemma":[0.0005624031,0.00013385013,0.004175563,0.0009567479,0.00024499986,0.0016584535,0.00075881963,0.0011261635,0.0005548123,0.013890039,0.9757783,0.00015977041],"about_ca_topic_score_codex":0.027137961,"about_ca_topic_score_gemma":0.034693033,"teacher_disagreement_score":0.1220867,"about_ca_system_score_codex":0.011005072,"about_ca_system_score_gemma":0.010531879,"threshold_uncertainty_score":0.07984775},"labels":[],"label_agreement":null},{"id":"W2180653297","doi":"10.1185/03007995.2015.1119677","title":"Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Medicine; Polypharmacy; Glycemic; MEDLINE; Type 2 diabetes; Psychological intervention; Clinical trial; Pharmacy; Family medicine; Health care; Medication adherence; PsycINFO; Patient education; Intensive care medicine; Diabetes mellitus; Nursing; Internal medicine","score_opus":0.8216353992386789,"score_gpt":0.674231368889912,"score_spread":0.14740403034876692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2180653297","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001761614,0.9982229,0.00017856785,0.000813897,0.00018382375,0.00013911705,0.00006187192,0.0000037700706,0.00021993209],"genre_scores_gemma":[0.00456153,0.99166834,0.0011642915,0.0014707507,0.00025148745,0.0007095705,0.00009119936,0.0000050195586,0.000077816214],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.959559,0.020040594,0.013714839,0.0016348023,0.004536865,0.0005139046],"domain_scores_gemma":[0.76120514,0.21017793,0.019303238,0.0018039927,0.006609006,0.000900688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035562433,0.0015263095,0.006494389,0.011948667,0.0009151982,0.005840033,0.0024823227,0.004108667,0.0036361974],"category_scores_gemma":[0.19400069,0.0013906016,0.0051620104,0.013677457,0.0017550121,0.006445436,0.0029070391,0.0028133672,0.0003212849],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015749104,0.000029968873,0.00053531607,0.86963636,0.003124738,0.00014011405,0.00084673666,0.00017064216,0.00009052009,0.002249112,0.0051193093,0.11789963],"study_design_scores_gemma":[0.00007353905,0.000089318164,0.0008182964,0.95390964,0.0062112515,0.00023083652,0.00037941782,0.00008665555,0.000060785573,0.0009171353,0.037200745,0.000022329223],"about_ca_topic_score_codex":0.003974993,"about_ca_topic_score_gemma":0.007883361,"teacher_disagreement_score":0.035562433,"about_ca_system_score_codex":0.0049060085,"about_ca_system_score_gemma":0.018012077,"threshold_uncertainty_score":0.18807441},"labels":[],"label_agreement":null},{"id":"W2181767505","doi":"10.1185/030079904x3285","title":"Risk factors for osteoporosis","year":2004,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Osteoporosis Canada","funders":"","keywords":"Medicine; Osteoporosis; Intensive care medicine; Internal medicine","score_opus":0.14192424243388757,"score_gpt":0.48032555789161774,"score_spread":0.33840131545773017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2181767505","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7562738,0.06690432,0.002184822,0.008868362,0.0009276506,0.0005981536,0.013476881,0.0002398853,0.15052609],"genre_scores_gemma":[0.96439517,0.013971803,0.0020159257,0.0013505821,0.0006968534,0.00021694356,0.0037499738,0.000017960101,0.013584782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967873,0.00003465369,0.000026742668,0.00004548361,0.00014192019,0.0000725163],"domain_scores_gemma":[0.9993819,0.000096197444,0.0002458958,0.000028443017,0.00011478419,0.00013279171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020278808,0.00037878953,0.00043253147,0.00088532816,0.0006013789,0.0003733759,0.00028820278,0.00046674616,0.022737922],"category_scores_gemma":[0.0015694108,0.00011013735,0.00040806743,0.0012405165,0.00019049758,0.00022251287,0.00026898913,0.00077007595,0.002255362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010358032,0.00034243547,0.93731016,0.00030295685,0.00013802972,0.001358404,0.00016067285,0.000059638503,0.0006273217,0.0006992462,0.011579031,0.047318567],"study_design_scores_gemma":[0.000037962178,0.00022296699,0.94584024,0.00053411763,0.00026309417,0.01130243,0.00019652894,0.0001870004,0.00019103597,0.0010612963,0.040146455,0.000016846274],"about_ca_topic_score_codex":0.003439831,"about_ca_topic_score_gemma":0.0038802885,"teacher_disagreement_score":0.022737922,"about_ca_system_score_codex":0.00016086639,"about_ca_system_score_gemma":0.0006943191,"threshold_uncertainty_score":0.0760659},"labels":[],"label_agreement":null},{"id":"W2192762816","doi":"10.1185/03007995.2015.1112772","title":"Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study","year":2015,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Meloxicam; Osteoarthritis; WOMAC; Acetaminophen; Placebo; Discontinuation; Adverse effect; Randomized controlled trial; Internal medicine; Anesthesia; Physical therapy","score_opus":0.1321570508707899,"score_gpt":0.4473242269642781,"score_spread":0.3151671760934882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192762816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98814696,0.002066584,0.0010089286,0.00037117666,0.00016555825,0.0056921868,0.0013084284,0.00017440105,0.0010656912],"genre_scores_gemma":[0.9766084,0.0023368625,0.0032236003,0.0015007656,0.00029620362,0.009922743,0.002120269,0.00007214716,0.003919017],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9992884,0.00032078626,0.00004709008,0.00011473953,0.00009534737,0.00013380755],"domain_scores_gemma":[0.9987012,0.00021878157,0.0003588324,0.00011336338,0.00014575121,0.0004620118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027205416,0.0019944555,0.0027093107,0.0005651671,0.0008008635,0.00124052,0.0014174458,0.0023779755,0.0061770864],"category_scores_gemma":[0.0013053444,0.0008218529,0.0025554697,0.0004708217,0.0012338667,0.0012515592,0.00040637082,0.0036579832,0.0014826074],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80109614,0.12955837,0.0015803117,0.0011690957,0.0010607752,0.000129937,0.00020785091,0.00078434934,0.032897837,0.000088765126,0.0018655541,0.029560927],"study_design_scores_gemma":[0.6435885,0.34728712,0.0051536122,0.00004661323,0.00032518458,0.00008964753,0.000034138044,0.00049375056,0.0021365539,0.000088095374,0.0007269653,0.000029932977],"about_ca_topic_score_codex":0.00079816265,"about_ca_topic_score_gemma":0.0021579713,"teacher_disagreement_score":0.0061770864,"about_ca_system_score_codex":0.0007984579,"about_ca_system_score_gemma":0.0021849785,"threshold_uncertainty_score":0.020664454},"labels":[],"label_agreement":null},{"id":"W2201330237","doi":"10.1185/03007995.2015.1123145","title":"A review of aripiprazole long-acting injection","year":2015,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; University of Alberta","funders":"New Mexico State University; Bristol-Myers Squibb","keywords":"Aripiprazole; Medicine; Tolerability; Antipsychotic; Schizophrenia (object-oriented programming); Placebo; Atypical antipsychotic; Psychiatry; Adverse effect; Pharmacology; Alternative medicine","score_opus":0.36827171712688916,"score_gpt":0.5696753129102482,"score_spread":0.20140359578335904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201330237","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067117006,0.9994142,0.000040735977,0.000089811874,0.00007899549,0.000009220964,0.000027520133,0.0000030667843,0.00026934355],"genre_scores_gemma":[0.00051795755,0.9989862,0.0001470529,0.000113850074,0.00007457632,0.00001173902,0.000031333202,9.682051e-7,0.000116255665],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994512,0.0000998944,0.00018517321,0.000081704544,0.00015543365,0.000026519057],"domain_scores_gemma":[0.9988937,0.0006238243,0.00024921176,0.000018114339,0.00017464993,0.000040497125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009746045,0.00093455735,0.0021053967,0.0052475017,0.00035034705,0.00097028114,0.0012431601,0.0010456453,0.006136879],"category_scores_gemma":[0.0024000064,0.00043353706,0.0015090298,0.0052256603,0.0003509797,0.0012613889,0.00055189495,0.0009237596,0.0010142326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014897935,0.00007123975,0.00024785334,0.3037164,0.00059418264,0.00037700066,0.00010963939,0.00019556558,0.00080482586,0.0010089965,0.02333317,0.6693921],"study_design_scores_gemma":[0.00011533473,0.0003585983,0.0029822765,0.13495725,0.0040947176,0.0039909836,0.00017745944,0.00015214534,0.0006414703,0.0011027533,0.85136896,0.00005801978],"about_ca_topic_score_codex":0.0023081286,"about_ca_topic_score_gemma":0.0035462978,"teacher_disagreement_score":0.006136879,"about_ca_system_score_codex":0.0007155587,"about_ca_system_score_gemma":0.0022152227,"threshold_uncertainty_score":0.020529866},"labels":[],"label_agreement":null},{"id":"W2234278652","doi":"10.1185/03007995.2016.1140030","title":"Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Hazard ratio; Internal medicine; Myeloid leukemia; Imatinib; Medicare Advantage; Medicare Part D; Emergency medicine; Health care; Medical prescription; Confidence interval; Pharmacology; Prescription drug","score_opus":0.11388979774079895,"score_gpt":0.3880523490510253,"score_spread":0.2741625513102264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2234278652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99934834,0.00017901023,0.000014033807,0.000039939187,0.0000014770928,0.0000031205973,0.0003187367,6.596569e-7,0.00009467767],"genre_scores_gemma":[0.9993538,0.00011683248,0.000031146876,0.000036970265,0.000005502985,0.0000063847438,0.0003855599,4.5530746e-7,0.000063318956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962485,0.00008413237,0.00007237505,0.00007634638,0.00006301452,0.00007933213],"domain_scores_gemma":[0.9989354,0.00012990023,0.00071015547,0.000025994892,0.00006700715,0.00013145038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004506252,0.0001541545,0.00029200077,0.00071010843,0.00031733752,0.00045332656,0.00022116552,0.0003595117,0.0009905127],"category_scores_gemma":[0.001664429,0.0001230455,0.00044133578,0.0010338105,0.00013547376,0.00045573775,0.00036744206,0.00031123805,0.00012910816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004224725,0.00002501411,0.99912375,0.0000039361025,0.000029003593,0.000014906338,0.0000255357,0.000020225134,0.00002763615,0.000004738374,0.000054077074,0.00062903],"study_design_scores_gemma":[0.000004839494,0.00005012986,0.99942756,0.000005768132,0.000014114851,0.00009006593,0.00016376209,0.00014696782,0.000017061438,0.000010703333,0.000067317065,0.0000017703865],"about_ca_topic_score_codex":0.009556763,"about_ca_topic_score_gemma":0.014839719,"teacher_disagreement_score":0.009556763,"about_ca_system_score_codex":0.0004337262,"about_ca_system_score_gemma":0.00029718567,"threshold_uncertainty_score":0.019002259},"labels":[],"label_agreement":null},{"id":"W2320257141","doi":"10.1185/03007995.2013.852525","title":"Risk factors associated with myocardial infarction in venous thromboembolism patients","year":2013,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Venous thromboembolism; Myocardial infarction; Population; Internal medicine; Intensive care medicine; Risk factor; Risk assessment; Cardiology; Thrombosis","score_opus":0.06071674484127297,"score_gpt":0.3625028343006414,"score_spread":0.3017860894593684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320257141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746346,0.0012490744,0.000087061955,0.00015775532,0.000010089357,0.000009990365,0.00042771373,0.0000032394921,0.00059153483],"genre_scores_gemma":[0.99893016,0.00039379307,0.00008423096,0.000033547032,0.000030372143,0.0000068509885,0.0004642805,8.56356e-7,0.000055943266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997136,0.00006996478,0.000038264407,0.000045165245,0.00007470076,0.0000582863],"domain_scores_gemma":[0.998547,0.00024975184,0.00088891445,0.00003636827,0.00008116022,0.00019674904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036780178,0.00017276303,0.00025011593,0.00058018096,0.0001914105,0.00039935907,0.00018400428,0.00028603507,0.0012397469],"category_scores_gemma":[0.0023776146,0.00011307102,0.00034988712,0.00083689584,0.00011461926,0.00022443735,0.00025423637,0.0006449638,0.00011605748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004037354,0.000012063093,0.99901676,0.0000071578893,0.000022194597,0.000040867886,0.000009500785,0.000021889964,0.0000314924,0.000008795576,0.00006285241,0.0007259338],"study_design_scores_gemma":[0.000004514893,0.00003797466,0.9993949,0.00000815548,0.000023643965,0.00024953304,0.000020239171,0.0001286542,0.000016613283,0.000024129484,0.000090305,0.0000012738789],"about_ca_topic_score_codex":0.0017514002,"about_ca_topic_score_gemma":0.0018557963,"teacher_disagreement_score":0.0017514002,"about_ca_system_score_codex":0.00017963379,"about_ca_system_score_gemma":0.00026175298,"threshold_uncertainty_score":0.004147351},"labels":[],"label_agreement":null},{"id":"W2348253579","doi":"10.1080/03007995.2016.1190325","title":"Risk factors associated with treatment discontinuation and down-titration in type 2 diabetes patients treated with sulfonylureas","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Discontinuation; Medicine; Hypoglycemia; Sulfonylurea; Hazard ratio; Internal medicine; Diabetes mellitus; Type 2 diabetes; Retrospective cohort study; Insulin; Endocrinology; Confidence interval","score_opus":0.06569403585936662,"score_gpt":0.366007461864272,"score_spread":0.3003134260049054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2348253579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975414,0.0014874644,0.00014891,0.000099858626,0.0000117085465,0.000011782116,0.00034818889,0.0000048432903,0.0003459545],"genre_scores_gemma":[0.9992655,0.00022862398,0.00009950924,0.000029279106,0.000018688123,0.000007742779,0.00027622457,0.0000013464651,0.00007315112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987459,0.00040643528,0.00021087484,0.00021614238,0.0002992569,0.000121299934],"domain_scores_gemma":[0.99137676,0.0019461564,0.005688655,0.00028671717,0.00030383925,0.00039780553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016168493,0.00024765212,0.00042206649,0.00052536646,0.0003334523,0.0005721704,0.000285254,0.0004924606,0.0011303169],"category_scores_gemma":[0.007095518,0.000221912,0.0012882977,0.0008548383,0.00013040693,0.00030766096,0.00034708498,0.0009831538,0.000082933424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019897331,0.000026983147,0.99806124,0.000010185309,0.0000877049,0.000028325736,0.00001728683,0.000050361617,0.000026220867,0.0000053096755,0.000043637956,0.0014437572],"study_design_scores_gemma":[0.000015541935,0.00011403643,0.99878615,0.000018915607,0.00010090589,0.00021445958,0.000039225753,0.0005344113,0.00003338266,0.000017142414,0.00012177112,0.000004179119],"about_ca_topic_score_codex":0.002592715,"about_ca_topic_score_gemma":0.0026915811,"teacher_disagreement_score":0.002592715,"about_ca_system_score_codex":0.0002651092,"about_ca_system_score_gemma":0.0003754488,"threshold_uncertainty_score":0.008550823},"labels":[],"label_agreement":null},{"id":"W2498107952","doi":"10.1080/03007995.2016.1220934","title":"Association between time to progression and subsequent survival inceritinib-treated patients with advanced ALK-positive non-small-cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Ceritinib; Hazard ratio; Internal medicine; Proportional hazards model; Confidence interval; Lung cancer; Anaplastic lymphoma kinase; Oncology; Gastroenterology; Surgery","score_opus":0.027203361286943395,"score_gpt":0.4169194016918633,"score_spread":0.3897160404049199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2498107952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98507684,0.013472205,0.00038359876,0.000066634675,0.000042219188,0.00003306694,0.00043954444,0.000015948612,0.00046982762],"genre_scores_gemma":[0.9979923,0.000955046,0.00011521608,0.000037133177,0.00006233083,0.00002496301,0.00060252845,0.000002373806,0.00020813574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989956,0.00042179943,0.00011485073,0.0001966892,0.00018130195,0.000089906374],"domain_scores_gemma":[0.9985024,0.0004937776,0.0006718068,0.00007428154,0.00012440459,0.0001333488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003006609,0.00048894767,0.0010248496,0.00047262775,0.00015704225,0.0005996793,0.00025600693,0.00058439164,0.0011208876],"category_scores_gemma":[0.002983755,0.00018462236,0.002138772,0.0004347115,0.0000989873,0.00036919786,0.00035675682,0.00053851714,0.000095388255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07252797,0.000573744,0.8247221,0.0013676196,0.03647544,0.00027552305,0.00008233867,0.0023766311,0.0049156263,0.00007008282,0.0011173508,0.05549552],"study_design_scores_gemma":[0.0017760346,0.008996005,0.9751625,0.000069398026,0.0101917,0.00049402914,0.000040352665,0.0014020185,0.0008077444,0.00006924458,0.00097496185,0.00001607445],"about_ca_topic_score_codex":0.0004932814,"about_ca_topic_score_gemma":0.0012139741,"teacher_disagreement_score":0.003006609,"about_ca_system_score_codex":0.00034525862,"about_ca_system_score_gemma":0.00031230363,"threshold_uncertainty_score":0.015900671},"labels":[],"label_agreement":null},{"id":"W2545262119","doi":"10.1080/03007995.2016.1255185","title":"A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder","year":2016,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Venlafaxine; Tolerability; Major depressive disorder; Placebo; Internal medicine; Adverse effect; Hamilton Rating Scale for Depression; Antidepressant","score_opus":0.30237590550256815,"score_gpt":0.5163051105067888,"score_spread":0.2139292050042207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545262119","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05569746,0.9388184,0.0016715771,0.00049101876,0.0006713333,0.00047745006,0.0011165538,0.00010113977,0.0009550682],"genre_scores_gemma":[0.7466138,0.24472155,0.003844499,0.0011100004,0.00042968316,0.0008914904,0.001447804,0.000066668654,0.00087447074],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9912062,0.005707488,0.0012329284,0.0009668252,0.0006740284,0.0002125513],"domain_scores_gemma":[0.9916236,0.0059653134,0.0012298063,0.00045587623,0.0005126512,0.00021262982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012135685,0.002639292,0.014652423,0.0038099415,0.0006528454,0.0030600692,0.0018451771,0.0020537837,0.0031811118],"category_scores_gemma":[0.017765373,0.0013417635,0.04268401,0.0035865153,0.0004982765,0.0012397056,0.0010683713,0.0020258916,0.00029690444],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010135823,0.000036326775,0.0023209504,0.029597968,0.9519501,0.00007263121,0.000020163687,0.0007874462,0.00025612992,0.00006159259,0.00027954904,0.0044813883],"study_design_scores_gemma":[0.0024091778,0.00046122653,0.003267931,0.0018725675,0.9907612,0.000051375893,0.000017210476,0.0003980914,0.00009367812,0.00012245588,0.00053185533,0.000013187916],"about_ca_topic_score_codex":0.006836943,"about_ca_topic_score_gemma":0.011040622,"teacher_disagreement_score":0.014652423,"about_ca_system_score_codex":0.0022019048,"about_ca_system_score_gemma":0.00156933,"threshold_uncertainty_score":0.064180374},"labels":[],"label_agreement":null},{"id":"W2547724305","doi":"10.1080/03007995.2016.1257977","title":"Systematic literature review of the health economic implications of early detection by screening populations at risk for type 2 diabetes","year":2016,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Cost effectiveness; Psychological intervention; MEDLINE; Diabetes mellitus; Scopus; Cost–benefit analysis; Intensive care medicine; Risk analysis (engineering); Psychiatry","score_opus":0.14747198322079405,"score_gpt":0.47129848790238665,"score_spread":0.3238265046815926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2547724305","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025129188,0.9922281,0.00031207682,0.0007423602,0.00020736562,0.00082275725,0.0021646037,0.000013982871,0.0009958069],"genre_scores_gemma":[0.025703713,0.9703169,0.0010684386,0.0006969783,0.000115360555,0.0011765459,0.0007489786,0.000010530292,0.00016242015],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98543453,0.0060084234,0.0050039766,0.00066124654,0.002515237,0.0003765995],"domain_scores_gemma":[0.92559916,0.05954141,0.009084874,0.0006765388,0.004597446,0.00050061155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013377642,0.0019175345,0.009025553,0.016115941,0.000766765,0.003486963,0.0024187372,0.0019188382,0.007240098],"category_scores_gemma":[0.08613579,0.0012174601,0.00866859,0.01625958,0.00094440987,0.0024128442,0.0017890859,0.0016037937,0.00040589442],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024215522,0.000014840938,0.00072426524,0.96542424,0.011464361,0.00012979338,0.000099506535,0.0001733139,0.000057707013,0.0002974887,0.0014227952,0.019949537],"study_design_scores_gemma":[0.00027753587,0.00012330047,0.0037485776,0.91628104,0.06879521,0.0002843609,0.00019048185,0.00012212424,0.00011141926,0.00044805097,0.009588709,0.000029212177],"about_ca_topic_score_codex":0.011728555,"about_ca_topic_score_gemma":0.031400677,"teacher_disagreement_score":0.016115941,"about_ca_system_score_codex":0.0079106735,"about_ca_system_score_gemma":0.017105991,"threshold_uncertainty_score":0.07074857},"labels":[],"label_agreement":null},{"id":"W2590491310","doi":"10.1080/03007995.2017.1300142","title":"The content validation of the Self-Reported Misuse, Abuse and Diversion of Prescription Opioids (SR-MAD) instrument for use in patients with acute or chronic pain","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Chronic pain; Content validity; Medical prescription; Opioid; Psychiatry; Cognition; Cognitive interview; Clinical psychology; Physical therapy; Psychometrics; Internal medicine","score_opus":0.12024160526015626,"score_gpt":0.3891779392027667,"score_spread":0.26893633394261046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590491310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938234,0.0002267377,0.0022528514,0.00032474834,0.00003002539,0.0014335362,0.0003939928,0.000015218464,0.0014995461],"genre_scores_gemma":[0.9873641,0.00021975281,0.009277271,0.00018312054,0.000015479402,0.0023133631,0.0003918459,0.000008565249,0.00022646294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98796123,0.007192177,0.0018329569,0.00044482126,0.0021287,0.00044014002],"domain_scores_gemma":[0.9558762,0.028004704,0.006252929,0.0018867081,0.0073034917,0.0006759794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025230696,0.0002454186,0.0006264747,0.0012792137,0.0007599986,0.0012939544,0.0008957539,0.0005023365,0.000924382],"category_scores_gemma":[0.054149035,0.00032754184,0.00096177123,0.0011586705,0.0014445942,0.0009489486,0.00222931,0.0007938853,0.00014660523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007874026,0.00063462957,0.77015465,0.0016596095,0.0002758712,0.00023876084,0.086113885,0.0006440029,0.0051834933,0.0014248139,0.00176537,0.13111748],"study_design_scores_gemma":[0.00015052022,0.0012292047,0.9384805,0.0009878208,0.00014591272,0.00055292004,0.046701156,0.002672917,0.0020534305,0.00090162654,0.006052377,0.00007170821],"about_ca_topic_score_codex":0.0018218142,"about_ca_topic_score_gemma":0.0032547617,"teacher_disagreement_score":0.025230696,"about_ca_system_score_codex":0.0018255224,"about_ca_system_score_gemma":0.0037060697,"threshold_uncertainty_score":0.13343424},"labels":[],"label_agreement":null},{"id":"W2679991926","doi":"10.1080/03007995.2017.1345730","title":"Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Liraglutide; Dipeptidyl peptidase-4; Type 2 diabetes; Dipeptidyl peptidase-4 inhibitor; Saxagliptin; Sitagliptin; Internal medicine; Diabetes mellitus; Dipeptidyl peptidase; Pharmacology; Glucagon-like peptide-1; Meta-analysis; Endocrinology; Enzyme; Biochemistry","score_opus":0.4695309847121052,"score_gpt":0.513261358917863,"score_spread":0.04373037420575776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2679991926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07502044,0.9128553,0.0055840313,0.0012713766,0.00069239835,0.00069051137,0.0023956706,0.00014489691,0.0013453498],"genre_scores_gemma":[0.88677174,0.10245244,0.0055438713,0.001124175,0.00031627362,0.001199036,0.0020605968,0.000059684535,0.00047225095],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.981072,0.0133775575,0.0023288282,0.0019317439,0.0009427442,0.0003471188],"domain_scores_gemma":[0.98251396,0.013174524,0.0023105068,0.00076682796,0.0009128227,0.00032122858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020647684,0.003026701,0.012935258,0.0056194076,0.0006410797,0.0026121445,0.002076065,0.001918904,0.0029349935],"category_scores_gemma":[0.033386093,0.0011343457,0.038969427,0.0054860944,0.00048142963,0.0015764642,0.0013884122,0.0014503857,0.00019456606],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004077117,0.0000360408,0.011696709,0.028146558,0.9470203,0.0001398048,0.000042537456,0.0026869879,0.00018407604,0.0001364526,0.00037834048,0.00545513],"study_design_scores_gemma":[0.0009067143,0.0002081848,0.0058437763,0.0012066831,0.9890161,0.00005425669,0.000019880681,0.0018605705,0.00007202926,0.00031923022,0.00047499663,0.000017701834],"about_ca_topic_score_codex":0.008918141,"about_ca_topic_score_gemma":0.012309949,"teacher_disagreement_score":0.020647684,"about_ca_system_score_codex":0.0023318322,"about_ca_system_score_gemma":0.0023515376,"threshold_uncertainty_score":0.10919672},"labels":[],"label_agreement":null},{"id":"W2754295200","doi":"10.1080/03007995.2017.1380617","title":"Moving toward consensus on diagnosis and management of severe asthma in adults","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Novartis","keywords":"Medicine; Asthma; Asthma management; Intensive care medicine; MEDLINE; Personalized medicine; Alternative medicine; Family medicine; Bioinformatics; Immunology; Pathology","score_opus":0.2616818952326109,"score_gpt":0.5082629594126179,"score_spread":0.24658106418000703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754295200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021497998,0.9674046,0.0013185961,0.025602004,0.0027839905,0.00002878461,0.0000696572,0.000019383844,0.0025580013],"genre_scores_gemma":[0.0033035446,0.9786461,0.003213588,0.011226284,0.0026323574,0.000047873116,0.00021171373,0.000011189876,0.00070732116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944589,0.0016638563,0.001427169,0.0005934805,0.0016567296,0.00019977885],"domain_scores_gemma":[0.99001545,0.005480157,0.0009482802,0.00023910358,0.0029474248,0.00036962834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008268512,0.00077277195,0.0021267345,0.0038184568,0.0008112132,0.0030893497,0.0028454983,0.0046986956,0.0038046406],"category_scores_gemma":[0.019637628,0.00041366497,0.0016030731,0.0024311303,0.0019513459,0.0045512696,0.0022476632,0.0061126305,0.0025828],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000554148,0.000064803084,0.00064239977,0.041776903,0.00023191191,0.00059676747,0.0007816786,0.0003852598,0.00060109963,0.019707419,0.10607095,0.8290854],"study_design_scores_gemma":[0.000026944557,0.0000729337,0.0011559183,0.06586984,0.00030767117,0.0019716641,0.00089685095,0.00016650646,0.00031468426,0.017402275,0.9117628,0.000051888328],"about_ca_topic_score_codex":0.002530057,"about_ca_topic_score_gemma":0.0034133254,"teacher_disagreement_score":0.008268512,"about_ca_system_score_codex":0.0019313525,"about_ca_system_score_gemma":0.007687164,"threshold_uncertainty_score":0.04372853},"labels":[],"label_agreement":null},{"id":"W2755128776","doi":"10.1080/03007995.2017.1380618","title":"Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Observational study; Quality of life (healthcare); Visual analogue scale; Physical therapy; Brief Pain Inventory; Patient satisfaction; Population; Chronic pain; Internal medicine; Surgery","score_opus":0.13078294745031657,"score_gpt":0.47060407354021966,"score_spread":0.3398211260899031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2755128776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992705,0.00033264534,0.000037425314,0.000026355112,0.000003745829,0.000017823597,0.00013016781,8.1489867e-7,0.0001806467],"genre_scores_gemma":[0.999385,0.00018572439,0.00008308914,0.000028638808,0.000011577824,0.000019160556,0.00022217193,6.4261735e-7,0.000063988075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988142,0.0004349828,0.00018262472,0.00011742044,0.0003046009,0.00014615523],"domain_scores_gemma":[0.9952814,0.0006891913,0.0027224673,0.00012288839,0.0006138458,0.0005701502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015906314,0.00021778038,0.00044446508,0.00079979777,0.00047196596,0.00063444226,0.00029138144,0.00041434358,0.0012215304],"category_scores_gemma":[0.0049736747,0.00016101493,0.0009246538,0.0011559036,0.00029715165,0.00051043986,0.0005697781,0.00041216114,0.0001682326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003205722,0.00019434863,0.99683654,0.000040300958,0.00015008004,0.000034947057,0.00015581629,0.000027060369,0.000043963588,0.000008532294,0.000070603404,0.0021172503],"study_design_scores_gemma":[0.00007098816,0.0009759142,0.99785197,0.000021917343,0.00006990199,0.00017844958,0.00042961235,0.00016164004,0.000023037956,0.000008277725,0.00020293334,0.0000053962644],"about_ca_topic_score_codex":0.004768519,"about_ca_topic_score_gemma":0.0049472414,"teacher_disagreement_score":0.004768519,"about_ca_system_score_codex":0.0008749861,"about_ca_system_score_gemma":0.00061406626,"threshold_uncertainty_score":0.009481549},"labels":[],"label_agreement":null},{"id":"W2767963750","doi":"10.1080/03007995.2017.1401529","title":"Real-world cardiovascular disease burden in patients with atherosclerotic cardiovascular disease: a comprehensive systematic literature review","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Mace; Stroke (engine); Internal medicine; Myocardial infarction; Incidence (geometry); Observational study; Adverse effect; Mortality rate; Percutaneous coronary intervention","score_opus":0.136619001560884,"score_gpt":0.42454012431765503,"score_spread":0.28792112275677106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767963750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016711432,0.9962746,0.00022074643,0.0002990541,0.00011734426,0.00045271337,0.0007346666,0.000012643784,0.00021710986],"genre_scores_gemma":[0.024085056,0.9721857,0.0012158126,0.0007503578,0.00013780536,0.0009801077,0.0005345684,0.0000100710195,0.00010064015],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9864196,0.0040708203,0.006118694,0.0010620726,0.0020312613,0.00029750666],"domain_scores_gemma":[0.9410344,0.042752996,0.0107002435,0.0008833464,0.0041618873,0.0004671247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012670567,0.0016970291,0.01053576,0.01465046,0.00069106254,0.003032306,0.001987466,0.0021904681,0.003854792],"category_scores_gemma":[0.057703216,0.001299836,0.0072301584,0.013912306,0.0010810384,0.0029353176,0.0018382041,0.001127589,0.00033635375],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009424334,0.000008999278,0.0009889711,0.97296935,0.010450239,0.00009351734,0.00014848025,0.000068456015,0.000106496445,0.00012688119,0.0009099995,0.014034359],"study_design_scores_gemma":[0.00018190939,0.00013495352,0.0051708235,0.89103794,0.09296195,0.00042682982,0.00027337277,0.00008770378,0.0001304754,0.00024164576,0.009311683,0.000040731236],"about_ca_topic_score_codex":0.0064365407,"about_ca_topic_score_gemma":0.020057121,"teacher_disagreement_score":0.01465046,"about_ca_system_score_codex":0.0039232597,"about_ca_system_score_gemma":0.013352975,"threshold_uncertainty_score":0.06700915},"labels":[],"label_agreement":null},{"id":"W2769813465","doi":"10.1080/03007995.2017.1410471","title":"Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies","year":2017,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Aripiprazole; Akathisia; Medicine; Tolerability; Positive and Negative Syndrome Scale; Placebo; Adverse effect; Internal medicine; Antipsychotic; Schizophrenia (object-oriented programming); Randomized controlled trial; Psychiatry; Psychosis","score_opus":0.2557213761562765,"score_gpt":0.5200668732555312,"score_spread":0.26434549709925476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769813465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44429803,0.5380204,0.0029238253,0.0010017202,0.0012446531,0.005708008,0.002508011,0.00011797875,0.0041773925],"genre_scores_gemma":[0.9321725,0.0588769,0.0033239482,0.0006723094,0.000488776,0.0026151661,0.0009055204,0.00002123272,0.0009237531],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929201,0.0044075833,0.0013369917,0.0006391671,0.0005617209,0.00013447691],"domain_scores_gemma":[0.98638797,0.008142948,0.003963172,0.00040800756,0.0007733697,0.00032464036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0093055675,0.0019164819,0.007870728,0.001709736,0.0004308839,0.002007502,0.0010642587,0.0021051401,0.006268331],"category_scores_gemma":[0.015342871,0.0010539688,0.012613666,0.0011362885,0.00084869267,0.0013065547,0.00084132777,0.0019020169,0.00047959838],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5149785,0.0017221543,0.005490843,0.10335284,0.3282013,0.00014495445,0.00025213978,0.0008106049,0.00232569,0.0003318735,0.00039483674,0.0419942],"study_design_scores_gemma":[0.34411907,0.049350478,0.014291028,0.007243558,0.578549,0.00025149554,0.0001685422,0.0014487813,0.0014095961,0.0007853896,0.0022762227,0.00010680897],"about_ca_topic_score_codex":0.0011934049,"about_ca_topic_score_gemma":0.0023206065,"teacher_disagreement_score":0.0093055675,"about_ca_system_score_codex":0.0014005663,"about_ca_system_score_gemma":0.001110406,"threshold_uncertainty_score":0.04921311},"labels":[],"label_agreement":null},{"id":"W2775608437","doi":"10.1080/03007995.2017.1416347","title":"Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Diphtheria; Copayment; Vaccination; Logistic regression; Tetanus; Confounding; Pertussis vaccine; Pediatrics; Immunization; Internal medicine; Health care; Immunology; Health insurance; Law; Antigen","score_opus":0.22308274570242578,"score_gpt":0.48135763649130087,"score_spread":0.2582748907888751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775608437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974775,0.00042111427,0.00013720729,0.00017998391,0.000011119044,0.000009504366,0.0013605179,0.0000065210756,0.00039648893],"genre_scores_gemma":[0.9987203,0.000083119594,0.00010809681,0.000038449452,0.00001898884,0.0000094647985,0.0009008437,0.0000022460167,0.00011867381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983015,0.0005406063,0.00029668442,0.0003009401,0.00039048638,0.00016980252],"domain_scores_gemma":[0.98476774,0.0039948565,0.009399872,0.000447077,0.000656833,0.0007336238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021088498,0.0002271512,0.00031291696,0.0008716958,0.00029456904,0.0006517585,0.00048569994,0.0005050407,0.002869361],"category_scores_gemma":[0.013113728,0.00025874842,0.0007928122,0.0012615668,0.00019202671,0.0005767033,0.00051379704,0.00092803774,0.000200912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008086851,0.000014669538,0.99937797,0.0000040680397,0.000056453482,0.000009802233,0.000008424915,0.000038707036,0.000019739062,0.00000855147,0.00006873714,0.00031193453],"study_design_scores_gemma":[0.0000060084,0.000056130022,0.99917847,0.000006290315,0.000031355736,0.000116167874,0.00003461515,0.00042094185,0.000024060337,0.0000098088785,0.000113812166,0.0000022295924],"about_ca_topic_score_codex":0.0076444633,"about_ca_topic_score_gemma":0.005718037,"teacher_disagreement_score":0.0076444633,"about_ca_system_score_codex":0.00053414196,"about_ca_system_score_gemma":0.00046891771,"threshold_uncertainty_score":0.015199959},"labels":[],"label_agreement":null},{"id":"W2778234808","doi":"10.1080/03007995.2017.1421146","title":"Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment","year":2017,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Dulaglutide; Persistence (discontinuity); Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Physical therapy; Exenatide; Endocrinology","score_opus":0.09947148768741258,"score_gpt":0.39894085193484075,"score_spread":0.29946936424742815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778234808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904317,0.00019974068,0.000049623744,0.00005898813,0.0000024459064,0.0000078069215,0.00044906628,0.0000018117072,0.00018728821],"genre_scores_gemma":[0.9993272,0.000073944946,0.00008169596,0.000026246265,0.0000069154876,0.000010624574,0.00044233844,9.259316e-7,0.000030155381],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969144,0.001502443,0.0005450101,0.00036951824,0.00048379274,0.00018477243],"domain_scores_gemma":[0.98741597,0.0026351046,0.008458276,0.00046930817,0.00053099,0.0004904543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029248374,0.00018698694,0.0004193036,0.0007545919,0.00032485832,0.0011251931,0.00043889723,0.0005481294,0.0009349448],"category_scores_gemma":[0.011585758,0.00022249887,0.0006510737,0.0013641573,0.00027089388,0.0008202892,0.00053203455,0.0006823673,0.00014988484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013598514,0.00006167103,0.9983713,0.000015146726,0.00010221949,0.000017942159,0.00005909486,0.00007520191,0.000021016054,0.0000069120824,0.000048808273,0.0010847338],"study_design_scores_gemma":[0.000020565936,0.00026322913,0.99831676,0.000019135332,0.00006303357,0.00018161435,0.0002683001,0.00069263176,0.000034744044,0.000018861603,0.000113611364,0.000007559402],"about_ca_topic_score_codex":0.0047125956,"about_ca_topic_score_gemma":0.0050057345,"teacher_disagreement_score":0.0047125956,"about_ca_system_score_codex":0.0005353415,"about_ca_system_score_gemma":0.0003943517,"threshold_uncertainty_score":0.01546824},"labels":[],"label_agreement":null},{"id":"W2809106259","doi":"10.1080/03007995.2018.1490255","title":"A palliative care perspective on deprescribing cholinesterase inhibitors in Alzheimer’s disease","year":2018,"lang":"en","type":"editorial","venue":"Current Medical Research and Opinion","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; Baycrest Hospital","funders":"","keywords":"Medicine; Deprescribing; Palliative care; Dementia; Quality of life (healthcare); Intensive care medicine; Disease; Perspective (graphical); Cholinesterase; End-of-life care; Polypharmacy; Psychiatry; Nursing; Internal medicine","score_opus":0.10565739365181995,"score_gpt":0.49304631603627236,"score_spread":0.38738892238445244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809106259","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005731537,0.028449684,0.00011588063,0.10429443,0.86594665,0.000023529652,0.00003331848,0.000034859575,0.00104437],"genre_scores_gemma":[0.00043040095,0.019915637,0.00009491052,0.05511104,0.9223607,0.000021372074,0.00001711226,0.0000147473975,0.0020340504],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938678,0.0019892561,0.0011611587,0.000484244,0.0021397076,0.0003577384],"domain_scores_gemma":[0.9640892,0.023641402,0.0015178383,0.00041944606,0.0070323627,0.003299638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011199016,0.0027902462,0.003438512,0.0030339672,0.0028968016,0.0055289688,0.0045703813,0.023139946,0.0065276986],"category_scores_gemma":[0.037183106,0.0010618349,0.0030940585,0.0017818258,0.0029240446,0.006383885,0.0018063405,0.030491909,0.004743189],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044981567,0.000022403046,0.00003214185,0.0006730092,0.000028793254,0.00019898896,0.00004893107,0.00003593727,0.00004222642,0.000509031,0.9879318,0.010431762],"study_design_scores_gemma":[0.0001646726,0.00010672728,0.00029790527,0.0026076804,0.00012518076,0.0006911042,0.00011481275,0.0001560453,0.00008893177,0.0014049883,0.99420655,0.000035283305],"about_ca_topic_score_codex":0.0017216597,"about_ca_topic_score_gemma":0.005558764,"teacher_disagreement_score":0.023139946,"about_ca_system_score_codex":0.0038886522,"about_ca_system_score_gemma":0.0043536094,"threshold_uncertainty_score":0.05922675},"labels":[],"label_agreement":null},{"id":"W2885386026","doi":"10.1080/03007995.2018.1512477","title":"Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis","year":2018,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Odds ratio; Schizophrenia (object-oriented programming); Confidence interval; Paliperidone Palmitate; Paliperidone; Young adult; Internal medicine; Pediatrics; Antipsychotic; Psychiatry","score_opus":0.05571376054149504,"score_gpt":0.4005687660881389,"score_spread":0.3448550055466439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885386026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99819356,0.00083276245,0.000076229575,0.000019223722,0.0000054495267,0.000020082967,0.0007069855,0.0000022652303,0.00014336336],"genre_scores_gemma":[0.9985215,0.0005486648,0.00007218301,0.000026430791,0.000007992913,0.000018848603,0.0007672162,0.000001363452,0.000035784058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991381,0.00013588845,0.00027741553,0.0001645579,0.00018172563,0.00010227176],"domain_scores_gemma":[0.99812394,0.00016814009,0.0012566183,0.00007588989,0.0001786946,0.00019672478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000848869,0.00024267344,0.0004402622,0.0010947066,0.0003234223,0.00042631757,0.00030588126,0.00028903875,0.00057092373],"category_scores_gemma":[0.0018502461,0.00030984182,0.0009754541,0.0012434976,0.00021820252,0.0004920494,0.00046934796,0.00031420932,0.00012279513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007831651,0.000010972624,0.9989543,0.000028289693,0.00009173136,0.00006767253,0.000047939393,0.00001790664,0.00007660013,0.000006248484,0.00004549354,0.00057444844],"study_design_scores_gemma":[0.0000061683413,0.000099529774,0.998919,0.00003287281,0.000054245567,0.00033452967,0.0002860053,0.00008893884,0.000047104022,0.000006447853,0.00012120959,0.000003892424],"about_ca_topic_score_codex":0.010461437,"about_ca_topic_score_gemma":0.013799315,"teacher_disagreement_score":0.010461437,"about_ca_system_score_codex":0.0004882791,"about_ca_system_score_gemma":0.0005854325,"threshold_uncertainty_score":0.020801127},"labels":[],"label_agreement":null},{"id":"W2912647253","doi":"10.1080/03007995.2019.1576479","title":"The role of sodium glucose cotransporter-2 (SGLT-2) inhibitors in heart failure and chronic kidney disease in type 2 diabetes","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Heart Research Centre; University of Toronto; St. Michael's Hospital; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Heart failure; Kidney disease; Canagliflozin; Cotransporter; Disease; Internal medicine; Sodium; Empagliflozin; Endocrinology","score_opus":0.05041699803246688,"score_gpt":0.391567039502338,"score_spread":0.34115004146987116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912647253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028099175,0.99890935,0.000044859655,0.00039259132,0.0001265575,0.0000030764222,0.000013141405,0.0000019137533,0.00022746528],"genre_scores_gemma":[0.004085269,0.9946936,0.0002068417,0.0005570064,0.0002942941,0.000013263501,0.0000269202,9.866683e-7,0.00012174065],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939644,0.00021531754,0.00014520259,0.00006437295,0.00014336388,0.00003535928],"domain_scores_gemma":[0.9986559,0.00088689005,0.00024213229,0.00001578979,0.0001576213,0.00004157541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015353485,0.00047491904,0.0015573218,0.0009465398,0.00018399463,0.0009315294,0.0005101616,0.00079833047,0.0017892137],"category_scores_gemma":[0.0023587942,0.00014303492,0.0014033527,0.0010426616,0.00027765162,0.0008381567,0.0003907871,0.0013020259,0.00023431201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064975984,0.000090042304,0.0012078093,0.06640657,0.0011981644,0.0002460818,0.000120540266,0.0004157604,0.0007673054,0.0024865593,0.014708419,0.91170293],"study_design_scores_gemma":[0.0010184585,0.0024672155,0.018607073,0.09882523,0.0095784515,0.0041026114,0.0003547659,0.0009708056,0.0014285155,0.007919008,0.8546167,0.00011130833],"about_ca_topic_score_codex":0.0010316441,"about_ca_topic_score_gemma":0.0023781972,"teacher_disagreement_score":0.0017892137,"about_ca_system_score_codex":0.0003692906,"about_ca_system_score_gemma":0.0012087898,"threshold_uncertainty_score":0.008119762},"labels":[],"label_agreement":null},{"id":"W2913275054","doi":"10.1080/03007995.2019.1580094","title":"Treatment sequence network meta-analysis in Crohn’s disease: a methodological case study","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Ustekinumab; Vedolizumab; Placebo; Internal medicine; Adalimumab; Crohn's disease; Randomization; Randomized controlled trial; Population; Meta-analysis; Infliximab; Clinical trial; Disease; Pathology","score_opus":0.41407654584083364,"score_gpt":0.5200536044546522,"score_spread":0.10597705861381856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913275054","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099415615,0.5147405,0.3392359,0.014968326,0.0019712786,0.014894679,0.004775754,0.0006629166,0.00933496],"genre_scores_gemma":[0.74962115,0.039627787,0.18547595,0.0034037891,0.0005379204,0.017932678,0.0020057543,0.00017771461,0.0012172043],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.59159476,0.38840917,0.00832463,0.0051939622,0.005613654,0.0008637459],"domain_scores_gemma":[0.4790347,0.48899874,0.015833568,0.010663085,0.004828944,0.0006409641],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21320587,0.0028548085,0.008197926,0.004639749,0.0012789981,0.0037035577,0.003412985,0.0045314226,0.0057928544],"category_scores_gemma":[0.38299412,0.0016806482,0.025909333,0.0045158784,0.0014795095,0.0030866119,0.0030788353,0.0030654462,0.00036132868],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023937218,0.00041356467,0.038686484,0.09876217,0.6859414,0.0020550096,0.0010957259,0.055825274,0.0006273973,0.024228435,0.0076142433,0.060813062],"study_design_scores_gemma":[0.015780294,0.002739503,0.013842801,0.027538879,0.7154322,0.002047768,0.0004989544,0.13004257,0.0006650774,0.07359772,0.017450634,0.00036359922],"about_ca_topic_score_codex":0.006343669,"about_ca_topic_score_gemma":0.008057669,"teacher_disagreement_score":0.7867941,"about_ca_system_score_codex":0.004346441,"about_ca_system_score_gemma":0.004103745,"threshold_uncertainty_score":0.9702572},"labels":[],"label_agreement":null},{"id":"W2940284440","doi":"10.1080/03007995.2019.1608101","title":"Ghostwriting in biomedicine: a review of the published literature","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Medical Association","keywords":"Medicine; Relevance (law); Consistency (knowledge bases); Publishing; Computer science; Law; Political science","score_opus":0.8005847108475234,"score_gpt":0.72599677644244,"score_spread":0.07458793440508338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940284440","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026370486,0.99829143,0.000122019366,0.00080212083,0.0002610727,0.00006497207,0.000067871144,0.0000071732406,0.0001196787],"genre_scores_gemma":[0.0055110957,0.9918669,0.00077368855,0.001124353,0.0003496792,0.0002009309,0.00010078342,0.000009028625,0.00006371029],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9515991,0.01663264,0.01929505,0.0027454968,0.0089070145,0.00082065864],"domain_scores_gemma":[0.74097043,0.1968656,0.039183136,0.003442981,0.01763207,0.0019056352],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.047106028,0.0021682717,0.006567804,0.03903198,0.0016713048,0.0061016176,0.0035511556,0.0039005023,0.0046908124],"category_scores_gemma":[0.14173397,0.0020938255,0.005938842,0.038738485,0.0029069616,0.00902407,0.0037347,0.0028027229,0.0009142307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011040744,0.000018663282,0.0011424833,0.90651697,0.0021819612,0.00028725804,0.00077377306,0.00010742222,0.00023241868,0.000530212,0.0058598774,0.08223867],"study_design_scores_gemma":[0.000046368164,0.00008389258,0.0025033054,0.95834124,0.0070009264,0.0006940439,0.0005695432,0.000073878575,0.0001223442,0.00072400016,0.029802216,0.000038156184],"about_ca_topic_score_codex":0.0047879657,"about_ca_topic_score_gemma":0.014177291,"teacher_disagreement_score":0.9960995,"about_ca_system_score_codex":0.00692974,"about_ca_system_score_gemma":0.024932219,"threshold_uncertainty_score":0.24912345},"labels":[],"label_agreement":null},{"id":"W2960566636","doi":"10.1080/03007995.2019.1636017","title":"Bipolar depression: the clinical characteristics and unmet needs of a complex disorder","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":207,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bipolar disorder; Medicine; Psychiatry; Depression (economics); Mania; Hypomania; Anxiety; Comorbidity; Prevalence of mental disorders; Psychosocial; Substance abuse; Mood","score_opus":0.3659037293290053,"score_gpt":0.5502939973862744,"score_spread":0.1843902680572691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2960566636","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017181838,0.9981865,0.000048056656,0.0007984036,0.00013475379,0.0000036559002,0.000023486413,0.0000025126894,0.00063075166],"genre_scores_gemma":[0.0015234554,0.9977088,0.0001119926,0.0003305714,0.00013806048,0.0000045623856,0.000038771217,8.4658836e-7,0.00014293806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995454,0.000117146774,0.00009260464,0.000046201378,0.00016849118,0.000030165995],"domain_scores_gemma":[0.99923766,0.00041847565,0.00014511295,0.00001295921,0.00013728526,0.00004846793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079862494,0.0004902023,0.0014643178,0.0013746873,0.0002672274,0.0013402726,0.0006150409,0.00085260364,0.002617147],"category_scores_gemma":[0.001977793,0.00022071955,0.0006835545,0.0017803761,0.0003523002,0.00087403203,0.00063006475,0.0012342987,0.000595497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052782263,0.000022980797,0.0008448006,0.038245074,0.0003658086,0.00021114355,0.00013628708,0.00015730351,0.00033335725,0.00246799,0.037807725,0.9193548],"study_design_scores_gemma":[0.000056580982,0.000112451125,0.009967664,0.0665297,0.001009834,0.006262329,0.000628478,0.00022775556,0.00015680664,0.0055353637,0.9094612,0.000051765885],"about_ca_topic_score_codex":0.0020580364,"about_ca_topic_score_gemma":0.0062614735,"teacher_disagreement_score":0.002617147,"about_ca_system_score_codex":0.00071804685,"about_ca_system_score_gemma":0.001577761,"threshold_uncertainty_score":0.008755267},"labels":[],"label_agreement":null},{"id":"W2963273115","doi":"10.1080/03007995.2019.1645999","title":"Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Provincial Health Services Authority; Simon Fraser University; AIDS Vancouver; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); COPD; Internal medicine; Population; Asthma; Kidney disease; Comorbidity; Cohort; Diabetes mellitus; Endocrinology","score_opus":0.04721944358949187,"score_gpt":0.41253330750242706,"score_spread":0.3653138639129352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963273115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975078,0.00019502424,0.00004862011,0.000040599145,0.0000028779893,0.000016370843,0.0017662436,0.0000043785017,0.00041804914],"genre_scores_gemma":[0.9984675,0.00014151887,0.00007258845,0.00002740506,0.0000047772096,0.000011385756,0.001155515,0.0000011611776,0.00011812871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995478,0.000051806266,0.00004555605,0.00009300119,0.00016801678,0.000093860304],"domain_scores_gemma":[0.9989286,0.00006712682,0.00042932472,0.000060232836,0.00028030603,0.0002343935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004120794,0.00023452681,0.0002734525,0.0010605222,0.000641594,0.0007506301,0.00051221054,0.000359449,0.0007900346],"category_scores_gemma":[0.0013938666,0.00027550937,0.00028671246,0.001937032,0.00028124652,0.00034753824,0.00042902623,0.00047540184,0.0001347389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009033567,0.000006675803,0.9995555,0.000002759558,0.000016894817,0.000012148505,0.000023596785,0.000014597253,0.000036646117,0.0000027563017,0.00005292094,0.0002664022],"study_design_scores_gemma":[0.0000011491962,0.0000072774405,0.9997665,0.0000026434727,0.000004820716,0.000041408883,0.00006037858,0.0000617786,0.0000074615104,0.0000022931345,0.000043117594,9.838957e-7],"about_ca_topic_score_codex":0.4361904,"about_ca_topic_score_gemma":0.52854955,"teacher_disagreement_score":0.4361904,"about_ca_system_score_codex":0.0016435776,"about_ca_system_score_gemma":0.0018090853,"threshold_uncertainty_score":0.86730295},"labels":[],"label_agreement":null},{"id":"W2963470829","doi":"10.1080/03007995.2019.1646001","title":"Evolving the management of acute perioperative pain towards opioid free protocols: a narrative review","year":2019,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals; Edwards Lifesciences; Mayo Clinic","keywords":"Medicine; Opioid; Perioperative; Intensive care medicine; Medical prescription; Health care; Chronic pain; Patient satisfaction; Narrative review; Anesthesia; Physical therapy; Nursing","score_opus":0.22411527359088387,"score_gpt":0.5262681989910906,"score_spread":0.30215292540020666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963470829","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024958476,0.9984578,0.000109330904,0.00057637796,0.0001280912,0.0000261834,0.000033812143,0.000002304571,0.00041649383],"genre_scores_gemma":[0.002495957,0.99645436,0.00023984163,0.00053315825,0.00013892542,0.000033990444,0.000028936312,0.0000011497382,0.000073667004],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983475,0.0005357277,0.0005498635,0.0001597879,0.0003429174,0.00006420869],"domain_scores_gemma":[0.99338347,0.004631881,0.0012524477,0.00007274154,0.00057424774,0.0000852834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023209706,0.0007652569,0.0012538586,0.0030668934,0.0004344532,0.0021820914,0.0010360936,0.0014215676,0.0026967162],"category_scores_gemma":[0.010807076,0.00034304793,0.0014713213,0.0037278985,0.0006408786,0.0021480855,0.00090036175,0.0012501046,0.0003687183],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017341878,0.000056110443,0.00093139935,0.57364434,0.0011576848,0.00043214572,0.0007683719,0.00029998046,0.0004097059,0.0046228226,0.01707695,0.40042704],"study_design_scores_gemma":[0.00006828307,0.0001752513,0.0034260897,0.6764582,0.006500801,0.0027369563,0.0009590286,0.00021614206,0.00030917194,0.0027591896,0.3063415,0.000049313814],"about_ca_topic_score_codex":0.0020054106,"about_ca_topic_score_gemma":0.0046528303,"teacher_disagreement_score":0.0030668934,"about_ca_system_score_codex":0.0012387407,"about_ca_system_score_gemma":0.0050757583,"threshold_uncertainty_score":0.012274623},"labels":[],"label_agreement":null},{"id":"W2965680320","doi":"10.1080/03007995.2019.1652053","title":"Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); University of Toronto; McGill University; University Health Network","funders":"","keywords":"Major depressive disorder; Medicine; Propensity score matching; Reuptake inhibitor; Serotonin reuptake inhibitor; Internal medicine; Antidepressant; Pediatrics; Psychiatry; Mood; Anxiety","score_opus":0.22911013328252444,"score_gpt":0.4943244858213626,"score_spread":0.2652143525388382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965680320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931738,0.0010078166,0.00009558856,0.00025947264,0.000015563981,0.00002808316,0.005066098,0.000005637937,0.0003479246],"genre_scores_gemma":[0.99598455,0.00040101554,0.000103306156,0.0000883851,0.000017373166,0.00003159717,0.003301953,0.0000026426985,0.000069202004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985746,0.00053082284,0.00025695175,0.00027423544,0.00017877306,0.00018454804],"domain_scores_gemma":[0.9947515,0.0010203597,0.0032483423,0.00019071932,0.00029576707,0.0004933643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010806487,0.00036251833,0.0004915529,0.0014297196,0.0003376091,0.0010106363,0.0007283714,0.00073994405,0.001720105],"category_scores_gemma":[0.005731464,0.00039455024,0.0016461688,0.0032481195,0.00033214292,0.0009434763,0.0008400793,0.0011552656,0.00019807198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003234016,0.00012159847,0.9971028,0.000040944156,0.0004025782,0.000056300043,0.000033193937,0.00038509487,0.000020180893,0.000053233503,0.0006234831,0.0008373348],"study_design_scores_gemma":[0.000041682106,0.00012304503,0.9969426,0.000034157165,0.00015121092,0.00014989717,0.00025527977,0.0019326648,0.000021235868,0.00006440286,0.0002708136,0.000012958874],"about_ca_topic_score_codex":0.026324574,"about_ca_topic_score_gemma":0.023090238,"teacher_disagreement_score":0.026324574,"about_ca_system_score_codex":0.001522436,"about_ca_system_score_gemma":0.00064865075,"threshold_uncertainty_score":0.052342713},"labels":[],"label_agreement":null},{"id":"W2966313356","doi":"10.1080/03007995.2019.1653068","title":"Safety and efficacy of fulranumab in osteoarthritis of the hip and knee: results from four early terminated phase III randomized studies","year":2019,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; WOMAC; Placebo; Adverse effect; Randomized controlled trial; Physical therapy; Joint pain; Internal medicine","score_opus":0.06471807264002945,"score_gpt":0.4008501879959862,"score_spread":0.3361321153559568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966313356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93862176,0.04526923,0.0026651835,0.0009836272,0.00030704244,0.007624019,0.0022022382,0.00019260953,0.002134387],"genre_scores_gemma":[0.976752,0.011032077,0.003303425,0.0013207986,0.0003627215,0.0043167537,0.0019457903,0.000044999084,0.00092137686],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9929134,0.0045225313,0.00083729334,0.000464947,0.0007679179,0.00049387396],"domain_scores_gemma":[0.9875802,0.004975309,0.0039489167,0.001077587,0.0013626025,0.0010553064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017594034,0.0015911796,0.0038857812,0.0005345196,0.00078157126,0.0018696426,0.0013810969,0.0023920462,0.002642173],"category_scores_gemma":[0.0117208045,0.0006371785,0.0054214667,0.0008546,0.0013139423,0.0010457409,0.00062100386,0.0022494348,0.00047300837],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.900417,0.0061478387,0.0069303066,0.0034981256,0.011509359,0.000117154035,0.00021790223,0.00049925764,0.008864542,0.00009102785,0.00081292755,0.060894597],"study_design_scores_gemma":[0.8112852,0.149285,0.025083197,0.00048613263,0.008392882,0.0001955168,0.00006373159,0.0003011086,0.0025216865,0.00015920844,0.002176956,0.00004937653],"about_ca_topic_score_codex":0.0008914397,"about_ca_topic_score_gemma":0.0022314142,"teacher_disagreement_score":0.017594034,"about_ca_system_score_codex":0.0012235565,"about_ca_system_score_gemma":0.0020175723,"threshold_uncertainty_score":0.09304726},"labels":[],"label_agreement":null},{"id":"W3004219983","doi":"10.1080/03007995.2020.1722945","title":"Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Persistence (discontinuity); Ankylosing spondylitis; Discontinuation; Proportional hazards model; Demography; Socioeconomic status; Etanercept; Internal medicine; Cohort study; Tumor necrosis factor alpha; Population; Environmental health","score_opus":0.23588589998103776,"score_gpt":0.4569416212889799,"score_spread":0.22105572130794215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004219983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964168,0.0005048474,0.00006982748,0.00008407257,0.000004177285,0.000043693006,0.002096763,0.000003954714,0.00077591423],"genre_scores_gemma":[0.9978325,0.00025304538,0.00008732105,0.000047900812,0.000007772455,0.000022640124,0.0016376625,0.00000251826,0.00010863954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990363,0.00017533313,0.000094568706,0.00023794736,0.00021277006,0.00024306405],"domain_scores_gemma":[0.9958567,0.00027829435,0.0019016245,0.00021181576,0.0011246292,0.0006270503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014259279,0.00038573047,0.0006674932,0.0013047273,0.0011766443,0.0010656548,0.00077628304,0.00046525302,0.0013400001],"category_scores_gemma":[0.003793726,0.00022570495,0.00065032265,0.0033353851,0.0005879236,0.0005521749,0.0006028851,0.000532678,0.0001626776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017002811,0.000037192436,0.998415,0.000015958633,0.00010294794,0.000034106306,0.00014871158,0.00001938456,0.00006844932,0.000018302177,0.00012717125,0.0008428585],"study_design_scores_gemma":[0.00002062627,0.00008568076,0.9990004,0.00001532525,0.000056871017,0.00010179229,0.0003398512,0.00008440044,0.000022167349,0.0000070527844,0.00025981947,0.000005935405],"about_ca_topic_score_codex":0.55091536,"about_ca_topic_score_gemma":0.53455734,"teacher_disagreement_score":0.55091536,"about_ca_system_score_codex":0.003922937,"about_ca_system_score_gemma":0.0034125533,"threshold_uncertainty_score":0.9034588},"labels":[],"label_agreement":null},{"id":"W3005412604","doi":"10.1080/03007995.2020.1725742","title":"The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Clinical trial; Meta-analysis; Transthyretin; Population; Adverse effect; Polyneuropathy; Internal medicine; Quality of life (healthcare); Disease; Intensive care medicine","score_opus":0.5737111034907555,"score_gpt":0.5725074252408492,"score_spread":0.0012036782499063037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005412604","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.084276415,0.38599268,0.45673913,0.031516176,0.009026046,0.010673577,0.0063177277,0.0013324806,0.014125758],"genre_scores_gemma":[0.87947965,0.014336983,0.08760569,0.0060287593,0.0014715936,0.008543472,0.0013580772,0.00029107797,0.00088465924],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.43232608,0.51713,0.02817058,0.0114259515,0.009735162,0.0012121737],"domain_scores_gemma":[0.30599084,0.65775186,0.01454888,0.017254932,0.003730469,0.0007231144],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.37732318,0.0027044797,0.007450414,0.0031534173,0.0009188674,0.0065769455,0.003583696,0.0037135878,0.0037478574],"category_scores_gemma":[0.54739493,0.0014870338,0.026192592,0.0044659814,0.0020259386,0.004773088,0.003460084,0.0045797015,0.00034336562],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01280781,0.00013795696,0.027885795,0.054290168,0.77669746,0.0006317555,0.0008784224,0.019815834,0.0010137247,0.010484065,0.0061463737,0.08921074],"study_design_scores_gemma":[0.008025056,0.00226444,0.024130771,0.017716479,0.7888112,0.00064581045,0.0004959292,0.03997201,0.0023251239,0.091804504,0.023448758,0.0003599689],"about_ca_topic_score_codex":0.00200927,"about_ca_topic_score_gemma":0.0032619159,"teacher_disagreement_score":0.37732318,"about_ca_system_score_codex":0.0018842563,"about_ca_system_score_gemma":0.0038931356,"threshold_uncertainty_score":0.7678714},"labels":[],"label_agreement":null},{"id":"W3006625121","doi":"10.1080/03007995.2020.1729708","title":"Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Varenicline; Medicine; Smoking cessation; Nicotine replacement therapy; Adverse effect; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.6961278574739443,"score_gpt":0.6769596484335964,"score_spread":0.019168209040347994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006625121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024370449,0.9918715,0.00035465238,0.0028858937,0.00019327128,0.00007957385,0.0002645068,0.000011201146,0.0019023607],"genre_scores_gemma":[0.04875286,0.9437703,0.0020238748,0.0034416516,0.0009257556,0.00015512636,0.0005218895,0.000010842539,0.00039771054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960991,0.0016343702,0.001213902,0.00034834826,0.00060644967,0.000097858545],"domain_scores_gemma":[0.98146355,0.013796244,0.0032003983,0.00022785434,0.0011263973,0.00018559898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075779334,0.00047596067,0.001953376,0.0029495487,0.0003541852,0.0018891727,0.0007908571,0.0012926925,0.00324242],"category_scores_gemma":[0.022365056,0.000286354,0.001659812,0.0025195528,0.0005206383,0.002382574,0.00077379483,0.0011028097,0.00054428016],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012250617,0.00009422045,0.006149482,0.21619768,0.0018872245,0.0004963781,0.00053380587,0.00028243204,0.0033332848,0.0028842788,0.013397633,0.75351864],"study_design_scores_gemma":[0.0011252072,0.0030892938,0.04943098,0.4555304,0.019267181,0.007518015,0.0017269917,0.0007689835,0.0032007007,0.008749198,0.4493779,0.00021509809],"about_ca_topic_score_codex":0.0013167533,"about_ca_topic_score_gemma":0.0034401077,"teacher_disagreement_score":0.0075779334,"about_ca_system_score_codex":0.0012475983,"about_ca_system_score_gemma":0.002722998,"threshold_uncertainty_score":0.040076435},"labels":[],"label_agreement":null},{"id":"W3010977327","doi":"10.1080/03007995.2020.1744120","title":"Use of dienogest in endometriosis: a narrative literature review and expert commentary","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Bayer","keywords":"Dienogest; Endometriosis; Medicine; Context (archaeology); Narrative review; Quality of life (healthcare); Pelvic pain; General surgery; Intensive care medicine; Gynecology; Surgery; Nursing","score_opus":0.28400794027305504,"score_gpt":0.5318228009939459,"score_spread":0.24781486072089082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010977327","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000701421,0.99702317,0.00006276606,0.0016023862,0.0006931309,0.00002640649,0.00012380068,0.0000036904014,0.00039454538],"genre_scores_gemma":[0.0011937935,0.9954508,0.00012567449,0.002286066,0.0005898069,0.00004891149,0.000087180524,0.000002417426,0.00021539618],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974382,0.000815249,0.0008279456,0.0002757494,0.00054824783,0.00009455349],"domain_scores_gemma":[0.98588413,0.010529763,0.0019828521,0.00013105721,0.0013239061,0.0001482247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041039945,0.0010549563,0.0038338853,0.0046811267,0.0005482699,0.0018834763,0.0017559663,0.0026763882,0.010497618],"category_scores_gemma":[0.021941029,0.0004352153,0.002624884,0.0054136226,0.00071903056,0.0020180705,0.001061082,0.0016576706,0.0011865066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019086669,0.00001880466,0.00024966654,0.71817756,0.0014749984,0.00051526166,0.000264904,0.00015803469,0.00028846986,0.0019863367,0.061314434,0.2153607],"study_design_scores_gemma":[0.000092206,0.00006116978,0.001015152,0.71802586,0.0058671776,0.0013672811,0.00023176319,0.000065421016,0.00014083354,0.001686442,0.27140698,0.000039724266],"about_ca_topic_score_codex":0.004434161,"about_ca_topic_score_gemma":0.011741474,"teacher_disagreement_score":0.010497618,"about_ca_system_score_codex":0.0017887674,"about_ca_system_score_gemma":0.006574285,"threshold_uncertainty_score":0.035118043},"labels":[],"label_agreement":null},{"id":"W3013459387","doi":"10.1080/03007995.2020.1747999","title":"Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Natalizumab; Internal medicine; Placebo; Multiple sclerosis; Clinical trial; Oncology; Disease; Pathology; Immunology; Alternative medicine","score_opus":0.5232521119595535,"score_gpt":0.527572708074761,"score_spread":0.00432059611520752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013459387","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8792209,0.05326402,0.039507654,0.0012733723,0.0032148308,0.00914644,0.006749782,0.00045435023,0.007168686],"genre_scores_gemma":[0.9784953,0.0023272494,0.011310852,0.00046842804,0.00021631323,0.0045127617,0.0015263202,0.00003556985,0.0011072101],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9716932,0.022239434,0.0020713946,0.0017322656,0.0017443841,0.0005194195],"domain_scores_gemma":[0.98076046,0.0139238965,0.0028078975,0.001516739,0.00066022604,0.0003308641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02448258,0.0018440788,0.00546495,0.0015168908,0.00031654193,0.0013405439,0.0012333444,0.0014035458,0.0077813575],"category_scores_gemma":[0.037342515,0.00047870868,0.012293616,0.0011641091,0.00094204047,0.0011548179,0.0014908946,0.0019505138,0.00038278496],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.66316324,0.0021037958,0.012326294,0.014249047,0.20859008,0.000094059804,0.00028520837,0.009720839,0.0020564161,0.003213359,0.0017387538,0.082458936],"study_design_scores_gemma":[0.3321821,0.13884905,0.06696491,0.0026796064,0.36904064,0.00037799805,0.00031426133,0.046109185,0.009579796,0.02191794,0.011634408,0.00035014577],"about_ca_topic_score_codex":0.0011044397,"about_ca_topic_score_gemma":0.0008663206,"teacher_disagreement_score":0.02448258,"about_ca_system_score_codex":0.0012492875,"about_ca_system_score_gemma":0.0014147453,"threshold_uncertainty_score":0.1294778},"labels":[],"label_agreement":null},{"id":"W3014083971","doi":"10.1080/03007995.2020.1747998","title":"The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Interferon beta-1a; Clinical trial; Multiple sclerosis; Physical therapy; Internal medicine; Oncology; Immunology; Interferon beta","score_opus":0.4790940381106173,"score_gpt":0.4984205220973128,"score_spread":0.01932648398669551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014083971","genre_codex":"methods","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3077104,0.10214091,0.48538315,0.05022369,0.004031961,0.020531382,0.004534795,0.0005125623,0.024931146],"genre_scores_gemma":[0.80146766,0.0051587066,0.17665128,0.0056040767,0.0007664581,0.008877827,0.0006919062,0.00019793537,0.0005841679],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.29552892,0.64961517,0.030604187,0.008952983,0.013811372,0.0014874184],"domain_scores_gemma":[0.13615681,0.78862077,0.036302425,0.02842395,0.009587298,0.0009088327],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.49592036,0.0025590335,0.005266432,0.0034723915,0.0020586476,0.0047205393,0.003963234,0.005093817,0.004911629],"category_scores_gemma":[0.6098733,0.0012820588,0.017517714,0.0055822567,0.0033102809,0.00616848,0.0031366197,0.0058190464,0.00046849326],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029068852,0.0012861511,0.29055667,0.047517527,0.18949538,0.013314832,0.011030191,0.023917446,0.0032625836,0.05539261,0.01185503,0.32330263],"study_design_scores_gemma":[0.01621865,0.023326987,0.15299928,0.036782153,0.25036553,0.02288481,0.008215389,0.0774664,0.0142565,0.2869719,0.10891069,0.0016017968],"about_ca_topic_score_codex":0.0032324493,"about_ca_topic_score_gemma":0.0051271864,"teacher_disagreement_score":0.50407964,"about_ca_system_score_codex":0.0034421335,"about_ca_system_score_gemma":0.006343032,"threshold_uncertainty_score":0.62161994},"labels":[],"label_agreement":null},{"id":"W3040176507","doi":"10.1080/03007995.2020.1790349","title":"Sensory descriptors which identify neuropathic pain mechanisms in low back pain: a systematic review","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Physiotherapy Association","funders":"","keywords":"Medicine; Dysesthesia; Neuropathic pain; Allodynia; Low back pain; Nociception; Systematic review; Physical therapy; Neuralgia; Quantitative sensory testing; Hyperalgesia; Physical medicine and rehabilitation; Anesthesia; Sensory system; MEDLINE; Neuroscience; Alternative medicine; Internal medicine; Psychology; Pathology","score_opus":0.19622458296503553,"score_gpt":0.4610019090772578,"score_spread":0.26477732611222227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040176507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029042203,0.99481755,0.00019403566,0.0002173432,0.000084467225,0.0007726214,0.0006640023,0.0000094,0.00033629435],"genre_scores_gemma":[0.047617506,0.9479916,0.0010645699,0.00065232307,0.00008509734,0.0017578609,0.00065696234,0.0000072233056,0.0001669263],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99165314,0.0027420633,0.0033604729,0.00055317685,0.0014132394,0.00027786885],"domain_scores_gemma":[0.9605906,0.028238514,0.0076097455,0.0004565838,0.0027395315,0.00036498602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008581445,0.0016934332,0.010158446,0.014329518,0.0008068429,0.0032827335,0.0021778294,0.0020121816,0.004831134],"category_scores_gemma":[0.043937277,0.0010914094,0.008946339,0.012964051,0.0013199716,0.003178384,0.001943101,0.0011413753,0.0003336641],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019915616,0.000018592335,0.0019667014,0.97130245,0.0074959495,0.000081800434,0.00017672684,0.000052863707,0.00007019378,0.00012243087,0.00057471875,0.017938346],"study_design_scores_gemma":[0.00033595867,0.00021481514,0.008852366,0.91552263,0.0683909,0.00041071585,0.00039823473,0.00009221074,0.00008788521,0.0002598909,0.005395562,0.0000387691],"about_ca_topic_score_codex":0.008711343,"about_ca_topic_score_gemma":0.029928127,"teacher_disagreement_score":0.014329518,"about_ca_system_score_codex":0.0040823678,"about_ca_system_score_gemma":0.008953956,"threshold_uncertainty_score":0.045383573},"labels":[],"label_agreement":null},{"id":"W3048971314","doi":"10.1080/03007995.2020.1810008","title":"Reply: RE: De Meo D, Zucchi B, Castagna V, et al. Validity and reliability of the Unified Classification System applied to periprosthetic femur fractures: a comparison with the Vancouver system. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1776232","year":2020,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Periprosthetic; Medicine; Reliability (semiconductor); Femur; Validity; Femur fracture; Arthroplasty; Surgery; Clinical psychology; Psychometrics","score_opus":0.07802097610167356,"score_gpt":0.38237448191454787,"score_spread":0.3043535058128743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3048971314","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029694836,0.0012833859,0.00008051055,0.9745831,0.022785509,0.000015114187,0.00009862205,0.000035302743,0.0008214935],"genre_scores_gemma":[0.0024695925,0.0012054929,0.00018011579,0.95785874,0.03504175,0.000051048093,0.00006926285,0.000024157005,0.0030998383],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99756587,0.00068460376,0.00047133825,0.0003057014,0.000727274,0.0002451594],"domain_scores_gemma":[0.98874015,0.005478362,0.00075382926,0.00030312827,0.0037330335,0.00099142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037164367,0.0011326855,0.0016831252,0.0012663961,0.0024244103,0.002397464,0.0019476505,0.034979083,0.006692566],"category_scores_gemma":[0.03599974,0.00093678874,0.0012246823,0.0010408028,0.0023345873,0.00366069,0.0013336024,0.03565346,0.012196873],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006205346,0.000019356787,0.00061214034,0.000057068828,0.000009799079,0.0011053794,0.00008430599,0.000028316905,0.00008376375,0.000437031,0.9930275,0.004473266],"study_design_scores_gemma":[0.00019533958,0.00011705111,0.003555589,0.0005478517,0.0000816185,0.009136886,0.0009940884,0.0006204707,0.0004658972,0.0057355156,0.9783533,0.00019638972],"about_ca_topic_score_codex":0.005843403,"about_ca_topic_score_gemma":0.0058382363,"teacher_disagreement_score":0.034979083,"about_ca_system_score_codex":0.0036571005,"about_ca_system_score_gemma":0.0027527618,"threshold_uncertainty_score":0.02653426},"labels":[],"label_agreement":null},{"id":"W3049727595","doi":"10.1080/03007995.2020.1810007","title":"RE: De Meo D, Zucchi B, Castagna V, et al. Validity and reliability of the Unified Classification System applied to periprosthetic femur fractures: a comparison with the Vancouver system. Curr Med Res Opin. 2020. DOI:10.1080/03007995.2020.1776232","year":2020,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Periprosthetic; Medicine; Reliability (semiconductor); Femur; Validity; Surgery; Arthroplasty; Clinical psychology; Psychometrics","score_opus":0.07768337343092892,"score_gpt":0.3837157413883578,"score_spread":0.3060323679574289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049727595","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042700535,0.0022616885,0.00010060858,0.9632145,0.0327882,0.000018028151,0.000118708784,0.000029827095,0.001041419],"genre_scores_gemma":[0.0048347204,0.0024992754,0.00021895504,0.92132246,0.06718021,0.000063497886,0.00010485148,0.000030111041,0.003745922],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967519,0.00087889325,0.00070976175,0.00038866483,0.0010203252,0.0002504639],"domain_scores_gemma":[0.98364866,0.0074052634,0.0011446025,0.00038201496,0.0064146067,0.001004842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041406914,0.0011328959,0.0017056097,0.0015676186,0.001975757,0.0023433196,0.0017168444,0.02762685,0.008727409],"category_scores_gemma":[0.051282976,0.00082533265,0.0012002874,0.001284458,0.0017421999,0.0036574285,0.0012826528,0.029113282,0.013266744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007139894,0.000023138455,0.0009871004,0.0000697388,0.000011631761,0.000894497,0.00009013561,0.000026165102,0.00008207489,0.00041839315,0.99047697,0.0068488168],"study_design_scores_gemma":[0.00029294085,0.00013840488,0.008585056,0.00097467576,0.000118759046,0.01111151,0.0012931199,0.00082600623,0.0005494878,0.006671978,0.96915215,0.00028577636],"about_ca_topic_score_codex":0.0069144126,"about_ca_topic_score_gemma":0.006938286,"teacher_disagreement_score":0.02762685,"about_ca_system_score_codex":0.0037704182,"about_ca_system_score_gemma":0.002560072,"threshold_uncertainty_score":0.029196084},"labels":[],"label_agreement":null},{"id":"W3080405503","doi":"10.1080/03007995.2020.1815683","title":"Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Chronic rhinosinusitis; Medical prescription; Quality of life (healthcare); Nasal polyps; Systematic review; Randomized controlled trial; MEDLINE; Internal medicine; Sinusitis; Health care; Endoscopic sinus surgery; Evidence-based medicine; Physical therapy; Surgery; Alternative medicine; Pathology","score_opus":0.08357800714526753,"score_gpt":0.44992370853035946,"score_spread":0.3663457013850919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080405503","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001396459,0.9956098,0.00026975528,0.00044146364,0.00016839933,0.00092952617,0.00075799105,0.000007516707,0.00041910875],"genre_scores_gemma":[0.039674822,0.95295215,0.002146932,0.0013476856,0.00026075484,0.0029183629,0.0005339304,0.000010946219,0.00015431382],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9627766,0.01600788,0.013899288,0.0018977649,0.0048645297,0.00055397506],"domain_scores_gemma":[0.904992,0.06814313,0.01795975,0.0013273568,0.0069633476,0.00061436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027744524,0.0021710757,0.011343037,0.018382901,0.00095813436,0.0037390527,0.0022708317,0.0024378514,0.0055692303],"category_scores_gemma":[0.111442454,0.0013613915,0.0113859875,0.013237458,0.001546946,0.003165642,0.0023041922,0.0015851988,0.00027330028],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001814732,0.000014920283,0.00087078393,0.96023554,0.01863631,0.00009961584,0.00011722457,0.00009685856,0.00005602365,0.00023717895,0.00078571006,0.018668298],"study_design_scores_gemma":[0.00033147735,0.00020630525,0.0043745497,0.8760235,0.107433476,0.0003398587,0.00025422656,0.000108141125,0.000100821206,0.0004467231,0.010334251,0.0000465331],"about_ca_topic_score_codex":0.009856486,"about_ca_topic_score_gemma":0.02459988,"teacher_disagreement_score":0.027744524,"about_ca_system_score_codex":0.007315998,"about_ca_system_score_gemma":0.019826408,"threshold_uncertainty_score":0.14672875},"labels":[],"label_agreement":null},{"id":"W3080596765","doi":"10.1080/03007995.2020.1815682","title":"Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis","year":2020,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Sinusitis and nasal conditions","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"AstraZeneca","keywords":"Medicine; Chronic rhinosinusitis; Epidemiology; Nasal polyps; Intensive care medicine; Dermatology; Clinical epidemiology; Systematic review; Sinusitis; MEDLINE; Internal medicine; Surgery","score_opus":0.187408076042334,"score_gpt":0.5285382074559681,"score_spread":0.34113013141363413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080596765","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002211889,0.994584,0.00024115859,0.00042073647,0.00014898596,0.00050354627,0.0015822802,0.000011650901,0.00029568115],"genre_scores_gemma":[0.03000211,0.9645502,0.0014614728,0.0008871994,0.0001913957,0.0014664787,0.0012923031,0.000011200147,0.00013765234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97998065,0.0060996525,0.008906271,0.0016742402,0.0029037676,0.0004354829],"domain_scores_gemma":[0.95497173,0.027569378,0.010775141,0.0008851036,0.0053774356,0.0004213126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013287823,0.0019482019,0.01017261,0.01908988,0.0007827138,0.002608172,0.0020295533,0.00194321,0.003972115],"category_scores_gemma":[0.057337217,0.001308278,0.011373606,0.016800387,0.0009412339,0.0023746835,0.0020031435,0.0012170764,0.00033627072],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013471092,0.000010757194,0.002264429,0.9591059,0.02118513,0.00011046884,0.00012555602,0.00009765889,0.00010984023,0.00012879471,0.0012446083,0.015482129],"study_design_scores_gemma":[0.00027054973,0.00021563502,0.012612414,0.7992793,0.17319989,0.00055704085,0.00027061088,0.00012305992,0.00015491534,0.00024844304,0.013016802,0.00005129935],"about_ca_topic_score_codex":0.01375797,"about_ca_topic_score_gemma":0.032537483,"teacher_disagreement_score":0.01908988,"about_ca_system_score_codex":0.0044392454,"about_ca_system_score_gemma":0.01675991,"threshold_uncertainty_score":0.07027358},"labels":[],"label_agreement":null},{"id":"W3092419127","doi":"10.1080/03007995.2020.1835851","title":"Healthcare resource utilization and costs associated with first-line ibrutinib compared to chemoimmunotherapy treatment among Medicare beneficiaries with chronic lymphocytic leukemia","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Ibrutinib; Medicine; Chemoimmunotherapy; Medicare Advantage; Chronic lymphocytic leukemia; Internal medicine; Ofatumumab; Pharmacy; Health care; Oncology; Leukemia; Family medicine","score_opus":0.13488527936780695,"score_gpt":0.4044661884187354,"score_spread":0.26958090905092846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092419127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737084,0.0006763012,0.000035022324,0.00012674395,0.0000065624567,0.000010515709,0.001508293,0.0000015550661,0.00026424302],"genre_scores_gemma":[0.9983317,0.00024307963,0.00004429182,0.00006466573,0.00001961408,0.000016547141,0.0012028167,9.3000693e-7,0.00007622908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895763,0.00027223036,0.00017438999,0.00018964584,0.00019585366,0.00021027766],"domain_scores_gemma":[0.9974699,0.00023740146,0.0019524908,0.00004684472,0.00008482337,0.00020867036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049748254,0.00018845501,0.00036959033,0.00072319055,0.00027078518,0.0006273148,0.00030358406,0.0004048981,0.0013442591],"category_scores_gemma":[0.0031083243,0.00014504082,0.00075610453,0.0011893134,0.00016977313,0.00043356867,0.00051690947,0.00055480795,0.0001079789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021242118,0.000068780006,0.99782723,0.000025783205,0.0001288595,0.000027550874,0.000022128483,0.00007587636,0.00005285877,0.000020546344,0.00017213945,0.0013658906],"study_design_scores_gemma":[0.000015621734,0.00012403107,0.99897873,0.000021363765,0.00005171514,0.00014725782,0.00010123662,0.00029099215,0.000032699143,0.000018404568,0.00021509148,0.0000029010985],"about_ca_topic_score_codex":0.011351741,"about_ca_topic_score_gemma":0.014105408,"teacher_disagreement_score":0.011351741,"about_ca_system_score_codex":0.0010311793,"about_ca_system_score_gemma":0.0004906464,"threshold_uncertainty_score":0.022571325},"labels":[],"label_agreement":null},{"id":"W3095779395","doi":"10.1080/03007995.2020.1846172","title":"Cost–utility analysis of second-line therapy with rituximab compared to tumour necrosis factor inhibitors in rheumatoid arthritis","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Rituximab; Rheumatoid arthritis; Second-line therapy; Antirheumatic Agents; Tumor necrosis factor alpha; Necrosis; Oncology; Internal medicine; Tumor necrosis factor α; Immunology; Chemotherapy; Lymphoma","score_opus":0.13620362382076182,"score_gpt":0.40953698873218386,"score_spread":0.273333364911422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095779395","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97357833,0.00834764,0.009337757,0.0011001125,0.000057177294,0.0005606315,0.0035541605,0.00005319121,0.0034109564],"genre_scores_gemma":[0.9962985,0.0005238762,0.0017896901,0.00010277016,0.000012323972,0.000107439075,0.00068981433,0.0000073398105,0.0004681794],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9956512,0.003214761,0.0001445258,0.00030993338,0.00038960128,0.00028998966],"domain_scores_gemma":[0.9867726,0.010611869,0.0012523421,0.00024190213,0.0007112707,0.00040995493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006810737,0.0010652575,0.0016012547,0.0016114463,0.00030722274,0.0017556028,0.0013686371,0.0011081726,0.0036046526],"category_scores_gemma":[0.021514812,0.00065668253,0.003957104,0.0013378329,0.0005372295,0.0009095125,0.0007572352,0.0011990943,0.00018357877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075755212,0.0005441615,0.048808742,0.00057586643,0.005977009,0.00025267384,0.0000671525,0.919907,0.0004651318,0.0022777044,0.0009628155,0.012586094],"study_design_scores_gemma":[0.0013606909,0.0022051928,0.040105354,0.00028499987,0.0031998581,0.00028389908,0.000116549054,0.9487037,0.00043508087,0.0018899647,0.0013245707,0.00009015838],"about_ca_topic_score_codex":0.08832698,"about_ca_topic_score_gemma":0.047961343,"teacher_disagreement_score":0.08832698,"about_ca_system_score_codex":0.01472831,"about_ca_system_score_gemma":0.004483951,"threshold_uncertainty_score":0.17562574},"labels":[],"label_agreement":null},{"id":"W3112727151","doi":"10.1080/03007995.2020.1860358","title":"The Rapid Mood Screener (RMS): a novel and pragmatic screener for bipolar I disorder","year":2020,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Bipolar disorder; Major depressive disorder; Mood; Medicine; Observational study; Psychiatry; Bipolar II disorder; Clinical psychology; Depression (economics); Bipolar I disorder; Medical diagnosis; Psychology; Internal medicine; Mania","score_opus":0.10576058156983975,"score_gpt":0.4115225177313636,"score_spread":0.30576193616152386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112727151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93699247,0.006409568,0.022029718,0.0043275724,0.00051812467,0.0055587217,0.009309072,0.00080570445,0.014048989],"genre_scores_gemma":[0.8721911,0.0033559257,0.10861452,0.0018036765,0.00033148815,0.0038023596,0.0060177124,0.000043672535,0.0038396025],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984243,0.00088573317,0.0001963648,0.00010387791,0.00033476893,0.00005492105],"domain_scores_gemma":[0.99771357,0.0008101727,0.00077005493,0.000106433356,0.00041787224,0.00018206873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002046344,0.00043979808,0.0007097506,0.00049331615,0.00018683082,0.0004159301,0.0003356044,0.0004567868,0.0029435165],"category_scores_gemma":[0.0065934686,0.00021380723,0.0005117779,0.0002505324,0.00016253031,0.00029421228,0.0005862039,0.0004300796,0.0005344613],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049566906,0.0018415647,0.38382873,0.0030412232,0.0006212333,0.0007805837,0.00085906155,0.0008555957,0.024296615,0.00087322993,0.047393747,0.53065175],"study_design_scores_gemma":[0.0019138062,0.005518939,0.9635971,0.0006396012,0.00041194688,0.0047084615,0.0003272872,0.0032826362,0.0029991947,0.00082037656,0.015655564,0.00012515274],"about_ca_topic_score_codex":0.0009587251,"about_ca_topic_score_gemma":0.0042631873,"teacher_disagreement_score":0.0029435165,"about_ca_system_score_codex":0.00028121565,"about_ca_system_score_gemma":0.00059490703,"threshold_uncertainty_score":0.010822237},"labels":[],"label_agreement":null},{"id":"W3119218090","doi":"10.1080/03007995.2021.1874324","title":"Effect of low-fat dairy products fortified with 1500IU nano encapsulated vitamin D<sub>3</sub> on cardiometabolic indicators in adults with abdominal obesity: a total blinded randomized controlled trial","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Institute for Medical Research Development","keywords":"Medicine; Vitamin D and neurology; Triglyceride; Randomized controlled trial; Glycemic; Obesity; Vitamin; Anthropometry; Internal medicine; Insulin; Gastroenterology; Endocrinology; Cholesterol","score_opus":0.021419472774957517,"score_gpt":0.35398708343574603,"score_spread":0.3325676106607885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3119218090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97647274,0.008157839,0.0010299,0.00053048314,0.0010692065,0.010741901,0.0009101747,0.00013060217,0.0009571198],"genre_scores_gemma":[0.9703296,0.005544891,0.003548666,0.0011320852,0.00070866046,0.014998809,0.00077941245,0.000019659143,0.002938214],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99887305,0.00045596992,0.00016195935,0.00026206044,0.00011273144,0.00013424573],"domain_scores_gemma":[0.9987984,0.00028901402,0.00029940763,0.00011494298,0.00016852381,0.00032971206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023043281,0.0016460465,0.0059071505,0.00061070727,0.00079145684,0.0011328122,0.0010621323,0.002448619,0.005113263],"category_scores_gemma":[0.0019338892,0.0009488455,0.0030465745,0.00054544373,0.0013464835,0.0009305102,0.0006069888,0.002019085,0.0005839168],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98666394,0.0062931255,0.0002999815,0.0009384302,0.00096608663,0.0000133670055,0.000025716432,0.000055020428,0.000970759,0.000020820738,0.00010565226,0.0036471607],"study_design_scores_gemma":[0.9398734,0.057290964,0.0011480986,0.00005428572,0.0009381265,0.000008774682,0.000018024908,0.0001539358,0.00024054144,0.000043729346,0.0002199679,0.000010194557],"about_ca_topic_score_codex":0.0016523256,"about_ca_topic_score_gemma":0.0026713705,"teacher_disagreement_score":0.0059071505,"about_ca_system_score_codex":0.0007618092,"about_ca_system_score_gemma":0.001555516,"threshold_uncertainty_score":0.01710558},"labels":[],"label_agreement":null},{"id":"W3161818128","doi":"10.1080/03007995.2021.1929896","title":"Development of a visual, patient-reported tool for assessing the multi-dimensional burden of endometriosis","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Endometriosis; Delphi method; Quality of life (healthcare); Psychosocial; Pelvic pain; Delphi; Patient-reported outcome; Physical therapy; Family medicine; Gynecology; Nursing; Psychiatry; Surgery","score_opus":0.18695679087554523,"score_gpt":0.5031652555898702,"score_spread":0.316208464714325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161818128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67217743,0.003360406,0.23325604,0.008892262,0.0011136724,0.023982633,0.010082506,0.0022515422,0.044883613],"genre_scores_gemma":[0.5576574,0.0014245692,0.42299372,0.00068992365,0.00013947571,0.01148465,0.0029452268,0.00010431534,0.0025607422],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.979317,0.014278393,0.0022534588,0.00047599766,0.003238958,0.00043621744],"domain_scores_gemma":[0.9650806,0.021588827,0.003905314,0.0012575713,0.007308225,0.00085937313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021760425,0.00083878305,0.00065812515,0.004100862,0.00044816837,0.0021472068,0.0011413204,0.0009206886,0.0043144934],"category_scores_gemma":[0.052576277,0.00039320637,0.0016033112,0.0013557734,0.0005073995,0.0020570848,0.0025620952,0.0010182579,0.000839046],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001329996,0.0010597304,0.14943811,0.0029299704,0.00038391657,0.00057614234,0.008517907,0.0030032066,0.004780654,0.0030015633,0.023701109,0.8012777],"study_design_scores_gemma":[0.0025099393,0.011266588,0.64466757,0.014881787,0.0015655234,0.009876708,0.03739718,0.05175118,0.021817604,0.013523971,0.18924499,0.0014970773],"about_ca_topic_score_codex":0.0008770336,"about_ca_topic_score_gemma":0.001976565,"teacher_disagreement_score":0.021760425,"about_ca_system_score_codex":0.0010830536,"about_ca_system_score_gemma":0.0025531736,"threshold_uncertainty_score":0.11508149},"labels":[],"label_agreement":null},{"id":"W3178434074","doi":"10.1080/03007995.2021.1953456","title":"Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Multiple myeloma; Gastroenterology; Refractory (planetary science); Progression-free survival; Odds ratio; Oncology; Overall survival","score_opus":0.2050472340995364,"score_gpt":0.46977746952371724,"score_spread":0.26473023542418084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178434074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874594,0.0038909987,0.0055154767,0.00013773359,0.00014612683,0.00062784506,0.0009262906,0.000050534527,0.0012455524],"genre_scores_gemma":[0.9974158,0.00023654,0.0013877035,0.00009015988,0.000036292164,0.00024607952,0.0003235685,0.000006127761,0.00025778633],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98963696,0.007850094,0.00044535927,0.0011084098,0.00064054655,0.00031861736],"domain_scores_gemma":[0.99328256,0.004281942,0.0016760698,0.00044472926,0.00015708794,0.00015753742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009185475,0.0008493039,0.0016819207,0.00044521928,0.00013104717,0.000678153,0.0007032238,0.0006163374,0.0029918205],"category_scores_gemma":[0.011455312,0.00027651517,0.0044063483,0.00040144203,0.00047034599,0.00058745005,0.0006908657,0.0011301124,0.00017352033],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6824494,0.0026131694,0.095507465,0.0033925117,0.076205686,0.0001412426,0.0002695692,0.014792807,0.0065997494,0.0018632578,0.0011154988,0.11504962],"study_design_scores_gemma":[0.08577976,0.37982312,0.34779868,0.00051190605,0.09255793,0.00067360053,0.00036654613,0.061332494,0.016712846,0.005261674,0.008977733,0.00020362703],"about_ca_topic_score_codex":0.00057869067,"about_ca_topic_score_gemma":0.00055472704,"teacher_disagreement_score":0.009185475,"about_ca_system_score_codex":0.00064362853,"about_ca_system_score_gemma":0.0006040207,"threshold_uncertainty_score":0.048578024},"labels":[],"label_agreement":null},{"id":"W3185110408","doi":"10.1080/03007995.2021.1957807","title":"Cognitive function improvement after fecal microbiota transplantation in Alzheimer’s dementia patient: a case report","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Medicine; Dementia; Fecal bacteriotherapy; Cognition; Transplantation; Intensive care medicine; Gerontology; Psychiatry; Internal medicine; Disease; Clostridium difficile; Antibiotics","score_opus":0.08422120638097003,"score_gpt":0.40744986422545176,"score_spread":0.32322865784448174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185110408","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845063,0.0072146216,0.0014988394,0.0023632268,0.0003070217,0.00011338752,0.00015096703,0.000071205824,0.0037745251],"genre_scores_gemma":[0.99509287,0.001997125,0.0006140515,0.00083673745,0.00050088414,0.000018616067,0.00009488669,0.000013783586,0.00083107746],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99954706,0.00004766459,0.000048323407,0.000118141004,0.00006516947,0.00017351467],"domain_scores_gemma":[0.99933976,0.00011308827,0.00015473779,0.000038855047,0.00007156972,0.00028192197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002599794,0.001408472,0.0017543371,0.0018970536,0.0029732087,0.0013032834,0.0008868255,0.0030938175,0.0013791649],"category_scores_gemma":[0.0012684852,0.00068521476,0.0014233115,0.001313041,0.0010910518,0.00128951,0.0011304063,0.0028448394,0.0004318875],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010279707,0.00010458581,0.015693814,0.000033621604,0.000023919263,0.98129714,0.00027234058,0.000026611086,0.0006153236,0.000045956203,0.00020827219,0.0015756249],"study_design_scores_gemma":[0.000021108854,0.00018024657,0.014234263,0.000032334683,0.000050988638,0.9840925,0.00027504822,0.0002070366,0.00032259512,0.00013672478,0.0004256879,0.000021581673],"about_ca_topic_score_codex":0.0041861064,"about_ca_topic_score_gemma":0.0046889093,"teacher_disagreement_score":0.0041861064,"about_ca_system_score_codex":0.0011523057,"about_ca_system_score_gemma":0.0007895928,"threshold_uncertainty_score":0.008360624},"labels":[],"label_agreement":null},{"id":"W3185400263","doi":"10.1080/03007995.2021.1954894","title":"Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Medicaid; Schizophrenia (object-oriented programming); Incidence (geometry); Cohort; Demography; Indirect costs; Health care; Psychiatry; Environmental health; Internal medicine","score_opus":0.05604061656589541,"score_gpt":0.39635568613872985,"score_spread":0.3403150695728344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185400263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99165183,0.0008084861,0.00014536147,0.0003480442,0.000007591385,0.00003980698,0.0058549205,0.00000765518,0.0011362887],"genre_scores_gemma":[0.99343324,0.0011527186,0.00040557177,0.000112768415,0.000034389835,0.00006398439,0.004483544,0.0000027284739,0.0003110537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956423,0.00008690511,0.00006507265,0.00005047278,0.00014790162,0.000085482156],"domain_scores_gemma":[0.99852484,0.00010330389,0.001042569,0.000025045932,0.0001768634,0.0001273508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008346715,0.00021297952,0.00013741045,0.0020861132,0.00035679914,0.00045607865,0.00022633508,0.00022678613,0.0011651658],"category_scores_gemma":[0.0024526406,0.00015361204,0.00038047298,0.0010654371,0.0001388273,0.00054871716,0.00073396374,0.00031041456,0.0001322156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035949408,0.000018658116,0.99562234,0.000022524988,0.000048307214,0.000037034788,0.000056196404,0.000070253336,0.00009351987,0.000048845985,0.0005311261,0.0034153124],"study_design_scores_gemma":[0.0000027406213,0.000019275241,0.9991015,0.00003037828,0.000021041998,0.000107603344,0.0001308553,0.00020180168,0.000026924885,0.00002948233,0.000325763,0.0000026094087],"about_ca_topic_score_codex":0.03642025,"about_ca_topic_score_gemma":0.049444806,"teacher_disagreement_score":0.03642025,"about_ca_system_score_codex":0.00095901836,"about_ca_system_score_gemma":0.00083635683,"threshold_uncertainty_score":0.072416544},"labels":[],"label_agreement":null},{"id":"W3191713770","doi":"10.1080/03007995.2021.1968362","title":"Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Novartis","keywords":"Medicine; Fingolimod; Propensity score matching; Matching (statistics); Multiple sclerosis; Ofatumumab; Physical therapy; Internal medicine; Psychiatry","score_opus":0.631404866743863,"score_gpt":0.5189867310299335,"score_spread":0.11241813571392945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191713770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83543193,0.020922376,0.117077164,0.0015987952,0.0011228296,0.0123277325,0.002995192,0.00019737787,0.008326617],"genre_scores_gemma":[0.97208863,0.00067799154,0.021077024,0.0003407568,0.00020276454,0.004376458,0.00057415385,0.00003404511,0.00062810624],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.73482245,0.2411174,0.01100149,0.005118273,0.0069480482,0.0009923702],"domain_scores_gemma":[0.6685955,0.28301296,0.023761943,0.019750962,0.003612142,0.0012665726],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17820564,0.0013729145,0.002673559,0.0013382885,0.0005003838,0.002184175,0.0014782696,0.0017268576,0.0069152378],"category_scores_gemma":[0.250845,0.0005326432,0.008570866,0.0014758068,0.0016532226,0.0018506445,0.0030179108,0.0019670133,0.00043615932],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40450615,0.0016754842,0.16682239,0.0084956465,0.22763626,0.0002348865,0.00083007215,0.019746544,0.0032906723,0.011721181,0.002436345,0.15260436],"study_design_scores_gemma":[0.16043048,0.1481385,0.29373112,0.0026452795,0.18067466,0.0008875529,0.00071026915,0.13442647,0.013920382,0.04368842,0.02016395,0.00058292825],"about_ca_topic_score_codex":0.0002934358,"about_ca_topic_score_gemma":0.00035353666,"teacher_disagreement_score":0.8217944,"about_ca_system_score_codex":0.0009192598,"about_ca_system_score_gemma":0.0013145643,"threshold_uncertainty_score":0.9424528},"labels":[],"label_agreement":null},{"id":"W3199623651","doi":"10.1080/03007995.2021.1981278","title":"Treatment patterns and sequencing in patients with rheumatic diseases: a retrospective claims data analysis","year":2021,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"Pfizer","keywords":"Medicine; Psoriatic arthritis; Biosimilar; Ankylosing spondylitis; Rheumatoid arthritis; Internal medicine; Etanercept; Retrospective cohort study; Arthritis","score_opus":0.07643300516365084,"score_gpt":0.4015707805054439,"score_spread":0.3251377753417931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199623651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582833,0.000640598,0.0003740625,0.000106140906,0.000005599826,0.00004275372,0.0025818832,0.0000067505334,0.00041392297],"genre_scores_gemma":[0.99718094,0.00018147363,0.00031284356,0.00005220403,0.000012416975,0.000035053778,0.0021661888,0.0000034650857,0.000055511577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949883,0.001627883,0.0011389849,0.0009519816,0.0009784433,0.00031440178],"domain_scores_gemma":[0.9837239,0.0030470095,0.010416595,0.0013575535,0.0008566949,0.0005984132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038113769,0.00025852254,0.00052986725,0.0021428333,0.00055936427,0.0010722552,0.0006378328,0.00063035666,0.0011416341],"category_scores_gemma":[0.010257806,0.00039836287,0.0008289918,0.0042308965,0.00041449448,0.0008215331,0.0009024862,0.0007825736,0.0002998295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010395546,0.0000300135,0.9984648,0.000018313232,0.00009034745,0.00004774535,0.00007885823,0.000074517,0.00005197825,0.00002816476,0.0001252041,0.0008860623],"study_design_scores_gemma":[0.000019612336,0.00014285346,0.99671704,0.000037912658,0.000101838465,0.0006519359,0.00038305036,0.0011346567,0.000098601835,0.00006758268,0.0006321437,0.000012799629],"about_ca_topic_score_codex":0.0067976154,"about_ca_topic_score_gemma":0.0041793236,"teacher_disagreement_score":0.0067976154,"about_ca_system_score_codex":0.00069991127,"about_ca_system_score_gemma":0.0008561788,"threshold_uncertainty_score":0.020156741},"labels":[],"label_agreement":null},{"id":"W4206114597","doi":"10.1080/03007995.2022.2031144","title":"The use of progestin subdermal implants in the management of endometriosis-related pain symptoms and quality of life: a systematic review","year":2022,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pelvic pain; Endometriosis; Medroxyprogesterone acetate; Progestin; Implant; Randomized controlled trial; Observational study; Quality of life (healthcare); Visual analogue scale; Gynecology; Surgery; Obstetrics; Internal medicine; Estrogen","score_opus":0.4168927478318649,"score_gpt":0.5228385278024101,"score_spread":0.10594577997054522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206114597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011002324,0.9981516,0.00007434323,0.00010977781,0.00006734367,0.00021774266,0.00012869184,0.0000042233505,0.00014602568],"genre_scores_gemma":[0.012706026,0.9858978,0.00044494984,0.00029296326,0.000063508014,0.00039079893,0.00010468246,0.0000028281247,0.000096478565],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99500656,0.0017680754,0.0019502405,0.00033280562,0.00078534795,0.00015694364],"domain_scores_gemma":[0.9825151,0.012064528,0.0037031965,0.00018658019,0.0013319434,0.00019866966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006007361,0.0013406798,0.008361268,0.0076348577,0.00052762375,0.0022819117,0.0014557102,0.0018894434,0.003482418],"category_scores_gemma":[0.021157742,0.00094924023,0.0067372606,0.008476774,0.00075804093,0.0016821233,0.0011292133,0.0009169277,0.00025215017],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021353533,0.000019657457,0.0004604002,0.9678593,0.0074925646,0.00007168974,0.000091724236,0.000058600475,0.00013983542,0.00008108543,0.00050254655,0.02300898],"study_design_scores_gemma":[0.00040807488,0.00046733484,0.0037935998,0.8842338,0.09747239,0.00041666967,0.0002521466,0.00012060755,0.00020023188,0.00015360628,0.0124447625,0.000036790872],"about_ca_topic_score_codex":0.0055553913,"about_ca_topic_score_gemma":0.016550329,"teacher_disagreement_score":0.008361268,"about_ca_system_score_codex":0.0026463633,"about_ca_system_score_gemma":0.008146757,"threshold_uncertainty_score":0.03177035},"labels":[],"label_agreement":null},{"id":"W4210946737","doi":"10.1080/03007995.2022.2037846","title":"Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Biosimilar; Infliximab; Innovator; Population; Rheumatoid arthritis; Discontinuation; Internal medicine; Disease","score_opus":0.11043825545334685,"score_gpt":0.4623763787597316,"score_spread":0.35193812330638474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210946737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992138,0.00020916322,0.000032339263,0.000069999456,0.000003834079,0.0000036041858,0.00020150263,0.0000019003995,0.0002638403],"genre_scores_gemma":[0.99956423,0.0000501315,0.000023547465,0.000031312193,0.000004986798,0.0000021123772,0.00025042935,0.000001352615,0.00007190072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833137,0.00059491623,0.00020305041,0.00030628833,0.00030731503,0.00025706558],"domain_scores_gemma":[0.99652785,0.00069182226,0.0019354798,0.00017621786,0.0003027523,0.00036581312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013899502,0.00016711297,0.00025524796,0.00074478023,0.00022054031,0.0007177722,0.00027222623,0.00048782644,0.0018702345],"category_scores_gemma":[0.0056978026,0.00012009364,0.000599952,0.00093582174,0.00022141871,0.0004424991,0.00034012945,0.000414187,0.00020955675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040228857,0.000042222066,0.9957209,0.0000060655416,0.00011212092,0.000015886319,0.00005193888,0.00007859818,0.00011996547,0.000016880009,0.00010101633,0.0033321343],"study_design_scores_gemma":[0.000017563245,0.00022277325,0.9987658,0.000008909238,0.00004329411,0.00009712261,0.00017013928,0.00041520153,0.00006791589,0.000018436234,0.00016926213,0.0000035057544],"about_ca_topic_score_codex":0.008165604,"about_ca_topic_score_gemma":0.008151247,"teacher_disagreement_score":0.008165604,"about_ca_system_score_codex":0.00055159547,"about_ca_system_score_gemma":0.00041317387,"threshold_uncertainty_score":0.016236126},"labels":[],"label_agreement":null},{"id":"W4220717164","doi":"10.1080/03007995.2022.2049162","title":"Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Algorithm; Internal medicine; Comorbidity; Framingham Risk Score; Emergency medicine; Pediatrics; Disease","score_opus":0.241932831906,"score_gpt":0.4448016409292165,"score_spread":0.20286880902321647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220717164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8275667,0.00092987303,0.16072808,0.0013115344,0.00011986016,0.0011550064,0.004039624,0.0015936975,0.00255571],"genre_scores_gemma":[0.9119601,0.00015502285,0.08394729,0.00014268766,0.000072064126,0.00028345673,0.0031418423,0.000025002839,0.00027248485],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974981,0.0010229712,0.0003852053,0.0004325675,0.00047307147,0.00018815149],"domain_scores_gemma":[0.9860598,0.008882154,0.0019871762,0.0003747101,0.0022594032,0.0004368177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007062852,0.00079653104,0.0009988248,0.0035500152,0.0005137165,0.0015923324,0.0009866623,0.0007789306,0.0009867112],"category_scores_gemma":[0.021939728,0.00027938694,0.0009032054,0.001298807,0.00025087874,0.0008382082,0.0009183851,0.0009543406,0.00033237477],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006367033,0.000313356,0.8560459,0.000089404326,0.00027805453,0.00015545754,0.00011541666,0.036526114,0.00051847455,0.00034996247,0.0023228861,0.102648176],"study_design_scores_gemma":[0.00014999806,0.00035339987,0.12457761,0.000112545706,0.00020717584,0.0004282681,0.00016955107,0.8703954,0.0012258426,0.0010032228,0.0013390746,0.000037854483],"about_ca_topic_score_codex":0.007206956,"about_ca_topic_score_gemma":0.00548904,"teacher_disagreement_score":0.007206956,"about_ca_system_score_codex":0.0007940317,"about_ca_system_score_gemma":0.0019099404,"threshold_uncertainty_score":0.037352383},"labels":[],"label_agreement":null},{"id":"W4230143059","doi":"10.1185/030079900542902","title":"Dose Response and Safety of Cizolirtine Citrate (E-4018) in Patients with Pain Following Extraction of Third Molars","year":2000,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Dental Radiography and Imaging","field":"Dentistry","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Molar; Dentistry; Anesthesia","score_opus":0.029024237747711804,"score_gpt":0.37399881758493514,"score_spread":0.34497457983722335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230143059","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525285,0.0036992882,0.00015300432,0.00010652106,0.000057339916,0.00025143888,0.00009148747,0.000018240069,0.0003698606],"genre_scores_gemma":[0.99704105,0.0014934128,0.00041332026,0.00018642601,0.00013976252,0.00015956222,0.0001419104,0.0000049691653,0.00041952496],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99887985,0.0006068171,0.0001707654,0.00007857333,0.00017762314,0.000086382206],"domain_scores_gemma":[0.9979272,0.0010010091,0.0006565541,0.00012532814,0.00014252229,0.00014743989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013634962,0.00045659198,0.0015841383,0.0003093719,0.00016220688,0.0004606204,0.00038035508,0.0008961086,0.0022414227],"category_scores_gemma":[0.0035219556,0.0003236339,0.00068322883,0.00028117868,0.00040913335,0.0003999931,0.00018883921,0.0009281735,0.00035663694],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76745546,0.010546676,0.01793973,0.002173015,0.001513052,0.00031078546,0.00028779573,0.0008180207,0.053427316,0.00008653124,0.00054564525,0.14489602],"study_design_scores_gemma":[0.20408645,0.671622,0.10595729,0.0001457551,0.0011494725,0.0006159467,0.0002507921,0.0012980906,0.01208524,0.00011272925,0.0026097682,0.00006657803],"about_ca_topic_score_codex":0.00025453785,"about_ca_topic_score_gemma":0.00045718037,"teacher_disagreement_score":0.0022414227,"about_ca_system_score_codex":0.00027886906,"about_ca_system_score_gemma":0.0002886411,"threshold_uncertainty_score":0.007498324},"labels":[],"label_agreement":null},{"id":"W4234826894","doi":"10.1185/03007995.2014.928275","title":"Once daily controlled-release pregabalin in the treatment of patients with fibromyalgia: a phase III, double-blind, randomized withdrawal, placebo-controlled study","year":2014,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Pfizer","keywords":"Pregabalin; Medicine; Placebo; Tolerability; Discontinuation; Clinical endpoint; Randomized controlled trial; Adverse effect; Fibromyalgia; Anesthesia; Clinical trial; Internal medicine","score_opus":0.053608015568913085,"score_gpt":0.4062697412229176,"score_spread":0.3526617256540045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234826894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97896636,0.004361467,0.0014220387,0.00045057465,0.00034515062,0.012389598,0.0010503009,0.00016339436,0.0008511438],"genre_scores_gemma":[0.9676912,0.0043492457,0.0053711776,0.0015208136,0.000704396,0.017057346,0.0012302172,0.00004668527,0.0020290737],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990508,0.00044950485,0.00008796107,0.00016493344,0.00011699616,0.0001298039],"domain_scores_gemma":[0.9988727,0.00026585461,0.0002948903,0.00012548362,0.00012932732,0.00031163948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029759097,0.001590283,0.0036022847,0.0006264103,0.0005910072,0.00096348405,0.001177855,0.0018822727,0.0042951196],"category_scores_gemma":[0.0016248224,0.0007756337,0.0016236556,0.0005802753,0.0011617108,0.0009636561,0.0003660212,0.0025187107,0.0009246586],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.87082994,0.059265107,0.00085170625,0.0016277576,0.0009046139,0.00007928496,0.00015825924,0.00043379204,0.022564167,0.000108444336,0.0007915943,0.04238535],"study_design_scores_gemma":[0.82903665,0.16799906,0.0014590563,0.000026486989,0.00015034032,0.00003512531,0.00001505622,0.00022448911,0.00072847656,0.000030654144,0.00028305617,0.000011543884],"about_ca_topic_score_codex":0.00056037045,"about_ca_topic_score_gemma":0.0015513113,"teacher_disagreement_score":0.0042951196,"about_ca_system_score_codex":0.00055251236,"about_ca_system_score_gemma":0.0017812337,"threshold_uncertainty_score":0.015738308},"labels":[],"label_agreement":null},{"id":"W4239583063","doi":"10.1185/030079907x253762","title":"Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany","year":2008,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clopidogrel; Aspirin; Myocardial infarction; Internal medicine; Stroke (engine); Cardiology; Framingham Risk Score; Emergency medicine; Disease","score_opus":0.14654931667180354,"score_gpt":0.4303641704455804,"score_spread":0.28381485377377685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239583063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7462858,0.011676454,0.18588087,0.0060917847,0.00028696476,0.00087919226,0.013155582,0.00035308918,0.035390183],"genre_scores_gemma":[0.98158884,0.001508366,0.011875371,0.00031897056,0.000037596517,0.00045377162,0.0014001557,0.00003793959,0.0027790572],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99920386,0.00052322634,0.000032923694,0.00007693581,0.00006304718,0.00010013481],"domain_scores_gemma":[0.9976701,0.0019053235,0.00017854982,0.000052925097,0.000121052384,0.00007204199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00224323,0.0011454418,0.0012711061,0.0013394157,0.00021415793,0.0017823677,0.0010227705,0.0014647655,0.0033582042],"category_scores_gemma":[0.0073550288,0.0006285291,0.001953391,0.0010931357,0.00048269282,0.0008419974,0.00058819656,0.00080614735,0.00031760597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016663414,0.000020796606,0.0011666501,0.000074040756,0.00016248714,0.00008726288,0.000013014766,0.9917156,0.000056454584,0.003462122,0.0005622765,0.0025126943],"study_design_scores_gemma":[0.00014443751,0.00009605266,0.0015565511,0.000094940035,0.00026523974,0.00011353985,0.0000239415,0.9921359,0.00010976004,0.004320874,0.0011202561,0.000018435268],"about_ca_topic_score_codex":0.026882257,"about_ca_topic_score_gemma":0.008375225,"teacher_disagreement_score":0.026882257,"about_ca_system_score_codex":0.0034528493,"about_ca_system_score_gemma":0.0020182407,"threshold_uncertainty_score":0.053451598},"labels":[],"label_agreement":null},{"id":"W4249688750","doi":"10.1185/03007991003715657","title":"Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?","year":2010,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Nasal administration; Dermatology; Allergy; Anesthesia; Pharmacology; Immunology","score_opus":0.08842048054114557,"score_gpt":0.38155415570002754,"score_spread":0.293133675158882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249688750","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073711335,0.00052259665,0.00007332705,0.9798415,0.016421678,0.000010965097,0.00006439508,0.000024283554,0.0023041945],"genre_scores_gemma":[0.005961775,0.00055001664,0.00026006406,0.9534925,0.034735814,0.000025616537,0.000042274587,0.000021413258,0.004910536],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973621,0.00053848326,0.00046329427,0.00040784574,0.0007155438,0.00051271537],"domain_scores_gemma":[0.993277,0.0031905305,0.0008433883,0.00018143709,0.0015435048,0.00096415804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021717253,0.0008336818,0.001694717,0.00074058364,0.0031525404,0.0024079792,0.0019935833,0.06554931,0.0091196075],"category_scores_gemma":[0.02316777,0.0007084109,0.0016208815,0.00086926017,0.0023952024,0.0037047807,0.001328484,0.033899292,0.007835226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014879082,0.000054242948,0.0021129379,0.00009801262,0.00003474284,0.0073310086,0.00019234646,0.00008908556,0.00021527283,0.0012871193,0.9809306,0.0075057927],"study_design_scores_gemma":[0.00053267187,0.00027224518,0.0074475575,0.0007799017,0.00021454938,0.018966038,0.0014632868,0.0017605956,0.00065518194,0.007989925,0.9597001,0.00021807732],"about_ca_topic_score_codex":0.008848877,"about_ca_topic_score_gemma":0.013737404,"teacher_disagreement_score":0.06554931,"about_ca_system_score_codex":0.005187094,"about_ca_system_score_gemma":0.0037178562,"threshold_uncertainty_score":0.037635207},"labels":[],"label_agreement":null},{"id":"W4280563518","doi":"10.1080/03007995.2022.2076474","title":"Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Forensic Toxicology and Drug Analysis","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada); Systems, Applications & Products in Data Processing (Canada); University of Toronto","funders":"","keywords":"Medicine; Placebo; Crossover study; Methylphenidate; Pharmacology; Anesthesia; Internal medicine; Psychiatry","score_opus":0.15587980583202146,"score_gpt":0.4960759154135574,"score_spread":0.3401961095815359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280563518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966793,0.0019512356,0.0004515784,0.000035368197,0.00001594694,0.0001254982,0.00012268742,0.000010294057,0.0006082159],"genre_scores_gemma":[0.9961081,0.0018144755,0.0011533349,0.00004515583,0.000036948655,0.00011738475,0.00010441192,0.00000381999,0.00061640947],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99958163,0.00019184085,0.000040614894,0.000053226624,0.00009142807,0.00004126948],"domain_scores_gemma":[0.99937254,0.00018728871,0.00023391985,0.00004840476,0.00006808852,0.000089820285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063907297,0.0003764541,0.00048422188,0.00019409134,0.00011072431,0.0002686749,0.0001987161,0.00028470706,0.0013984551],"category_scores_gemma":[0.0009070129,0.0002117234,0.00035889534,0.00013651687,0.0003417313,0.00038734946,0.00018060897,0.00052343006,0.00014744891],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16938466,0.009622827,0.02118348,0.0014808661,0.00080087857,0.00034510694,0.00023361435,0.0008236796,0.4806693,0.0003809319,0.00043924927,0.3146354],"study_design_scores_gemma":[0.016174642,0.5678487,0.09331286,0.0001467769,0.0012196738,0.0019906498,0.00028924557,0.0023716318,0.3124707,0.00021781524,0.0039072,0.00005022906],"about_ca_topic_score_codex":0.00039561593,"about_ca_topic_score_gemma":0.00082466047,"teacher_disagreement_score":0.0013984551,"about_ca_system_score_codex":0.00015346461,"about_ca_system_score_gemma":0.00027272553,"threshold_uncertainty_score":0.0046782494},"labels":[],"label_agreement":null},{"id":"W4281383295","doi":"10.1080/03007995.2022.2081455","title":"Risk factors and pooled incidence of intestinal stoma complications: systematic review and Meta-analysis","year":2022,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Stoma care and complications","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Meta-analysis; Observational study; Systematic review; Risk factor; Overweight; Epidemiology; MEDLINE; Surgery; Internal medicine; Obesity","score_opus":0.42147780713320093,"score_gpt":0.5376191069850134,"score_spread":0.11614129985181243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281383295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002302406,0.9958753,0.0006255124,0.00013938174,0.00011930345,0.00023940844,0.00052693696,0.00001828695,0.00015340927],"genre_scores_gemma":[0.097067125,0.89664835,0.0028245247,0.00061134546,0.00033149243,0.0012408925,0.0010010015,0.000028338116,0.00024694524],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98681474,0.005332433,0.0045925397,0.0014039455,0.001467852,0.0003884494],"domain_scores_gemma":[0.9729497,0.019698752,0.0043472536,0.000784807,0.0019965512,0.00022296538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017635174,0.0033805624,0.017266518,0.010345528,0.0005767731,0.0035110626,0.0018280039,0.0019909504,0.0033068026],"category_scores_gemma":[0.04852819,0.0015114875,0.036623627,0.009373837,0.0007167243,0.001846487,0.0016770056,0.0016494298,0.00031085816],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087688194,0.000019101493,0.0065478333,0.49110374,0.48663804,0.00012287051,0.0000693671,0.00041473226,0.0001687905,0.00015333376,0.00058322423,0.013302147],"study_design_scores_gemma":[0.00021924703,0.00012794556,0.0046482394,0.036697626,0.9558148,0.00014735744,0.000044809323,0.00014873428,0.00012206112,0.00020791315,0.0017993049,0.000022144704],"about_ca_topic_score_codex":0.004807341,"about_ca_topic_score_gemma":0.010203443,"teacher_disagreement_score":0.017635174,"about_ca_system_score_codex":0.002202085,"about_ca_system_score_gemma":0.004810168,"threshold_uncertainty_score":0.09326488},"labels":[],"label_agreement":null},{"id":"W4283836524","doi":"10.1080/03007995.2022.2096351","title":"Rapid improvement in severe long COVID following perispinal etanercept","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Etanercept; Neuroinflammation; Stroke (engine); Trail Making Test; Internal medicine; Physical therapy; Physical medicine and rehabilitation; Tumor necrosis factor alpha; Inflammation","score_opus":0.0729468863621934,"score_gpt":0.4428301901702262,"score_spread":0.3698833038080328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283836524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992512,0.001827063,0.0011039253,0.00049693545,0.00004251092,0.00008947053,0.00013572433,0.000053165673,0.0037392993],"genre_scores_gemma":[0.998353,0.0003667161,0.00025861588,0.00030029766,0.00004099608,0.000017651038,0.00010713071,0.0000026466016,0.0005530946],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.99989176,0.000013782675,0.000015499323,0.000026818354,0.000019797259,0.00003233841],"domain_scores_gemma":[0.9996923,0.00003948318,0.00008887436,0.000016484171,0.000051490028,0.00011131354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001306752,0.00044985823,0.00073715945,0.00020223006,0.00034469872,0.00025236592,0.00021339113,0.00050252373,0.00074362423],"category_scores_gemma":[0.000486531,0.00009827655,0.00035536443,0.00015052162,0.00030570079,0.00027326198,0.00023031754,0.00081576343,0.00019289767],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010379261,0.0017096692,0.43692806,0.001111201,0.00047356242,0.31386778,0.0019881162,0.0016640649,0.09724974,0.0005688475,0.0027842487,0.13127545],"study_design_scores_gemma":[0.00044514012,0.015650237,0.6523591,0.00015194034,0.0002804238,0.3121445,0.0006091546,0.0028057464,0.0102523845,0.00028280218,0.0049404902,0.000078088466],"about_ca_topic_score_codex":0.0015928122,"about_ca_topic_score_gemma":0.003302421,"teacher_disagreement_score":0.0015928122,"about_ca_system_score_codex":0.00052570656,"about_ca_system_score_gemma":0.00041823095,"threshold_uncertainty_score":0.0038143396},"labels":[],"label_agreement":null},{"id":"W4292202432","doi":"10.1080/03007995.2022.2113689","title":"Efficacy and safety of tanezumab, NSAIDs, and placebo in patients with moderate to severe hip or knee osteoarthritis and a history of depression, anxiety, or insomnia: post-hoc analysis of phase 3 trials","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; WOMAC; Insomnia; Placebo; Anxiety; Osteoarthritis; Depression (economics); Internal medicine; Physical therapy; Post-hoc analysis; Psychiatry; Alternative medicine","score_opus":0.06947531499666458,"score_gpt":0.3925690875726348,"score_spread":0.3230937725759702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292202432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94559973,0.0374738,0.0024266345,0.000744689,0.00064657355,0.007209284,0.0033129167,0.00019667731,0.00238961],"genre_scores_gemma":[0.9848162,0.0048664697,0.0022104573,0.00063029217,0.00032062814,0.003989597,0.0020861083,0.00005537028,0.0010248991],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99134725,0.0059137354,0.0009862281,0.0007192082,0.0005478627,0.00048569686],"domain_scores_gemma":[0.99056447,0.0048017395,0.0023932904,0.0008044322,0.0008022886,0.0006337979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017005758,0.0023267295,0.0061730337,0.0008610631,0.00058399915,0.0021193326,0.0011386556,0.0014997384,0.0043956116],"category_scores_gemma":[0.011473972,0.00089041,0.01546425,0.00090375973,0.0011534507,0.001854562,0.0008037603,0.0024540292,0.00051421084],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92956674,0.0020017312,0.0037333476,0.002592651,0.044726696,0.00005896739,0.0001058087,0.0007249334,0.003121095,0.000060473627,0.00068340707,0.012624154],"study_design_scores_gemma":[0.7849497,0.13121527,0.02637405,0.0003631651,0.051122405,0.00017165914,0.00012945803,0.0013285282,0.001905186,0.00030491842,0.002048774,0.00008687009],"about_ca_topic_score_codex":0.0007910606,"about_ca_topic_score_gemma":0.002561883,"teacher_disagreement_score":0.017005758,"about_ca_system_score_codex":0.0013029819,"about_ca_system_score_gemma":0.0021407187,"threshold_uncertainty_score":0.08993614},"labels":[],"label_agreement":null},{"id":"W4307092490","doi":"10.1080/03007995.2022.2139052","title":"Updated results from a matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Confidence interval; Hazard ratio; Odds ratio; Gastroenterology; Oncology","score_opus":0.18304367590100745,"score_gpt":0.4477553956450189,"score_spread":0.2647117197440115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307092490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851305,0.0042830384,0.0017664738,0.00016381076,0.00011846674,0.00019663083,0.006882997,0.00005484038,0.0014032371],"genre_scores_gemma":[0.9963721,0.00022517426,0.00060748943,0.00009386427,0.00004850879,0.00010394197,0.002045022,0.000012836485,0.00049113116],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941673,0.0037390064,0.00039779392,0.00086491,0.0005086542,0.00032223336],"domain_scores_gemma":[0.9885522,0.006071188,0.0035176314,0.0011373906,0.00037710308,0.0003444461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008018131,0.00073282834,0.0012696057,0.000655057,0.00017318841,0.0009060058,0.00080877385,0.0006159087,0.0048507745],"category_scores_gemma":[0.012568002,0.00031486063,0.0050373487,0.00077174907,0.00026108226,0.00060153,0.00069059845,0.0010340618,0.0002869616],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46697047,0.0009266206,0.30121627,0.0023893574,0.14580011,0.00027902232,0.00026013318,0.0071373596,0.00362566,0.0007050757,0.0041681114,0.06652178],"study_design_scores_gemma":[0.030627351,0.034766305,0.8114677,0.00021517678,0.1027519,0.0005019689,0.0001899787,0.009904104,0.0038553863,0.00057405786,0.0050546997,0.0000914694],"about_ca_topic_score_codex":0.0024824727,"about_ca_topic_score_gemma":0.0029436103,"teacher_disagreement_score":0.008018131,"about_ca_system_score_codex":0.0006831702,"about_ca_system_score_gemma":0.00046395932,"threshold_uncertainty_score":0.042404473},"labels":[],"label_agreement":null},{"id":"W4320032979","doi":"10.1080/03007995.2023.2177401","title":"A Latin American consensus meeting on the essentials of mixed pain","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Latin Americans; Population; MEDLINE; Alternative medicine; Consensus conference; Neuropathic pain; Family medicine; Law; Political science; Pathology","score_opus":0.343799713959595,"score_gpt":0.5194971402766067,"score_spread":0.17569742631701163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320032979","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070754993,0.2868323,0.026319914,0.5472627,0.09242065,0.011686568,0.0039524115,0.0003053195,0.024144594],"genre_scores_gemma":[0.10146175,0.39177582,0.2562612,0.15792888,0.018824983,0.039106537,0.011597576,0.00043114508,0.022612106],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.91414124,0.045185603,0.02393691,0.0030032732,0.010834491,0.0028984414],"domain_scores_gemma":[0.85366774,0.04599014,0.01111828,0.0029444762,0.07752825,0.008751194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14356406,0.0018334438,0.0041246754,0.01155437,0.004009688,0.0052447,0.007201809,0.011397237,0.0057142074],"category_scores_gemma":[0.12997854,0.0014657254,0.008505168,0.0076219602,0.0030166241,0.005154427,0.009364034,0.010264886,0.00240051],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083669333,0.00018363455,0.0034746053,0.08728725,0.0011770349,0.0018837679,0.009720128,0.00073908415,0.0040728557,0.013888261,0.5364025,0.3403341],"study_design_scores_gemma":[0.0004256544,0.00014549664,0.0045876717,0.14749874,0.0017558447,0.0011700118,0.005264677,0.000532369,0.0010349151,0.010799809,0.82658744,0.00019730783],"about_ca_topic_score_codex":0.010111465,"about_ca_topic_score_gemma":0.0101586,"teacher_disagreement_score":0.14356406,"about_ca_system_score_codex":0.0127619505,"about_ca_system_score_gemma":0.0712858,"threshold_uncertainty_score":0.7592484},"labels":[],"label_agreement":null},{"id":"W4320493944","doi":"10.1080/03007995.2023.2177413","title":"Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Major depressive disorder; Medical diagnosis; Mood; Bipolar disorder; Cohort; Health care; Health plan; Psychiatry; Internal medicine","score_opus":0.06807593206071481,"score_gpt":0.40398455834636776,"score_spread":0.33590862628565293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4320493944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420954,0.0014774541,0.003872976,0.0029736257,0.00006160646,0.00012349508,0.0030920946,0.000094506715,0.0040947585],"genre_scores_gemma":[0.99724245,0.00036756007,0.0012499449,0.00021259897,0.000015922176,0.00002904455,0.00064278295,0.0000034842276,0.00023619934],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9995473,0.00025099775,0.000026220696,0.000044339537,0.000055527584,0.000075636875],"domain_scores_gemma":[0.9993061,0.00033262421,0.00017547984,0.000027051816,0.000060275193,0.00009846231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007379952,0.00040759606,0.0004142399,0.00036531687,0.0001710459,0.0006161712,0.00040727563,0.00049791706,0.003401974],"category_scores_gemma":[0.0035345138,0.00022806048,0.0011700144,0.00038817953,0.00012699894,0.0005153949,0.0004907804,0.00044513948,0.00019256449],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005692999,0.001156401,0.36714187,0.0005849924,0.0019747978,0.00062282867,0.00013761307,0.46861324,0.001745956,0.0029360894,0.010133497,0.13925967],"study_design_scores_gemma":[0.0027329184,0.0056482856,0.3977116,0.00059524237,0.0027089133,0.0012918572,0.00041236737,0.5741413,0.0015095897,0.008267567,0.0048844162,0.00009588875],"about_ca_topic_score_codex":0.016239801,"about_ca_topic_score_gemma":0.014199459,"teacher_disagreement_score":0.016239801,"about_ca_system_score_codex":0.001834225,"about_ca_system_score_gemma":0.001797053,"threshold_uncertainty_score":0.03229052},"labels":[],"label_agreement":null},{"id":"W4379376267","doi":"10.1080/03007995.2023.2219155","title":"Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brain and Cognition Discovery Foundation; University of Toronto","funders":"National Eye Institute; H. Lundbeck A/S; Otsuka Pharmaceutical","keywords":"Medicine; Aripiprazole; Tolerability; Clinical Global Impression; Adverse effect; Young Mania Rating Scale; Bipolar disorder; Bipolar I disorder; Randomized controlled trial; Clinical endpoint; Visual analogue scale; Internal medicine; Mania; Schizophrenia (object-oriented programming); Mood; Psychiatry; Anesthesia; Placebo","score_opus":0.056950610330233215,"score_gpt":0.4097856326431164,"score_spread":0.3528350223128832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379376267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341935,0.0015334579,0.00029747587,0.00013629599,0.00006826375,0.001299701,0.0021399886,0.000033756154,0.0010717479],"genre_scores_gemma":[0.99328893,0.00064002414,0.00062806404,0.0003056523,0.00020796145,0.0013475651,0.0028022593,0.000014762835,0.00076485047],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998401,0.00077788834,0.00017304106,0.00031903794,0.00019416233,0.00013494906],"domain_scores_gemma":[0.9962458,0.0006056324,0.0018378398,0.00025139848,0.0004107799,0.00064845954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003706649,0.001484463,0.0022593883,0.000464267,0.00041040775,0.0010101093,0.0007106064,0.0010664586,0.0037328037],"category_scores_gemma":[0.0028201551,0.0005354193,0.0030812465,0.0005343808,0.00054576044,0.0007985207,0.00039731688,0.0019709151,0.0006705371],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93091094,0.010830122,0.023297925,0.00087019365,0.004171597,0.00013833145,0.000115308314,0.0004607143,0.00884895,0.00006477766,0.0013191695,0.018971877],"study_design_scores_gemma":[0.62731206,0.21845736,0.14343476,0.00007654123,0.004382581,0.0002971046,0.000073737705,0.0013218274,0.0028284888,0.00016308518,0.0015887939,0.00006364357],"about_ca_topic_score_codex":0.0006791331,"about_ca_topic_score_gemma":0.0015549369,"teacher_disagreement_score":0.0037328037,"about_ca_system_score_codex":0.00061109447,"about_ca_system_score_gemma":0.00096758315,"threshold_uncertainty_score":0.019602895},"labels":[],"label_agreement":null},{"id":"W4382918906","doi":"10.1080/03007995.2023.2222583","title":"A systematic literature review of the economic and healthcare resource burden of cytomegalovirus","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Moderna","keywords":"Medicine; Population; Psychological intervention; Asymptomatic; Cytomegalovirus; MEDLINE; Health care; Indirect costs; Economic impact analysis; Economic cost; Systematic review; Latin Americans; Meta-analysis; Pediatrics; Environmental health; Demography; Family medicine; Gerontology; Economic growth; Surgery; Human immunodeficiency virus (HIV); Pathology; Psychiatry; Political science","score_opus":0.15570494742637214,"score_gpt":0.4847372610479011,"score_spread":0.32903231362152896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382918906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013932417,0.9949254,0.00021357743,0.0006874857,0.00020371558,0.00047157847,0.0012600138,0.000010808749,0.00083409826],"genre_scores_gemma":[0.010233229,0.9874821,0.0006093274,0.00052455097,0.00009211544,0.00055938493,0.0003481264,0.000006821277,0.00014429251],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98844016,0.0040117926,0.004197644,0.000558123,0.0024322765,0.000360003],"domain_scores_gemma":[0.9591624,0.027762327,0.0076595563,0.00042713323,0.004587497,0.00040104642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010072456,0.0018078027,0.0077696885,0.01768978,0.0007903716,0.0040845885,0.0020388074,0.0019874384,0.0076509006],"category_scores_gemma":[0.055523362,0.001033625,0.007570507,0.017896574,0.00086119724,0.0028150238,0.0018732152,0.0014093864,0.0005243661],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001654142,0.000012689733,0.00066242076,0.9602885,0.0058486564,0.00013833864,0.00011539472,0.00013246885,0.00007713323,0.00034218899,0.0021372705,0.030079396],"study_design_scores_gemma":[0.00012997056,0.00010521323,0.002251277,0.9508335,0.03135233,0.00034682092,0.00018133124,0.00007689596,0.000083005,0.0002886525,0.014328786,0.000022251103],"about_ca_topic_score_codex":0.01010635,"about_ca_topic_score_gemma":0.02526444,"teacher_disagreement_score":0.01768978,"about_ca_system_score_codex":0.0072145644,"about_ca_system_score_gemma":0.020241514,"threshold_uncertainty_score":0.05326885},"labels":[],"label_agreement":null},{"id":"W4386083867","doi":"10.1080/03007995.2023.2247968","title":"Enhancement and external validation of algorithms using diagnosis codes to identify invasive <i>Escherichia coli</i> disease","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Data-Driven Disease Surveillance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Algorithm; Medicine; Diagnosis code; Bacteremia; Predictive value; Sepsis; Disease; Internal medicine; Computer science","score_opus":0.15565135152360093,"score_gpt":0.48168646841257445,"score_spread":0.3260351168889735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386083867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9186349,0.002178762,0.06671515,0.0006119161,0.0003633073,0.0013120571,0.0030207965,0.001505261,0.005657858],"genre_scores_gemma":[0.94139946,0.00032344062,0.052419543,0.00036464838,0.00011102956,0.00042209058,0.004464162,0.00018545835,0.00031034564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9515392,0.025461787,0.0061046486,0.008165709,0.007610113,0.001118532],"domain_scores_gemma":[0.78694797,0.13703991,0.020006213,0.013741503,0.040533397,0.0017309731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08178789,0.0016972682,0.0011603589,0.0041244463,0.0007301258,0.0042913286,0.0020466237,0.001939483,0.0009290981],"category_scores_gemma":[0.19127902,0.0005549655,0.0015376045,0.0025343988,0.0012016549,0.002282612,0.0022489703,0.0014314567,0.0006919302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023729503,0.0006193803,0.8818401,0.00047792858,0.0014167229,0.000098000295,0.0006346753,0.023377467,0.003215852,0.0006964923,0.0025631003,0.08268735],"study_design_scores_gemma":[0.0009768915,0.0023062741,0.53007853,0.0007309646,0.0012788828,0.0010473981,0.00050963974,0.4314477,0.020638864,0.0019343317,0.008893294,0.00015720089],"about_ca_topic_score_codex":0.0037221683,"about_ca_topic_score_gemma":0.0023187546,"teacher_disagreement_score":0.08178789,"about_ca_system_score_codex":0.0015061966,"about_ca_system_score_gemma":0.0027808563,"threshold_uncertainty_score":0.4325409},"labels":[],"label_agreement":null},{"id":"W4388500252","doi":"10.1080/03007995.2023.2281503","title":"The performance of bibliometric analyses in the health sciences","year":2023,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Scopus; China; Bibliometrics; Medicine; Pace; Biomedical sciences; Citation impact; Citation; MEDLINE; Library science; Political science; Computer science; Geography; Pathology","score_opus":0.9614202202530888,"score_gpt":0.7944987910901559,"score_spread":0.16692142916293295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388500252","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34977648,0.32805863,0.12518601,0.018068137,0.0035386283,0.006052809,0.06684683,0.0030547373,0.09941771],"genre_scores_gemma":[0.8857072,0.03323587,0.05975903,0.0005646094,0.0016744323,0.0032714393,0.014106786,0.0003552345,0.0013254038],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6949775,0.16547728,0.052796677,0.0148560265,0.06878313,0.0031094137],"domain_scores_gemma":[0.41162547,0.46140137,0.05446642,0.021381844,0.048961993,0.002163025],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20292875,0.0025627387,0.0067466097,0.17781222,0.002453027,0.01637526,0.0027026397,0.0019788023,0.004431951],"category_scores_gemma":[0.5099684,0.00091097347,0.008069217,0.23016863,0.0025675274,0.010041252,0.008743437,0.0014194457,0.0012409786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012424767,0.00024219196,0.30590567,0.054834712,0.04070794,0.0005083312,0.008462103,0.016850946,0.001305268,0.026254259,0.026764197,0.516922],"study_design_scores_gemma":[0.00061685115,0.0013858882,0.56118125,0.026136545,0.035103053,0.0016507651,0.013801551,0.07584679,0.00595623,0.124499954,0.15272976,0.0010913399],"about_ca_topic_score_codex":0.0060006767,"about_ca_topic_score_gemma":0.0047902544,"teacher_disagreement_score":0.8221878,"about_ca_system_score_codex":0.0065922444,"about_ca_system_score_gemma":0.0090415655,"threshold_uncertainty_score":0.9829308},"labels":[],"label_agreement":null},{"id":"W4389763594","doi":"10.1080/03007995.2023.2295411","title":"The use of large language models in medicine: proceeding with caution","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital; Carleton University; University of Toronto","funders":"","keywords":"Medicine; Transparency (behavior); Consistency (knowledge bases); Liability; Internet privacy; Computer security; Artificial intelligence; Law","score_opus":0.6244928489176927,"score_gpt":0.5985246997722155,"score_spread":0.025968149145477293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389763594","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0043901624,0.035160266,0.20950128,0.72564286,0.010951869,0.000386855,0.00064214546,0.0012739885,0.012050538],"genre_scores_gemma":[0.13247375,0.02586505,0.4147117,0.38902915,0.022898,0.0019833574,0.00041763333,0.0012095529,0.011411784],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.88854843,0.0798882,0.008138826,0.00464054,0.018153215,0.0006308182],"domain_scores_gemma":[0.5872764,0.33538693,0.010160932,0.035519242,0.028785292,0.0028711245],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15952437,0.0016174875,0.0028322078,0.0031937624,0.0032880765,0.01060328,0.008469796,0.009404132,0.0029706822],"category_scores_gemma":[0.3762024,0.0017463305,0.002325885,0.0015904208,0.016635653,0.015757404,0.008567633,0.033644117,0.0048600826],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010653635,0.00014288723,0.009049654,0.005114642,0.0018802093,0.0031935796,0.011685491,0.0057939887,0.0027526624,0.3706021,0.31013283,0.27858663],"study_design_scores_gemma":[0.00019243492,0.00015340056,0.0019194006,0.007572133,0.0004645014,0.0027408667,0.0022262381,0.011854694,0.0030669714,0.6008216,0.36861223,0.00037539602],"about_ca_topic_score_codex":0.008013935,"about_ca_topic_score_gemma":0.013826852,"teacher_disagreement_score":0.8404756,"about_ca_system_score_codex":0.0029024663,"about_ca_system_score_gemma":0.0068421448,"threshold_uncertainty_score":0.8436556},"labels":[],"label_agreement":null},{"id":"W4389937130","doi":"10.1080/03007995.2023.2286102","title":"Chatbots, generative AI, and scholarly manuscripts: WAME recommendations on chatbots and generative artificial intelligence in relation to scholarly publications","year":2023,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Generative grammar; Relation (database); Artificial intelligence; Cognitive science; Computer science; Data mining; Psychology","score_opus":0.544422434547207,"score_gpt":0.5616866559129249,"score_spread":0.017264221365717924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389937130","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013908586,0.041773092,0.018935813,0.8803573,0.015008135,0.00022329342,0.00029166785,0.0005185008,0.041501317],"genre_scores_gemma":[0.08463265,0.16211124,0.11461127,0.46957958,0.04060214,0.0024421501,0.0013878533,0.0017023968,0.122930735],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9789163,0.01155304,0.0021754843,0.0013948523,0.004709396,0.0012509112],"domain_scores_gemma":[0.6353082,0.28605092,0.011509557,0.011092388,0.044488207,0.011550709],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034020446,0.0009829922,0.0012726821,0.00887737,0.00672765,0.02944002,0.0045820237,0.020947454,0.033564206],"category_scores_gemma":[0.12155892,0.0008868969,0.0015907115,0.008104134,0.016306432,0.036669888,0.009584221,0.016866272,0.011108878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014291906,0.00028804524,0.0011808637,0.0026922072,0.000056538007,0.00025815875,0.007497513,0.00047438822,0.0006681482,0.25019875,0.5508761,0.18566641],"study_design_scores_gemma":[0.000040280735,0.00003893713,0.0008769385,0.006579549,0.000036487814,0.0000880938,0.0055154357,0.00048549517,0.000294593,0.09952573,0.8864414,0.00007703753],"about_ca_topic_score_codex":0.011862233,"about_ca_topic_score_gemma":0.03649629,"teacher_disagreement_score":0.9659796,"about_ca_system_score_codex":0.0055722552,"about_ca_system_score_gemma":0.015113515,"threshold_uncertainty_score":0.17991942},"labels":[],"label_agreement":null},{"id":"W4392197973","doi":"10.1080/03007995.2024.2322048","title":"Prevalence of comorbidities with the potential to increase the risk of nonadherence to topical ocular hypotensive medication in patients with open-angle glaucoma","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heidelberg Engineering; Santen; AbbVie Canada; Alimera Sciences; Pfizer","keywords":"Medicine; Glaucoma; Open angle glaucoma; Medication adherence; Ocular hypertension; Comorbidity; Glaucoma medication; Ophthalmology; Internal medicine; Intensive care medicine","score_opus":0.028271684341487562,"score_gpt":0.35465903525410997,"score_spread":0.3263873509126224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392197973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99823856,0.000565248,0.000040851006,0.00010927908,0.0000064059145,0.000008555056,0.0006209637,0.0000020923642,0.00040787883],"genre_scores_gemma":[0.99930155,0.00017501978,0.000067433284,0.00003022927,0.000011974252,0.000006615427,0.0003555305,6.134322e-7,0.000050861043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988368,0.00024060957,0.0002335139,0.00017896706,0.00035383072,0.00015623949],"domain_scores_gemma":[0.9952402,0.00056715484,0.0034009756,0.00012822202,0.00028413843,0.00037927457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084618066,0.00015908944,0.00032129622,0.0011952433,0.0003302752,0.00066448376,0.0002873657,0.0004936372,0.0015047329],"category_scores_gemma":[0.004637006,0.00019962518,0.000566913,0.0015497059,0.00024020483,0.00064023276,0.0006671364,0.00060614763,0.00015092014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000132013065,0.000007388325,0.9995247,0.000004735617,0.000016350701,0.000018527153,0.000012077551,0.000009142097,0.000019080353,0.0000039886836,0.000027244216,0.0003435307],"study_design_scores_gemma":[0.0000022875047,0.000021847025,0.99959725,0.000008801535,0.000008961359,0.00017100429,0.00006223442,0.00006913515,0.000008129592,0.000006092466,0.00004317831,0.000001181004],"about_ca_topic_score_codex":0.008476542,"about_ca_topic_score_gemma":0.013598233,"teacher_disagreement_score":0.008476542,"about_ca_system_score_codex":0.00045240187,"about_ca_system_score_gemma":0.00049719453,"threshold_uncertainty_score":0.016854405},"labels":[],"label_agreement":null},{"id":"W4394576831","doi":"10.1080/03007995.2024.2326585","title":"Real-world clinical outcomes and healthcare costs in patients with Crohn’s disease treated with vedolizumab versus ustekinumab in the United States","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vedolizumab; Ustekinumab; Medicine; Crohn's disease; Health care; Disease; Internal medicine; Intensive care medicine; Adalimumab","score_opus":0.0629340616122963,"score_gpt":0.43190965535171183,"score_spread":0.3689755937394155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394576831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794024,0.00078698614,0.000092352035,0.00011643514,0.000008485216,0.000011081234,0.00085151085,0.0000016932747,0.00019126154],"genre_scores_gemma":[0.9984962,0.00022244289,0.00012157078,0.00006330529,0.000014787969,0.000017540326,0.0010299106,0.0000010850516,0.000033231958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997724,0.0010784473,0.00035475622,0.00036939926,0.0002875362,0.00018571425],"domain_scores_gemma":[0.99438727,0.0011181864,0.003808073,0.000133235,0.00024051515,0.00031270046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020968504,0.00024302654,0.0006127873,0.0008171273,0.00023283175,0.00094927003,0.00035311579,0.0004531898,0.00075240043],"category_scores_gemma":[0.008404199,0.00021169959,0.00089020893,0.0012896396,0.00030945186,0.00088569557,0.0006413192,0.00062220974,0.00008142796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017697446,0.0001471698,0.991931,0.00006912369,0.00077583815,0.000065723136,0.00007754106,0.00093856466,0.000086068656,0.00011256247,0.00036382748,0.0036628677],"study_design_scores_gemma":[0.00019602351,0.00088717823,0.9931224,0.00006768037,0.00035423375,0.00031130595,0.00037240644,0.0037564957,0.00011107124,0.00019245695,0.0006079522,0.000020778692],"about_ca_topic_score_codex":0.0044167135,"about_ca_topic_score_gemma":0.0047704997,"teacher_disagreement_score":0.0044167135,"about_ca_system_score_codex":0.0009660375,"about_ca_system_score_gemma":0.00040533935,"threshold_uncertainty_score":0.011089325},"labels":[],"label_agreement":null},{"id":"W4394680555","doi":"10.1080/03007995.2024.2340720","title":"Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Medicine; Cross-sectional study; Clinical trial; Family medicine; Environmental health; Internal medicine; Pathology","score_opus":0.8072724322065451,"score_gpt":0.7220520273630743,"score_spread":0.08522040484347082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394680555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985612,0.00018906107,0.00006071661,0.00020221891,0.000007750203,0.00003463255,0.00028693042,0.0000024208807,0.0006551844],"genre_scores_gemma":[0.9989058,0.0001568503,0.00013797694,0.00033641123,0.000010719262,0.000047245478,0.00018673674,0.0000015540543,0.00021675623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987602,0.0004556526,0.00018461263,0.00015615748,0.00029570446,0.00014753228],"domain_scores_gemma":[0.994955,0.0016129316,0.0019813096,0.00018869565,0.00060708926,0.0006549887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002969379,0.0002253117,0.0003473968,0.00072304683,0.00068083557,0.0011037982,0.00028586303,0.0010456617,0.0029400329],"category_scores_gemma":[0.007550182,0.0004915946,0.0005123951,0.00061397464,0.00033735426,0.001283427,0.0006018288,0.001181138,0.0005062927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008141407,0.00036278498,0.99340606,0.00004531021,0.0000718293,0.000055431377,0.0028156594,0.000019895573,0.00016446612,0.000022516724,0.0003519331,0.0026026168],"study_design_scores_gemma":[0.000024532443,0.00055747817,0.9925764,0.00006459457,0.000051053263,0.00026079395,0.0054727695,0.0001601959,0.00007152606,0.000039073737,0.0007087317,0.0000128142465],"about_ca_topic_score_codex":0.004548706,"about_ca_topic_score_gemma":0.005289351,"teacher_disagreement_score":0.004548706,"about_ca_system_score_codex":0.00024366318,"about_ca_system_score_gemma":0.00042606978,"threshold_uncertainty_score":0.015703797},"labels":[],"label_agreement":null},{"id":"W4399123297","doi":"10.1080/03007995.2024.2360128","title":"A prospective cohort study of chronic postsurgical pain after ambulatory surgeries","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Ambulatory; Prospective cohort study; Chronic pain; Cohort; Anesthesia; Surgery; Physical therapy; Internal medicine","score_opus":0.046364448613669784,"score_gpt":0.40627871379956104,"score_spread":0.35991426518589126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399123297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856573,0.00018335313,0.00010413496,0.000027096585,0.000009565996,0.000055808203,0.0007963362,0.0000024326346,0.00025554304],"genre_scores_gemma":[0.9984303,0.00013969722,0.00015437744,0.000060770864,0.000024248851,0.000087114364,0.00079284346,0.0000024223668,0.00030810205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987122,0.00035498905,0.00014048601,0.0002919896,0.00026798612,0.00023232444],"domain_scores_gemma":[0.997995,0.0002809172,0.00079364097,0.0002429754,0.00024334273,0.00044414692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001555396,0.0003528582,0.00055962027,0.0008175814,0.00087942777,0.00067007873,0.00040754804,0.0005841244,0.0023858198],"category_scores_gemma":[0.0025652898,0.0005490918,0.00065507705,0.0013252881,0.000283355,0.0007553473,0.0005530308,0.0008343808,0.0004754197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021037883,0.000117183605,0.9987627,0.00001261231,0.00007015126,0.00008093912,0.00008297486,0.0000070757887,0.00013497518,0.000010375583,0.000075043296,0.00043560544],"study_design_scores_gemma":[0.000037082653,0.00065500924,0.99836284,0.00000863764,0.00003897746,0.00039066607,0.00021978238,0.000052308344,0.000025046384,0.000011976667,0.00019248587,0.0000050954013],"about_ca_topic_score_codex":0.005089421,"about_ca_topic_score_gemma":0.0059046173,"teacher_disagreement_score":0.005089421,"about_ca_system_score_codex":0.0002642454,"about_ca_system_score_gemma":0.0005640758,"threshold_uncertainty_score":0.010119617},"labels":[],"label_agreement":null},{"id":"W4399327477","doi":"10.1080/03007995.2024.2363945","title":"Medical cannabis and its efficacy/effectiveness on the management of osteoarthritis pain and function","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute on Disability, Independent Living, and Rehabilitation Research; Northwestern University","keywords":"Medicine; Osteoarthritis; Cannabis; Medical prescription; Medical cannabis; Physical therapy; Opioid; Pain management; Alternative medicine; Psychiatry; Internal medicine; Pharmacology","score_opus":0.10707905605491527,"score_gpt":0.45743100656459956,"score_spread":0.35035195050968426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399327477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015885156,0.99584323,0.000090892005,0.00057495007,0.00016547639,0.00046410522,0.0004645104,0.000007725997,0.0008006194],"genre_scores_gemma":[0.030261703,0.9667575,0.00069331186,0.0008322655,0.00018666465,0.0007379957,0.00027675842,0.000006335528,0.000247348],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98979706,0.004469886,0.0031324036,0.0005164822,0.0017996049,0.00028456916],"domain_scores_gemma":[0.9669566,0.024805631,0.0057924674,0.00028202217,0.0018839942,0.0002792889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009431187,0.0009440409,0.006444117,0.006653764,0.0007219043,0.0031547153,0.0013967914,0.0024969843,0.009262774],"category_scores_gemma":[0.053276535,0.00075695023,0.007420663,0.0050054397,0.0010563914,0.0017023578,0.0014274816,0.0014639393,0.00045270257],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037416015,0.000023392928,0.0005872085,0.9496509,0.0077364454,0.00004828778,0.00014342634,0.00005891754,0.000098100005,0.00034499174,0.0016033015,0.03933089],"study_design_scores_gemma":[0.0006556579,0.0003491307,0.005539146,0.91253,0.06324662,0.00023979126,0.00025633324,0.00011295104,0.00019070043,0.00052406103,0.016319169,0.000036558344],"about_ca_topic_score_codex":0.00931237,"about_ca_topic_score_gemma":0.024183556,"teacher_disagreement_score":0.009431187,"about_ca_system_score_codex":0.003851152,"about_ca_system_score_gemma":0.010489923,"threshold_uncertainty_score":0.049877465},"labels":[],"label_agreement":null},{"id":"W4399458977","doi":"10.1080/03007995.2024.2366443","title":"Update on efficacy of the approved remdesivir regimen for treatment of COVID-19: a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; George & Fay Yee Centre for Healthcare Innovation","funders":"","keywords":"Medicine; Meta-analysis; Regimen; Randomized controlled trial; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Intensive care medicine; Internal medicine; Virology; Disease","score_opus":0.5002402108300233,"score_gpt":0.6203149645727072,"score_spread":0.12007475374268384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399458977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009097485,0.99656975,0.00064393366,0.0004806283,0.0002505648,0.00041155884,0.0004977343,0.000026183157,0.00020995075],"genre_scores_gemma":[0.041112904,0.949323,0.004440561,0.0020264708,0.0004988576,0.0014270397,0.00086605607,0.00004673174,0.0002583812],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97856987,0.009587404,0.0072872406,0.0014865168,0.0026663574,0.0004025707],"domain_scores_gemma":[0.935889,0.046783637,0.00993373,0.0015737795,0.0053471797,0.00047265604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03388984,0.0029241922,0.020025777,0.0113944495,0.00059410266,0.0041810046,0.002748074,0.002366213,0.0042215753],"category_scores_gemma":[0.08261242,0.0018442386,0.032887552,0.0077531524,0.00094838097,0.0033498965,0.001919053,0.0025493877,0.00043898486],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010352111,0.000025712669,0.0011886504,0.74852735,0.21026006,0.00007707656,0.00009492422,0.0003775187,0.00018864797,0.0003717552,0.0017949832,0.036058173],"study_design_scores_gemma":[0.0011131269,0.00026953168,0.0026788777,0.18558565,0.7989191,0.00015464645,0.000060415165,0.00034278774,0.00018594669,0.0009461939,0.009691012,0.000052729578],"about_ca_topic_score_codex":0.0066137635,"about_ca_topic_score_gemma":0.015568177,"teacher_disagreement_score":0.03388984,"about_ca_system_score_codex":0.0045179604,"about_ca_system_score_gemma":0.008177976,"threshold_uncertainty_score":0.17922878},"labels":[],"label_agreement":null},{"id":"W4399531955","doi":"10.1080/03007995.2024.2360647","title":"Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; University of Ottawa; University Health Network; Brain and Cognition Discovery Foundation","funders":"Brain and Cognition Discovery Foundation","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Depressive symptoms; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Post-hoc analysis; Depression (economics); Association (psychology); Psychiatry; Internal medicine; Disease; Anxiety; Virology; Outbreak","score_opus":0.055173774999207524,"score_gpt":0.44765564981482914,"score_spread":0.39248187481562163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399531955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815184,0.0001794796,0.0003123098,0.00002284673,0.000035593115,0.0002793614,0.0006828268,0.00001240441,0.00032343817],"genre_scores_gemma":[0.9972395,0.00005386602,0.0004701131,0.00004960771,0.000046315155,0.0005729283,0.0009557291,0.000007816809,0.00060399994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997663,0.0010635927,0.00019177726,0.00042855964,0.0003040375,0.000348986],"domain_scores_gemma":[0.9962446,0.001993211,0.0005411589,0.0004151636,0.00048401576,0.00032177567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028154831,0.0006177774,0.0013467041,0.00062796415,0.0003056358,0.00052293437,0.0005318545,0.0004899143,0.004002941],"category_scores_gemma":[0.0038794372,0.00025266685,0.0023337565,0.0004265855,0.00032350866,0.0005450444,0.00053929404,0.00074481854,0.00032695592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15884466,0.005823288,0.7918894,0.00065461936,0.0074371607,0.00045590772,0.0005255266,0.0008517587,0.008524153,0.00016498756,0.002805559,0.022022901],"study_design_scores_gemma":[0.0038517592,0.056218635,0.9312295,0.00002393719,0.002617749,0.00019516564,0.00031606542,0.0024756216,0.0019136153,0.00005463837,0.0010713146,0.000031981894],"about_ca_topic_score_codex":0.0014065559,"about_ca_topic_score_gemma":0.0015638801,"teacher_disagreement_score":0.004002941,"about_ca_system_score_codex":0.0004213748,"about_ca_system_score_gemma":0.0007044869,"threshold_uncertainty_score":0.014889896},"labels":[],"label_agreement":null},{"id":"W4400238199","doi":"10.1080/03007995.2024.2374510","title":"Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a <i>post-hoc</i> analysis","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Brain and Cognition Discovery Foundation","funders":"","keywords":"Anhedonia; Medicine; Psychosocial; Pleasure; Coronavirus disease 2019 (COVID-19); Post-hoc analysis; 2019-20 coronavirus outbreak; Post hoc; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Clinical psychology; Psychiatry; Internal medicine; Psychotherapist; Psychology; Schizophrenia (object-oriented programming); Virology; Disease","score_opus":0.10443084912476105,"score_gpt":0.4860879345447012,"score_spread":0.38165708541994015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400238199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984368,0.0009810021,0.0037477873,0.00021269057,0.00036584274,0.0044398946,0.003372825,0.00017874186,0.0023330715],"genre_scores_gemma":[0.98095006,0.0001942816,0.0048519713,0.0002476383,0.0001293965,0.008272741,0.0025042924,0.00008223538,0.0027673119],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9889768,0.0066370573,0.0006678066,0.0014726949,0.0012974864,0.0009481964],"domain_scores_gemma":[0.9730006,0.020354252,0.0025234881,0.00188095,0.0014400894,0.00080053625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014458468,0.001394664,0.0031934544,0.0012423582,0.00043095293,0.00088450266,0.0014871166,0.001283025,0.012984459],"category_scores_gemma":[0.016357144,0.0004480644,0.00664245,0.000829675,0.0010285004,0.0012676385,0.0009921594,0.0023583635,0.0007560595],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65590525,0.01348751,0.19812465,0.004201355,0.061373457,0.0006627121,0.001046962,0.0045596343,0.012725801,0.0012405522,0.011126943,0.03554521],"study_design_scores_gemma":[0.034448933,0.25322485,0.62590855,0.0002664544,0.034976196,0.0004131027,0.00081658334,0.030782832,0.009242682,0.00087941776,0.008810442,0.00022993605],"about_ca_topic_score_codex":0.0013752249,"about_ca_topic_score_gemma":0.0013969503,"teacher_disagreement_score":0.014458468,"about_ca_system_score_codex":0.0011145168,"about_ca_system_score_gemma":0.0016224169,"threshold_uncertainty_score":0.07646459},"labels":[],"label_agreement":null},{"id":"W4400587954","doi":"10.1080/03007995.2024.2380006","title":"Use of telerehabilitation platforms for delivering patient education among patients with asthma: a scoping review","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Telerehabilitation; Asthma; Telemedicine; Physical therapy; Quality of life (healthcare); Telehealth; Intensive care medicine; Physical medicine and rehabilitation; Medical emergency; Health care; Nursing; Internal medicine","score_opus":0.15963977368541205,"score_gpt":0.48733094734846666,"score_spread":0.3276911736630546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400587954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000495501,0.9978745,0.00019425417,0.00030159616,0.00013302815,0.0002994064,0.00012140533,0.000006363848,0.00057396275],"genre_scores_gemma":[0.005308334,0.99279493,0.0006211545,0.0002931981,0.00008174867,0.0006779508,0.000118276585,0.0000047291774,0.000099711964],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9848408,0.0064888587,0.004696537,0.000937387,0.0026682133,0.00036818007],"domain_scores_gemma":[0.94661844,0.043155253,0.0055361227,0.000644529,0.0037759524,0.0002697194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018108316,0.0015046356,0.0046553467,0.012372161,0.0010802447,0.00413824,0.0021855722,0.0029663132,0.0046286634],"category_scores_gemma":[0.060582265,0.0010188124,0.0065802177,0.011813821,0.0009538953,0.0032721006,0.0021091506,0.0017271002,0.0005436422],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013039242,0.00005253299,0.00066209136,0.8240015,0.002670471,0.000079524,0.0005613151,0.00022440583,0.00016053769,0.00068603747,0.003022063,0.16774917],"study_design_scores_gemma":[0.000042950764,0.00010763922,0.0014745344,0.9681017,0.007934776,0.00016632566,0.00033731543,0.00008245433,0.0001573048,0.0001917823,0.021384541,0.00001874584],"about_ca_topic_score_codex":0.007145052,"about_ca_topic_score_gemma":0.012257654,"teacher_disagreement_score":0.018108316,"about_ca_system_score_codex":0.0039471798,"about_ca_system_score_gemma":0.013441547,"threshold_uncertainty_score":0.09576714},"labels":[],"label_agreement":null},{"id":"W4400813247","doi":"10.1080/03007995.2024.2378172","title":"Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Sanofi-Aventis Deutschland; Sanofi","keywords":"Fexofenadine; Medicine; Antihistamine; Sedation; Sedative; Histamine H1 receptor; Cetirizine; Pharmacology; Histamine H1 Antagonists; Terfenadine; Psychomotor learning; Histamine; Anesthesia; Cognition; Internal medicine; Receptor; Antagonist; Psychiatry","score_opus":0.14287436446427945,"score_gpt":0.47640026400199953,"score_spread":0.33352589953772005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400813247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003396013,0.9990396,0.000054001608,0.0002521273,0.0000877903,0.000048276488,0.00008034293,0.000002227427,0.00009598363],"genre_scores_gemma":[0.0059473002,0.9926789,0.00026737427,0.0007365222,0.00009425474,0.00011671063,0.000086847605,0.0000033211065,0.00006888193],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99657863,0.0008479047,0.0015264048,0.00032753203,0.0006129916,0.00010659269],"domain_scores_gemma":[0.9894521,0.006895897,0.0021250632,0.00014823857,0.0012462456,0.0001323533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041981894,0.0009637869,0.0069823847,0.0055113775,0.00046261374,0.002396992,0.0013597977,0.0020091103,0.003016075],"category_scores_gemma":[0.016305216,0.0007125112,0.004708169,0.0060113035,0.0008035635,0.0023154113,0.0009097418,0.0008411935,0.00026679947],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018311736,0.000013691874,0.00042832145,0.9358182,0.004544735,0.00012009828,0.00014704635,0.000064388594,0.0003120753,0.00030295472,0.002357276,0.05570805],"study_design_scores_gemma":[0.00029428484,0.00025518192,0.003228113,0.88145566,0.061505675,0.00082833396,0.00035151702,0.00010377549,0.0003239394,0.0006812364,0.050922416,0.0000497774],"about_ca_topic_score_codex":0.0056033586,"about_ca_topic_score_gemma":0.013855704,"teacher_disagreement_score":0.0069823847,"about_ca_system_score_codex":0.0018340129,"about_ca_system_score_gemma":0.0076657436,"threshold_uncertainty_score":0.022202432},"labels":[],"label_agreement":null},{"id":"W4401371156","doi":"10.1080/03007995.2024.2388839","title":"Comparison of real-world healthcare resource utilization among advanced therapy-naïve and advanced therapy-experienced patients with ulcerative colitis initiated on ustekinumab or vedolizumab","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vedolizumab; Medicine; Ustekinumab; Ulcerative colitis; Health care; Physical therapy; Internal medicine; Disease; Infliximab","score_opus":0.11734899045336464,"score_gpt":0.46125905180242377,"score_spread":0.3439100613490591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401371156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99672914,0.00088126934,0.00014226255,0.000078894154,0.0000062916733,0.000011323186,0.0017753735,0.0000032112696,0.00037231244],"genre_scores_gemma":[0.9981731,0.0002825761,0.0000975292,0.00003082403,0.000010034745,0.000012396254,0.0013491627,0.0000013199212,0.000043058975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976585,0.00097147754,0.0004379072,0.00038158134,0.00034113973,0.000209426],"domain_scores_gemma":[0.995548,0.0011958281,0.002659894,0.00014441439,0.00019121545,0.00026065708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015484308,0.00020642602,0.00041101172,0.0013235518,0.0001443588,0.0008363672,0.00042338684,0.0004369096,0.0009654661],"category_scores_gemma":[0.0051260632,0.00017035335,0.0009598086,0.0017227541,0.00022918044,0.00063715724,0.0006260343,0.00042048763,0.00010993296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023544923,0.000042545053,0.9965139,0.000039853418,0.0003732526,0.0000346346,0.000040042723,0.0005176868,0.00005900816,0.00007190019,0.00016333823,0.0019083632],"study_design_scores_gemma":[0.00001816192,0.00011897159,0.997088,0.000026132746,0.00007313373,0.00015546623,0.00023443556,0.001943844,0.000040911542,0.000044966793,0.00024780183,0.000008225848],"about_ca_topic_score_codex":0.007757875,"about_ca_topic_score_gemma":0.008773828,"teacher_disagreement_score":0.007757875,"about_ca_system_score_codex":0.0006601004,"about_ca_system_score_gemma":0.00041243486,"threshold_uncertainty_score":0.015425444},"labels":[],"label_agreement":null},{"id":"W4401520882","doi":"10.1080/03007995.2024.2391112","title":"Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2–4 prior lines of therapy: a matching-adjusted indirect comparison","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Medicine; Refractory (planetary science); Internal medicine; Multiple myeloma; Oncology; Surgery","score_opus":0.17942306898730398,"score_gpt":0.4459208483556996,"score_spread":0.26649777936839564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401520882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924091,0.0038318376,0.0011751719,0.00015725245,0.000098804405,0.00057142857,0.000519373,0.000025888188,0.0012110486],"genre_scores_gemma":[0.9977608,0.00046798095,0.00074242154,0.00009976797,0.000044539793,0.00030003654,0.00030091053,0.0000035017924,0.0002800638],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9948632,0.004003565,0.00022698184,0.00036015062,0.0003619547,0.00018417065],"domain_scores_gemma":[0.9962286,0.0021555338,0.0010091263,0.00024315213,0.00011431131,0.00024932265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052145794,0.0008693119,0.002089501,0.00055192737,0.00015117088,0.0007045674,0.00070392014,0.00080602407,0.0033507976],"category_scores_gemma":[0.00692499,0.00030813765,0.0037637558,0.00044119422,0.0005157664,0.0006110479,0.0007531472,0.0011570068,0.00023353832],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8841811,0.0022319613,0.026058141,0.0015818835,0.0223544,0.000059883125,0.00015463788,0.0058705118,0.0017756124,0.0004818118,0.00041244554,0.054837592],"study_design_scores_gemma":[0.27819568,0.5248392,0.13305125,0.0004466364,0.03152361,0.00038715935,0.0002792323,0.019924315,0.005033516,0.0020736887,0.004121441,0.0001242572],"about_ca_topic_score_codex":0.0007876888,"about_ca_topic_score_gemma":0.0009501138,"teacher_disagreement_score":0.0052145794,"about_ca_system_score_codex":0.00090656144,"about_ca_system_score_gemma":0.00055193575,"threshold_uncertainty_score":0.027577698},"labels":[],"label_agreement":null},{"id":"W4402169337","doi":"10.1080/03007995.2024.2391553","title":"Matching-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Dexamethasone; Multiple myeloma; Internal medicine; Propensity score matching; Refractory (planetary science); Oncology","score_opus":0.07985771078524738,"score_gpt":0.405961925221136,"score_spread":0.3261042144358886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402169337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667395,0.0060583637,0.0014486287,0.00024954815,0.00031493386,0.0013081674,0.001461575,0.000054386976,0.002430378],"genre_scores_gemma":[0.9960782,0.0004734706,0.0009187588,0.00024930952,0.00008844663,0.0007775347,0.00071648846,0.000009441381,0.0006883867],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945439,0.0038679775,0.00038334483,0.00048999954,0.0004109953,0.0003037374],"domain_scores_gemma":[0.99680614,0.00136643,0.0010258164,0.00036618422,0.00018294071,0.00025247093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005018735,0.0011093983,0.0024109043,0.0004472534,0.00024751166,0.0009826374,0.0009900725,0.00083739747,0.0056439554],"category_scores_gemma":[0.0074761673,0.00039292907,0.0049122046,0.0005046728,0.00049817364,0.00068341446,0.0010011104,0.001797692,0.00036973148],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93429065,0.0017369997,0.009415307,0.0012218704,0.024932697,0.000037908783,0.00009098824,0.002792506,0.0013399753,0.00040491138,0.00063199294,0.02310433],"study_design_scores_gemma":[0.47765574,0.3641368,0.079354405,0.00036000228,0.05217583,0.00026765236,0.00023007834,0.01336175,0.0035545018,0.0023378849,0.006432438,0.00013291124],"about_ca_topic_score_codex":0.0012026677,"about_ca_topic_score_gemma":0.001673965,"teacher_disagreement_score":0.0056439554,"about_ca_system_score_codex":0.001119277,"about_ca_system_score_gemma":0.000854736,"threshold_uncertainty_score":0.026541948},"labels":[],"label_agreement":null},{"id":"W4402274480","doi":"10.1080/03007995.2024.2401632","title":"A systematic review and meta-analysis evaluating the association of high sensitivity troponin levels with outcomes in patients with stable coronary artery disease","year":2024,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Acute Myocardial Infarction Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Coronary artery disease; Meta-analysis; Internal medicine; Cardiology; Troponin; Myocardial infarction","score_opus":0.23309387247825514,"score_gpt":0.4991350349256298,"score_spread":0.26604116244737464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402274480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004375515,0.99313736,0.0007076409,0.00021897214,0.00016142453,0.00045179704,0.0006742856,0.000025055206,0.00024806598],"genre_scores_gemma":[0.14267482,0.8491944,0.003511221,0.0009356959,0.0002851173,0.0020295011,0.0010221408,0.000029618104,0.00031743528],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98892444,0.005317736,0.0032438382,0.0010718396,0.0011257378,0.00031644184],"domain_scores_gemma":[0.9792029,0.01589697,0.002840973,0.00052435015,0.0013183695,0.00021643993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015279987,0.0028861854,0.01953604,0.008970944,0.0007907429,0.0035654674,0.0020074197,0.0022523392,0.0033338147],"category_scores_gemma":[0.038951233,0.0013341302,0.032776218,0.009144166,0.00076442823,0.0018087245,0.0014405444,0.0014560873,0.00028493843],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012237572,0.000030015553,0.003866974,0.4590852,0.5220971,0.00016962209,0.00009169819,0.00061128015,0.00022191207,0.00015672047,0.00061834947,0.011827387],"study_design_scores_gemma":[0.0003314031,0.00014722258,0.0025863477,0.027556153,0.9674607,0.00009619863,0.000034145905,0.00015754615,0.00007435548,0.0001694145,0.0013696556,0.00001687042],"about_ca_topic_score_codex":0.007192215,"about_ca_topic_score_gemma":0.016429974,"teacher_disagreement_score":0.01953604,"about_ca_system_score_codex":0.002910642,"about_ca_system_score_gemma":0.0054167067,"threshold_uncertainty_score":0.080809295},"labels":[],"label_agreement":null},{"id":"W4403042441","doi":"10.1080/03007995.2024.2408464","title":"Letter to Editor regarding: “Between human and AI: methodological issues on reliability, effectiveness and accuracy to avoid misinterpretation” by Semeraro et al.","year":2024,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reliability (semiconductor); Medical physics","score_opus":0.4292428938627757,"score_gpt":0.6237447560590911,"score_spread":0.19450186219631538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403042441","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017509928,0.00088753604,0.00009243342,0.95185506,0.046101436,0.00001103143,0.000057319758,0.00003068767,0.0007894872],"genre_scores_gemma":[0.0025511212,0.0013237138,0.00023248245,0.9064899,0.08579079,0.00004423713,0.00004092569,0.000038693495,0.0034881302],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956115,0.0013715458,0.0006591527,0.0006136314,0.0013807365,0.00036336455],"domain_scores_gemma":[0.97475713,0.013123696,0.0015670089,0.0005579145,0.00819716,0.0017971817],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054936702,0.00080465886,0.001583302,0.0008170455,0.0028847177,0.0037345102,0.0022721144,0.030092215,0.007581861],"category_scores_gemma":[0.06151856,0.00072658755,0.0010519515,0.0006960728,0.0023847327,0.004030462,0.00096176163,0.029457,0.009855849],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026526142,0.0000075161342,0.00014664805,0.000036562815,0.0000060233415,0.0003974018,0.000046956135,0.000010983718,0.000032078733,0.00034945208,0.9964031,0.0025367585],"study_design_scores_gemma":[0.0001395292,0.00005822881,0.0010931315,0.0005963039,0.000045058518,0.004022864,0.00047224454,0.00037788032,0.000342753,0.004646704,0.988128,0.000077238175],"about_ca_topic_score_codex":0.0033124653,"about_ca_topic_score_gemma":0.004569045,"teacher_disagreement_score":0.99450636,"about_ca_system_score_codex":0.002996008,"about_ca_system_score_gemma":0.0042779404,"threshold_uncertainty_score":0.029053628},"labels":[],"label_agreement":null},{"id":"W4403072264","doi":"10.1080/03007995.2024.2393863","title":"Getting Help During Active Pain Crises in Sickle Cell Disease: Patient and Caregiver Perspectives in Canada","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Occupational and Environmental Medical Association of Canada","funders":"Pfizer Canada","keywords":"Medicine; Disease; Intensive care medicine; Physical therapy; Internal medicine","score_opus":0.03115207663068522,"score_gpt":0.3448050922203728,"score_spread":0.3136530155896876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403072264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94424677,0.008223496,0.000064912216,0.026449014,0.00028583396,0.00008904329,0.0008678345,0.000008730883,0.019764474],"genre_scores_gemma":[0.9827959,0.008256738,0.00013659036,0.0052892584,0.000053721393,0.00003070364,0.00024146278,0.00001165392,0.0031838922],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99797195,0.0005243034,0.00015899344,0.0000857473,0.000473094,0.00078587036],"domain_scores_gemma":[0.990928,0.0015612656,0.0010361215,0.00006592628,0.0027825602,0.0036260325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001730844,0.00016010249,0.00045737956,0.0008173115,0.009866039,0.0035002204,0.00073215546,0.0008870735,0.006051963],"category_scores_gemma":[0.009732602,0.00026875123,0.00028401305,0.0030492248,0.0014903452,0.0013908871,0.0021733989,0.001937067,0.00027792205],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003950981,0.00024270483,0.2085499,0.001045316,0.000046410594,0.0052030296,0.67936295,0.00012445291,0.00061209226,0.0024185178,0.04282151,0.05917794],"study_design_scores_gemma":[0.00003116469,0.00012090825,0.14942737,0.0011565082,0.000024262894,0.0011162426,0.7948066,0.0001474837,0.000102294194,0.00023119546,0.05274295,0.0000930239],"about_ca_topic_score_codex":0.916368,"about_ca_topic_score_gemma":0.96359324,"teacher_disagreement_score":0.08363199,"about_ca_system_score_codex":0.030023228,"about_ca_system_score_gemma":0.052783597,"threshold_uncertainty_score":0.21783483},"labels":[],"label_agreement":null},{"id":"W4403231995","doi":"10.1080/03007995.2024.2409837","title":"Patient-reported outcomes in patients with relapsed or refractory follicular lymphoma treated with zanubrutinib plus obinutuzumab versus obinutuzumab monotherapy: results from the ROSEWOOD trial","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"BeiGene","keywords":"Medicine; Obinutuzumab; Internal medicine; Refractory (planetary science); Oncology; Follicular lymphoma; Lymphoma; Rituximab","score_opus":0.07134928530396044,"score_gpt":0.3822081702828955,"score_spread":0.31085888497893505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403231995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870652,0.0105999885,0.00015466726,0.00025910587,0.00005602745,0.00015951757,0.000554086,0.000015042771,0.0011364359],"genre_scores_gemma":[0.99561113,0.002075721,0.0002787447,0.00039686562,0.00013641053,0.00027419187,0.0008877368,0.0000043338364,0.00033494388],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99880517,0.0008118326,0.00007281132,0.00011118824,0.000119393415,0.000079559635],"domain_scores_gemma":[0.99908996,0.000327833,0.0003379782,0.00006079733,0.000049044633,0.00013435942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029545184,0.00040854348,0.0011600035,0.00016652126,0.000166383,0.0006324885,0.00045185428,0.00045624372,0.0010983523],"category_scores_gemma":[0.0020372237,0.00011865483,0.0011994118,0.00032712275,0.0003398672,0.00041478322,0.00026900836,0.0009880009,0.00016686856],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69793016,0.004609395,0.08928731,0.0023750744,0.010565348,0.00020069441,0.00032806906,0.0022787126,0.008047131,0.00042575545,0.0050304327,0.17892194],"study_design_scores_gemma":[0.39043918,0.18437165,0.38987285,0.0005612993,0.01414268,0.0007163616,0.0003079943,0.005089647,0.0029906514,0.00097541284,0.010420275,0.00011198109],"about_ca_topic_score_codex":0.000448891,"about_ca_topic_score_gemma":0.0011598842,"teacher_disagreement_score":0.0029545184,"about_ca_system_score_codex":0.00035405322,"about_ca_system_score_gemma":0.00031290774,"threshold_uncertainty_score":0.01562512},"labels":[],"label_agreement":null},{"id":"W4404144841","doi":"10.1080/03007995.2024.2418993","title":"Dapagliflozin or saxagliptin in pediatric type 2 diabetes: a plain language summary","year":2024,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Medicine; Dapagliflozin; Saxagliptin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Pediatrics; Endocrinology; Sitagliptin","score_opus":0.07953331488767264,"score_gpt":0.43195344674160274,"score_spread":0.3524201318539301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404144841","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026590466,0.5917018,0.0017302483,0.2810376,0.08904856,0.0011641202,0.0067446143,0.00028750478,0.025626466],"genre_scores_gemma":[0.016416775,0.56581193,0.004095213,0.22499865,0.14578976,0.0025144,0.0060109943,0.00017606297,0.034186214],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99682236,0.0013320757,0.0010009207,0.0001732,0.00050588226,0.0001656432],"domain_scores_gemma":[0.9743901,0.014776731,0.003962701,0.00034816857,0.0056944387,0.0008278792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005137634,0.0010177328,0.00284799,0.0018510796,0.0005488777,0.0038645838,0.001475532,0.0034162172,0.031782303],"category_scores_gemma":[0.020668939,0.0005195945,0.0020347193,0.0015945588,0.00077732303,0.0021656805,0.0008878079,0.0044996827,0.008211576],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015871878,0.00020433421,0.00053459627,0.019446595,0.00019860794,0.00023506436,0.00010477357,0.00019762717,0.0003955392,0.0014957597,0.7841023,0.1914976],"study_design_scores_gemma":[0.0011621024,0.0009908632,0.0036227133,0.0386074,0.00064409286,0.00048221854,0.00022454704,0.0001872384,0.00041942913,0.0016257674,0.9519672,0.000066368135],"about_ca_topic_score_codex":0.002769539,"about_ca_topic_score_gemma":0.0025345061,"teacher_disagreement_score":0.031782303,"about_ca_system_score_codex":0.0016922035,"about_ca_system_score_gemma":0.0033995626,"threshold_uncertainty_score":0.10632241},"labels":[],"label_agreement":null},{"id":"W4406034549","doi":"10.1080/03007995.2024.2440059","title":"Effects of brexpiprazole on patient life engagement in schizophrenia: <i>post hoc</i> analysis of Positive and Negative Syndrome Scale data","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"H. Lundbeck A/S","keywords":"Medicine; Positive and Negative Syndrome Scale; Post-hoc analysis; Schizophrenia (object-oriented programming); Post hoc; Psychiatry; Negative symptom; Scale (ratio); Clinical psychology; Internal medicine; Psychosis","score_opus":0.0960438075940058,"score_gpt":0.4539796613723036,"score_spread":0.35793585377829784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406034549","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902624,0.0009582937,0.0017053148,0.00018544041,0.00013308898,0.0024591638,0.0025139006,0.00010090098,0.0016815554],"genre_scores_gemma":[0.9892854,0.0003225864,0.0025610614,0.0001984244,0.00008655699,0.0040422385,0.0021707593,0.00006438967,0.001268595],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98979235,0.0067125256,0.0008719001,0.0010147715,0.0008090487,0.0007994095],"domain_scores_gemma":[0.97978437,0.014204425,0.0027265418,0.0012694275,0.0014396965,0.0005755261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013455149,0.0012897784,0.003031728,0.00094601646,0.00046811247,0.0012008271,0.0008272424,0.00063857523,0.0045782146],"category_scores_gemma":[0.014109248,0.00047243657,0.0070959614,0.0007727006,0.0007392425,0.0010051697,0.0010061848,0.0016621927,0.00042220816],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82622534,0.00822873,0.06133791,0.002184784,0.027566094,0.00027523065,0.00055000396,0.0029896295,0.015227969,0.0002396583,0.003187562,0.051987067],"study_design_scores_gemma":[0.06780996,0.34952784,0.48692775,0.0002604952,0.055129692,0.00024188685,0.0006490199,0.012010689,0.020836117,0.0005191461,0.0058376016,0.0002498863],"about_ca_topic_score_codex":0.0017617381,"about_ca_topic_score_gemma":0.0028270225,"teacher_disagreement_score":0.013455149,"about_ca_system_score_codex":0.00093225174,"about_ca_system_score_gemma":0.0017921892,"threshold_uncertainty_score":0.07115847},"labels":[],"label_agreement":null},{"id":"W4406919465","doi":"10.1080/03007995.2025.2458538","title":"Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère; Queensway-Carleton Hospital; St. Joseph’s Healthcare Hamilton; St. Michael's Hospital; Western University; LMC Diabetes & Endocrinology (Canada); Queen's University; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk Canada; Eli Lilly Canada","keywords":"Medicine; Narrative review; Perioperative; Glucagon-like peptide 1 receptor; Intensive care medicine; Receptor; Agonist; Internal medicine; Anesthesia","score_opus":0.09666611352847027,"score_gpt":0.4688349465877436,"score_spread":0.37216883305927334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406919465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095331154,0.99826115,0.000095252544,0.0007772911,0.00019516594,0.0000175259,0.000056982677,0.0000047002954,0.00049662794],"genre_scores_gemma":[0.0007909574,0.9980387,0.0002544309,0.00051576283,0.00014652571,0.000020310521,0.000049953895,0.0000013700184,0.00018191629],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99931026,0.00016851244,0.00021212285,0.00008404704,0.00018636837,0.000038737206],"domain_scores_gemma":[0.99745065,0.0015782921,0.0005358642,0.000032504628,0.0003464001,0.000056237244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015460389,0.0008230131,0.0015109695,0.0029058175,0.00031066738,0.0014421599,0.000936306,0.0011473633,0.005114234],"category_scores_gemma":[0.0058115423,0.00031432166,0.0018675403,0.0024945757,0.000350219,0.0012974001,0.00074998406,0.0012070385,0.0009142482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016852531,0.000052793093,0.00038006986,0.2762827,0.0008654909,0.0002265847,0.0002347733,0.00032443917,0.00042452273,0.0034051116,0.04692753,0.6707075],"study_design_scores_gemma":[0.000080381695,0.00016108667,0.001602105,0.28960726,0.0036467027,0.0015321391,0.00025658746,0.00018865045,0.00027216075,0.002942696,0.69966435,0.000045959023],"about_ca_topic_score_codex":0.0019185288,"about_ca_topic_score_gemma":0.0044218996,"teacher_disagreement_score":0.005114234,"about_ca_system_score_codex":0.0008827935,"about_ca_system_score_gemma":0.0036762867,"threshold_uncertainty_score":0.017108798},"labels":[],"label_agreement":null},{"id":"W4406962517","doi":"10.1080/03007995.2025.2459784","title":"US general population food allergy treatment preferences: a discrete choice experiment","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Food allergy; Population; Allergy; Environmental health; Immunology","score_opus":0.3011725331382148,"score_gpt":0.4000065059508784,"score_spread":0.0988339728126636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406962517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99618524,0.000031351792,0.0011952659,0.0000919907,0.000024608891,0.001505866,0.00030976502,0.000014479506,0.0006414947],"genre_scores_gemma":[0.98283535,0.000082636354,0.008040201,0.0005529257,0.000043063435,0.0066900067,0.0004555054,0.000005342606,0.0012948655],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9932346,0.0053451853,0.00021574032,0.0004588499,0.0005031485,0.0002425423],"domain_scores_gemma":[0.9888186,0.008196717,0.0015250414,0.00066579157,0.00025397632,0.0005397756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011254687,0.000878784,0.00096476957,0.00036530953,0.00049842376,0.0009833163,0.0006065331,0.0013079696,0.004921095],"category_scores_gemma":[0.012104296,0.0006294352,0.00076934503,0.0004650807,0.0009231194,0.00072478846,0.00066943216,0.0014300832,0.0004275063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37317976,0.2880828,0.2046288,0.0011775433,0.0022814944,0.00043040243,0.0043458496,0.019519487,0.02302601,0.0059972494,0.004873349,0.07245727],"study_design_scores_gemma":[0.12272488,0.519611,0.18157364,0.00021100591,0.001860242,0.00044865362,0.002141622,0.14090188,0.008377825,0.013408718,0.008406791,0.00033373776],"about_ca_topic_score_codex":0.001576489,"about_ca_topic_score_gemma":0.0017978076,"teacher_disagreement_score":0.011254687,"about_ca_system_score_codex":0.0005997801,"about_ca_system_score_gemma":0.0008692188,"threshold_uncertainty_score":0.05952114},"labels":[],"label_agreement":null},{"id":"W4409033671","doi":"10.1080/03007995.2025.2476743","title":"Expert advice on helping people with obstructive sleep apnea and excessive daytime sleepiness: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Child Nutrition and Feeding Issues","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Jazz Pharmaceuticals","keywords":"Medicine; Obstructive sleep apnea; Advice (programming); Excessive daytime sleepiness; Sleep (system call); Daytime; Plain language; Sleep apnea; Physical therapy; Psychiatry; Sleep disorder; Anesthesia; Insomnia; Linguistics","score_opus":0.033556498537416025,"score_gpt":0.39812654675971754,"score_spread":0.3645700482223015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409033671","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063967407,0.013375908,0.018043885,0.82936525,0.03616198,0.007700395,0.0017874856,0.00092027936,0.08624815],"genre_scores_gemma":[0.09266878,0.05942418,0.12492036,0.58415174,0.021229787,0.023917582,0.0030846884,0.00065675244,0.089946225],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95542,0.03248322,0.0042756777,0.0008759816,0.005072199,0.0018728622],"domain_scores_gemma":[0.89493275,0.05259737,0.0038128442,0.0017967694,0.039974406,0.006885872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04377675,0.0015708661,0.0009871502,0.002143243,0.00304516,0.0031006902,0.002021882,0.007419033,0.054098625],"category_scores_gemma":[0.11012619,0.00083583663,0.0017287905,0.0012901014,0.0018728032,0.007182313,0.005449859,0.0057560587,0.02247774],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056307574,0.000111461995,0.00054692064,0.0020321761,0.000015436988,0.00043149487,0.006408928,0.00010701709,0.00034386583,0.00089084776,0.9206626,0.06839295],"study_design_scores_gemma":[0.00014729462,0.00027337196,0.0020829567,0.012864259,0.000051330942,0.0014193399,0.032014884,0.00036094154,0.00036158337,0.0057543716,0.94451785,0.00015172522],"about_ca_topic_score_codex":0.003304545,"about_ca_topic_score_gemma":0.005564637,"teacher_disagreement_score":0.054098625,"about_ca_system_score_codex":0.001957207,"about_ca_system_score_gemma":0.009434667,"threshold_uncertainty_score":0.23151636},"labels":[],"label_agreement":null},{"id":"W4409117945","doi":"10.1080/03007995.2025.2488948","title":"Response to “Frontiers in bibliometric analysis: the overrepresentation of bibliometric analyses in grey publisher journals”","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Medicine; Bibliometrics; Grey literature; Library science; MEDLINE; Computer science","score_opus":0.7187109624252355,"score_gpt":0.6964715231902021,"score_spread":0.022239439235033354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409117945","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034462393,0.0006369648,0.0001453526,0.9570351,0.041062064,0.00001914915,0.00027796178,0.00008695771,0.00039185176],"genre_scores_gemma":[0.002314574,0.000743619,0.00024244447,0.9618499,0.032410562,0.00005758374,0.00012496478,0.000055798344,0.0022003914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918799,0.0018884159,0.0015970661,0.00088815927,0.0028961662,0.000850242],"domain_scores_gemma":[0.9288196,0.03446596,0.006592135,0.0012996049,0.023204425,0.0056183212],"candidate_categories":["bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.009897895,0.0011919735,0.0017684663,0.0019989507,0.0033538071,0.0048890044,0.0027168945,0.030774953,0.011717716],"category_scores_gemma":[0.10360072,0.0008584437,0.0018252468,0.0027471401,0.003074389,0.0034975787,0.003388986,0.030162062,0.009790147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046433808,0.000009895421,0.0003809241,0.000084877145,0.000015444413,0.00020923879,0.00011760863,0.000023804394,0.00012796099,0.00028462635,0.99595994,0.0027392474],"study_design_scores_gemma":[0.0001270778,0.00012054707,0.005265124,0.0008511377,0.000077246346,0.0015805942,0.0015355072,0.00048728305,0.00096645835,0.0022527743,0.9865442,0.00019214085],"about_ca_topic_score_codex":0.0059855822,"about_ca_topic_score_gemma":0.0054011205,"teacher_disagreement_score":0.99800104,"about_ca_system_score_codex":0.005059415,"about_ca_system_score_gemma":0.0057714074,"threshold_uncertainty_score":0.052345753},"labels":[],"label_agreement":null},{"id":"W4409209288","doi":"10.1080/03007995.2025.2488951","title":"Letter to the editor: author response for “why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review”","year":2025,"lang":"en","type":"letter","venue":"Current Medical Research and Opinion","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Fexofenadine; Antihistamine; Terfenadine; Pharmacology","score_opus":0.07809174928061956,"score_gpt":0.4191702298417136,"score_spread":0.341078480561094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409209288","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013286665,0.0015351542,0.000074983516,0.953621,0.043984696,0.000018441333,0.0001865079,0.00003227856,0.00041411154],"genre_scores_gemma":[0.0014984607,0.0015039913,0.00015781165,0.936665,0.057982806,0.00006742002,0.000063624204,0.00002847576,0.0020324322],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9931156,0.0025178064,0.0012651322,0.00080744294,0.0017568021,0.00053728034],"domain_scores_gemma":[0.9600007,0.017946247,0.0039920984,0.0006308942,0.014374686,0.0030554046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009594936,0.0010038122,0.0026814458,0.0013754271,0.0029081742,0.0039261323,0.0024203784,0.026218995,0.010909575],"category_scores_gemma":[0.09161085,0.0010925839,0.002176434,0.0012907904,0.0017939712,0.0037103011,0.0015331206,0.024738923,0.0083565805],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038844584,0.0000057158177,0.00015600998,0.00013353761,0.00002107718,0.00024037917,0.000042558073,0.000016280443,0.00002535698,0.00017411807,0.9974675,0.0016785893],"study_design_scores_gemma":[0.0004883403,0.00012949196,0.0017620064,0.0025128603,0.000245956,0.003242059,0.0005363299,0.00042464453,0.00039363944,0.0042630676,0.98583466,0.00016690313],"about_ca_topic_score_codex":0.006167609,"about_ca_topic_score_gemma":0.007994643,"teacher_disagreement_score":0.026218995,"about_ca_system_score_codex":0.004086301,"about_ca_system_score_gemma":0.0092421165,"threshold_uncertainty_score":0.05074346},"labels":[],"label_agreement":null},{"id":"W4409643669","doi":"10.1080/03007995.2025.2495171","title":"Association of OFF period characteristics with patient communication behaviors in Parkinson’s disease","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Parkinson's disease; Association (psychology); Disease; Period (music); Internal medicine; Gerontology","score_opus":0.03760859820761235,"score_gpt":0.385980931094842,"score_spread":0.34837233288722963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409643669","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930596,0.00014595802,0.000041052397,0.000028960152,0.0000022106549,0.000005552347,0.00018188969,0.0000018299119,0.0002865609],"genre_scores_gemma":[0.9995009,0.000088918285,0.0000821716,0.000012529847,0.0000058042583,0.000007624884,0.00021163182,0.000001019005,0.00008936238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991559,0.00030444597,0.00016872004,0.000105891886,0.00018035693,0.00008471059],"domain_scores_gemma":[0.99264985,0.001663391,0.0048288875,0.00017375234,0.00034212248,0.00034193593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010816354,0.00022330244,0.0002305408,0.00073012855,0.0003062676,0.0005843444,0.00021260843,0.0003476647,0.0015115947],"category_scores_gemma":[0.0057357126,0.00014286018,0.00033067467,0.0007702088,0.0001773429,0.00045188426,0.0005510161,0.0004713134,0.00012915618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052675583,0.000026211666,0.998741,0.000011413241,0.000017920427,0.000038100992,0.00007627691,0.000016472253,0.000050761493,0.0000037289672,0.000026029024,0.0009393927],"study_design_scores_gemma":[0.0000019497418,0.00010913014,0.9992481,0.00000825977,0.000011583914,0.0002412655,0.00017961556,0.000095751115,0.000027675751,0.000007680479,0.000066810506,0.0000020966704],"about_ca_topic_score_codex":0.0018459819,"about_ca_topic_score_gemma":0.00220073,"teacher_disagreement_score":0.0018459819,"about_ca_system_score_codex":0.00022936954,"about_ca_system_score_gemma":0.00023079239,"threshold_uncertainty_score":0.0057202578},"labels":[],"label_agreement":null},{"id":"W4410395778","doi":"10.1080/03007995.2025.2503976","title":"Functional improvement as a treatment goal in major depressive disorder: a narrative review of the evidence for vortioxetine","year":2025,"lang":"en","type":"review","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Grey Nuns Community Hospital","funders":"H. Lundbeck A/S","keywords":"Vortioxetine; Medicine; Narrative review; Major depressive disorder; Psychotherapist; Psychiatry; Clinical psychology; Intensive care medicine; Mood","score_opus":0.19688177402998905,"score_gpt":0.5313244995851152,"score_spread":0.3344427255551261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410395778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018037646,0.9991592,0.000035054083,0.00029641396,0.00008119364,0.000028621853,0.000039279344,0.0000017160784,0.00017821518],"genre_scores_gemma":[0.0038456093,0.9950321,0.00026967563,0.00056116644,0.00009659717,0.00008021693,0.00004366613,0.0000016904735,0.00006931143],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971052,0.0012769853,0.0009555685,0.0001842083,0.0004126033,0.000065553584],"domain_scores_gemma":[0.98778194,0.009840228,0.001608843,0.00010343693,0.0005713027,0.00009414502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004505188,0.0008351404,0.0031580434,0.0033775868,0.0003568905,0.0024692793,0.0012039514,0.001495305,0.002422921],"category_scores_gemma":[0.016075933,0.00048444484,0.0028828036,0.0032012796,0.0006506931,0.0014795533,0.0007709688,0.001674935,0.00027804158],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005016513,0.00004335958,0.0003155837,0.74503696,0.0027106488,0.00016158076,0.00030626022,0.00021819009,0.00027920995,0.0015576407,0.0073729926,0.24149603],"study_design_scores_gemma":[0.00028674013,0.00038434344,0.0018433369,0.8679055,0.011019309,0.00057929265,0.0004038928,0.00014180025,0.00021842997,0.0007650962,0.11641769,0.00003448511],"about_ca_topic_score_codex":0.002724213,"about_ca_topic_score_gemma":0.0071267644,"teacher_disagreement_score":0.004505188,"about_ca_system_score_codex":0.0015788309,"about_ca_system_score_gemma":0.0043815607,"threshold_uncertainty_score":0.023826003},"labels":[],"label_agreement":null},{"id":"W4410601738","doi":"10.1080/03007995.2025.2506808","title":"Patient-reported real-world experience of risankizumab on-body device (OBD) for the treatment of Crohn’s disease in the UK (COMMODUS)","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Medicine; Crohn's disease; Disease; Internal medicine; Gastroenterology","score_opus":0.06658225976352167,"score_gpt":0.4296402699105698,"score_spread":0.36305801014704814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410601738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99923277,0.00018468764,0.00004015171,0.000079800506,0.000003712468,0.000010977128,0.00010497375,0.0000027528379,0.00034020888],"genre_scores_gemma":[0.99950993,0.00009573713,0.00009497606,0.000073402385,0.0000054639677,0.000008384529,0.00008135735,0.0000011472786,0.00012949045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982249,0.0009756744,0.00024137569,0.00012196773,0.00026609655,0.00017000808],"domain_scores_gemma":[0.99176484,0.0020026432,0.004482772,0.0001728865,0.00059567427,0.0009812096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017814373,0.00017477598,0.00035399297,0.00031533677,0.00027728788,0.0008042101,0.00020048048,0.0006003876,0.002060696],"category_scores_gemma":[0.007782395,0.00016819619,0.00044716368,0.00028758083,0.00038217715,0.0006420017,0.00057196134,0.00057676126,0.00040436562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010807925,0.00045503015,0.9778797,0.00018362908,0.0002028785,0.00055790716,0.0041649034,0.0003272796,0.0009158799,0.000024413974,0.0005314456,0.013676042],"study_design_scores_gemma":[0.0000931705,0.0040615625,0.98602235,0.00007376786,0.00010334882,0.0027363815,0.004253369,0.0006978235,0.00039128095,0.000019417259,0.0014866292,0.00006077024],"about_ca_topic_score_codex":0.0010694329,"about_ca_topic_score_gemma":0.0015805704,"teacher_disagreement_score":0.002060696,"about_ca_system_score_codex":0.00031674115,"about_ca_system_score_gemma":0.00017262028,"threshold_uncertainty_score":0.009421229},"labels":[],"label_agreement":null},{"id":"W4411429725","doi":"10.1080/03007995.2025.2515280","title":"Real-world clinical outcomes of patients with moderate-to-severe rheumatoid arthritis initiating upadacitinib in the United Kingdom: final analysis from a prospective observational cohort study (ENDEAVOUR)","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Observational study; Internal medicine; Quality of life (healthcare); Clinical trial; Cohort; Physical therapy; Clinical endpoint; Outpatient clinic; Rheumatology; Cohort study","score_opus":0.16487967930514588,"score_gpt":0.46151269522096755,"score_spread":0.2966330159158217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411429725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99749315,0.000327403,0.00008552114,0.000033702345,0.000005152958,0.000036109992,0.0018621755,0.0000027691335,0.00015402102],"genre_scores_gemma":[0.9962745,0.00016078904,0.00011589267,0.000052956453,0.000010704289,0.000059195063,0.003210552,0.000003313859,0.00011207781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966601,0.0013708199,0.00053107535,0.0005921061,0.00045336867,0.00039249484],"domain_scores_gemma":[0.9891517,0.0015641251,0.0060647656,0.0010301594,0.001149239,0.0010400619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002910715,0.0006321182,0.00096647936,0.00077538105,0.0003855588,0.0012346567,0.00065061,0.0008039315,0.0015071981],"category_scores_gemma":[0.0069298977,0.0005192472,0.0014479437,0.0016673179,0.00044674551,0.00070963794,0.0016473164,0.0007925629,0.00048074772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094603305,0.000050752536,0.9970385,0.00006317653,0.00028161553,0.00010834149,0.00019605615,0.000056965884,0.00012653774,0.000011543768,0.00020782738,0.00091269537],"study_design_scores_gemma":[0.000071305156,0.00030172887,0.99883264,0.000026468773,0.00009044075,0.00018692849,0.00018769233,0.00008296136,0.000023355871,0.0000051736256,0.00018180803,0.000009500012],"about_ca_topic_score_codex":0.011668326,"about_ca_topic_score_gemma":0.014281893,"teacher_disagreement_score":0.011668326,"about_ca_system_score_codex":0.0009120913,"about_ca_system_score_gemma":0.00067912444,"threshold_uncertainty_score":0.02320081},"labels":[],"label_agreement":null},{"id":"W4412156752","doi":"10.1080/03007995.2025.2529991","title":"Why wastewater-based epidemiology must tackle noncommunicable diseases","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Scope (computer science); Global health; Health care; Epidemiological transition; Epidemiology; Developing country; Healthcare system; Disease; Disease burden; Environmental health; Economic growth; Risk analysis (engineering); Public health; Computer science; Pathology; Economics","score_opus":0.22785099741348938,"score_gpt":0.50564488386113,"score_spread":0.2777938864476407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412156752","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089078397,0.029029895,0.0053555667,0.9548724,0.0057592266,0.00003258952,0.00009558635,0.00010071236,0.003863112],"genre_scores_gemma":[0.09069099,0.12570335,0.0332608,0.71267223,0.028188257,0.00028801052,0.000347454,0.00032444025,0.008524478],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98087925,0.009792626,0.0013226824,0.0019819906,0.0045912717,0.0014321934],"domain_scores_gemma":[0.92887574,0.03730949,0.004177468,0.003379851,0.020042418,0.0062150806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03593175,0.0010923726,0.0018961122,0.0019405826,0.001977617,0.0126925865,0.0025478906,0.016572416,0.011783617],"category_scores_gemma":[0.08178589,0.00072403636,0.0015341472,0.0014024851,0.014111,0.022883475,0.0068491306,0.018124102,0.0062582786],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023127472,0.00037858041,0.011787864,0.004578345,0.00037032797,0.00051247014,0.002264736,0.0016926328,0.0019733023,0.15958832,0.53057593,0.28604615],"study_design_scores_gemma":[0.00013403178,0.00025265198,0.0054556127,0.0047961017,0.00014007858,0.00071395905,0.0066081095,0.0011593507,0.0010398851,0.3049592,0.6746025,0.00013853352],"about_ca_topic_score_codex":0.009139462,"about_ca_topic_score_gemma":0.009153279,"teacher_disagreement_score":0.03593175,"about_ca_system_score_codex":0.005848073,"about_ca_system_score_gemma":0.01887015,"threshold_uncertainty_score":0.19002753},"labels":[],"label_agreement":null},{"id":"W4412178851","doi":"10.1080/03007995.2025.2530736","title":"Impact of moderate-to-severe ulcerative colitis and Crohn’s disease on sexual activity: United States and European patient perspectives from the communicating needs and features of IBD experiences (CONFIDE) survey","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Crohn's disease; Inflammatory bowel disease; Disease; Family medicine; Dermatology; Internal medicine","score_opus":0.04442576170667768,"score_gpt":0.387553048967778,"score_spread":0.3431272872611003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412178851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952434,0.00056887866,0.000059979844,0.0007046678,0.000016784752,0.000029925453,0.0012823247,0.0000041823573,0.0020898439],"genre_scores_gemma":[0.99819344,0.0003959404,0.00015993719,0.00023698171,0.000014249036,0.000032679764,0.00078496384,0.0000017726373,0.00018006709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969278,0.0017885173,0.00045021073,0.00012236928,0.00044458173,0.00026654446],"domain_scores_gemma":[0.9922003,0.0022620352,0.0033743815,0.00018871325,0.00078463077,0.0011899438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003751261,0.00016865275,0.0003615854,0.0008378357,0.00042033734,0.00083299814,0.00021949122,0.00046259476,0.0014560235],"category_scores_gemma":[0.008387462,0.0001408941,0.0007217588,0.0011053024,0.000342658,0.0007090633,0.0013539838,0.0006609389,0.0001385752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014128812,0.00008213809,0.98520803,0.00011103399,0.00013327002,0.000098377415,0.0026242097,0.00009108833,0.00012187013,0.00005986402,0.0012233201,0.010105538],"study_design_scores_gemma":[0.000012761386,0.00018687913,0.9922693,0.000086191416,0.000036344274,0.00026549713,0.0051708417,0.00012039766,0.00007457083,0.00003336468,0.0017293313,0.000014392977],"about_ca_topic_score_codex":0.0029032005,"about_ca_topic_score_gemma":0.006253675,"teacher_disagreement_score":0.003751261,"about_ca_system_score_codex":0.00036574932,"about_ca_system_score_gemma":0.0004331116,"threshold_uncertainty_score":0.01983881},"labels":[],"label_agreement":null},{"id":"W4412522050","doi":"10.1080/03007995.2025.2536607","title":"Diagnostic accuracy of cardiovascular and imaging biomarkers to identify index patients with familial hypercholesterolaemia","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Internal medicine; Cohort; Intima-media thickness; Population; Cardiology; Carotid arteries","score_opus":0.03401270397466517,"score_gpt":0.40080789210865436,"score_spread":0.3667951881339892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412522050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956713,0.0013008186,0.00056381925,0.00016368582,0.00003489805,0.000029974488,0.00030989325,0.000025975663,0.0018997261],"genre_scores_gemma":[0.99896145,0.00014923551,0.00038448907,0.00005219744,0.000036407175,0.0000117424015,0.00024594524,0.0000027500648,0.00015573025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880457,0.00040198685,0.00018327145,0.00023951754,0.00025852615,0.00011221017],"domain_scores_gemma":[0.9956376,0.0016488715,0.0011299838,0.00041211565,0.00064069673,0.0005307026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019427625,0.00064402464,0.00073587365,0.0011990914,0.00033619473,0.001045615,0.000471563,0.0009856584,0.0010056391],"category_scores_gemma":[0.012002826,0.00028379433,0.0005186452,0.00044329115,0.00027865806,0.00045250452,0.0005186858,0.0005539981,0.00044749948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023543951,0.000021053953,0.9969842,0.000008341937,0.000044630935,0.000049857637,0.00002763344,0.000049985654,0.00023754987,0.000011481953,0.000090185,0.002239558],"study_design_scores_gemma":[0.000031703436,0.00020227107,0.9966055,0.000017323624,0.000091589194,0.00063367665,0.00006098776,0.0017879996,0.00024822837,0.00007466407,0.00023966169,0.000006482737],"about_ca_topic_score_codex":0.0015759006,"about_ca_topic_score_gemma":0.0021541181,"teacher_disagreement_score":0.0019427625,"about_ca_system_score_codex":0.00028561623,"about_ca_system_score_gemma":0.00019308168,"threshold_uncertainty_score":0.01027447},"labels":[],"label_agreement":null},{"id":"W4412636315","doi":"10.1080/03007995.2025.2537898","title":"Development and validation of patient-reported outcome measures for platysma prominence","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AbbVie Canada; Allergan","keywords":"Medicine; Outcome (game theory); Patient-reported outcome; Physical medicine and rehabilitation; Quality of life (healthcare)","score_opus":0.22141489727314584,"score_gpt":0.48248296953270764,"score_spread":0.2610680722595618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412636315","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7987131,0.0037618517,0.1015986,0.0020026895,0.0006314337,0.06414131,0.010024556,0.00050375727,0.01862274],"genre_scores_gemma":[0.7326202,0.0016633901,0.16326883,0.00096105615,0.00019018872,0.09228753,0.0068107545,0.00013213584,0.0020659277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9655915,0.016860083,0.005484444,0.0017050788,0.0097089065,0.00065003574],"domain_scores_gemma":[0.92822534,0.027032396,0.015761133,0.003617794,0.024341252,0.0010222048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.056829926,0.00088085176,0.0009045127,0.00221757,0.00083467894,0.001629478,0.0014629685,0.0010353655,0.0021479474],"category_scores_gemma":[0.07311478,0.00047830044,0.0021631832,0.0013511569,0.0008256316,0.0012229629,0.0015962876,0.0017202876,0.00081573124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049377745,0.006248769,0.50014096,0.004114308,0.0014076226,0.00020390037,0.005461515,0.003675729,0.0073885303,0.003983013,0.014677695,0.44776028],"study_design_scores_gemma":[0.0016583867,0.012726199,0.92504454,0.0019163464,0.0009168422,0.0007779509,0.0027539295,0.01090657,0.009570581,0.0033592405,0.030106505,0.00026291236],"about_ca_topic_score_codex":0.0006962055,"about_ca_topic_score_gemma":0.001957944,"teacher_disagreement_score":0.056829926,"about_ca_system_score_codex":0.0011739212,"about_ca_system_score_gemma":0.0033168113,"threshold_uncertainty_score":0.30054897},"labels":[],"label_agreement":null},{"id":"W4413100043","doi":"10.1080/03007995.2025.2544596","title":"Patient preferences for food allergy treatments in the United States: a discrete choice experiment","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"Genentech; National Institutes of Health; Food Allergy Research and Education","keywords":"Medicine; Confidence interval; Odds ratio; Food allergy; Allergy; Logistic regression; Relative risk; Anaphylaxis; Odds; Demography; Internal medicine; Pediatrics; Immunology","score_opus":0.14009381977495514,"score_gpt":0.47220170540025347,"score_spread":0.33210788562529836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413100043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813086,0.000036056073,0.00053673534,0.0001502014,0.000018462364,0.00046105537,0.00014824298,0.000004934359,0.00051344733],"genre_scores_gemma":[0.9956915,0.000070094924,0.0020756025,0.00030834918,0.000021736358,0.0013269885,0.0001368381,0.000001613236,0.00036729668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.991401,0.0069484734,0.0003507451,0.00044162234,0.0005843486,0.0002737617],"domain_scores_gemma":[0.97700965,0.017849302,0.0028396866,0.0008169649,0.00030970987,0.0011746347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013671378,0.00058935594,0.0007666444,0.00025078427,0.00050560787,0.001348255,0.00044423554,0.0010373845,0.0042307517],"category_scores_gemma":[0.01909183,0.000565346,0.0008087122,0.0002866698,0.0010537901,0.00083397934,0.00059352175,0.0014117615,0.00040809877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30864298,0.20183666,0.3765846,0.00077073957,0.0017355704,0.0004329733,0.006950228,0.01938443,0.013533733,0.0045803436,0.0034985072,0.06204924],"study_design_scores_gemma":[0.0726862,0.4923537,0.26421183,0.0003336345,0.0011544222,0.0005629942,0.005155051,0.13844727,0.008669995,0.00841547,0.0075558973,0.0004535361],"about_ca_topic_score_codex":0.00093748525,"about_ca_topic_score_gemma":0.0007737896,"teacher_disagreement_score":0.013671378,"about_ca_system_score_codex":0.00057933945,"about_ca_system_score_gemma":0.00090456917,"threshold_uncertainty_score":0.07230204},"labels":[],"label_agreement":null},{"id":"W4414011969","doi":"10.1080/03007995.2025.2552277","title":"Real world treatment patterns and unmet needs of migraine preventive treatments in Japan: JMDC claims analysis","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Amgen Astellas Biopharma; Eli Lilly Japan; Pfizer Japan; Eisai; Otsuka Pharmaceutical; Daiichi Sankyo Company; AbbVie Canada; Lundbeckfonden","keywords":"Medicine; Migraine; Alternative medicine; Migraine treatment; Intensive care medicine; Family medicine; Traditional medicine; Internal medicine; Pathology","score_opus":0.09211711857671473,"score_gpt":0.4799770714778839,"score_spread":0.38785995290116915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414011969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99551755,0.00024364873,0.00007581735,0.000086436805,0.0000038775097,0.000020864272,0.0037257106,0.000004191568,0.00032180652],"genre_scores_gemma":[0.9954567,0.00013969581,0.00014455615,0.000044183984,0.000011287742,0.000036269408,0.0040464033,0.0000023064936,0.00011851183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851865,0.00031082897,0.00047301652,0.00021667429,0.00028331135,0.00019752723],"domain_scores_gemma":[0.9942674,0.0004716245,0.0038042655,0.00026249918,0.0006875935,0.0005066767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014747229,0.00030385423,0.00042813396,0.0017154539,0.00043173952,0.0007938796,0.0004921535,0.00051459175,0.0011087877],"category_scores_gemma":[0.004099215,0.0003075266,0.0010118947,0.003060382,0.00026869078,0.0005236027,0.0008799135,0.0004929152,0.00022020518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006704834,0.000026490316,0.9986727,0.000025226518,0.00008638101,0.000030346946,0.00008008848,0.000055578774,0.00004134938,0.0000070762308,0.00014487482,0.0007628047],"study_design_scores_gemma":[0.000007810939,0.000035607245,0.99902546,0.000010844725,0.00004784278,0.0000753832,0.00023212333,0.0003829155,0.000017720597,0.0000059152107,0.00015358883,0.000004808083],"about_ca_topic_score_codex":0.032098483,"about_ca_topic_score_gemma":0.030401751,"teacher_disagreement_score":0.032098483,"about_ca_system_score_codex":0.0012320593,"about_ca_system_score_gemma":0.0009156849,"threshold_uncertainty_score":0.06382328},"labels":[],"label_agreement":null},{"id":"W4414036237","doi":"10.1080/03007995.2025.2558140","title":"Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada; University of Toronto; University of Calgary; Translational Research in Oncology; University of Alberta","funders":"","keywords":"Medicine; Major depressive disorder; Open label; Adjunctive treatment; Psychiatry; Internal medicine; Clinical trial; Mood","score_opus":0.12058437022977776,"score_gpt":0.5085594885769612,"score_spread":0.38797511834718346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414036237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950315,0.00045326713,0.0003183362,0.000082914055,0.000031981886,0.0025773114,0.0006613035,0.000049717484,0.0007937156],"genre_scores_gemma":[0.9886523,0.0006244583,0.0016220976,0.00034437192,0.00015372079,0.0063862717,0.0011086224,0.00001106701,0.0010970868],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99884194,0.00060564873,0.000095241994,0.00016247472,0.00016395749,0.0001307183],"domain_scores_gemma":[0.99847454,0.0003788009,0.0005404134,0.0001576788,0.00016154742,0.0002870122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026463768,0.0011371218,0.0019478598,0.00045742447,0.0004232367,0.0007958088,0.0007102509,0.00125427,0.0030806959],"category_scores_gemma":[0.0021522648,0.00048437284,0.0010290007,0.0004124294,0.00076649984,0.0010414682,0.00040637451,0.0018768883,0.00064296793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7538694,0.1285563,0.012871043,0.0012761394,0.0019544782,0.00017087856,0.00052876805,0.0006809482,0.023108464,0.00012507419,0.0013167408,0.07554181],"study_design_scores_gemma":[0.28491247,0.6690992,0.04068592,0.000052595173,0.0007398518,0.000113178,0.00010605911,0.0007367022,0.0021194846,0.000107415166,0.0012867989,0.00004031743],"about_ca_topic_score_codex":0.0003939656,"about_ca_topic_score_gemma":0.001053201,"teacher_disagreement_score":0.0030806959,"about_ca_system_score_codex":0.0005795849,"about_ca_system_score_gemma":0.000697779,"threshold_uncertainty_score":0.013995528},"labels":[],"label_agreement":null},{"id":"W4414159968","doi":"10.1080/03007995.2025.2556012","title":"Enhanced guidance on artificial intelligence for medical publication and communication professionals","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"WiLAN (Canada)","funders":"","keywords":"Transparency (behavior); Action (physics); Position paper; Value (mathematics); Work (physics); Field (mathematics); Health care; Applications of artificial intelligence","score_opus":0.42752275509540927,"score_gpt":0.6220029593459846,"score_spread":0.19448020425057533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414159968","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010708743,0.003986474,0.0017525997,0.96661067,0.01840283,0.000069593465,0.00003707466,0.00013881344,0.008894789],"genre_scores_gemma":[0.003954089,0.0037982953,0.0071567288,0.94283515,0.030022172,0.00026925525,0.000078318815,0.00021745497,0.011668485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7601939,0.13262808,0.031977054,0.011888948,0.054081578,0.009230459],"domain_scores_gemma":[0.3579323,0.4929992,0.023516892,0.023206089,0.082405336,0.019940168],"candidate_categories":["metaresearch","scholarly_communication"],"consensus_categories":[],"category_scores_codex":[0.13924657,0.0017645764,0.002330966,0.0043468145,0.012067324,0.029530035,0.007718446,0.09784941,0.020486087],"category_scores_gemma":[0.42450708,0.0021662237,0.0034541849,0.0029089248,0.023825543,0.03426053,0.017265402,0.072077654,0.02215123],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030671432,0.00003343349,0.00010020798,0.00036988908,0.000012441926,0.00025414457,0.0032077748,0.000084732106,0.00018201873,0.028844606,0.9448748,0.022005139],"study_design_scores_gemma":[0.000016922146,0.000014179762,0.000103866034,0.0009820212,0.000008020854,0.00017199216,0.0007825008,0.00008571788,0.00008932268,0.013769203,0.98393285,0.00004335859],"about_ca_topic_score_codex":0.006064356,"about_ca_topic_score_gemma":0.009851033,"teacher_disagreement_score":0.97046995,"about_ca_system_score_codex":0.010869279,"about_ca_system_score_gemma":0.043114144,"threshold_uncertainty_score":0.736415},"labels":[],"label_agreement":null},{"id":"W4414251322","doi":"10.1080/03007995.2025.2559871","title":"High-dose influenza vaccine for elderly: a closer look into the real-world data","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Vaccination; Influenza vaccine; Observational study; Vaccine efficacy; Age groups; Public health; Seasonal influenza; Live attenuated influenza vaccine","score_opus":0.2952574141746262,"score_gpt":0.5582042879172429,"score_spread":0.26294687374261666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414251322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00064341124,0.9938903,0.00013696846,0.004260121,0.00035305452,0.00002267351,0.0003698385,0.00000546094,0.0003182323],"genre_scores_gemma":[0.005121343,0.98916966,0.00057118724,0.0042577055,0.00037615976,0.00006728337,0.0003380516,0.000005515965,0.00009303134],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9957432,0.0018516773,0.001269392,0.00024681687,0.0007742196,0.000114698865],"domain_scores_gemma":[0.9719743,0.01955467,0.0036570793,0.0005266143,0.0039283894,0.00035896193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008131978,0.00051638426,0.002663578,0.002866458,0.00021220402,0.0016341739,0.0007673176,0.0014582507,0.002568502],"category_scores_gemma":[0.025813686,0.00042597778,0.0026634638,0.004055133,0.00037401073,0.0038367547,0.0007806088,0.0023829716,0.00043490794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006175639,0.0000994973,0.0070052543,0.33758366,0.0032835691,0.0003207967,0.00077613856,0.00062460284,0.0009008677,0.0033252686,0.06066982,0.584793],"study_design_scores_gemma":[0.0002453741,0.00068386283,0.03868132,0.33413613,0.0060591795,0.001122218,0.0010829401,0.00034204376,0.00022854602,0.0030831362,0.61423236,0.000102812955],"about_ca_topic_score_codex":0.0055014077,"about_ca_topic_score_gemma":0.010887739,"teacher_disagreement_score":0.008131978,"about_ca_system_score_codex":0.0012060599,"about_ca_system_score_gemma":0.003478239,"threshold_uncertainty_score":0.04300654},"labels":[],"label_agreement":null},{"id":"W4415029843","doi":"10.1080/03007995.2025.2573652","title":"Unlocking insights from mother-infant linked data in pharmacoepidemiology: opportunities, challenges, and future directions","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Institute for Clinical Evaluative Sciences; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Linkage (software); Linked data; SAFER; Identification (biology); Data quality; Health care; Record linkage","score_opus":0.40354280813984633,"score_gpt":0.5143832288103051,"score_spread":0.11084042067045874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415029843","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021678766,0.36621532,0.033019725,0.58239406,0.010445923,0.00024256858,0.0009110061,0.00010792482,0.004495658],"genre_scores_gemma":[0.06156531,0.6076867,0.07474662,0.21182643,0.039608937,0.0012935557,0.0009783509,0.00023070429,0.0020633736],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.87767553,0.09897354,0.0067461804,0.0045741415,0.01019624,0.0018343992],"domain_scores_gemma":[0.4041998,0.55162716,0.009116842,0.011782856,0.020493498,0.002779867],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16901489,0.0011611875,0.0036362873,0.006126456,0.0029336265,0.012332017,0.0048030904,0.009556221,0.00684345],"category_scores_gemma":[0.3275935,0.0010541445,0.0036828541,0.00784346,0.013036009,0.030963553,0.010002581,0.016786126,0.0010398751],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044845784,0.00014919134,0.00809352,0.033301,0.0013692715,0.0008271459,0.016496249,0.0021287492,0.00034307057,0.35249984,0.12575668,0.45858672],"study_design_scores_gemma":[0.000106672465,0.00014281692,0.0029633208,0.06798289,0.00061881647,0.0008373214,0.00914693,0.0022831932,0.000281973,0.45605257,0.45939994,0.0001835972],"about_ca_topic_score_codex":0.008646957,"about_ca_topic_score_gemma":0.01811475,"teacher_disagreement_score":0.8309851,"about_ca_system_score_codex":0.0075323586,"about_ca_system_score_gemma":0.030785266,"threshold_uncertainty_score":0.8938468},"labels":[],"label_agreement":null},{"id":"W4415267400","doi":"10.1080/03007995.2025.2573654","title":"Closing the loop in colorectal cancer screening: real-world adherence to follow-up colonoscopy after positive mt-sDNA vs FIT/FOBT, stratified by payer type","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Colonoscopy; Colorectal cancer; Closing (real estate); Loop (graph theory); Cancer; MEDLINE","score_opus":0.09587312390493323,"score_gpt":0.45968778223763185,"score_spread":0.3638146583326986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415267400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99842215,0.00032551447,0.0000711648,0.00015212869,0.0000084592175,0.000011241935,0.0007365887,0.0000030518247,0.00026965674],"genre_scores_gemma":[0.99927145,0.000075938384,0.000050485858,0.000045368106,0.0000120565865,0.000009619301,0.00047510717,0.0000011640725,0.000058829733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778324,0.0008142697,0.0003134298,0.0004354394,0.00032009883,0.00033359943],"domain_scores_gemma":[0.98788285,0.0018316164,0.008481109,0.00044807637,0.0003798965,0.00097652007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024637182,0.00017628717,0.00036476197,0.00090140855,0.00036841555,0.0009916896,0.00071145507,0.0008624171,0.0012674889],"category_scores_gemma":[0.010859399,0.00025746334,0.000888772,0.0017087489,0.00032345284,0.00081570674,0.0007254557,0.00079689967,0.00017717406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001269204,0.00003704894,0.99898785,0.0000069277316,0.000061981664,0.000012481136,0.000027928905,0.00004398546,0.0000151221375,0.00001161142,0.00006538738,0.0006027606],"study_design_scores_gemma":[0.0000066764846,0.00007963437,0.99924386,0.000009114687,0.00003022003,0.00005292922,0.0000992954,0.0003781195,0.000013437927,0.000020349693,0.00006304278,0.0000032618993],"about_ca_topic_score_codex":0.012976945,"about_ca_topic_score_gemma":0.012549989,"teacher_disagreement_score":0.012976945,"about_ca_system_score_codex":0.00058733777,"about_ca_system_score_gemma":0.00049341616,"threshold_uncertainty_score":0.025802791},"labels":[],"label_agreement":null},{"id":"W4415522922","doi":"10.1080/03007995.2025.2580036","title":"Profiles and diagnostic patterns of colorectal cancers among 602 patients attending a tertiary care center in Saudi Arabia for suspected colic disease","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Tertiary care; Disease; Center (category theory); Colorectal cancer; Cancer; Tertiary level","score_opus":0.02996666037109281,"score_gpt":0.3779224111454222,"score_spread":0.3479557507743294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415522922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994242,0.000113457994,0.000018403136,0.000033278266,0.0000017442135,0.0000049043147,0.00026424695,0.000001760709,0.0001379988],"genre_scores_gemma":[0.9995704,0.000070788876,0.000029033223,0.000023212693,0.0000032532153,0.000003548806,0.00024416888,5.1007254e-7,0.000055026798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997178,0.0000549793,0.000056229666,0.000053342173,0.00005462522,0.00006302951],"domain_scores_gemma":[0.99914634,0.00014121347,0.0004187488,0.000029437519,0.000104426,0.00015972035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023459457,0.0001863908,0.00020867148,0.0007645463,0.0003993844,0.00038358202,0.00025815627,0.00029509017,0.0017500144],"category_scores_gemma":[0.0012560012,0.00021386473,0.00015236842,0.0007813318,0.00025614217,0.00028399218,0.0003919618,0.00020750605,0.0002436086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016373247,0.0000064456553,0.9993293,0.000004867933,0.0000033668289,0.000102791055,0.000073443305,0.0000067233686,0.00010974855,0.0000027800893,0.000041290474,0.00030270487],"study_design_scores_gemma":[0.0000026456635,0.000049720173,0.9982951,0.0000076262677,0.000004885906,0.00080337207,0.0005803029,0.00008050409,0.000058564066,0.000004745519,0.000110552515,0.000002043352],"about_ca_topic_score_codex":0.010913934,"about_ca_topic_score_gemma":0.012697846,"teacher_disagreement_score":0.010913934,"about_ca_system_score_codex":0.00045964072,"about_ca_system_score_gemma":0.00035312236,"threshold_uncertainty_score":0.0217008},"labels":[],"label_agreement":null},{"id":"W4415952402","doi":"10.1080/03007995.2025.2583758","title":"Impact of increased patient out-of-pocket costs on oral anticoagulant discontinuation among Medicare beneficiaries with atrial fibrillation treated with apixaban","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Apixaban; Discontinuation; Oral anticoagulant; Atrial fibrillation; Formulary; Rivaroxaban; Warfarin; Stroke (engine)","score_opus":0.09397982059196973,"score_gpt":0.4422105197232904,"score_spread":0.34823069913132065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415952402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554294,0.0009728034,0.00011782023,0.0004358025,0.000017860983,0.000017773544,0.0020537192,0.000006176777,0.0008351423],"genre_scores_gemma":[0.9982462,0.00026678905,0.00008813465,0.00012635293,0.00004365741,0.000014239493,0.0010662996,0.0000026484622,0.00014561146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984195,0.00044064384,0.00022493977,0.00021497089,0.00036532574,0.0003346042],"domain_scores_gemma":[0.9904233,0.0013933366,0.00687272,0.00022736746,0.0004963878,0.00058693055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011629553,0.00027061228,0.0004480915,0.0007819284,0.0003944079,0.00096238544,0.00035425613,0.0004328363,0.002401193],"category_scores_gemma":[0.008437453,0.00022421595,0.0015952012,0.000883247,0.00019385312,0.0006093485,0.00080676284,0.001062063,0.00015148357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029598785,0.000056591965,0.99476814,0.000033681572,0.00024424994,0.00007215816,0.000032466713,0.00025595416,0.000056486606,0.000042715084,0.00035211598,0.0037894754],"study_design_scores_gemma":[0.000012780218,0.00006427532,0.99863005,0.000026072563,0.00006868007,0.00016047888,0.00005100025,0.0006290041,0.000026552896,0.000041323445,0.00028574836,0.000004201779],"about_ca_topic_score_codex":0.013972866,"about_ca_topic_score_gemma":0.017789029,"teacher_disagreement_score":0.013972866,"about_ca_system_score_codex":0.0011644912,"about_ca_system_score_gemma":0.0009586452,"threshold_uncertainty_score":0.027783096},"labels":[],"label_agreement":null},{"id":"W4416466577","doi":"10.1080/03007995.2025.2585558","title":"Understanding patient, caregiver, and prescriber preferences for an antipsychotic regimen administered once every 2 months for schizophrenia or bipolar I disorder: a qualitative interview study in North America","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"H. Lundbeck A/S; Otsuka Pharmaceutical","keywords":"Schizophrenia (object-oriented programming); Qualitative research; Antipsychotic; Regimen; Schizophrenia research; Bipolar disorder; Young adult","score_opus":0.37491160157817793,"score_gpt":0.5063250928710146,"score_spread":0.13141349129283664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416466577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873647,0.0011105023,0.0024130607,0.0043396996,0.00008735261,0.00025206315,0.0001805776,0.000015719548,0.004236394],"genre_scores_gemma":[0.9933756,0.001309807,0.0012523608,0.0015062651,0.000021630569,0.00042987568,0.0000970412,0.000025976196,0.0019813525],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9856214,0.011169926,0.00037042896,0.0005464111,0.00064350455,0.0016482532],"domain_scores_gemma":[0.97448707,0.019055383,0.0016114749,0.0003631996,0.002236327,0.0022464877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019991241,0.00076357165,0.0009157931,0.0018008308,0.012294849,0.004349387,0.0019293021,0.0018801186,0.0027628962],"category_scores_gemma":[0.026077878,0.0009265389,0.0006358075,0.0017277211,0.009369991,0.00502923,0.0060021784,0.0038220012,0.00029029782],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001670139,0.000013563869,0.0018785542,0.000048509828,0.000002196343,0.00028157426,0.9960524,0.00001533838,0.00021987829,0.0003581811,0.000188043,0.0009250069],"study_design_scores_gemma":[0.0000018913792,0.000011827244,0.0005395116,0.00006769598,0.000001512708,0.0000742309,0.9972262,0.000038419803,0.000056044446,0.00008564009,0.0018911981,0.0000057891657],"about_ca_topic_score_codex":0.04371959,"about_ca_topic_score_gemma":0.06275688,"teacher_disagreement_score":0.04371959,"about_ca_system_score_codex":0.011645752,"about_ca_system_score_gemma":0.0116176745,"threshold_uncertainty_score":0.10572499},"labels":[],"label_agreement":null},{"id":"W7127186683","doi":"10.1080/03007995.2026.2615874","title":"Community HERO treatment survey: US subanalysis of a global survey on the experiences of people with HIV","year":2025,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Gilead Sciences","keywords":"HERO; Human immunodeficiency virus (HIV); Alternative medicine; Health care; Qualitative research; Antiretroviral therapy","score_opus":0.16322829696107724,"score_gpt":0.4889261639739713,"score_spread":0.32569786701289405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7127186683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751887,0.0004846199,0.0005068606,0.00022458562,0.000021688253,0.0006637045,0.019379934,0.000018771281,0.0035111692],"genre_scores_gemma":[0.9816457,0.00042134413,0.0007840742,0.00035248074,0.000026326285,0.0015348082,0.014277561,0.000009376216,0.0009484869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847883,0.0007559079,0.00017655343,0.0001216885,0.00029354813,0.00017353315],"domain_scores_gemma":[0.99760014,0.00033244104,0.001062748,0.00017724778,0.0005077888,0.0003197094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015870482,0.00026987586,0.00026421543,0.0015327133,0.00059822184,0.0003728891,0.00037106551,0.000320131,0.0018450805],"category_scores_gemma":[0.0030346855,0.00022577103,0.00050149515,0.0034753776,0.00020539782,0.0006286001,0.001501745,0.0004700222,0.0003496012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007984387,0.000108917164,0.9897899,0.0001071664,0.00008796482,0.00003833323,0.0007337886,0.00004387041,0.00014702395,0.000035718334,0.0020770568,0.0067504747],"study_design_scores_gemma":[0.000011786252,0.000083921404,0.9968054,0.000033029963,0.000018024757,0.000061986255,0.0013756023,0.00006627823,0.000052171483,0.00001511961,0.0014729121,0.000003859497],"about_ca_topic_score_codex":0.012935983,"about_ca_topic_score_gemma":0.019529454,"teacher_disagreement_score":0.012935983,"about_ca_system_score_codex":0.00047774843,"about_ca_system_score_gemma":0.00069874024,"threshold_uncertainty_score":0.025721371},"labels":[],"label_agreement":null}]}